Archive BacDiveID:10.13145/bacdive12759.20230509.8.1

Strain identifier

BacDive ID: 12759

Type strain:

Species: Pseudomonas aeruginosa

Strain Designation: Boston 41501, 41501

Strain history: CIP <- 1976, ATCC <- 1976, A. Medeiros, Boston, USA: strain 41501

NCBI tax ID(s): 1236529 (strain), 287 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.

General

@ref: 565

BacDive-ID: 12759

DSM-Number: 1117

keywords: genome sequence, 16S sequence, Bacteria, aerobe, mesophilic, motile, antibiotic resistance, human pathogen

description: Pseudomonas aeruginosa Boston 41501 is an aerobe, mesophilic, motile human pathogen that has multiple antibiotic resistances and was isolated from blood culture.

NCBI tax id

NCBI tax id	Matching level
1236529	strain
287	species

strain history

@ref	history
565	<- ATCC; ATCC 27853 <- A. Madeiros; Boston 41501
67770	ATCC 27853 <-- A. A. Medeiros strain Boston 41501.
67772	ATCC <- A. Madeiros, Boston 41501
116094	CIP <- 1976, ATCC <- 1976, A. Medeiros, Boston, USA: strain 41501

doi: 10.13145/bacdive12759.20230509.8.1

Name and taxonomic classification

LPSN

@ref: 20215
description: domain/bacteria
keyword: phylum/pseudomonadota
domain: Bacteria
phylum: Pseudomonadota
class: Gammaproteobacteria
order: Pseudomonadales
family: Pseudomonadaceae
genus: Pseudomonas
species: Pseudomonas aeruginosa
full scientific name: Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980)
synonyms
- @ref: 20215
- synonym: Bacterium aeruginosum

@ref: 565

domain: Bacteria

phylum: Proteobacteria

class: Gammaproteobacteria

order: Pseudomonadales

family: Pseudomonadaceae

genus: Pseudomonas

species: Pseudomonas aeruginosa

full scientific name: Pseudomonas aeruginosa (Schroeter 1872) Migula 1900

strain designation: Boston 41501, 41501

type strain: no

Morphology

cell morphology

@ref	motility	confidence	gram stain	cell shape
69480	yes	99.117
69480		99.984	negative
116094	yes		negative	rod-shaped

colony morphology

@ref: 116094

pigmentation

@ref: 116094
production: yes
name: Pyocyanin

Culture and growth conditions

culture medium

@ref	name	growth	link	composition
565	COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)	yes	https://mediadive.dsmz.de/medium/693	Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
565	TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)	yes	https://mediadive.dsmz.de/medium/92	Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water
565	NUTRIENT AGAR (DSMZ Medium 1)	yes	https://mediadive.dsmz.de/medium/1	Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water
41849	MEDIUM 72- for trypto casein soja agar	yes		Distilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g)
116094	CIP Medium 72	yes	https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72
116094	CIP Medium 3	yes	https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=3

culture temp

@ref	growth	type	temperature	range
565	positive	growth	37	mesophilic
41849	positive	growth	30	mesophilic
46633	positive	growth	37	mesophilic
67770	positive	growth	37	mesophilic
67772	positive	optimum	37	mesophilic
116094	positive	growth	30-45
116094	no	growth	5	psychrophilic

Physiology and metabolism

oxygen tolerance

@ref	oxygen tolerance
46633	aerobe
116094	obligate aerobe

antibiogram

@ref	medium	incubation temperature	incubation time	oxygen condition	ticarcillin	mezlocillin	cefotaxime	aztreonam	imipenem	tetracycline	chloramphenicol	gentamycin	amikacin	erythromycin	ofloxacin	norfloxacin	colistin	pipemidic acid	polymyxin b	neomycin	doxycycline	ceftriaxone	clindamycin	fosfomycin	moxifloxacin	linezolid	nystatin	quinupristin/dalfopristin	teicoplanin	piperacillin/tazobactam
565	Mueller-Hinton Agar	37	1	aerob	30	20	22	30	24	14	0	22	26	8	20	30	14	12	16	12	10	24	0	34	24	0	0	0	0	28
565	Mueller-Hinton Agar	37	1	aerob	26	18	22	28	24	14	0	22	26	6-8	20	30	14	12-14	14	12	8-10	24	0	34	22	0	0	0	0	28
565	Mueller-Hinton Agar	37		aerob	24-26	18	22	28	24	16	6-8	24	28	10	20	30	16	12	16	14	10	24	0	34	24	0	0	0	0	26-28
565	Mueller-Hinton Agar	37		aerob	28	18	22	28-30	24	12	6	20-22	26	6-8	20	30	16	12	16	10	8-10	24	0	32-34	24	0	0	0	0	26-28
565	Mueller-Hinton Agar				26	20	22	28	26	16	8	22	26	0	20	30	14	12	16	14	10	24	0	34	22	0	0	0	0	28
565	Mueller-Hinton Agar	37			26-28	20	22	30	24	18	8	20-22	26	6-8	22	30-32	14-16	16	16-18	10	12-14	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.
565	Mueller-Hinton Agar	30		aerob	28	20	22	30	26	20	8	24-26	30	10	22	30	16-18	16	18-20	12	16-18	26	0	40	20-22	0	0	0	0	30
565	Mueller-Hinton Agar	30		aerob	28	20	22	30	26	20	8	24-26	30	10	22	30	16-18	16	18-20	12	16-18	26	0	40	20-22	0	0	0	0	30

spore formation

@ref	spore formation	confidence
69481	no	100
69480	no	99.981

halophily

@ref	salt	growth	tested relation	concentration
116094	NaCl	positive	growth	0-6 %
116094	NaCl	no	growth	8 %
116094	NaCl	no	growth	10 %

observation

@ref: 565
observation: not ESBL

metabolite utilization

@ref	Chebi-ID	metabolite	utilization activity	kind of utilization tested
68369	25115	malate	+	assimilation
68369	17128	adipate	+	assimilation
68369	27689	decanoate	+	assimilation
68369	24265	gluconate	+	assimilation
68369	17306	maltose	-	assimilation
68369	59640	N-acetylglucosamine	+	assimilation
68369	16899	D-mannitol	+	assimilation
68369	16024	D-mannose	-	assimilation
68369	17634	D-glucose	+	assimilation
68369	5291	gelatin	+	hydrolysis
68369	4853	esculin	-	hydrolysis
68369	29016	arginine	+	hydrolysis
68369	27897	tryptophan	-	energy source
116094	16947	citrate	+	carbon source
116094	4853	esculin	-	hydrolysis
116094	17632	nitrate	+	reduction
116094	16301	nitrite	+	reduction
116094	15882	phenol	+	degradation
116094	17632	nitrate	+	respiration

metabolite production

@ref	Chebi-ID	metabolite	production
68369	35581	indole	no
116094	35581	indole	no

metabolite tests

@ref: 68369
Chebi-ID: 35581
metabolite: indole
indole test: -

enzymes

@ref	value	activity	ec
68369	cytochrome oxidase	+	1.9.3.1
68369	gelatinase	+
68369	beta-glucosidase	-	3.2.1.21
68369	arginine dihydrolase	+	3.5.3.6
116094	oxidase	+
116094	beta-galactosidase	-	3.2.1.23
116094	alcohol dehydrogenase	+	1.1.1.1
116094	gelatinase	+
116094	amylase	-
116094	caseinase	+	3.4.21.50
116094	catalase	+	1.11.1.6
116094	tween esterase	+
116094	lysine decarboxylase	-	4.1.1.18
116094	ornithine decarboxylase	-	4.1.1.17
116094	tryptophan deaminase	-
116094	urease	-	3.5.1.5
68382	alkaline phosphatase	+	3.1.3.1
68382	esterase (C 4)	+
68382	esterase lipase (C 8)	+
68382	lipase (C 14)	+
68382	leucine arylamidase	+	3.4.11.1
68382	valine arylamidase	-
68382	cystine arylamidase	-	3.4.11.3
68382	trypsin	+	3.4.21.4
68382	alpha-chymotrypsin	-	3.4.21.1
68382	acid phosphatase	+	3.1.3.2
68382	naphthol-AS-BI-phosphohydrolase	+
68382	alpha-galactosidase	-	3.2.1.22
68382	beta-galactosidase	-	3.2.1.23
68382	beta-glucuronidase	-	3.2.1.31
68382	alpha-glucosidase	-	3.2.1.20
68382	beta-glucosidase	-	3.2.1.21
68382	N-acetyl-beta-glucosaminidase	-	3.2.1.52
68382	alpha-mannosidase	-	3.2.1.24
68382	alpha-fucosidase	-	3.2.1.51

fatty acid profile

fatty acids

@ref	fatty acid	percentage	ECL
46633	C12:0	4.1	12
46633	C14:0	0.8	14
46633	C15:0	0.7	15
46633	C16:0	25.7	16
46633	C18:0	0.3	18
46633	C10:0 3OH	4.3	11.423
46633	C12:0 2OH	6.3	13.178
46633	C12:0 3OH	4.9	13.455
46633	C16:1 ω7c	16	15.819
46633	C17:0 CYCLO	1.9	16.888
46633	C17:1 ω8c	0.3	16.792
46633	C18:1 ω7c /12t/9t	30.6	17.824
46633	C18:1 ω9c	0.6	17.769
46633	C18:2 ω6,9c/C18:0 ANTE	1.1	17.724
46633	C19:0 CYCLO ω8c	2.2	18.9

type of FA analysis: whole cell analysis
method/protocol: CCUG

API zym

@ref	Control	Alkaline phosphatase	Esterase	Esterase Lipase	Lipase	Leucine arylamidase	Valine arylamidase	Cystine arylamidase	Trypsin	alpha- Chymotrypsin	Acid phosphatase	Naphthol-AS-BI-phosphohydrolase	alpha- Galactosidase	beta- Galactosidase	beta- Glucuronidase	alpha- Glucosidase	beta- Glucosidase	N-acetyl-beta- glucosaminidase	alpha- Mannosidase	alpha- Fucosidase
116094	-	+	+	+	+	+	-	-	+	-	+	+	-	-	-	-	-	-	-	-

API 20NE

@ref	NO3	TRP	GLU_ Ferm	ADH Arg	URE	ESC	GEL	PNPG	GLU_ Assim	ARA	MNE	MAN	NAG	MAL	GNT	CAP	ADI	MLT	CIT	PAC	OX
565	-	-	-	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
565	-	-	-	+	+/-	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
565	-	-	-	+	+	-	+	-	+	+/-	-	+	+	-	+	+	+	+	+	-	+
565	+	-	-	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
46633	+	-	+	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
565	+	-	-	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
565	+	-	-	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
565	+	-	-	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+

API biotype100

@ref	GLU	FRU	GAL	TRE	MNE	SBE	MEL	SAC	RAF	MTE	MAL	LAC	LTE	MbGa	MaGa	CEL	GEN	MbGu	ESC	RIB	ARA	XYL	PLE	RHA	FUC	MLZ	DARL	LARL	XLT	DUL	TAG	GLY	INO	MAN	MTL	TUR	SOR	ADO	HBG	LYX	ERY	MDG	3MDG	SAT	MUC	LTAT	DTAT	MTAT	DMLT	LMLT	CATE	TATE	TTE	CIT	GRT	GAT	2KG	5KG	TRY	NAG	GNT	PAC	PAT	pOBE	QAT	GTE	mOBE	BAT	PPAT	CMT	TGE	BET	PCE	ABT	HIN	LAT	CAP	CYT	HIS	SUC	FUM	GRE	GYT	AVT	ETN	TTN	GLN	ITA	3OBU	APT	GTT	PRO	DALA	LALA	SER	MNT	PROP	TYR	2KT
116094	+	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	+	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	+	-	-	+	-	-	+	-	-	+	+	-	+	+	+	+	-	+	-	-	-	+	+	+	+	+	+	+	-	+	+	+	+	+	+	-	-	+	+	+	+	+	+	+	-	+	+	+	+

Isolation, sampling and environmental information

isolation

@ref	sample type	sampling date	country	origin.country	continent
565	blood culture
46633	Human blood
67770	Clinical specimen
67772	Blood culture	1977
116094	Blood		United States of America	USA	North America

isolation source categories

Cat1	Cat2	Cat3
#Infection	#Patient	#Blood culture
#Host Body Product	#Fluids	#Blood

taxonmaps

@ref: 69479
File name: preview.99_42.png
url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_23;96_36;97_37;98_40;99_42&stattab=map
Last taxonomy: Pseudomonas aeruginosa
16S sequence: AY268175
Sequence Identity:
Total samples: 22757
soil counts: 1669
aquatic counts: 5046
animal counts: 14748
plant counts: 1294

Safety information

risk assessment

@ref	pathogenicity human	pathogenicity animal	biosafety level	biosafety level comment
565	yes	yes	2	Risk group (German classification)
67772			2
116094			2	Risk group (French classification)

Sequence information

16S sequences

@ref	description	accession	length	database	NCBI tax ID
20218	Pseudomonas aeruginosa gene for 16S ribosomal RNA, strain:ATCC 27853	AB037545	1526	ena	287
20218	Pseudomonas aeruginosa strain ATCC 27853 16S ribosomal RNA gene, partial sequence	AF094719	1460	ena	287
20218	Pseudomonas aeruginosa strain ATCC 27853 16S ribosomal RNA gene, partial sequence	AY268175	1466	ena	287
20218	Pseudomonas aeruginosa strain ATCC 27853 16S-23S ribosomal RNA intergenic spacer, complete sequence	AY684792	471	ena	287
565	Pseudomonas aeruginosa gene for 16S rRNA, partial sequence, strain: JCM 6119	AB594760	1458	ena	287

Genome sequences

@ref	description	accession	assembly level	database	NCBI tax ID
66792	Pseudomonas aeruginosa ATCC 27853	GCA_001687285	complete	ncbi	287
66792	Pseudomonas aeruginosa ATCC 27853	GCA_001618925	complete	ncbi	287
66792	Pseudomonas aeruginosa ATCC 27853	GCA_001997195	scaffold	ncbi	287
66792	Pseudomonas aeruginosa JCM 6119	GCA_000615525	contig	ncbi	1236529
66792	Pseudomonas aeruginosa JCM 6119	1236529.3	wgs	patric	1236529
66792	Pseudomonas aeruginosa strain ATCC 27853	287.1769	wgs	patric	287
66792	Pseudomonas aeruginosa strain ATCC 27853	287.6323	complete	patric	287
66792	Pseudomonas aeruginosa strain ATCC 27853	287.2665	complete	patric	287
66792	Pseudomonas aeruginosa strain ATCC 27853	287.3723	wgs	patric	287
66792	Pseudomonas aeruginosa ATCC 27853	2912953232	complete	img	287
66792	Pseudomonas aeruginosa ATCC 27853	2700989384	draft	img	287
66792	Pseudomonas aeruginosa ATCC 27853	2687453218	complete	img	287
67770	Pseudomonas aeruginosa ATCC 27853	GCA_001086625	contig	ncbi	287
66792	Pseudomonas aeruginosa ATCC 27853	GCA_024507955	complete	ncbi	287

GC content

@ref: 565
GC-content: 66.8
method: thermal denaturation, midpoint method (Tm)

Genome-based predictions

predictions

trait	prediction	confidence	training_data
spore-forming	no	100	no
flagellated	yes	82.281	no
gram-positive	no	98.418	no
anaerobic	no	98.52	yes
aerobic	yes	93.39	yes
halophile	no	90.897	no
spore-forming	no	93.097	no
glucose-util	yes	89.442	yes
thermophile	no	99.835	yes
motile	yes	88.844	no
glucose-ferment	no	90.67	no

External links

@ref: 565

culture collection no.: DSM 1117, ATCC 27853, CCM 3955, CCUG 17619, CECT 108, CIP 76.110, JCM 6119, LMG 6395, NCIMB 12469, WDCM 00025, UCCCB116, LMG 18448, CCUG 1423, CCUG 7737, NCTC 12903

straininfo link

@ref: 81968
straininfo: 92376

literature

topic	Pubmed-ID	title	authors	journal	DOI	year	mesh	topic2
Pathogenicity	101130	Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa.	Pollock HM, Minshew BH, Kenny MA, Schoenknecht FD	Antimicrob Agents Chemother	10.1128/AAC.14.3.360	1978	Agar/standards, Gentamicins/pharmacology, Microbial Sensitivity Tests/standards, Pseudomonas aeruginosa/drug effects, Quality Control
Pathogenicity	101134	Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study.	Prior RB, Fass RJ	Antimicrob Agents Chemother	10.1128/AAC.14.3.507	1978	Carbenicillin/pharmacology, Escherichia coli/drug effects, Microbial Sensitivity Tests/standards, Penicillins/pharmacology, Pseudomonas aeruginosa/drug effects, Ticarcillin/*pharmacology
Pathogenicity	110825	Standardization of direct susceptibility test for blood cultures.	Fay D, Oldfather JE	J Clin Microbiol	10.1128/jcm.9.3.347-350.1979	1979	Anti-Bacterial Agents/pharmacology, Blood/microbiology, Escherichia coli/drug effects, Humans, Microbial Sensitivity Tests/methods/standards, Pseudomonas aeruginosa/drug effects, Sepsis/microbiology, Staphylococcus aureus/drug effects
Pathogenicity	116543	Evaluation of the moving intermediate zone concept for determing susceptibility of pseudomonads to gentamicin by the standardized disk agar-diffusion test.	Woolfrey BF, Ramadei WA, Quall CO	Am J Clin Pathol	10.1093/ajcp/72.5.861	1979	Fluorescence, Gentamicins/pharmacology, Microbial Sensitivity Tests/methods, Pseudomonas/drug effects, Pseudomonas aeruginosa/drug effects
Pathogenicity	118705	Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.	Fass RJ, Barnishan J	Antimicrob Agents Chemother	10.1128/AAC.16.5.622	1979	Anti-Bacterial Agents/pharmacology, Escherichia coli/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/*drug effects
Pathogenicity	464567	Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study.	Washington JA 2nd, Yu PK, Gavan TL, Schoenknecht FD, Thornsberry C	Antimicrob Agents Chemother	10.1128/AAC.15.3.400	1979	Amikacin/pharmacology, Bacteria/drug effects, Kanamycin/analogs & derivatives, Methods, Microbial Sensitivity Tests/methods
Pathogenicity	1416886	Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.	Barclay ML, Begg EJ, Chambers ST	Antimicrob Agents Chemother	10.1128/AAC.36.9.1951	1992	Drug Resistance, Microbial/physiology, Gentamicins/pharmacokinetics/pharmacology, Half-Life, Humans, Models, Biological, Pseudomonas aeruginosa/drug effects	Enzymology
Pathogenicity	1418079	Synthesis of some hydroxamic acid derivatives of benzimidazole and their antibacterial and antifungal activities.	Gunes HS, Cosar G	Arzneimittelforschung		1992	Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Benzimidazoles/chemical synthesis/pharmacology, Fungi/drug effects, Hydroxamic Acids/chemical synthesis/pharmacology, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests
Enzymology	1482142	Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.	McGrath BJ, Bailey EM, Lamp KC, Rybak MJ	Antimicrob Agents Chemother	10.1128/AAC.36.12.2741	1992	Amikacin/pharmacokinetics/therapeutic use, Aztreonam/pharmacokinetics/therapeutic use, Cefepime, Ceftazidime/pharmacokinetics/therapeutic use, Cephalosporins/pharmacokinetics/therapeutic use, Drug Therapy, Combination/pharmacokinetics/therapeutic use, Half-Life, Humans, In Vitro Techniques, Pseudomonas Infections/*drug therapy/microbiology	Pathogenicity
Pathogenicity	1510793	Synthesis and evaluation of antimicrobial activity of new 4-nitroso and 4-diazopyrazole derivatives.	Daidone G, Plescia S, Raffa D, Maggio B, Schillaci D	Farmaco		1992	Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Diazonium Compounds/chemical synthesis/pharmacology, Fungi/drug effects, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Nitroso Compounds/chemical synthesis/pharmacology, Pyrazoles/chemical synthesis
Enzymology	1757546	Ability of National Committee for Clinical Laboratory Standards-recommended quality control strains from the American Type Culture Collection to detect errors in disk diffusion susceptibility tests.	Yechouron A, Dascal A, Stevenson J, Mendelson J	J Clin Microbiol	10.1128/jcm.29.12.2758-2762.1991	1991	Clinical Laboratory Techniques/standards, Escherichia coli/isolation & purification, Microbial Sensitivity Tests/methods/standards, Pseudomonas aeruginosa/isolation & purification, Quality Control, Staphylococcus aureus/isolation & purification, United States	Phylogeny
Pathogenicity	1822083	Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.	White RL, Kays MB, Friedrich LV, Brown EW, Koonce JR	J Clin Microbiol	10.1128/jcm.29.2.398-400.1991	1991	Drug Resistance, Microbial, Drug Stability, Humans, Imipenem/analysis/pharmacology, Microbial Sensitivity Tests/instrumentation/standards, Pseudomonas aeruginosa/*drug effects/isolation & purification, Quality Control	Metabolism
Pathogenicity	1906262	Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa.	Park MK, Muhvich KH, Myers RA, Marzella L	Antimicrob Agents Chemother	10.1128/AAC.35.4.691	1991	Anti-Bacterial Agents/pharmacology, Bacterial Proteins/biosynthesis, Hyperbaric Oxygenation, Indicators and Reagents, Microbial Sensitivity Tests, Oxygen/pharmacology, Pseudomonas aeruginosa/*drug effects, Tobramycin/pharmacology
Pathogenicity	1909018	[Time-killing curves of Pseudomonas aeruginosa strains exposed to polymyxin B].	Peyret M, Flandrois JP, Fardel G	Pathol Biol (Paris)		1991	Dose-Response Relationship, Drug, In Vitro Techniques, Polymyxin B/pharmacology, Pseudomonas aeruginosa/drug effects, Time Factors
Pathogenicity	1915384	In vitro phagocytic interaction between Trichomonas vaginalis isolates and bacteria.	Juliano C, Cappuccinelli P, Mattana A	Eur J Clin Microbiol Infect Dis	10.1007/BF01963936	1991	Animals, Enterobacter cloacae/immunology, Escherichia coli/immunology, Female, Gram-Negative Bacteria/immunology, Gram-Positive Bacteria/immunology, Humans, Lactobacillus/immunology, Phagocytosis, Pseudomonas aeruginosa/immunology, Staphylococcus aureus/immunology, Trichomonas vaginalis/immunology, Vagina/microbiology/parasitology
Metabolism	2113435	Nitrosoguanidine-induced adaptive repair in Pseudomonas aeruginosa.	Rasool SA, Mirza A, Khan MA	Curr Genet	10.1007/BF00334521	1990	Adaptation, Physiological, Alkylation, Chloramphenicol/pharmacology, DNA Repair, DNA, Bacterial/metabolism, Methylnitronitrosoguanidine/pharmacology, Mutation, Pseudomonas aeruginosa/*genetics/growth & development/metabolism, Time Factors
Metabolism	2210988	Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis.	Hobden JA, Reidy JJ, O'Callaghan RJ, Insler MS, Hill JM	Invest Ophthalmol Vis Sci		1990	Aminoglycosides/therapeutic use, Animals, Aqueous Humor/metabolism, Ciprofloxacin/administration & dosage/pharmacokinetics/therapeutic use, Colony Count, Microbial, Drug Resistance, Microbial, Iontophoresis, Keratitis/etiology, Osmolar Concentration, Pseudomonas Infections/drug therapy/microbiology, Rabbits	Enzymology
Pathogenicity	2492304	Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.	Fuchs PC, Jones RN, Barry AL, Gavan TL	J Clin Microbiol	10.1128/jcm.27.1.49-52.1989	1989	Bacteria/drug effects, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests/standards, Multicenter Studies as Topic, Ofloxacin/*pharmacology, Pseudomonas aeruginosa/drug effects, Quality Control, Staphylococcus aureus/drug effects
Metabolism	2509364	Evidence for different pyoverdine-mediated iron uptake systems among Pseudomonas aeruginosa strains.	Cornelis P, Hohnadel D, Meyer JM	Infect Immun	10.1128/iai.57.11.3491-3497.1989	1989	Amino Acids/analysis, Bacterial Outer Membrane Proteins/analysis/immunology, Biological Transport, Blotting, Western, Iron/metabolism, Oligopeptides, Pigments, Biological/analysis/metabolism, Pseudomonas aeruginosa/classification/growth & development/immunology/metabolism, Species Specificity	Phylogeny
Pathogenicity	2510593	Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa.	Muhvich KH, Park MK, Myers RA, Marzella L	Antimicrob Agents Chemother	10.1128/AAC.33.9.1526	1989	Anti-Bacterial Agents/pharmacology, Colony Count, Microbial, Drug Synergism, Escherichia coli/drug effects, Gentamicins/pharmacology, Microbial Sensitivity Tests, Nitrofurantoin/pharmacology, Oxidation-Reduction, Oxygen/pharmacology, Pseudomonas aeruginosa/drug effects, Tobramycin/pharmacology, Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology
Pathogenicity	2511223	Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.	Staneck JL, Glenn S, DiPersio JR, Leist PA	J Clin Microbiol	10.1128/jcm.27.10.2277-2285.1989	1989	Aminoglycosides, Anti-Bacterial Agents/pharmacology, Drug Resistance, Microbial, Evaluation Studies as Topic, Humans, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/*drug effects, Quality Control
Enzymology	2614380	Glutathione transferase in bacteria: subunit composition and antigenic characterization.	Piccolomini R, Di Ilio C, Aceto A, Allocati N, Faraone A, Cellini L, Ravagnan G, Federici G	J Gen Microbiol	10.1099/00221287-135-11-3119	1989	Anti-Bacterial Agents/antagonists & inhibitors/pharmacology, Antigens, Bacterial/isolation & purification, Bacteria/drug effects/enzymology/immunology, Cross Reactions, Glutathione Transferase/immunology/isolation & purification/pharmacology, Isoenzymes/immunology/isolation & purification/pharmacology, Molecular Weight, Protein Conformation	Phylogeny
Pathogenicity	2621552	Synthesis and biological activity of 6-acyl-3-substituted-2(3H)-benzoxazolones.	Erol DD, Erdogan H, Yulug N	J Pharm Belg		1989	Anti-Bacterial Agents/chemical synthesis, Bacteria/drug effects, Benzoxazoles/chemical synthesis/pharmacology, Microbial Sensitivity Tests
Pathogenicity	2808211	Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay.	Pitkin DH, Sheikh W, Nadler H	J Antimicrob Chemother	10.1093/jac/24.suppl_a.251	1989	Bacteria/drug effects, Carbapenems/pharmacology, Culture Media, Meropenem, Microbial Sensitivity Tests, Quality Control, Thienamycins/pharmacology	Cultivation
Pathogenicity	2818673	Synthesis of some new Mannich bases derived from 6-acyl-3-(3,5-dimethylpiperidinomethyl)-2(3H)-benzoxazolones+ ++ and their biological activities.	Erol DD, Rosen A, Erdogan H, Yulug N	Arzneimittelforschung		1989	Amines/chemical synthesis, Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis, Bacteria/drug effects, Benzoxazoles/chemical synthesis/pharmacology, Diffusion, Fungi/drug effects, Magnetic Resonance Spectroscopy, Mannich Bases/chemical synthesis/pharmacology, Mass Spectrometry, Microbial Sensitivity Tests, Piperidines/*chemical synthesis/pharmacology, Spectrophotometry, Infrared
Pathogenicity	3086377	Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray.	Staneck JL	J Clin Microbiol	10.1128/jcm.23.6.1134-1135.1986	1986	Bacteria/drug effects, Drug Stability, Enterobacteriaceae/drug effects, Imipenem, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects, Temperature, Thienamycins/pharmacology, Time Factors
Pathogenicity	3090007	In-vitro emergence of beta-lactam-resistant variants of Pseudomonas aeruginosa.	Eng RH, Smith SM, Cherubin CE	J Antimicrob Chemother	10.1093/jac/17.6.717	1986	Anti-Bacterial Agents/analysis/pharmacology, Biotransformation, Drug Resistance, Microbial, Mutation, Pseudomonas aeruginosa/drug effects/genetics, beta-Lactams
Pathogenicity	3098779	Quality control limits for microdilution susceptibility tests with norfloxacin.	Barry AL, Gavan TL, Ayers LW, Fuchs PC, Gerlach EH, Thornsberry C	J Clin Microbiol	10.1128/jcm.25.1.165-166.1987	1987	Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests/standards, Norfloxacin/pharmacology, Prospective Studies, Pseudomonas aeruginosa/drug effects, Quality Control, Staphylococcus aureus/*drug effects
Pathogenicity	3104483	Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.	Aronoff SC, Shlaes DM	J Infect Dis	10.1093/infdis/155.5.936	1987	Anti-Bacterial Agents/pharmacology, Drug Resistance, Microbial, Enterobacter/drug effects/enzymology/genetics, Enterobacteriaceae/drug effects, Enzyme Induction, Mutation, Penicillin Resistance, Pseudomonas aeruginosa/drug effects/enzymology/genetics, beta-Lactamases/*biosynthesis, beta-Lactams	Enzymology
Pathogenicity	3117698	In vitro and in vivo inhibition of lectin mediated adhesion of Pseudomonas aeruginosa by receptor blocking carbohydrates.	Ko HL, Beuth J, Solter J, Schroten H, Uhlenbruck G, Pulverer G	Infection	10.1007/BF01644121	1987	Animals, Bacterial Adhesion/drug effects, Kidney/microbiology, Lectins/antagonists & inhibitors/metabolism, Liver/microbiology, Lung/microbiology, Male, Mice, Mice, Inbred BALB C, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/drug effects/physiology, Sialic Acids/*pharmacology	Metabolism
Pathogenicity	3121667	Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.	Jones RN, Barry AL	J Clin Microbiol	10.1128/jcm.25.11.2211-2213.1987	1987	Cephalosporins/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Haemophilus influenzae/drug effects, Microbial Sensitivity Tests/standards, Providencia/drug effects, Pseudomonas aeruginosa/drug effects, Quality Control, Regression Analysis, Staphylococcus aureus/drug effects
Metabolism	3125051	Lectin-mediated bacterial adhesion to human tissue.	Beuth J, Ko HL, Uhlenbruck G, Pulverer G	Eur J Clin Microbiol	10.1007/BF02014258	1987	Acetylglucosamine/pharmacology, Adhesins, Bacterial, Bacterial Adhesion, Bacterial Proteins/metabolism, Humans, Kidney/microbiology, Lectins/metabolism, Lung/microbiology, Pseudomonas aeruginosa/physiology, Sialic Acids/pharmacology, Streptococcus pneumoniae/*physiology	Pathogenicity
Pathogenicity	3141886	[Preliminary study of the antagonistic effects between fosfomycin and beta-lactams on Pseudomonas aeruginosa observed on the antibiogram].	Buisson Y, Bercion R, Mauclere P, Hugard L, Schill H	Pathol Biol (Paris)		1988	Anti-Bacterial Agents/administration & dosage, Drug Antagonism, Drug Therapy, Combination/pharmacology, Fosfomycin/administration & dosage, Humans, In Vitro Techniques, Microbial Sensitivity Tests, Pseudomonas Infections/drug therapy, Pseudomonas aeruginosa/*drug effects, beta-Lactams
Cultivation	3144552	Effect of method, medium, pH and inoculum on the in-vitro antibacterial activities of fleroxacin and norfloxacin.	Hohl P, Felber AM	J Antimicrob Chemother	10.1093/jac/22.supplement_d.71	1988	Anti-Infective Agents/pharmacology, Bacteria/drug effects, Ciprofloxacin/analogs & derivatives/pharmacology, Culture Media, Fleroxacin, Hydrogen-Ion Concentration, Methods, Norfloxacin/pharmacology	Pathogenicity
Pathogenicity	3145172	Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.	Traub WH, Spohr M, Bauer D	Chemotherapy	10.1159/000238582	1988	Anti-Bacterial Agents/pharmacology, Blood Bactericidal Activity, Drug Combinations, Fibrinolysis, Humans, Microbial Sensitivity Tests, Pseudomonas aeruginosa/*drug effects/isolation & purification	Enzymology
Pathogenicity	3370932	Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.	Jones RN, Barry AL, Pfaller M, Allen SD, Ayers LW, Fuchs PC	Diagn Microbiol Infect Dis	10.1016/0732-8893(88)90063-6	1988	Administration, Oral, Cefaclor/pharmacology, Ceftizoxime/analogs & derivatives, Cephalexin/pharmacology, Cephalosporins/administration & dosage/pharmacology/standards, Cephradine/pharmacology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Microbial Sensitivity Tests, Quality Control
Cultivation	3693552	Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.	Jones RN, Barry AL	J Clin Microbiol	10.1128/jcm.25.11.2243-2246.1987	1987	Anti-Bacterial Agents/pharmacology, Aztreonam/pharmacology, Culture Media, Gram-Negative Bacteria/drug effects, Microbial Sensitivity Tests/standards, Quality Control, Regression Analysis	Pathogenicity
	3856570	Proposed quality control and interpretive criteria for disk diffusion susceptibility testing with enoxacin.	Rudrik JT, Cavalieri SJ, Britt EM	J Clin Microbiol	10.1128/jcm.21.3.332-334.1985	1985	Anti-Infective Agents/pharmacology, Diffusion, Enoxacin, Microbial Sensitivity Tests/standards, Naphthyridines/*pharmacology, Quality Control, Regression Analysis
Pathogenicity	3867331	Stability of imipenem in Mueller-Hinton agar stored at 4 degrees C.	Turgeon PL, Desrochers C	Antimicrob Agents Chemother	10.1128/AAC.28.5.711	1985	Agar/analysis, Bacteria/drug effects, Drug Stability, Drug Storage, Imipenem, Microbial Sensitivity Tests, Temperature, Thienamycins/*analysis/pharmacology, Time Factors
Metabolism	3909316	Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.	Barry AL, Thornsberry C, Jones RN, Gavan TL	Rev Infect Dis	10.1093/clinids/7.supplement_4.s594	1985	Aztreonam/metabolism/pharmacology, Cefoperazone/pharmacology, Cefotaxime/pharmacology, Ceftazidime/pharmacology, Enterobacteriaceae/drug effects, Gram-Negative Bacteria/drug effects/enzymology, Microbial Sensitivity Tests/methods/standards, Penicillin Resistance, Piperacillin/pharmacology, Quality Control, Ticarcillin/pharmacology, beta-Lactamases/metabolism	Pathogenicity
Enzymology	3909700	Investigations on the bactericidal activity of fosfomycin using the membrane filter-agar dilution method and the time-kill technique.	Haag R, Hoffmann R	Zentralbl Bakteriol Mikrobiol Hyg A	10.1016/s0176-6724(85)80123-1	1985	Agar, Bacteria/drug effects, Culture Media/pharmacology, Dose-Response Relationship, Drug, Filtration/instrumentation, Fosfomycin/pharmacology, Indicator Dilution Techniques, Kinetics, Membranes, Artificial, Microbial Sensitivity Tests/instrumentation/methods, Time Factors	Pathogenicity
Pathogenicity	3918482	Antimicrobial activity of bupivacaine and morphine.	Rosenberg PH, Renkonen OV	Anesthesiology	10.1097/00000542-198502000-00015	1985	Bacillus cereus/drug effects, Bacteria/drug effects, Bupivacaine/pharmacology, Candida albicans/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests, Morphine/*pharmacology, Staphylococcus/drug effects, Streptococcus/drug effects
Pathogenicity	3920179	Computer-controlled in-vitro simulation of multiple dosing regimens.	Ledergerber B, Blaser J, Luthy R	J Antimicrob Chemother	10.1093/jac/15.suppl_a.169	1985	Computers, Gentamicins/administration & dosage/pharmacology, Humans, Models, Biological, Nephelometry and Turbidimetry, Pseudomonas aeruginosa/drug effects
Pathogenicity	3931545	[Comparative evaluation of 2 methods--dilution in agar and diffusion in agar--in determining Pseudomonas aeruginosa sensitivity to antibiotics].	Gabrielian SA, Bogdanova LF, Vorob'eva LS, Givental' NI	Antibiot Med Biotekhnol		1985	Agar, Anti-Bacterial Agents/pharmacology, Diffusion, Dose-Response Relationship, Drug, Evaluation Studies as Topic, Indicator Dilution Techniques, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects
	3980689	Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays.	Nickolai DJ, Lammel CJ, Byford BA, Morris JH, Kaplan EB, Hadley WK, Brooks GF	J Clin Microbiol	10.1128/jcm.21.3.366-370.1985	1985	Anti-Bacterial Agents/pharmacology, Drug Stability, Drug Storage, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Temperature, beta-Lactams
Pathogenicity	6219620	Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.	Tenney JH, Maack RW, Chippendale GR	Antimicrob Agents Chemother	10.1128/AAC.23.1.188	1983	Anti-Bacterial Agents/pharmacology, Drug Resistance, Microbial, Escherichia coli/drug effects, Nalidixic Acid/analogs & derivatives/pharmacology, Norfloxacin, Pseudomonas aeruginosa/drug effects
Pathogenicity	6223938	Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.	Kronvall G	J Clin Microbiol	10.1128/jcm.17.6.975-980.1983	1983	Bacteria/drug effects, Cefoperazone, Cephalosporins/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Reference Values, Regression Analysis, Staphylococcus aureus/drug effects
	6226677	Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacin.	Shungu DL, Tutlane V, Gadebusch HH	J Clin Microbiol	10.1128/jcm.18.4.988-991.1983	1983	Anti-Infective Agents/pharmacology, Bacteriological Techniques/standards, Microbial Sensitivity Tests, Nalidixic Acid/*analogs & derivatives/pharmacology, Norfloxacin, Quality Control, Reference Standards
Pathogenicity	6339416	Criteria for the assessment of susceptibility to ceftazidime using the disc diffusion procedure.	Grimm H	Infection	10.1007/BF01641104	1983	Agar, Bacteria/drug effects, Bacteriological Techniques, Ceftazidime, Cephalosporins/*pharmacology, Enterobacteriaceae/drug effects, Microbial Sensitivity Tests, Regression Analysis
Pathogenicity	6350348	Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.	Jones RN, Barry AL, Thornsberry C	J Clin Microbiol	10.1128/jcm.18.1.211-214.1983	1983	Agar, Bacteria/drug effects, Ceftazidime, Cephalosporins/pharmacology, Microbial Sensitivity Tests, Quality Control, Reference Standards
Pathogenicity	6419493	Bactericidal activity of antimicrobial drugs in simulated urine specimens at various temperatures of incubation.	Traub WH, Spohr M, Arnold M, Klotz M	Zentralbl Bakteriol Mikrobiol Hyg A		1983	Adult, Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Humans, Male, Pseudomonas aeruginosa/drug effects, Specimen Handling, Staphylococcus aureus/drug effects, Temperature, Urine/*microbiology
Pathogenicity	6439736	Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.	Barry AL, Thornsberry C, Gavan TL, Jones RN	J Clin Microbiol	10.1128/jcm.20.5.988-989.1984	1984	Anti-Bacterial Agents/pharmacology, Escherichia coli/drug effects, Imipenem, Microbial Sensitivity Tests/standards, Pseudomonas aeruginosa/drug effects, Quality Control, Staphylococcus aureus/drug effects, Thienamycins/pharmacology
Pathogenicity	6456892	Anomalous effect of serum on the antimicrobial activity of cefoperazone.	Lang SD, Cameron GL, Mullins PR	Drugs	10.2165/00003495-198100221-00012	1981	Bacteria/drug effects, Cefoperazone, Cephalosporins/blood/pharmacology, Humans, Microbial Sensitivity Tests
Enzymology	6753141	[Studies on bacteriologic contamination of potassium chloride solution 25% in multidose containers regularly used on hospital wards].	Schramm G, Bianchi S	Schweiz Med Wochenschr		1982	Drug Contamination, Escherichia coli/isolation & purification, Potassium Chloride, Solutions, Staphylococcus aureus/isolation & purification, Surgery Department, Hospital	Phylogeny
Pathogenicity	6779623	Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.	Woolfrey BF, Fox JM, Quall CO	Am J Clin Pathol	10.1093/ajcp/75.1.39	1981	Aminoglycosides/pharmacology, Anti-Bacterial Agents/pharmacology, Carbenicillin/pharmacology, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/*drug effects, Ticarcillin/pharmacology
Pathogenicity	6791584	Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum.	Reimer LG, Stratton CW, Reller LB	Antimicrob Agents Chemother	10.1128/AAC.19.6.1050	1981	Anti-Bacterial Agents/pharmacology, Blood, Calcium/pharmacology, Culture Media, Escherichia coli/drug effects, Humans, Magnesium/pharmacology, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/*drug effects	Cultivation
Cultivation	6791589	Effect of ionized calcium and soluble magnesium on the predictability of the performance of Mueller-Hinton agar susceptibility testing of Pseudomonas aeruginosa with gentamicin.	Casillas E, Kenny MA, Minshew BH, Schoenknecht FD	Antimicrob Agents Chemother	10.1128/AAC.19.6.987	1981	Calcium/pharmacology, Culture Media, Gentamicins/pharmacology, Magnesium/pharmacology, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/*drug effects	Pathogenicity
Pathogenicity	6809788	Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks.	Barry AL, Jones RN, Thornsberry C, Gavan TL	J Clin Microbiol	10.1128/jcm.16.1.135-140.1982	1982	Azlocillin, Microbial Sensitivity Tests/standards, Microchemistry, Penicillins/pharmacology, Pseudomonas aeruginosa/drug effects, Quality Control, Regression Analysis
Enzymology	6813385	Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.	Gerber AU, Vastola AP, Brandel J, Craig WA	J Infect Dis	10.1093/infdis/146.5.691	1982	Aminoglycosides/pharmacology, Animals, Anti-Bacterial Agents/pharmacology, Drug Synergism, Female, Gentamicins/administration & dosage/pharmacology, Kinetics, Leukopenia/physiopathology, Mice, Mice, Inbred ICR, Mice, Inbred Strains, Penicillin Resistance, Pseudomonas aeruginosa/drug effects, Ticarcillin/administration & dosage/pharmacology	Pathogenicity
Pathogenicity	6818249	Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing.	Kronvall G	J Clin Microbiol	10.1128/jcm.16.5.784-793.1982	1982	Bacteria/drug effects, Culture Media, Diffusion, Enterococcus faecalis/drug effects, Gentamicins/pharmacology, Microbial Sensitivity Tests/methods/*standards, Quality Control, Regression Analysis	Cultivation
	7102817	Evaluations of antimicrobial susceptibility test proficiency by the College of American Pathologists Survey program. A clarification of quality control recommendations.	Jones RN, Edson DC, Marymont JV	Am J Clin Pathol	10.1093/ajcp/78.2.168	1982	Cost Control, Evaluation Studies as Topic, Hospitals, Laboratories/standards, Microbial Sensitivity Tests/economics/standards, Pathology, Pathology Department, Hospital/standards, Quality Control, Societies, Medical, Time Factors
Pathogenicity	7125631	Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test.	Fass RJ	Antimicrob Agents Chemother	10.1128/AAC.22.1.28	1982	Azlocillin, Bacteria/drug effects, Microbial Sensitivity Tests/standards, Penicillins/pharmacology, Quality Control
Enzymology	7486921	Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.	Cappelletty DM, Kang SL, Palmer SM, Rybak MJ	Antimicrob Agents Chemother	10.1128/AAC.39.8.1797	1995	Amikacin/administration & dosage/pharmacokinetics/therapeutic use, Anti-Bacterial Agents/administration & dosage/therapeutic use, Ceftazidime/administration & dosage/pharmacokinetics/therapeutic use, Cephalosporin Resistance, Cephalosporins/administration & dosage/pharmacokinetics/therapeutic use, Drug Therapy, Combination/administration & dosage/pharmacokinetics/therapeutic use, Half-Life, Humans, Infusions, Intravenous, Injections, Intravenous, Microbial Sensitivity Tests, Models, Biological, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects	Pathogenicity
Enzymology	7695294	Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro.	Barclay ML, Begg EJ, Chambers ST, Boswell DR	Antimicrob Agents Chemother	10.1128/AAC.39.1.132	1995	Ceftazidime/administration & dosage/pharmacokinetics, Chromatography, High Pressure Liquid, Drug Administration Schedule, Fluorescence Polarization Immunoassay, Gentamicins/administration & dosage/pharmacokinetics, Half-Life, Microbial Sensitivity Tests, Pseudomonas aeruginosa/*drug effects, Time Factors	Pathogenicity
Phylogeny	7699050	Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.	Barry AL, Fuchs PC, Allen SD, Tenover FC, Jorgensen JH, Reller LB	J Clin Microbiol	10.1128/jcm.33.1.235-238.1995	1995	Anti-Infective Agents/pharmacology, Diffusion, Fluoroquinolones, Microbial Sensitivity Tests/standards, Naphthyridines/pharmacology, Prodrugs/pharmacology, Quality Control, Species Specificity
	7744722	Antibiotic activity of isoxazolylnaphthoquinone imines on mice infected with Staphylococcus aureus.	Albesa I, Bogdanov P, Eraso A, Sperandeo NR, de Bertorello MM	J Appl Bacteriol	10.1111/j.1365-2672.1995.tb03420.x	1995	Animals, Anti-Infective Agents/pharmacology/therapeutic use, Female, Isoxazoles/pharmacology/therapeutic use, Male, Mice, Mice, Inbred BALB C, Microbial Sensitivity Tests, Molecular Structure, Naphthols/pharmacology/therapeutic use, Naphthoquinones, Staphylococcal Infections/drug therapy/prevention & control
Pathogenicity	7805695	In vitro antibacterial activity of sucralfate.	Bergmans D, Bonten M, Gaillard C, van Tiel F, van der Geest S, Stobberingh E	Eur J Clin Microbiol Infect Dis	10.1007/BF01971318	1994	Bacteria/drug effects, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Sucralfate/pharmacology
	7814505	Imipenem stability in a predried susceptibility panel.	Daly JS, Deluca BA, Hebert SR, Dodge RA, Soja DT	J Clin Microbiol	10.1128/jcm.32.10.2584-2587.1994	1994	Chromatography, High Pressure Liquid, Drug Stability, Imipenem/analysis/chemistry/pharmacology, Microbial Sensitivity Tests
Pathogenicity	7840569	Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection.	Strayer AH, Gilbert DH, Pivarnik P, Medeiros AA, Zinner SH, Dudley MN	Antimicrob Agents Chemother	10.1128/AAC.38.10.2351	1994	Bacteria/drug effects, Drug Resistance, Microbial, Drug Therapy, Combination, Escherichia coli/drug effects, Microbial Sensitivity Tests, Penicillanic Acid/administration & dosage/analogs & derivatives/pharmacokinetics/pharmacology, Piperacillin/administration & dosage/pharmacokinetics/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Tazobactam, beta-Lactamase Inhibitors	Enzymology
Pathogenicity	7842820	Agar disk diffusion (Bauer-Kirby) tests with various fastidious and nonfastidious reference (ATCC) strains: comparison of several agar media.	Traub WH, Leonhard B	Chemotherapy	10.1159/000239296	1994	Agar, Anti-Bacterial Agents/pharmacology, Bacteria/drug effects/growth & development, Culture Media, Humans, Microbial Sensitivity Tests/methods, Species Specificity	Cultivation
Metabolism	7887601	Relationship between glycocalyx and povidone-iodine resistance in Pseudomonas aeruginosa (ATCC 27853) biofilms.	Brown ML, Aldrich HC, Gauthier JJ	Appl Environ Microbiol	10.1128/aem.61.1.187-193.1995	1995	Biofilms/growth & development, Biomass, Cell Adhesion, Cell Death, Glycoproteins/metabolism/ultrastructure, Microscopy, Electron, Polysaccharides/metabolism/ultrastructure, Povidone-Iodine/metabolism/pharmacology, Pseudomonas/*physiology/ultrastructure
Pathogenicity	7889952	Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.	Barry A, Fuchs P, Tenover F, Allen S, Hardy D, Jorgensen J, McLaughlin J, Reller L	Eur J Clin Microbiol Infect Dis	10.1007/BF02111343	1994	Bacteriological Techniques, Culture Media, Escherichia coli/drug effects, Levofloxacin, Microbial Sensitivity Tests, Ofloxacin/pharmacology, Pseudomonas aeruginosa/drug effects, Quality Control, Staphylococcus aureus/*drug effects	Cultivation
Pathogenicity	7956017	Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group.	Bale MJ, Jones RN, Erwin ME	Diagn Microbiol Infect Dis	10.1016/0732-8893(94)90054-x	1994	Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Bacteria/drug effects, Ceftizoxime/analogs & derivatives/pharmacology, Fluoroquinolones, Levofloxacin, Microbial Sensitivity Tests/standards, Ofloxacin/pharmacology, Piperazines/pharmacology, Quality Control, Quinolones/pharmacology, Reference Values, Spiro Compounds/pharmacology, Thienamycins/pharmacology
Pathogenicity	8067772	Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.	Mouton JW, den Hollander JG	Antimicrob Agents Chemother	10.1128/AAC.38.5.931	1994	Ceftazidime/administration & dosage/pharmacokinetics/pharmacology, Culture Media, Humans, Infusions, Intravenous, Microbial Sensitivity Tests, Models, Biological, Pseudomonas aeruginosa/*drug effects/enzymology/growth & development, beta-Lactamases/biosynthesis	Enzymology
Cultivation	8089067	Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro.	Karlowsky JA, Zhanel GG, Davidson RJ, Hoban DJ	J Antimicrob Chemother	10.1093/jac/33.5.937	1994	Aminoglycosides, Anti-Bacterial Agents/pharmacology, Culture Media, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects	Pathogenicity
Metabolism	8239596	Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.	Hobden JA, Hill JM, Engel LS, O'Callaghan RJ	Antimicrob Agents Chemother	10.1128/AAC.37.9.1856	1993	Aging/physiology, Animals, Aqueous Humor/metabolism, Biological Assay, Ciprofloxacin/pharmacokinetics/pharmacology/therapeutic use, Cornea/microbiology/pathology, Drug Therapy, Combination, Flurbiprofen/therapeutic use, Keratitis/drug therapy/pathology, Leukocyte Count, Neutrophils/drug effects, Photic Stimulation, Prednisolone/therapeutic use, Pseudomonas Infections/drug therapy/pathology, Rabbits, Treatment Outcome	Enzymology
Enzymology	8239608	Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.	McGrath BJ, Lamp KC, Rybak MJ	Antimicrob Agents Chemother	10.1128/AAC.37.9.1931	1993	Amikacin/administration & dosage/pharmacokinetics/pharmacology, Colony Count, Microbial, Culture Media, Drug Resistance, Microbial, Drug Therapy, Combination/administration & dosage/pharmacokinetics/pharmacology, Humans, Imipenem/administration & dosage/pharmacokinetics/pharmacology, Microbial Sensitivity Tests, Models, Biological, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects/growth & development	Pathogenicity
Pathogenicity	8269366	The effectiveness of gentamicin or polymyxin B for the control of bacterial growth in equine semen stored at 20 degrees C or 5 degrees C for up to forty-eight hours.	Vaillancourt D, Guay P, Higgins R	Can J Vet Res		1993	Animals, Bacteria/drug effects/growth & development, Cold Temperature, Gentamicins/pharmacology, Horses, Male, Polymyxin B/pharmacology, Pseudomonas aeruginosa/drug effects/growth & development, Semen/microbiology, Semen Preservation/*veterinary, Time Factors
Pathogenicity	8408586	Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.	Bale MJ, Jones RN	J Clin Microbiol	10.1128/jcm.31.9.2538-2540.1993	1993	Anti-Infective Agents/pharmacology, Cefdinir, Cefepime, Cefmetazole/pharmacology, Ceftizoxime/analogs & derivatives/pharmacology, Cephalosporins/pharmacology, Fluoroquinolones, Humans, Microbial Sensitivity Tests/standards, Quality Control, Quinolones/*pharmacology
Pathogenicity	8464607	Efficacy of various surface disinfectants on an irregular surface.	Lado EA, Anekal S, Stout FW	Oral Surg Oral Med Oral Pathol	10.1016/0030-4220(93)90167-3	1993	Cresols/pharmacology, Disinfectants/pharmacology, Equipment Contamination, Evaluation Studies as Topic, *Glass, Glutaral/pharmacology, Iodophors/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Sodium Hypochlorite/pharmacology, Sulfones/pharmacology, Surface Properties
Pathogenicity	8478079	Synthetic peptides of human lysosomal cathepsin G with potent antipseudomonal activity.	Shafer WM, Shepherd ME, Boltin B, Wells L, Pohl J	Infect Immun	10.1128/iai.61.5.1900-1908.1993	1993	Amino Acid Sequence, Cathepsin G, Cathepsins/chemistry/pharmacology, Cations, Divalent/pharmacology, Humans, Hydrogen-Ion Concentration, Lysosomes/enzymology, Molecular Sequence Data, Osmolar Concentration, Peptides/pharmacology, Pseudomonas aeruginosa/*drug effects, Sequence Alignment, Serine Endopeptidases, Stereoisomerism, Structure-Activity Relationship	Genetics
Pathogenicity	8595095	Synthesis and antimicrobial activity of substituted benzimidazole, benzothiazole and imidazole derivatives.	Kucukbay H, Cetinkaya E, Durmaz R	Arzneimittelforschung		1995	Anti-Bacterial Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Benzimidazoles/chemical synthesis/pharmacology, Benzothiazoles, Imidazoles/chemical synthesis/pharmacology, Indicators and Reagents, Magnetic Resonance Spectroscopy, Mass Spectrometry, Microbial Sensitivity Tests, Spectrophotometry, Infrared, Thiazoles/chemical synthesis/pharmacology
Pathogenicity	8595953	Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.	O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM	Invest Ophthalmol Vis Sci		1996	ADP Ribose Transferases, Animals, Bacterial Toxins, Colony Count, Microbial, Cornea/microbiology, Exotoxins/physiology, Eye Infections, Bacterial/etiology/physiopathology, Female, Keratitis/microbiology/physiopathology, Mice, Peptide Hydrolases/physiology, Pseudomonas Infections/etiology/physiopathology, Pseudomonas aeruginosa/enzymology/pathogenicity, Rabbits, Serine Endopeptidases/physiology, Virulence, Virulence Factors	Enzymology
Pathogenicity	8720315	Synthesis of ethanone derived from 2-benzoxazolinones and their antimicrobial activities.	Erol DD, Calis U, Yulug N	Arzneimittelforschung		1996	Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Chemical Phenomena, Chemistry, Physical, Culture Media, Fungi/*drug effects, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectrophotometry, Infrared	Cultivation
Enzymology	8722536	A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa.	Madaras-Kelly KJ, Larsson AJ, Rotschafer JC	J Antimicrob Chemother	10.1093/jac/37.4.703	1996	Analysis of Variance, Anti-Infective Agents/pharmacokinetics/pharmacology, Ciprofloxacin/pharmacokinetics/pharmacology, In Vitro Techniques, Microbial Sensitivity Tests, Ofloxacin/pharmacokinetics/pharmacology, Pseudomonas aeruginosa/drug effects/metabolism	Pathogenicity
Enzymology	8723496	Kill kinetics and regrowth patterns of Pseudomonas aeruginosa exposed to concentration-time profiles of tobramycin simulating in vivo infusion and bolus dosing.	Wood PJ, Ioannides-Demos LL, Bastone EB, Spicer WJ, McLean AJ	Antimicrob Agents Chemother	10.1128/AAC.40.5.1321	1996	Anti-Bacterial Agents/administration & dosage/pharmacokinetics/pharmacology, Colony Count, Microbial, Infusions, Intravenous, Injections, Intravenous, Models, Biological, Pseudomonas aeruginosa/drug effects, Tobramycin/administration & dosage/pharmacokinetics/pharmacology	Pathogenicity
Pathogenicity	8818906	Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin.	Marshall SA, Jones RN, Wanger A, Washington JA, Doern GV, Leber AL, Haugen TH	J Clin Microbiol	10.1128/jcm.34.8.2027-2029.1996	1996	Anti-Bacterial Agents/pharmacology, Dose-Response Relationship, Drug, Enterobacteriaceae/drug effects, Laboratories, Microbial Sensitivity Tests/standards/veterinary, Pseudomonas aeruginosa/drug effects, Quality Control, Staphylococcus aureus/drug effects
Pathogenicity	8843303	Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.	White RL, Burgess DS, Manduru M, Bosso JA	Antimicrob Agents Chemother	10.1128/AAC.40.8.1914	1996	Bacteria/drug effects, Cefepime, Ceftazidime/pharmacology, Cephalosporins/pharmacology, Ciprofloxacin/pharmacology, Drug Synergism, Drug Therapy, Combination/pharmacology, Enterobacter cloacae/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Tobramycin/pharmacology
Pathogenicity	8851592	Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa.	Cappelletty DM, Rybak MJ	Antimicrob Agents Chemother	10.1128/AAC.40.3.677	1996	Aminoglycosides, Anti-Bacterial Agents/pharmacology, Culture Media, Drug Combinations, Drug Resistance, Microbial, Drug Synergism, Lactams, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects, Time Factors	Cultivation
Enzymology	8857035	Physical mapping of several heat-shock genes in Pseudomonas aeruginosa and the cloning of the mopA (GroEL) gene.	Farinha MA, Mockett R, Went CJ, Jardine S, Naczynski LM, Kropinski AM	Can J Microbiol	10.1139/m96-048	1996	Amino Acid Sequence, Base Sequence, Chromosome Mapping, Cloning, Molecular, Genes, Bacterial/genetics, Heat-Shock Proteins/genetics, Molecular Sequence Data, Oligonucleotide Probes/chemical synthesis, Pseudomonas aeruginosa/genetics	Genetics
Pathogenicity	8890249	Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content.	Shafer WM, Hubalek F, Huang M, Pohl J	Infect Immun	10.1128/iai.64.11.4842-4845.1996	1996	Amino Acid Sequence, Anti-Bacterial Agents/chemistry/pharmacology, Arginine/analysis, Cathepsin G, Cathepsins/chemistry, Colony Count, Microbial, Humans, Intercellular Signaling Peptides and Proteins, Lysosomes/enzymology, Molecular Sequence Data, Peptides/chemistry/pharmacology, Proteins/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Serine Endopeptidases, Staphylococcus aureus/drug effects	Genetics
Enzymology	8892513	In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacteria representing the normal colonic flora in man.	Jokelainen K, Siitonen A, Jousimies-Somer H, Nosova T, Heine R, Salaspuro M	Alcohol Clin Exp Res	10.1111/j.1530-0277.1996.tb01932.x	1996	Acetaldehyde/metabolism, Alcohol Dehydrogenase/physiology, Bacteria, Aerobic/enzymology, Bacteriological Techniques, Colon/microbiology, Escherichia coli/enzymology, Ethanol/pharmacokinetics, Humans, Klebsiella/enzymology, Pseudomonas aeruginosa/enzymology	Pathogenicity
Pathogenicity	9006791	Synthesis and antimicrobial activity of electron rich olefin derived cyclic ureas.	Cetinkaya B, Cetinkaya E, Kucukbay H, Durmaz R	Arzneimittelforschung		1996	Alkenes/chemical synthesis/pharmacology, Anti-Bacterial Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Magnetic Resonance Spectroscopy, Mass Spectrometry, Microbial Sensitivity Tests, Spectrophotometry, Infrared, Urea/analogs & derivatives/*chemical synthesis/pharmacology
Pathogenicity	9069551	The effect of antimicrobial agents on the induction of tumour necrosis factor by alveolar macrophages in vitro in response to endotoxin.	Nwariaku FE, McIntyre KL, Sikes PJ, Mileski WJ	J Antimicrob Chemother	10.1093/jac/39.2.265	1997	Animals, Anti-Bacterial Agents/pharmacology, Lipopolysaccharides/pharmacology, Macrophages, Alveolar/drug effects/metabolism, Pseudomonas aeruginosa/pathogenicity, Rabbits, Tumor Necrosis Factor-alpha/biosynthesis	Metabolism
Pathogenicity	9105551	Synthesis and antimicrobial evaluation of indole containing derivatives of 1,3,4-thiadiazole, 1,2,4-triazole and their open-chain counterparts.	Tsotinis A, Varvaresou A, Calogeropoulou T, Siatra-Papastaikoudi T, Tiligada A	Arzneimittelforschung		1997	Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Fungi/drug effects, Indoles/chemical synthesis/pharmacology, Microbial Sensitivity Tests, Thiadiazoles/chemical synthesis/pharmacology, Triazoles/chemical synthesis/pharmacology
Pathogenicity	9125286	Antimicrobial activity of carbene complexes of rhodium(I) and ruthenium(II).	Cetinkaya B, Cetinkaya E, Kucukbay H, Durmaz R	Arzneimittelforschung		1996	Ampicillin/pharmacology, Anti-Bacterial Agents/pharmacology, Benzimidazoles/chemistry/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Hydrocarbons, Methane/analogs & derivatives/chemistry, Microbial Sensitivity Tests, Penicillins/pharmacology, Pseudomonas aeruginosa/drug effects, Rhodium/chemistry/pharmacology, Ruthenium/chemistry/pharmacology, Staphylococcus aureus/*drug effects
Pathogenicity	9150863	Synthesis and antimicrobial activity of 1-dialkylaminomethyl- 2-(p-substituted phenyl)-5-substituted benzimidazole derivatives.	Ersan S, Nacak S, Acar N, Noyanalpan N	Arzneimittelforschung		1997	Anti-Bacterial Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Benzimidazoles/chemical synthesis/pharmacology, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectrophotometry, Infrared, Sulfides
Pathogenicity	9181976	[The synergistic action of quaternary ammonium derivatives and inhibitors of nitrate reduction in respect to Pseudomonas aeruginosa].	Vievskii AN	Mikrobiol Z		1994	Aerobiosis/drug effects, Dose-Response Relationship, Drug, Drug Resistance, Microbial, Drug Synergism, Humans, Microbial Sensitivity Tests/methods, Nitrate Reductase, Nitrate Reductases/antagonists & inhibitors, Oxidation-Reduction/drug effects, Pseudomonas aeruginosa/drug effects/isolation & purification/metabolism, Quaternary Ammonium Compounds/*pharmacology	Enzymology
Pathogenicity	9248647	Does tea tree oil have a place in the topical treatment of burns?	Faoagali J, George N, Leditschke JF	Burns	10.1016/s0305-4179(96)00130-1	1997	Anti-Infective Agents, Local/pharmacology, Bacteria/drug effects, Burns/drug therapy, Enterococcus faecalis/drug effects/physiology, Escherichia coli/drug effects/physiology, Humans, Microbial Sensitivity Tests, Oils, Volatile/pharmacology, Plant Oils/*pharmacology, Plants, Medicinal, Pseudomonas aeruginosa/drug effects/physiology, Staphylococcus aureus/drug effects/physiology, Tea Tree Oil, Triclosan/pharmacology
Pathogenicity	9272392	Susceptibility testing quality control studies with fosfomycin tromethamine.	Fuchs PC, Barry AL, Brown SD	Eur J Clin Microbiol Infect Dis	10.1007/BF01708240	1997	Anti-Bacterial Agents/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Fosfomycin/analogs & derivatives/pharmacology, Gram-Positive Cocci/drug effects, Microbial Sensitivity Tests/methods/standards, Observer Variation, Pseudomonas aeruginosa/drug effects, Quality Control, Reproducibility of Results, Staphylococcus aureus/drug effects, Tromethamine/analogs & derivatives/pharmacology
Pathogenicity	9296284	Synthesis and antimicrobial activities of 2-[(alpha-methylbenzylidene)-hydrazino]benzoxazoles.	Ersan S, Nacak S, Berkem R, Ozden T	Arzneimittelforschung		1997	Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Benzoxazoles/chemical synthesis/pharmacology, Benzylidene Compounds/chemical synthesis/pharmacology, Candida/drug effects, Chemical Phenomena, Chemistry, Physical, Culture Media, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectrophotometry, Infrared	Cultivation
Pathogenicity	9311491	Nebulization and anti-Pseudomonas aeruginosa activity of colistin.	Diot P, Gagnadoux F, Martin C, Ellataoui H, Furet Y, Breteau M, Boissinot E, Lemarie E	Eur Respir J	10.1183/09031936.97.10091995	1997	Administration, Inhalation, Aerosols, Anti-Bacterial Agents/administration & dosage/pharmacology, Colistin/administration & dosage/pharmacology, Nebulizers and Vaporizers, Particle Size, Pseudomonas aeruginosa/*drug effects/growth & development, Technetium
Pathogenicity	9333065	Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa.	Nakano M, Deguchi T, Kawamura T, Yasuda M, Kimura M, Okano Y, Kawada Y	Antimicrob Agents Chemother	10.1128/AAC.41.10.2289	1997	Amino Acid Sequence, Anti-Infective Agents/pharmacology, Base Sequence, DNA, Bacterial/drug effects/genetics, Drug Resistance, Microbial/genetics, Fluoroquinolones, Genes, Bacterial/genetics, Molecular Sequence Data, Mutation/physiology, Polymerase Chain Reaction, Pseudomonas aeruginosa/drug effects/*genetics	Genetics
Pathogenicity	9466787	Failure of quality control measures to prevent reporting of false resistance to imipenem, resulting in a pseudo-outbreak of imipenem-resistant Pseudomonas aeruginosa.	Carmeli Y, Eichelberger K, Soja D, Dakos J, Venkataraman L, DeGirolami P, Samore M	J Clin Microbiol	10.1128/JCM.36.2.595-597.1998	1998	Case-Control Studies, Diagnostic Errors, Disease Outbreaks, Drug Resistance, Microbial, False Positive Reactions, Imipenem/pharmacology, Microbial Sensitivity Tests/methods, Pseudomonas Infections/diagnosis/drug therapy/epidemiology, Pseudomonas aeruginosa/drug effects, Quality Control, Thienamycins/pharmacology
Pathogenicity	9553688	Antibacterial activity of rhodium, iridium, and ruthenium tripodal phosphine complexes.	Sulu M, Kucukbay H, Durmaz R, Gunal S	Arzneimittelforschung		1998	Anti-Bacterial Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Chemical Phenomena, Chemistry, Physical, Iridium/pharmacology, Microbial Sensitivity Tests, Molecular Conformation, Organometallic Compounds/*chemical synthesis/pharmacology, Rhodium/pharmacology, Ruthenium/pharmacology
Pathogenicity	9624477	Changes in MIC alter responses of Pseudomonas aeruginosa to tobramycin exposure.	Ioannides-Demos LL, Liolios L, Wood P, Spicer WJ, McLean AJ	Antimicrob Agents Chemother	10.1128/AAC.42.6.1365	1998	Anti-Bacterial Agents/administration & dosage/pharmacology, Humans, Microbial Sensitivity Tests, Pseudomonas/drug effects, Pseudomonas aeruginosa/drug effects, Time Factors, Tobramycin/administration & dosage/*pharmacology
Pathogenicity	9630409	Application of X-ray micrography and imaging to study the effect of gentamicin on Pseudomonas aeruginosa.	Rajyaguru JM, Torres DS, Abel E, Richardson MC, Muszynski MJ	J Antimicrob Chemother	10.1093/jac/41.5.557	1998	Anti-Bacterial Agents/pharmacology, Gentamicins/pharmacology, Lasers, Microscopy, Atomic Force, Pseudomonas aeruginosa/*drug effects/ultrastructure, X-Rays
Metabolism	9666179	The synthesis and antibacterial activity of two pyoverdin-ampicillin conjugates, entering Pseudomonas aeruginosa via the pyoverdin-mediated iron uptake pathway.	Kinzel O, Tappe R, Gerus I, Budzikiewicz H	J Antibiot (Tokyo)	10.7164/antibiotics.51.499	1998	Ampicillin/chemical synthesis/metabolism, Anti-Bacterial Agents/chemistry/metabolism/pharmacology, Iron/metabolism, Iron Chelating Agents/chemical synthesis/chemistry/metabolism, Magnetic Resonance Spectroscopy, Mass Spectrometry, Microbial Sensitivity Tests, Molecular Structure, Oligopeptides, Pigments, Biological/chemical synthesis/chemistry/metabolism, Pseudomonas aeruginosa/metabolism, Siderophores/chemical synthesis/chemistry/metabolism
Metabolism	9721671	The effect of sulindac on arylamine N-acetyltransferase activity in Pseudomonas aeruginosa.	Lo HH, Hsieh SE, Chung JG	Microbios		1998	Anti-Inflammatory Agents, Non-Steroidal/pharmacology, Arylamine N-Acetyltransferase/antagonists & inhibitors/metabolism, Bacterial Proteins/antagonists & inhibitors/metabolism, Carcinogens/metabolism, Chromatography, High Pressure Liquid, Fluorenes/metabolism, Humans, Pseudomonas aeruginosa/drug effects/enzymology, Sulindac/*pharmacology, Time Factors	Pathogenicity
Pathogenicity	9791759	In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.	Jones RN, Erwin ME	Diagn Microbiol Infect Dis	10.1016/s0732-8893(98)00063-7	1998	Animals, Anti-Infective Agents/pharmacology/therapeutic use, Chickens, Ciprofloxacin/analogs & derivatives/pharmacology/therapeutic use, Escherichia coli/drug effects, Escherichia coli Infections/drug therapy/veterinary, Fluoroquinolones, Humans, Infection Control, Microbial Sensitivity Tests/standards, Poultry Diseases/*drug therapy, Quality Control
	9875990	The role of Pseudomonas aeruginosa biofilm in the attachment of Acanthamoeba to four types of hydrogel contact lens materials.	Simmons PA, Tomlinson A, Seal DV	Optom Vis Sci	10.1097/00006324-199812000-00007	1998	Acanthamoeba/physiology, Adsorption, Animals, Biofilms, Cell Adhesion, Contact Lenses/parasitology, Hydrogel, Polyethylene Glycol Dimethacrylate, Pseudomonas aeruginosa/physiology
Pathogenicity	10049262	Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.	Kamberi M, Tsutsumi K, Kotegawa T, Kawano K, Nakamura K, Niki Y, Nakano S	Antimicrob Agents Chemother	10.1128/AAC.43.3.525	1999	Adult, Anti-Infective Agents/pharmacokinetics/pharmacology/urine, Area Under Curve, Calcium/urine, Chromatography, Gas, Ciprofloxacin/pharmacokinetics/pharmacology/urine, Culture Media, Escherichia coli/drug effects, *Fluoroquinolones, Half-Life, Humans, Hydrogen-Ion Concentration, Magnesium/urine, Male, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects	Enzymology
	10212751	Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group.	Jones RN, Kugler KC, Erwin ME, Biedenbach DJ, Beach ML, Pfaller MA	Diagn Microbiol Infect Dis	10.1016/s0732-8893(98)00086-8	1999	Anti-Infective Agents/chemistry/pharmacology, Fluoroquinolones, Gatifloxacin, Least-Squares Analysis, Microbial Sensitivity Tests/methods/*standards, Molecular Structure, Quality Control
Pathogenicity	10325322	The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.	Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A	J Clin Microbiol	10.1128/JCM.37.6.1771-1776.1999	1999	Alberta, Anti-Bacterial Agents/pharmacology, Biofilms, Escherichia coli/drug effects/growth & development/ultrastructure, Laboratories/standards, Microbial Sensitivity Tests/instrumentation/methods/standards, Pseudomonas aeruginosa/drug effects/growth & development, Quality Control, Reproducibility of Results, Sensitivity and Specificity, Staphylococcus aureus/*drug effects/growth & development
Pathogenicity	10326736	New derivatives of benzimidazole and their antimicrobial activity.	Cetinkaya E, Alici B, Gok Y, Durmaz R, Gunal S	J Chemother	10.1179/joc.1999.11.2.83	1999	Anti-Bacterial Agents/pharmacology, Benzimidazoles/pharmacology, Dose-Response Relationship, Drug, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	10348766	In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens.	Schwab U, Gilligan P, Jaynes J, Henke D	Antimicrob Agents Chemother	10.1128/AAC.43.6.1435	1999	Amino Acid Sequence, Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Cystic Fibrosis/microbiology, Drug Resistance, Microbial, Drug Resistance, Multiple, Humans, Microbial Sensitivity Tests, Molecular Sequence Data, Osmolar Concentration, Peptides	Genetics
Metabolism	10368165	Uptake of pyocin S3 occurs through the outer membrane ferripyoverdine type II receptor of Pseudomonas aeruginosa.	Baysse C, Meyer JM, Plesiat P, Geoffroy V, Michel-Briand Y, Cornelis P	J Bacteriol	10.1128/JB.181.12.3849-3851.1999	1999	Bacterial Outer Membrane Proteins/biosynthesis/genetics/metabolism, Bacterial Proteins/metabolism/pharmacology, Biological Transport, Cell Membrane/metabolism, Cystic Fibrosis/microbiology, Humans, Iron/metabolism, Iron Chelating Agents/pharmacology, Mutagenesis, Insertional, Oligopeptides, Pigments, Biological/pharmacology, Pseudomonas aeruginosa/drug effects/isolation & purification/*physiology, Pyocins/metabolism/pharmacology	Pathogenicity
Pathogenicity	10387947	New cytokine dressings. II. Stimulation of oxidative burst in leucocytes in vitro and reduction of viable bacteria within an infected wound.	Grzybowski J, Janiak MK, Oldak E, Lasocki K, Wrembel-Wargocka J, Cheda A, Antos-Bielska M, Pojda Z	Int J Pharm	10.1016/s0378-5173(99)00064-2	1999	Animals, Bacteria/drug effects, Bandages, Cytokines/administration & dosage/pharmacology, Drug Delivery Systems, Epidermal Growth Factor/administration & dosage/pharmacology, Flow Cytometry, Granulocyte Colony-Stimulating Factor/administration & dosage/pharmacology, Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage/pharmacology, Humans, Leukocyte Count, Leukocytes/drug effects/metabolism, Mice, Mice, Inbred C3H, Phagocytosis/drug effects, Recombinant Proteins/administration & dosage/pharmacology, Respiratory Burst/drug effects, Wound Healing/drug effects, Wounds and Injuries/*microbiology	Metabolism
Pathogenicity	10417872	Antibacterial and antifungal activities of complexes of ruthenium (II).	Cetinkaya B, Ozdemir I, Binbasioglu B, Durmaz R, Gunal S	Arzneimittelforschung	10.1055/s-0031-1300457	1999	Anti-Bacterial Agents, Anti-Infective Agents/pharmacology, Antifungal Agents/pharmacology, Bacteria/drug effects, Fungi/drug effects, Microbial Sensitivity Tests, Ruthenium Compounds/*pharmacology, Structure-Activity Relationship
Enzymology	10445164	The effects of ellagic acid on arylamine N-acetyltransferase activity in the bacterium Pseudomonas aeruginosa.	Lo HH, Hsieh SE, Tsai KJ, Chung JG	Drug Chem Toxicol	10.3109/01480549909042532	1999	Anticarcinogenic Agents/pharmacology, Arylamine N-Acetyltransferase/antagonists & inhibitors, Dose-Response Relationship, Drug, Ellagic Acid/pharmacology, Enzyme Inhibitors/pharmacology, Kinetics, Pseudomonas aeruginosa/*enzymology
Pathogenicity	10487435	Decontamination of human sclera: an in vitro study.	Lucci LM, Yu MC, Hofling-Lima AL	Cornea	00003226-199909000-00011	1999	Bacillus cereus/drug effects/growth & development, Benzalkonium Compounds/pharmacology, Colony Count, Microbial, Decontamination/methods, Drug Resistance, Microbial, Ethanol/pharmacology, Glycerol/pharmacology, Humans, Microbial Sensitivity Tests, Preservatives, Pharmaceutical/pharmacology, Pseudomonas aeruginosa/drug effects/growth & development, Sclera/microbiology, Staphylococcus aureus/drug effects/growth & development, Tissue Preservation
Pathogenicity	10543420	Reduction of the bacterial load by the silver-coated endotracheal tube (SCET), a laboratory investigation.	Hartmann M, Guttmann J, Muller B, Hallmann T, Geiger K	Technol Health Care		1999	Bacterial Infections/prevention & control/transmission, Equipment Contamination/prevention & control, Humans, Intubation, Intratracheal/adverse effects, Models, Biological, Pneumonia/etiology/prevention & control, Pseudomonas aeruginosa/drug effects, Respiration, Artificial/adverse effects, Silver/*therapeutic use
Pathogenicity	10552980	In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.	Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G	J Antimicrob Chemother	10.1093/jac/44.5.641	1999	Anti-Bacterial Agents/pharmacology, Antimicrobial Cationic Peptides, Colony Count, Microbial, Drug Resistance, Microbial/genetics, Drug Synergism, Drug Therapy, Combination, Humans, Magainins, Microbial Sensitivity Tests, Nisin/pharmacology, Peptides/pharmacology, Peptides, Cyclic/pharmacology, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/drug effects/genetics/growth & development, *Xenopus Proteins
Pathogenicity	10618141	Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.	Odland BA, Erwin ME, Jones RN	J Clin Microbiol	10.1128/JCM.38.1.453-455.2000	2000	Aminoglycosides, Anti-Bacterial Agents/pharmacology, Fluoroquinolones, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Macrolides, Microbial Sensitivity Tests/standards/veterinary, Quality Control
Enzymology	10674258	[Inter-laboratory reproducibility of pulsed-field electrophoresis for the study of 12 types of Pseudomonas aeruginosa].	Foissaud V, Puyhardy JM, Chapalain JC, Salord H, Depina JJ, Morillon M, Nicolas P, Perrier-Gros-Claude JD	Pathol Biol (Paris)		1999	Electrophoresis, Gel, Pulsed-Field/methods/standards, France, Genetic Linkage, Genotype, Humans, Laboratories/standards, Phylogeny, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/classification/genetics/isolation & purification, Quality Assurance, Health Care, Reproducibility of Results	Phylogeny
Phylogeny	10876646	Antimicrobial properties of copper-coated electroconductive polyester fibers.	Grzybowski J, Trafny EA	Polim Med		1999	Antisepsis/methods, Colony Count, Microbial, Copper, Electric Conductivity, Fungi/growth & development, Materials Testing, Microbial Sensitivity Tests, Polyesters, Pseudomonas aeruginosa/growth & development, Species Specificity, Staphylococcus aureus/growth & development, Textiles
Pathogenicity	10947319	Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.	Todisco T, Eslami A, Baglioni S, Sposini T, Tascini C, Sommer E, Knoch M	J Aerosol Med	10.1089/jam.2000.13.11	2000	Aerosols, Anti-Bacterial Agents/administration & dosage/pharmacology, Escherichia coli/drug effects, Imipenem/administration & dosage/pharmacology, Microbial Sensitivity Tests, Nebulizers and Vaporizers, Particle Size, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Streptomycin/administration & dosage/pharmacology, Thienamycins/administration & dosage/pharmacology, Tobramycin/administration & dosage/*pharmacology
Pathogenicity	11189310	[Antibacterial activity of histidine-rich polypeptides in human parotid saliva].	Wu Q, Yang M, Zhong D	Zhonghua Kou Qiang Yi Xue Za Zhi		1997	Escherichia coli/drug effects, Parotid Gland/metabolism, Proteins/isolation & purification/pharmacology, Pseudomonas aeruginosa/drug effects, Saliva/chemistry/metabolism, Salivary Proteins and Peptides/isolation & purification/pharmacology, Staphylococcus aureus/drug effects, Streptococcus mutans/*drug effects	Metabolism
Pathogenicity	11199762	In vitro evaluation of antimicrobial activity of sealers and pastes used in endodontics.	Leonardo MR, da Silva LA, Tanomaru Filho M, Bonifacio KC, Ito IY	J Endod	10.1097/00004770-200007000-00003	2000	Adult, Bacteria/drug effects, Barium Sulfate/chemistry, Bismuth/chemistry, Borates/chemistry, Calcium Chloride, Calcium Hydroxide/chemistry, Colony Count, Microbial, Dental Leakage/prevention & control, Drug Combinations, Enterococcus faecalis/drug effects, Epoxy Resins/chemistry, Escherichia coli/drug effects, Eugenol/chemistry, Glass Ionomer Cements/chemistry, Humans, Immunodiffusion, Microbial Sensitivity Tests, Micrococcus luteus/drug effects, Potassium Chloride, Pseudomonas aeruginosa/drug effects, Resins, Synthetic/chemistry, Root Canal Filling Materials/chemistry/pharmacology, Salicylates/chemistry, Saliva/microbiology, Sodium Bicarbonate, Sodium Chloride, Staphylococcus/drug effects, Streptococcus mutans/drug effects, Zinc Oxide/chemistry
Pathogenicity	11210272	Antimicrobial and chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and Dycal.	Estrela C, Bammann LL, Estrela CR, Silva RS, Pecora JD	Braz Dent J		2000	Aluminum Compounds/analysis/chemistry/pharmacology, Anti-Bacterial Agents, Anti-Infective Agents/pharmacology, Bacillus subtilis/drug effects, Calcium Compounds/analysis/chemistry/pharmacology, Calcium Hydroxide/chemistry/pharmacology, Candida albicans/drug effects, Dental Cements/analysis/chemistry/pharmacology, Dental Pulp Capping, Diffusion, Drug Combinations, Enterococcus faecalis/drug effects, Humans, Minerals/chemistry/pharmacology, Oxides/analysis/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Root Canal Filling Materials/chemistry/*pharmacology, Salicylates/chemistry/pharmacology, Silicates/analysis/chemistry/pharmacology, Spectrometry, Fluorescence, Staphylococcus aureus/drug effects
Pathogenicity	11266409	Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar.	Dominguez MC, de La Rosa M, Borobio MV	J Antimicrob Chemother	10.1093/jac/47.4.391	2001	Agar, Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Bacteria/drug effects/growth & development, Ciprofloxacin/pharmacology, Colony Count, Microbial, Escherichia coli/drug effects/growth & development, Gentamicins/pharmacology, Kinetics, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Spectrophotometry/methods, Staphylococcus aureus/drug effects/growth & development	Enzymology
Enzymology	11328773	In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model.	Robaux MA, Dube L, Caillon J, Bugnon D, Kergueris MF, Navas D, Le Conte P, Baron D, Potel G	J Antimicrob Chemother	10.1093/jac/47.5.617	2001	Amikacin/administration & dosage/pharmacokinetics/therapeutic use, Animals, Anti-Bacterial Agents/administration & dosage/pharmacokinetics/therapeutic use, Ceftazidime/administration & dosage/pharmacokinetics/therapeutic use, Cephalosporins/administration & dosage/pharmacokinetics/therapeutic use, Colony Count, Microbial, Disease Models, Animal, Endocarditis, Bacterial/*drug therapy/metabolism, Female, Humans, Kinetics, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Rabbits	Pathogenicity
Cultivation	11405651	Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific Therapy against Pseudomonas aeruginosa.	Hennard C, Truong QC, Desnottes JF, Paris JM, Moreau NJ, Abdallah MA	J Med Chem	10.1021/jm990508g	2001	Anti-Infective Agents/chemical synthesis/pharmacology, Chromatography, High Pressure Liquid, Culture Media, Enzyme Inhibitors/chemical synthesis/pharmacology, Iron/metabolism, Iron Chelating Agents/chemical synthesis/pharmacology, Kinetics, Microbial Sensitivity Tests, Mutation/drug effects, Norfloxacin/chemical synthesis/pharmacology, Oligopeptides, Pigments, Biological/chemical synthesis/pharmacology, Pseudomonas aeruginosa/drug effects/genetics/growth & development, Spectrophotometry, Ultraviolet, Structure-Activity Relationship, Topoisomerase II Inhibitors	Enzymology
Pathogenicity	11413744	Synthesis of some benzimidazole derivatives and their antibacterial and antifungal activities.	Kucukbay H, Durmaz R, Guven M, Gunal S	Arzneimittelforschung	10.1055/s-0031-1300057	2001	Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Benzimidazoles/chemical synthesis/pharmacology, Candida/drug effects, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectroscopy, Fourier Transform Infrared, Structure-Activity Relationship
Metabolism	11518582	Biosynthesis and structural characterization of medium-chain-length poly(3-hydroxyalkanoates) produced by Pseudomonas aeruginosa from fatty acids.	Ballistreri A, Giuffrida M, Guglielmino SP, Carnazza S, Ferreri A, Impallomeni G	Int J Biol Macromol	10.1016/s0141-8130(01)00154-4	2001	Chromatography, Gas, Fatty Acids/metabolism, Macromolecular Substances, Magnetic Resonance Spectroscopy, Molecular Structure, Molecular Weight, Polyesters/chemistry/metabolism, Pseudomonas aeruginosa/chemistry/*metabolism, Spectrometry, Mass, Fast Atom Bombardment
Pathogenicity	11533009	Effect of serum from different patient populations on the serum bactericidal test.	Kays MB, White RL, Friedrich LV	J Antimicrob Chemother	10.1093/jac/48.3.417	2001	Adult, Burns/blood, Ceftazidime/blood/pharmacology, Cephalosporins/blood/pharmacology, Escherichia coli/drug effects, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Neutropenia/blood, Pseudomonas aeruginosa/drug effects, *Serum Bactericidal Test, Uremia/blood
Pathogenicity	11570902	Method preferences and test accuracy of antimicrobial susceptibility testing: updates from the College of Amercian Pathologists Microbiology Surveys Program.	Jones RN	Arch Pathol Lab Med	10.5858/2001-125-1285-MPATAO	2001	Anti-Bacterial Agents/administration & dosage/pharmacology, Data Collection, Escherichia coli/drug effects/growth & development, Humans, Laboratories/standards, Microbial Sensitivity Tests/methods/standards, Penicillins/administration & dosage/pharmacology, Pseudomonas/drug effects/growth & development, Quality Control, Reproducibility of Results, Sensitivity and Specificity, Streptococcus pneumoniae/drug effects/growth & development
Pathogenicity	11741112	Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.	Yanyali A, Cetin S, Talu H, Vahaboglu H	Ophthalmologica	10.1159/000050905	2001	Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Cefazolin/pharmacology, Ceftazidime/pharmacology, Cephalosporins/pharmacology, Drug Synergism, Endophthalmitis/microbiology, Microbial Sensitivity Tests, Ofloxacin/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Sulfur Hexafluoride/*pharmacology, Tobramycin/pharmacology
Pathogenicity	11771575	Two methods to evaluate the antimicrobial action of calcium hydroxide paste.	Estrela C, Rodrigues de Araujo Estrela C, Bammann LL, Pecora JD	J Endod	10.1097/00004770-200112000-00002	2001	Analysis of Variance, Bacillus subtilis/drug effects, Calcium Hydroxide/pharmacology, Candida albicans/drug effects, Enterococcus faecalis/drug effects, Microbial Sensitivity Tests/methods, Pharmaceutical Vehicles, Pseudomonas aeruginosa/drug effects, Root Canal Irrigants/*pharmacology, Staphylococcus aureus/drug effects, Statistics, Nonparametric
Pathogenicity	11777665	Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.	Biedenbach DJ, Jones RN	Diagn Microbiol Infect Dis	10.1016/s0732-8893(01)00294-2	2001	Anti-Infective Agents/chemistry/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Fluoroquinolones, Haemophilus influenzae/drug effects, Indoles, Microbial Sensitivity Tests, Molecular Structure, Pseudomonas aeruginosa/drug effects, Quality Control, Quinolones, Staphylococcus aureus/drug effects, Streptococcus pneumoniae/drug effects
Pathogenicity	11802985	[Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].	Xu Z, Liu F, Wang X	Zhonghua Jie He He Hu Xi Za Zhi		2001	Anti-Bacterial Agents/pharmacology, Biofilms/drug effects/growth & development, Erythromycin/pharmacology, Fosfomycin/pharmacology, Humans, Microbial Sensitivity Tests, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/*drug effects/physiology/ultrastructure
Pathogenicity	11815586	Reproducibility of control organism zone diameters for batches of IsoSensitest agar manufactured from 1996 to 2000 using the BSAC disc susceptibility test method.	Landrygan J, James PA, Brooks D, Kubiak EM	J Antimicrob Chemother	10.1093/jac/49.2.391	2002	Agar/analysis, Anti-Bacterial Agents/pharmacology, Culture Media/analysis, Escherichia coli/drug effects/growth & development, Microbial Sensitivity Tests/methods/*statistics & numerical data/trends, Pseudomonas aeruginosa/growth & development, Staphylococcus aureus/drug effects/growth & development	Cultivation
Metabolism	11828997	Differential involvement of reactive oxygen species and myeloperoxidase in oxygen-dependent killing of urinary tract bacterial isolates by polymorphonuclear leukocytes.	Oh-oka H, Fujisawa M, Okada H, Arakawa S, Kamidono S	Urol Res	10.1007/s002400100217	2001	Humans, Luminescent Measurements, Neutrophils/enzymology/microbiology, Peroxidase/metabolism, Pseudomonas Infections/immunology/metabolism, Pseudomonas aeruginosa/growth & development, Reactive Oxygen Species/metabolism, Regression Analysis, Urinary Tract Infections/*immunology/metabolism	Pathogenicity
Pathogenicity	11845118	[In vitro antimicrobial activity of glutaraldehyde plus O-phenylphenol association (ratio 2:1)].	D'Ercole S, Catamo G, De Fazio P, Piccolomini R	Minerva Stomatol		2002	Anti-Bacterial Agents, Bacteria/drug effects, Biphenyl Compounds, Disinfectants, *Glutaral, Microbial Sensitivity Tests
Pathogenicity	12043862	Bacteriologic evaluation of the effect of Nd:YAG laser irradiation in experimental infected root canals.	Piccolomini R, D'Arcangelo C, D'Ercole S, Catamo G, Schiaffino G, De Fazio P	J Endod	10.1097/00004770-200204000-00004	2002	Actinomyces/growth & development/radiation effects, Aluminum Silicates, Chi-Square Distribution, Colony Count, Microbial, Dental Pulp Cavity/microbiology, Disinfectants/therapeutic use, Humans, Laser Therapy, Neodymium, Pseudomonas aeruginosa/growth & development/radiation effects, Root Canal Irrigants/therapeutic use, Root Canal Preparation/methods, Sodium Hypochlorite/therapeutic use, Statistics as Topic, Sterilization/*methods, Yttrium
Pathogenicity	12058815	Synthesis and antimicrobial activities of N-substituted imides.	Zentz F, Valla A, Le Guillou R, Labia R, Mathot AG, Sirot D	Farmaco	10.1016/s0014-827x(02)01217-x	2002	Anti-Bacterial Agents/chemical synthesis/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, In Vitro Techniques, Maleimides/chemical synthesis/chemistry/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Succinimides/chemical synthesis/chemistry/*pharmacology
Pathogenicity	12064055	Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives.	Raffa D, Migliara O, Daidone G, Maggio B, Schillaci D	Boll Chim Farm		2002	Acetamides/chemical synthesis/pharmacology, Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Fungi/drug effects, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Indicators and Reagents, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Phenyl Ethers/chemical synthesis/pharmacology
Pathogenicity	12120877	Remarkable substituent effects on antimicrobial activities of 1,3-diorganylimidazolidinium salts.	Cetinkaya E, Denizci A, Ozdemir I, Ozturk HT, Karaboz I, Cetinkaya B	J Chemother	10.1179/joc.2002.14.3.241	2002	Anti-Bacterial Agents, Anti-Infective Agents/chemistry/pharmacology/therapeutic use, Candida albicans/drug effects, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Imidazoles/chemistry/*pharmacology/therapeutic use, Microbial Sensitivity Tests, Structure-Activity Relationship
Pathogenicity	12239838	Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital.	Mathur P, Kapil A, Das B, Dhawan B	Indian J Med Res		2002	Cross Infection/epidemiology, Gram-Negative Bacteria/metabolism, Gram-Negative Bacterial Infections/epidemiology/microbiology, Humans, India/epidemiology, Prevalence, beta-Lactamases/*biosynthesis	Metabolism
Pathogenicity	12384367	Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection.	Bonapace CR, Friedrich LV, Bosso JA, White RL	Antimicrob Agents Chemother	10.1128/AAC.46.11.3574-3579.2002	2002	Animals, Anti-Bacterial Agents/pharmacokinetics/pharmacology, Bacillus subtilis/drug effects, Bacterial Infections/drug therapy/microbiology, Colony Count, Microbial, Linear Models, Mice, Microbial Sensitivity Tests, Models, Biological, Neutropenia/complications/microbiology, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects, Time Factors	Enzymology
Pathogenicity	12385686	Re-evaluations of disk diffusion quality control ranges for 11 drugs: report from the QC working group of the national committee for clinical laboratory standards.	Jones RN, Cullen S	Int J Antimicrob Agents	10.1016/s0924-8579(02)00184-x	2002	Anti-Bacterial Agents/pharmacology, Escherichia coli/drug effects, Guidelines as Topic, Laboratories, Microbial Sensitivity Tests/standards, Pseudomonas aeruginosa/drug effects, Quality Control, Quinolones/pharmacology, Reference Standards
Metabolism	12392822	Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection.	Omri A, Suntres ZE, Shek PN	Biochem Pharmacol	10.1016/s0006-2952(02)01346-1	2002	Animals, Anti-Bacterial Agents/administration & dosage/pharmacokinetics/therapeutic use, Disease Models, Animal, Drug Carriers, Drug Delivery Systems, Kidney/metabolism, Liposomes, Lung Diseases/drug therapy/metabolism/physiopathology, Microbial Sensitivity Tests, Organ Size/drug effects, Peptidyl-Dipeptidase A/metabolism, Peroxidase/metabolism, Phospholipases A/metabolism, Polymyxin B/administration & dosage/pharmacokinetics/therapeutic use, Pseudomonas Infections/*drug therapy, Pseudomonas aeruginosa/drug effects, Rats, Rats, Sprague-Dawley	Enzymology
Pathogenicity	12442642	Synthesis and antimicrobial activity evaluation of some new adamantane derivatives.	Calis U, Yarim M, Koksal M, Ozalp M	Arzneimittelforschung		2002	Adamantane/chemical synthesis/pharmacology, Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Candida/drug effects, Fungi/drug effects, Indicators and Reagents, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectrophotometry, Infrared, Spectroscopy, Fourier Transform Infrared, Structure-Activity Relationship
Cultivation	12507381	Morphologic variations in bacteria under stress conditions: near-field optical studies.	Cefali E, Patane S, Arena A, Saitta G, Guglielmino S, Cappello S, Nicolo M, Allegrini M	Scanning	10.1002/sca.4950240601	2002	Biomass, Colony Count, Microbial, Culture Media, Microscopy, Electron, Scanning/methods, Microscopy, Phase-Contrast, Pseudomonas aeruginosa/growth & development/physiology/ultrastructure	Stress
Pathogenicity	12539290	[Isolation, purification and antibacterial activities of salivary histidine-rich polypeptides].	Luo H, Huang N, Yang M, Tang B, Wu Q, Wang B	Hua Xi Kou Qiang Yi Xue Za Zhi		1999	Adult, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Histidine, Humans, Peptides, Pseudomonas aeruginosa/drug effects, Salivary Proteins and Peptides/isolation & purification/pharmacology, Staphylococcus aureus/drug effects, Streptococcus mutans/*drug effects	Enzymology
Enzymology	12669966	In vitro evaluation of nebulization properties, antimicrobial activity, and regional airway surface liquid concentration of liposomal polymyxin B sulfate.	Desai TR, Tyrrell GJ, Ng T, Finlay WH	Pharm Res	10.1023/a:1022664406840	2003	Anti-Bacterial Agents/administration & dosage/pharmacokinetics/pharmacology, Chemistry, Pharmaceutical, Forecasting, In Vitro Techniques, Liposomes, Lung/metabolism, Mathematics, Models, Biological, Nebulizers and Vaporizers, Particle Size, Polymyxin B/*administration & dosage/pharmacokinetics/pharmacology, Pseudomonas aeruginosa/drug effects, Respiratory Mucosa/metabolism, Surface Properties, Surface-Active Agents/chemistry	Metabolism
Pathogenicity	12741434	Assessment of differences in antimicrobial effect determined with two in vitro pharmacodynamic models: impact of surface area to volume ratio.	White RL, Bonapace CR, Friedrich LV, Rybak MJ, Cappelletty DM, Mercier RC, Houlihan HH, Aeschlimann JR, Bosso JA	Pharmacotherapy	10.1592/phco.23.5.603.32193	2003	Anti-Bacterial Agents/pharmacology, Area Under Curve, Ceftazidime/pharmacology, Microbial Sensitivity Tests, Models, Biological, Pilot Projects, Pseudomonas aeruginosa/drug effects, Surface Properties, Time Factors
	12767382	Synthesis, antibacterial and antifungal activities of electron-rich olefins derived benzimidazole compounds.	Kucukbay H, Durmaz R, Orhan E, Gunal S	Farmaco	10.1016/S0014-827X(03)00068-5	2003	Alkenes/chemical synthesis/pharmacology, Anti-Bacterial Agents/chemical synthesis/pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Benzimidazoles/chemical synthesis/pharmacology, *Electrons, Microbial Sensitivity Tests/methods
Pathogenicity	12787962	Screening of anti-bacterial activity of medicinal plants from Belize (Central America).	Camporese A, Balick MJ, Arvigo R, Esposito RG, Morsellino N, De Simone F, Tubaro A	J Ethnopharmacol	10.1016/s0378-8741(03)00115-6	2003	Anti-Bacterial Agents/isolation & purification/pharmacology, Aristolochia/chemistry, Belize, Bursera/chemistry, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Hamelia/chemistry, Humans, Malvaceae/*chemistry, Microbial Sensitivity Tests, Plant Bark/chemistry, Plant Extracts/pharmacology, Plant Leaves/chemistry, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects	Enzymology
Metabolism	12871724	Enhanced microbial biomass assay using mutant luciferase resistant to benzalkonium chloride.	Hattori N, Sakakibara T, Kajiyama N, Igarashi T, Maeda M, Murakami S	Anal Biochem	10.1016/s0003-2697(03)00322-1	2003	Adenosine Triphosphate/analysis/metabolism, Benzalkonium Compounds/chemistry/pharmacology, Biomass, Colony Count, Microbial, Drug Resistance, Bacterial, Gram-Negative Bacteria/growth & development/metabolism, Gram-Positive Bacteria/growth & development/metabolism, Kinetics, Luciferases/analysis/genetics/metabolism, Luminescent Measurements, Trichloroacetic Acid/chemistry	Enzymology
Pathogenicity	12960550	Bacterial reduction by cell salvage washing and leukocyte depletion filtration.	Waters JH, Tuohy MJ, Hobson DF, Procop G	Anesthesiology	10.1097/00000542-200309000-00021	2003	Blood/microbiology, Blood Preservation/methods, Cell Separation/methods, Colony Count, Microbial, Filtration, Humans, In Vitro Techniques, Leukocytes/physiology
Pathogenicity	13679097	Essential oil analysis and antimicrobial activity of eight Stachys species from Greece.	Skaltsa HD, Demetzos C, Lazari D, Sokovic M	Phytochemistry	10.1016/s0031-9422(03)00386-8	2003	Anti-Infective Agents/analysis/chemistry/pharmacology, Escherichia coli/drug effects, Fungi/drug effects, Gas Chromatography-Mass Spectrometry, Gram-Positive Bacteria/drug effects, Greece, Hydrocarbons/analysis/chemistry/pharmacology, Microbial Sensitivity Tests, Oils, Volatile/analysis/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Stachys/*chemistry/classification	Phylogeny
Pathogenicity	14769216	PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.	Yang YX, Feng Y, Wang BY, Wu Q	Acta Pharmacol Sin		2004	Amino Acid Sequence, Anti-Bacterial Agents/pharmacology, Antimicrobial Cationic Peptides, Base Sequence, DNA, Complementary/genetics, Escherichia coli/drug effects/genetics, Genetic Vectors, Hemolysis/drug effects, Humans, Molecular Sequence Data, Mutagenesis, Site-Directed, Peptides/genetics/isolation & purification/pharmacology, Pseudomonas aeruginosa/drug effects	Genetics
Cultivation	14979611	Synthesis and antibacterial activities of new bis-benzimidazoles.	Kucukbay H, Durmaz R, Okuyucu N, Gunal S, Kazaz C	Arzneimittelforschung	10.1055/s-0031-1296938	2004	Anti-Bacterial Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Benzimidazoles/chemical synthesis/*pharmacology, Culture Media, Indicators and Reagents, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectrophotometry, Infrared, Spectroscopy, Fourier Transform Infrared, Structure-Activity Relationship	Pathogenicity
Metabolism	15183885	Differences in biofilm and planktonic cell mediated reduction of metalloid oxyanions.	Harrison JJ, Ceri H, Stremick C, Turner RJ	FEMS Microbiol Lett	10.1016/j.femsle.2004.05.005	2004	Animals, Biofilms/drug effects/growth & development, Culture Media, Drug Resistance, Bacterial, Metals, Heavy/metabolism/pharmacology, Oxidation-Reduction, Plankton/drug effects/growth & development/metabolism, Pseudomonas aeruginosa/drug effects/genetics/metabolism, Sodium Selenite/metabolism/pharmacology, Staphylococcus aureus/drug effects/growth & development/*metabolism, Tellurium/metabolism/pharmacology	Pathogenicity
Pathogenicity	15216473	Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.	Cirioni O, Giacometti A, Ghiselli R, Orlando F, Kamysz W, D'Amato G, Mocchegiani F, Lukasiak J, Silvestri C, Saba V, Scalise G	J Infect Dis	10.1086/421913	2004	Abdominal Cavity/pathology, Animals, Antimicrobial Cationic Peptides/chemistry/pharmacology/therapeutic use, Disease Models, Animal, Endotoxins/blood, Histatins, Imipenem/administration & dosage/therapeutic use, Male, Microbial Sensitivity Tests, Plasma/microbiology, Polymyxins/administration & dosage/therapeutic use, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects/growth & development, Rats, Rats, Wistar, Salivary Proteins and Peptides/administration & dosage/pharmacology/therapeutic use, Sepsis/drug therapy/microbiology, Survival Analysis, Tumor Necrosis Factor-alpha/analysis
Metabolism	15296164	Comparative biodegradation examination of Pseudomonas aeruginosa (ATCC 27853) and other oil degraders on hydrocarbon contaminated soil.	Szoboszlay S, Atzel B, Kriszt B	Commun Agric Appl Biol Sci		2003	Biodegradation, Environmental, Fuel Oils, Humans, Hydrocarbons, Pseudomonas aeruginosa/growth & development/isolation & purification/metabolism, *Soil Pollutants	Pathogenicity
Pathogenicity	15314198	Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosa.	Fonseca AP, Extremina C, Fonseca AF, Sousa JC	J Med Microbiol	10.1099/jmm.0.45637-0	2004	Anti-Bacterial Agents/pharmacology, Bacterial Adhesion/drug effects, Biofilms/drug effects/growth & development, Humans, Hydrophobic and Hydrophilic Interactions, Microbial Sensitivity Tests, Oxidative Stress, Penicillanic Acid/analogs & derivatives/pharmacology, Piperacillin/pharmacology, Pseudomonas aeruginosa/drug effects/growth & development/pathogenicity/physiology, Surface Properties/drug effects, Tazobactam
Pathogenicity	15317741	Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.	Navas D, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Bugnon D, Potel G	J Antimicrob Chemother	10.1093/jac/dkh381	2004	Animals, Anti-Bacterial Agents/administration & dosage/blood/therapeutic use, Cefepime, Cephalosporins/administration & dosage/blood/therapeutic use, Disease Models, Animal, Drug Therapy, Combination, Endocarditis, Bacterial/drug therapy/microbiology, Female, Humans, Imipenem/administration & dosage/blood/therapeutic use, Microbial Sensitivity Tests, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/*drug effects, Rabbits, Tobramycin/administration & dosage/blood/therapeutic use	Enzymology
Phylogeny	15388706	Streptomyces africanus sp. nov., a novel streptomycete with blue aerial mycelium.	Meyers PR, Goodwin CM, Bennett JA, Aken BL, Price CE, van Rooyen JM	Int J Syst Evol Microbiol	10.1099/ijs.0.02738-0	2004	Antibiosis, Bacterial Typing Techniques, DNA, Bacterial/chemistry/isolation & purification, DNA, Ribosomal/chemistry/isolation & purification, Enterococcus faecium/growth & development, Escherichia coli/growth & development, Genes, rRNA, Molecular Sequence Data, Nucleic Acid Hybridization, Phylogeny, Pigments, Biological/biosynthesis, Pseudomonas aeruginosa/growth & development, RNA, Bacterial/genetics, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNA, Soil Microbiology, South Africa, Spores, Bacterial/cytology, Streptomyces/classification/cytology/*isolation & purification/physiology/ultrastructure, Temperature	Enzymology
Metabolism	15530065	Microbial synthesis of poly(3-hydroxyalkanoates) by Pseudomonas aeruginosa from fatty acids: identification of higher monomer units and structural characterization.	Barbuzzi T, Giuffrida M, Impallomeni G, Carnazza S, Ferreri A, Guglielmino SP, Ballistreri A	Biomacromolecules	10.1021/bm049583l	2004	Calorimetry, Differential Scanning, Chromatography, Gas, Fatty Acids/chemistry/metabolism, Hydroxy Acids/metabolism, Magnesium/chemistry, Magnetic Resonance Spectroscopy, Models, Chemical, Pentanoic Acids/chemistry, Polyesters/chemistry/metabolism, Pseudomonas aeruginosa/*metabolism, Spectrometry, Mass, Electrospray Ionization, Temperature, Thermodynamics
Pathogenicity	15544792	Syntheses, in vitro antibacterial and cytotoxic activities of a series of 3-substituted succinimides.	Zentz F, Le Guillou R, Labia R, Sirot D, Linard B, Valla A	Farmaco	10.1016/j.farmac.2004.07.007	2004	Animals, Anti-Bacterial Agents/chemical synthesis/pharmacology, Chlorocebus aethiops, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Succinimides/chemical synthesis/pharmacology, Vero Cells
Pathogenicity	15560820	Biofilm susceptibility to metal toxicity.	Harrison JJ, Ceri H, Stremick CA, Turner RJ	Environ Microbiol	10.1111/j.1462-2920.2004.00656.x	2004	Anti-Bacterial Agents/pharmacology, Biofilms/drug effects/growth & development, Cations/pharmacology, Escherichia coli/drug effects/growth & development, Metals/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus aureus/*drug effects/growth & development
Enzymology	15633678	Characterization and antimicrobial activity of bacteriocin 217 produced by natural isolate Lactobacillus paracasei subsp. paracasei BGBUK2-16.	Lozo J, Vukasinovic M, Strahinic I, Topisirovic L	J Food Prot	10.4315/0362-028x-67.12.2727	2004	Antibiosis, Bacteriocins/biosynthesis/isolation & purification/pharmacology, Colony Count, Microbial, Dairy Products/microbiology, Food Microbiology, Food Preservation, Hydrogen-Ion Concentration, Kinetics, Lactobacillus/*metabolism, Molecular Weight, Temperature, Time Factors	Biotechnology
Pathogenicity	15654434	Antimicrobial activity and chemical investigation of Brazilian Drosera.	Ferreira DT, Andrei CC, Saridakis HO, Faria Tde J, Vinhato E, Carvalho KE, Daniel JF, Machado SL, Saridakis DP, Braz-Filho R	Mem Inst Oswaldo Cruz	10.1590/s0074-02762004000700016	2005	Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Candida albicans/drug effects, Drosera/chemistry, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Plant Extracts/chemistry/pharmacology	Enzymology
Pathogenicity	15686887	Synthesis and antibacterial activities of 5-hydroxy-4-amino-2(5H)-furanones.	Lattmann E, Dunn S, Niamsanit S, Sattayasai N	Bioorg Med Chem Lett	10.1016/j.bmcl.2004.12.051	2005	Anti-Bacterial Agents/chemical synthesis, Drug Resistance, Bacterial, Escherichia coli/drug effects, Furans/chemical synthesis/*pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	15695708	Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.	Jones RN, Anderegg TR, Swenson JM	J Clin Microbiol	10.1128/JCM.43.2.925-927.2005	2005	Anti-Bacterial Agents/pharmacology, Colistin/pharmacology, Drug Resistance, Multiple, Bacterial, Escherichia coli/drug effects, Humans, Laboratories/standards, Microbial Sensitivity Tests/methods/standards, Polymyxin B/pharmacology, Pseudomonas aeruginosa/drug effects, Quality Control, Reference Standards
Pathogenicity	15708658	[Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community].	Weber P, Dib C, Durand C, Moniot-Ville N	Pathol Biol (Paris)	10.1016/j.patbio.2004.03.015	2005	Anti-Infective Agents, Urinary/pharmacology/therapeutic use, Bacterial Infections/drug therapy, Community-Acquired Infections/drug therapy, Escherichia coli/drug effects, Escherichia coli Infections/drug therapy, Humans, Levofloxacin, Microbial Sensitivity Tests, Ofloxacin/pharmacology/therapeutic use, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Urinary Tract Infections/drug therapy
Pathogenicity	15723208	Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials.	Gonzalez-Diaz H, Torres-Gomez LA, Guevara Y, Almeida MS, Molina R, Castanedo N, Santana L, Uriarte E	J Mol Model	10.1007/s00894-004-0228-3	2005	Anti-Bacterial Agents/chemistry/pharmacology, Computer-Aided Design, Drug Design, Escherichia coli/drug effects/growth & development, Markov Chains, Microbial Sensitivity Tests, Models, Molecular, Pseudomonas aeruginosa/drug effects/growth & development, Quantitative Structure-Activity Relationship
Pathogenicity	15728143	Post-antibiotic effect induced by an antibiotic combination: influence of altered susceptibility to individual components.	Li RC, Tang MC	J Antimicrob Chemother	10.1093/jac/dki035	2005	Anti-Bacterial Agents/pharmacology, Drug Resistance, Multiple, Bacterial, Drug Synergism, Drug Therapy, Combination/pharmacology, Gentamicins/pharmacology, Piperacillin/pharmacology, Pseudomonas aeruginosa/*drug effects, Time Factors
Pathogenicity	15772144	Activity of histone H1.2 in infected burn wounds.	Jacobsen F, Baraniskin A, Mertens J, Mittler D, Mohammadi-Tabrisi A, Schubert S, Soltau M, Lehnhardt M, Behnke B, Gatermann S, Steinau HU, Steinstraesser L	J Antimicrob Chemother	10.1093/jac/dki067	2005	Animals, Antimicrobial Cationic Peptides, Bacteria/drug effects, Burns/complications, Cells, Cultured, Disease Models, Animal, Erythrocytes/drug effects, Hemolysis, Histones/administration & dosage/pharmacology/therapeutic use/toxicity, Humans, Keratinocytes/drug effects, Microbial Sensitivity Tests, Proteins/pharmacology, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects, Rats, Skin/cytology, Toxicity Tests, Wound Infection/*drug therapy/microbiology
Pathogenicity	15857207	Antibacterial screening of anthocyanic and proanthocyanic fractions from cranberry juice.	Leitao DP, Polizello AC, Ito IY, Spadaro AC	J Med Food	10.1089/jmf.2005.8.36	2005	Anthocyanins/pharmacology, Anti-Bacterial Agents/pharmacology, Colony Count, Microbial, Enterococcus faecalis/drug effects/growth & development, Escherichia coli/drug effects/growth & development, Immunodiffusion, Microbial Sensitivity Tests, Micrococcus luteus/drug effects/growth & development, Plant Extracts/pharmacology, Proanthocyanidins/pharmacology, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus aureus/drug effects/growth & development, Streptococcus mutans/drug effects/growth & development, Vaccinium macrocarpon/*chemistry
Enzymology	15875360	The efficacy of piperacillin/tazobactam in experimental Pseudomonas aeruginosa endophthalmitis: a histopathological and microbiological evaluation.	Ozkiris A, Evereklioglu C, Esel D, Akgun H, Goktas S, Erkilic K	Curr Eye Res	10.1080/02713680490894180	2005	Animals, Anti-Bacterial Agents/therapeutic use, Colony Count, Microbial, Disease Models, Animal, Drug Therapy, Combination, Endophthalmitis/drug therapy/microbiology/pathology, Eye Infections, Bacterial/drug therapy/microbiology/pathology, Female, Male, Penicillanic Acid/analogs & derivatives/therapeutic use, Piperacillin/therapeutic use, Pseudomonas Infections/*drug therapy/microbiology/pathology, Pseudomonas aeruginosa/isolation & purification, Rabbits, Tazobactam, Treatment Outcome, Vitreous Body/microbiology, beta-Lactamase Inhibitors	Phylogeny
Pathogenicity	15946294	Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa.	Harrison JJ, Turner RJ, Ceri H	Environ Microbiol	10.1111/j.1462-2920.2005.00777.x	2005	Animals, Anti-Bacterial Agents/pharmacology, Biofilms/drug effects/growth & development, Cations/pharmacology, Colony Count, Microbial, Culture Media, Metals/pharmacology, Microbial Sensitivity Tests/methods, Plankton/drug effects/growth & development, Pseudomonas aeruginosa/cytology/drug effects/growth & development	Cultivation
Pathogenicity	16011772	In vitro antimicrobial activity of Fill Canal, Sealapex, Mineral Trioxide Aggregate, Portland cement and EndoRez.	Sipert CR, Hussne RP, Nishiyama CK, Torres SA	Int Endod J	10.1111/j.1365-2591.2005.00984.x	2005	Aluminum Compounds/pharmacology, Anti-Infective Agents/pharmacology, Bacteria/drug effects, Barium Sulfate/pharmacology, Bismuth/pharmacology, Borates/pharmacology, Calcium Compounds/pharmacology, Calcium Hydroxide/pharmacology, Candida albicans/drug effects, Composite Resins/pharmacology, Drug Combinations, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Eugenol/pharmacology, Humans, Materials Testing, Micrococcus luteus/drug effects, Oxides/pharmacology, Pseudomonas aeruginosa/drug effects, Resins, Synthetic/pharmacology, Root Canal Filling Materials/*pharmacology, Salicylates/pharmacology, Silicates/pharmacology, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Zinc Oxide/pharmacology
Pathogenicity	16115376	Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2).	Feng Y, Huang N, Wu Q, Bao L, Wang BY	Acta Pharmacol Sin	10.1111/j.1745-7254.2005.00132.x	2005	Anti-Infective Agents/pharmacology, Candida albicans/drug effects, Escherichia coli/drug effects/metabolism, HMGN2 Protein/chemical synthesis/genetics/metabolism/pharmacology, Microbial Sensitivity Tests, Protein Structure, Tertiary/genetics, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Transformation, Genetic	Metabolism
Pathogenicity	16127047	Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase.	Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Fujino T, Kobayashi I, Morita K, Kikuchi Y, Kuratsuji T, Kirikae T	Antimicrob Agents Chemother	10.1128/AAC.49.9.3734-3742.2005	2005	Acetyltransferases/metabolism, Amino Acid Sequence, Anti-Bacterial Agents/pharmacology, Cross Infection/epidemiology/microbiology, DNA, Bacterial/genetics, Disinfectants/pharmacology, Drug Resistance, Multiple, Bacterial, Electrophoresis, Gel, Pulsed-Field, Gene Transfer, Horizontal, Genes, Bacterial/genetics, Genotype, Hospital Units, Humans, Integrons, Microbial Sensitivity Tests, Molecular Sequence Data, Neurosurgery, Phenotype, Pseudomonas Infections/epidemiology/microbiology, Pseudomonas aeruginosa/drug effects/genetics, Reverse Transcriptase Polymerase Chain Reaction	Genetics
Pathogenicity	16136907	[Establishing a model of neutropenia rat with Pseudomonas aeruginosa pneumonia and a study on its inflammatory reaction].	Li Z, Qu J, He L	Zhonghua Jie He He Hu Xi Za Zhi		2001	Animals, Disease Models, Animal, Inflammation/microbiology/pathology, Lung/pathology, Male, Neutropenia/microbiology/pathology, Pneumonia, Bacterial/pathology, *Pseudomonas Infections/pathology, Pseudomonas aeruginosa/pathogenicity, Rats, Rats, Sprague-Dawley
Pathogenicity	16189092	Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue.	Joukhadar C, Dehghanyar P, Traunmuller F, Sauermann R, Mayer-Helm B, Georgopoulos A, Muller M	Antimicrob Agents Chemother	10.1128/AAC.49.10.4149-4153.2005	2005	Adult, Anti-Infective Agents/administration & dosage/blood/pharmacokinetics, Ciprofloxacin/administration & dosage/blood/pharmacokinetics, Computer Simulation, Humans, Infusions, Intravenous, Laser-Doppler Flowmetry, Lower Extremity/blood supply, Male, Microcirculation, Microdialysis, Pseudomonas aeruginosa/drug effects, Regional Blood Flow/drug effects, Skin Temperature, Subcutaneous Fat/blood supply/*drug effects, Temperature	Enzymology
Pathogenicity	16202124	High-throughput metal susceptibility testing of microbial biofilms.	Harrison JJ, Turner RJ, Ceri H	BMC Microbiol	10.1186/1471-2180-5-53	2005	Biofilms/drug effects/growth & development, Cations/pharmacology, Escherichia coli/drug effects/growth & development/ultrastructure, Metals/pharmacology, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Pseudomonas aeruginosa/drug effects/growth & development/ultrastructure
Pathogenicity	16204630	HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?	Feng Y, Huang N, Wu Q, Wang B	J Leukoc Biol	10.1189/jlb.0505280	2005	Anti-Infective Agents/chemistry/isolation & purification/pharmacology, Candida albicans/drug effects, Escherichia coli/drug effects, HMGN2 Protein/chemistry/isolation & purification/pharmacology, Humans, Interleukin-2/pharmacology, Leukocytes, Mononuclear/*chemistry/drug effects, Microbial Sensitivity Tests, Peptides/chemistry/isolation & purification/pharmacology, Protein Conformation, Protein Structure, Secondary, Pseudomonas aeruginosa/drug effects, Reference Values	Enzymology
Enzymology	16212035	Purification of bovine milk lactoperoxidase and investigation of antibacterial properties at different thiocyanate mediated.	Uguz MT, Ozdemir H	Prikl Biokhim Mikrobiol		2005	Animals, Anti-Bacterial Agents/chemistry/pharmacology, Cattle, Chromatography, Gel, Chromatography, Ion Exchange, Electrophoresis, Polyacrylamide Gel, Hydrogen Peroxide/chemistry, Lactoperoxidase/isolation & purification/metabolism/pharmacology, Microbial Sensitivity Tests, Milk/enzymology, Thiocyanates/chemistry	Phylogeny
Pathogenicity	16229118	Synthesis and evaluation of analgesic/ anti-inflammatory and antimicrobial activities of 3-substituted- 1,2,4-triazole-5-thiones.	Tozkoparan B, Kupeli E, Yesilada E, Isik S, Ozalp M, Ertan M	Arzneimittelforschung	10.1055/s-0031-1296901	2005	Analgesics/chemical synthesis/pharmacology, Animals, Anti-Infective Agents/chemical synthesis/pharmacology, Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis/pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Biological Assay, Carrageenan, Edema/chemically induced/prevention & control, Indicators and Reagents, Magnetic Resonance Spectroscopy, Male, Mice, Microbial Sensitivity Tests, Models, Molecular, Spectrophotometry, Infrared, Stomach Ulcer/chemically induced/prevention & control, Thiones/chemical synthesis/pharmacology, Triazoles/chemical synthesis/pharmacology
	16242721	Wound healing potential of Cassia fistula on infected albino rat model.	Senthil Kumar M, Sripriya R, Vijaya Raghavan H, Sehgal PK	J Surg Res	10.1016/j.jss.2005.08.025	2005	Animals, Cassia/chemistry, Male, Phytotherapy, Plant Extracts/pharmacology, Plant Leaves/chemistry, Pseudomonas Infections/drug therapy, Rats, Rats, Wistar, Staphylococcal Infections/drug therapy, Surgical Wound Infection/drug therapy, Treatment Outcome, *Wound Healing
Pathogenicity	16252547	In vitro efficacy of ciprofloxacin and gentamicin against a biofilm of Pseudomonas aeruginosa and its free-living forms.	Agarwal G, Kapil A, Kabra SK, Das BK, Dwivedi SN	Natl Med J India		2005	Biofilms/drug effects, Ciprofloxacin/pharmacology, Gentamicins/pharmacology, Humans, In Vitro Techniques, Microbial Sensitivity Tests, Pseudomonas aeruginosa
	16296436	Failure of anti-retraction valves and the procedure for between patient flushing: a rationale for chemical control of dental unit waterline contamination.	Montebugnoli L, Dolci G, Spratt DA, Puttaiah R	Am J Dent		2005	Colony Count, Microbial, Decontamination/methods, Dental Disinfectants, Dental Equipment, Detergents, Equipment Contamination, Equipment Failure, Ethylenediamines, Infection Control, Dental/instrumentation/methods, Linear Models, Pseudomonas aeruginosa, Spores, Bacterial, *Water Microbiology
Pathogenicity	16320610	Antibacterial activity of coumarins.	de Souza SM, Delle Monache F, Smania A Jr	Z Naturforsch C J Biosci	10.1515/znc-2005-9-1006	2005	Anti-Bacterial Agents/pharmacology, Bacillus subtilis/drug effects/growth & development, Coumarins/chemistry/pharmacology, Escherichia coli/drug effects/growth & development, Gram-Negative Bacteria/drug effects/genetics, Gram-Positive Bacteria/*drug effects/genetics, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus aureus/drug effects/growth & development, Structure-Activity Relationship
Phylogeny	16335120	Isolation of DNA for PCR assays from noncultivable Campylobacter jejuni isolates.	Callicott KA, Stern NJ, Hiett KL	Poult Sci	10.1093/ps/84.10.1530	2005	Campylobacter jejuni/genetics/isolation & purification, DNA, Bacterial/isolation & purification, Genetic Markers/genetics, Polymerase Chain Reaction/methods	Enzymology
	16349001	Cell Density and Growth Phase as Factors in the Resistance of a Biofilm of Pseudomonas aeruginosa (ATCC 27853) to Iodine.	Brown ML, Gauthier JJ	Appl Environ Microbiol	10.1128/aem.59.7.2320-2322.1993	1993
Pathogenicity	16356593	Synthesis, antibacterial activity and QSAR studies of 1,2-disubstituted-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines.	Tiwari RK, Singh D, Singh J, Chhillar AK, Chandra R, Verma AK	Eur J Med Chem	10.1016/j.ejmech.2005.10.010	2005	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests/statistics & numerical data, Quantitative Structure-Activity Relationship, Tetrahydroisoquinolines/chemical synthesis/chemistry/pharmacology
Pathogenicity	16375832	Flavonoid analysis and antimicrobial activity of commercially available propolis products.	Kosalec I, Pepeljnjak S, Bakmaz M, Vladimir-Knezevic S	Acta Pharm		2005	Anti-Infective Agents/chemistry/pharmacology, Flavanones/analysis, Flavones/analysis, Flavonoids/analysis, Flavonols/analysis, Gram-Negative Bacteria/drug effects/growth & development, Gram-Positive Bacteria/drug effects/growth & development, Microbial Sensitivity Tests, Propolis/chemistry/*pharmacology, Yeasts/drug effects/growth & development
Pathogenicity	16410969	Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination.	Silva MT, Simas SM, Batista TG, Cardarelli P, Tomassini TC	Mem Inst Oswaldo Cruz	10.1590/s0074-02762005000700018	2006	Agar, Anti-Bacterial Agents/therapeutic use, Candida albicans/drug effects, Culture Media, Drug Evaluation, Preclinical, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Lactones/therapeutic use, Microbial Sensitivity Tests/methods, Physalis, Plant Extracts/pharmacology, Secosteroids, Steroids/*therapeutic use	Cultivation
Pathogenicity	16454960	[Multiresistant Pseudomonas spp. in vitro susceptibility to a combination of two antibiotics].	Pliego-Castaneda QF, Yanez-Viguri JA, Lopez-Valle T	Cir Cir		2005	Aminoglycosides/pharmacology, Anti-Bacterial Agents/pharmacology, Drug Resistance, Multiple, Bacterial, Drug Therapy, Combination, Humans, Microbial Sensitivity Tests, Pseudomonas/*drug effects, Quinolones/pharmacology, beta-Lactams/pharmacology
Pathogenicity	16464562	In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.	Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO	Int J Antimicrob Agents	10.1016/j.ijantimicag.2005.10.012	2006	Acinetobacter Infections/drug therapy/microbiology, Acinetobacter baumannii/drug effects/isolation & purification, Anti-Bacterial Agents/pharmacology/therapeutic use, Drug Resistance, Multiple, Bacterial, Drug Synergism, Drug Therapy, Combination, Humans, Intensive Care Units, Microbial Sensitivity Tests, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects/isolation & purification	Enzymology
	16557612	Biological activities of some natural compounds from Sideritis sipylea Boiss.	Logoglu E, Arslan S, Oktemer A, Sakoyan I	Phytother Res	10.1002/ptr.1855	2006	Bacillus subtilis, Candida albicans, Diterpenes/analysis/pharmacology, Escherichia coli, Microbial Sensitivity Tests, Pseudomonas aeruginosa, Sideritis/chemistry, Staphylococcus aureus
	16615824	The in-vitro antibacterial activity of Annona senegalensis, Securidacca longipendiculata and Steganotaenia araliacea - Ugandan medicinal plants.	Lino A, Deogracious O	Afr Health Sci	10.5555/afhs.2006.6.1.31	2006	Annona, Anti-Bacterial Agents/therapeutic use, Araliaceae, Plant Extracts/pharmacology, Plants, Medicinal
Pathogenicity	16633038	Antibacterial analysis in vitro of ethyl-cyanoacrylate against ocular pathogens.	de Almeida Manzano RP, Naufal SC, Hida RY, Guarnieri LO, Nishiwaki-Dantas MC	Cornea	10.1097/01.ico.0000183490.16131.e3	2006	Anti-Bacterial Agents/pharmacology, Bacteriological Techniques, Corneal Diseases/microbiology, Cyanoacrylates/pharmacology, Eye Infections, Bacterial/microbiology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Tissue Adhesives/*pharmacology
Pathogenicity	16870751	Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.	Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA	Antimicrob Agents Chemother	10.1128/AAC.01165-05	2006	Anti-Bacterial Agents/pharmacology, Colony Count, Microbial, Dose Fractionation, Radiation, Dose-Response Relationship, Drug, Gentamicins/pharmacology, Humans, In Vitro Techniques, Kinetics, Microbial Sensitivity Tests, Models, Biological, Models, Statistical, Pseudomonas aeruginosa/drug effects/genetics/growth & development/isolation & purification, Reproducibility of Results, Staphylococcus aureus/drug effects/genetics/isolation & purification, Time Factors	Enzymology
Pathogenicity	16878603	Effect of neuraminidase on adherence of Pseudomonas aeruginosa to human buccal epithelial cells. Inhibition of adhesion by monosaccharides.	Wolska K, Zabielska K, Jakubczak A	Pol J Microbiol		2006	Bacterial Adhesion/drug effects, Clostridium perfringens/enzymology, Epithelial Cells/microbiology, Humans, Monosaccharides/pharmacology, Mouth Mucosa/cytology, Neuraminidase/antagonists & inhibitors/pharmacology, Pseudomonas aeruginosa/physiology	Enzymology
Pathogenicity	16955742	Antibacterial activity of crude methanolic extract and its fractions of aerial parts of Anthemis tinctoria.	Akgul C, Saglikoglu G	Indian J Biochem Biophys		2005	Anthemis/chemistry, Anti-Bacterial Agents/chemistry/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Methanol, Microbial Sensitivity Tests, Plant Extracts/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/*drug effects
Pathogenicity	16955743	Antibacterial activity of some unsymmetrical diorganyltellurium(IV) dichlorides.	Soni D, Gupta PK, Kumar Y, Chandrashekhar TG	Indian J Biochem Biophys		2005	Anti-Bacterial Agents/chemistry/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Tellurium/chemistry/pharmacology
Pathogenicity	16986171	Screening antimicrobial activity of various extracts of Artemisia dracunculus L.	Benli M, Kaya I, Yigit N	Cell Biochem Funct	10.1002/cbf.1373	2007	Acetone/chemistry, Anti-Infective Agents/chemistry/isolation & purification/pharmacology, Artemisia/chemistry, Candida/drug effects, Chloroform/chemistry, Escherichia coli/drug effects, Listeria monocytogenes/drug effects, Methanol/chemistry, Microbial Sensitivity Tests/methods, Microscopy, Electron, Scanning, Plant Extracts/chemistry/isolation & purification/*pharmacology, Pseudomonas aeruginosa/drug effects/ultrastructure, Saccharomyces cerevisiae/drug effects, Shigella/drug effects, Species Specificity	Phylogeny
Pathogenicity	16987639	In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.	Tong W, Wang R, Chai D, Li Z, Pei F	Int J Antimicrob Agents	10.1016/j.ijantimicag.2006.08.008	2006	Acinetobacter/drug effects/isolation & purification, Acinetobacter baumannii/drug effects, Anti-Bacterial Agents/pharmacology, Carbapenems/pharmacology, Cefepime, Cephalosporins/pharmacology, Drug Resistance, Bacterial, Drug Synergism, Humans, Microbial Sensitivity Tests, Sulbactam/pharmacology, *beta-Lactam Resistance	Enzymology
Pathogenicity	17023121	[Towards new antibacterial drugs. Interest of para-guanidinoethylcalix[4]arene].	Grare M, Mourer M, Regnouf de Vains JB, Finance C, Duval RE	Pathol Biol (Paris)	10.1016/j.patbio.2006.07.022	2006	Anti-Bacterial Agents/pharmacology, Benzamidines/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Guanidines/chemistry/pharmacology, Microbial Sensitivity Tests, Molecular Conformation, Molecular Structure, Staphylococcus aureus/drug effects
Enzymology	17190440	Decaspirones F-I, bioactive secondary metabolites from the saprophytic fungus Helicoma viridis.	Hu H, Guo H, Li E, Liu X, Zhou Y, Che Y	J Nat Prod	10.1021/np0603830	2006	Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, China, Crystallography, X-Ray, Fungi/chemistry, Lactococcus lactis/drug effects, Molecular Conformation, Molecular Structure, Naphthalenes/chemistry/isolation & purification/pharmacology, Nuclear Magnetic Resonance, Biomolecular, Pseudomonas aeruginosa/drug effects, Spiro Compounds/chemistry/isolation & purification/pharmacology	Phylogeny
Pathogenicity	17329859	CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.	Kim J, Ha JR, Oh SW, Kim HG, Lee JM, Lee DG, Lee SH, Kim JG	Biol Pharm Bull	10.1248/bpb.30.575	2007	Animals, Anti-Bacterial Agents/administration & dosage/chemistry/pharmacology, Bacteria/drug effects/growth & development, Bacterial Infections/microbiology/prevention & control, Carbapenems/administration & dosage/chemistry/pharmacology, Cilastatin/administration & dosage/chemistry/pharmacology, Dose-Response Relationship, Drug, Enterococcus faecalis/drug effects/growth & development, Escherichia coli/drug effects/growth & development, Injections, Intravenous, Meropenem, Methicillin Resistance, Mice, Microbial Sensitivity Tests, Molecular Structure, Protease Inhibitors/administration & dosage/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects/growth & development, Pyrrolidines/administration & dosage/chemistry/*pharmacology, Staphylococcus aureus/drug effects/growth & development, Thienamycins/administration & dosage/pharmacology, Vancomycin Resistance
Enzymology	17359326	Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa.	Tam VH, Schilling AN, LaRocco MT, Gentry LO, Lolans K, Quinn JP, Garey KW	Clin Microbiol Infect	10.1111/j.1469-0691.2006.01674.x	2007	Bacteremia/microbiology, Bacterial Proteins/genetics, Electrophoresis, Gel, Pulsed-Field, Humans, Isoelectric Focusing, Point Mutation, Pseudomonas aeruginosa/drug effects/enzymology/genetics, Reverse Transcriptase Polymerase Chain Reaction, Spectrophotometry, beta-Lactam Resistance, beta-Lactamases/*genetics	Pathogenicity
Pathogenicity	17365707	Antimicrobial activity and pollen composition of honey samples collected from different provinces in Turkey.	Mercan N, Guvensen A, Celik A, Katircioglu H	Nat Prod Res	10.1080/14786410600906277	2007	Anti-Infective Agents/analysis/pharmacology, Bacteria/drug effects, Flowers, Fungi/drug effects, Honey/analysis, Microbial Sensitivity Tests, Pinus/chemistry, Pollen/*chemistry, Turkey
Pathogenicity	17376617	Amikacin-loaded vascular prosthesis as an effective drug carrier.	Ginalska G, Kowalczuk D, Osinska M	Int J Pharm	10.1016/j.ijpharm.2007.02.016	2007	Amikacin/administration & dosage/chemistry, Anti-Bacterial Agents/administration & dosage, Bacterial Infections/prevention & control, Blood Vessel Prosthesis, Chromatography, High Pressure Liquid, Drug Carriers, Humans, Microbial Sensitivity Tests, Postoperative Complications/prevention & control
Pathogenicity	17384853	In vitro antimicrobial activity of different gutta-percha points and calcium hydroxide pastes.	Tanomaru JM, Pappen FG, Tanomaru Filho M, Spolidorio DM, Ito IY	Braz Oral Res	10.1590/s1806-83242007000100006	2007	Analysis of Variance, Anti-Infective Agents, Local/pharmacology, Calcium Hydroxide/pharmacology, Chlorhexidine/pharmacology, Endodontics, Escherichia coli/drug effects, Gram-Positive Bacteria/drug effects, *Gutta-Percha/standards, Micrococcus luteus/drug effects, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Tooth Root/drug effects/microbiology
Pathogenicity	17429181	In vitro antimicrobial activity of endodontic sealers, MTA-based cements and Portland cement.	Tanomaru-Filho M, Tanomaru JM, Barros DB, Watanabe E, Ito IY	J Oral Sci	10.2334/josnusd.49.41	2007	Bacteria/drug effects, Candida albicans/drug effects, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Immunodiffusion, Microbial Sensitivity Tests, Micrococcus luteus/drug effects, Pseudomonas aeruginosa/drug effects, Retrograde Obturation, Root Canal Filling Materials/*pharmacology, Staphylococcus aureus/drug effects
	17452938	Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.	Cirioni O, Ghiselli R, Orlando F, Silvestri C, Mocchegiani F, Rocchi M, Chiodi L, Abbruzzetti A, Saba V, Scalise G, Giacometti A	Crit Care Med	10.1097/01.CCM.0000266685.25436.03	2007	Animals, Anti-Bacterial Agents/administration & dosage/pharmacology, Cells, Cultured, Colistin/administration & dosage/pharmacology, Colony Count, Microbial, Drug Resistance, Multiple, Bacterial, Drug Synergism, Drug Therapy, Combination, Male, Microbial Sensitivity Tests, Prospective Studies, Pseudomonas Infections/drug therapy, Random Allocation, Rats, Rats, Wistar, Rifampin/administration & dosage/pharmacology, Shock, Septic/drug therapy, Survival Analysis
Cultivation	17494717	Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.	Brown SD, Traczewski MM	J Clin Microbiol	10.1128/JCM.02351-06	2007	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Culture Media, Drug Resistance, Bacterial, Microbial Sensitivity Tests, Minocycline/analogs & derivatives/pharmacology, Quality Control, Tetracycline/pharmacology, Tigecycline	Pathogenicity
Biotechnology	17574697	The identification of antibacterial compounds for the development of enhanced media for the detection of foodborne fungi.	Tournas VH, Kohn JS, Katsoudas EJ	Int J Food Microbiol	10.1016/j.ijfoodmicro.2007.04.013	2007	Anti-Bacterial Agents/pharmacology, Chloramphenicol/pharmacology, Chlortetracycline/pharmacology, Colony Count, Microbial, Culture Media/chemistry, Dose-Response Relationship, Drug, Food Microbiology, Fungi/growth & development/*isolation & purification, Gentamicins/pharmacology, Microbial Sensitivity Tests, Mitosporic Fungi/growth & development/isolation & purification	Enzymology
Pathogenicity	17574822	Effect of shear stress on growth, adhesion and biofilm formation of Pseudomonas aeruginosa with antibiotic-induced morphological changes.	Fonseca AP, Sousa JC	Int J Antimicrob Agents	10.1016/j.ijantimicag.2007.04.011	2007	Anti-Bacterial Agents/pharmacology, Bacterial Adhesion/drug effects, Biofilms/drug effects/growth & development, Microbial Sensitivity Tests, Microscopy, Electron, Pseudomonas aeruginosa/drug effects/growth & development/physiology, Stress, Mechanical	Stress
Metabolism	17593817	[BCG cell wall proteins enhance clearance of Pseudomonas aeruginosa in rat lungs].	Liu XK, Zhou H, Huang N, Zhu BD, Feng Y, Wu Q, Wang BY	Sichuan Da Xue Xue Bao Yi Xue Ban		2007	Animals, Bacterial Proteins/chemistry/immunology/isolation & purification, Cell Wall/chemistry, Defensins/genetics, Gene Expression Regulation/immunology, Lung/immunology/metabolism/microbiology, Male, Molecular Weight, Mycobacterium bovis/cytology, Pseudomonas aeruginosa/physiology, RNA, Messenger/genetics/metabolism, Rats, Rats, Wistar, Reverse Transcriptase Polymerase Chain Reaction	Enzymology
Pathogenicity	17626025	In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria.	Grare M, Mourer M, Fontanay S, Regnouf-de-Vains JB, Finance C, Duval RE	J Antimicrob Chemother	10.1093/jac/dkm244	2007	Anti-Bacterial Agents/chemistry/pharmacology, Benzamidines/pharmacology, Calixarenes/chemistry/pharmacology, Cell Line, Tumor, Cell Survival/drug effects, Drug Resistance, Bacterial/drug effects, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/*drug effects, Guanidines/pharmacology, Humans, Microbial Sensitivity Tests, Neutral Red, Structure-Activity Relationship, Tetrazolium Salts, Thiazoles
Enzymology	17822333	[Species-identification and antimicrobial susceptibility tests by the fully automated RAISUS using an early-harvested cell suspension].	Nakasone I, Kisanuki K, Higa M, Kinjo T, Yamane N	Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi		2006	Automation, Bacteriological Techniques/instrumentation, Enterococcus faecalis/isolation & purification, Escherichia coli/isolation & purification, Microbial Sensitivity Tests/instrumentation, Pseudomonas aeruginosa, Staphylococcus aureus/isolation & purification, Streptococcus pneumoniae/isolation & purification	Phylogeny
	17983739	Direct quantification of test bacteria in synthetic water-polluted samples by square wave voltammetry and chemometric methods.	Carpani I, Conti P, Lanteri S, Legnani PP, Leoni E, Tonelli D	Biosens Bioelectron	10.1016/j.bios.2007.09.018	2007	Biosensing Techniques/instrumentation/methods, Colony Count, Microbial/instrumentation/methods, Combinatorial Chemistry Techniques/methods, Electrochemistry/instrumentation/methods, Environmental Monitoring/instrumentation/methods, Microelectrodes, Reproducibility of Results, Sensitivity and Specificity, Water Microbiology, Water Pollution/*analysis
Pathogenicity	18227094	Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.	Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW	J Antimicrob Chemother	10.1093/jac/dkm511	2008	Anti-Bacterial Agents/administration & dosage/pharmacology, Colistin/administration & dosage/pharmacology, Drug Administration Schedule, Drug Resistance, Bacterial/drug effects/physiology, Humans, Models, Biological, Pseudomonas aeruginosa/*drug effects/isolation & purification	Enzymology
Pathogenicity	18315514	Synergistic action of starch and honey against Pseudomonas aeruginosa in correlation with diastase number.	Boukraa L, Benbarek H, Aissat S	J Altern Complement Med	10.1089/acm.2007.0589	2008	Amylases/drug effects, Anti-Bacterial Agents/pharmacology, Colony Count, Microbial, Dose-Response Relationship, Drug, Drug Synergism, Honey, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/enzymology/growth & development, Starch/administration & dosage	Enzymology
Genetics	18321207	Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa.	Giske CG, Buaro L, Sundsfjord A, Wretlind B	Microb Drug Resist	10.1089/mdr.2008.0778	2008	Amino Acid Sequence, Carbapenems/pharmacology, Membrane Transport Proteins/genetics, Microbial Sensitivity Tests, Molecular Sequence Data, Norway, Penicillin-Binding Proteins/genetics, Porins/genetics, Pseudomonas aeruginosa/genetics/isolation & purification, Sweden, Transcription, Genetic, beta-Lactam Resistance/genetics	Enzymology
Pathogenicity	18332629	Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi.	Ryge TS, Frimodt-Moller N, Hansen PR	Chemotherapy	10.1159/000119707	2008	Anti-Infective Agents/chemistry/pharmacology, Bacteria/drug effects/isolation & purification, Drug Resistance, Microbial/physiology, Fungi/drug effects/isolation & purification/physiology, Humans, Lysine/chemistry/pharmacology, Microbial Sensitivity Tests/methods, Peptoids/chemistry/*pharmacology	Enzymology
	18376586	Development and validation of an agar diffusion assay for determination of ceftazidime in pharmaceutical preparations.	Schmidt CA, Carazzo M, Laporta LV, Bittencourt CF, Santos MR, Friedrich M	J AOAC Int		2008	Agar, Anti-Bacterial Agents/analysis, Calibration, Ceftazidime/analysis, Diffusion
Metabolism	18396316	Growth-inhibitory effects of sulfonamides at different pH: dissimilar susceptibility patterns of a soil bacterium and a test bacterium used for antibiotic assays.	Tappe W, Zarfl C, Kummer S, Burauel P, Vereecken H, Groeneweg J	Chemosphere	10.1016/j.chemosphere.2008.02.041	2008	Anti-Bacterial Agents/analysis/metabolism/toxicity, Bacteria/chemistry/drug effects/metabolism, Biological Assay, Culture Media, Data Interpretation, Statistical, Homeostasis, Hydrogen-Ion Concentration, Models, Statistical, Pantoea/chemistry/drug effects/metabolism, Pseudomonas aeruginosa/chemistry/drug effects/metabolism, Soil Microbiology, Sulfonamides/analysis/metabolism/toxicity	Pathogenicity
Cultivation	18437853	Variation of the adhesion to polystyrene of phenotypic mutants of Pseudomonas aeruginosa ATCC 27853 during starvation conditions.	Cappello S	New Microbiol		2008	Bacterial Adhesion, Culture Media, Humans, Hydrophobic and Hydrophilic Interactions, Mutation, Phenotype, Phosphates/metabolism, Polystyrenes, Pseudomonas aeruginosa/genetics/growth & development/*physiology	Pathogenicity
	18467077	Comparison of contact angle measurement and microbial adhesion to solvents for assaying electron donor-electron acceptor (acid-base) properties of bacterial surface.	Hamadi F, Latrache H	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2008.03.010	2008	Acid-Base Equilibrium, Bacillus subtilis/physiology, Bacterial Adhesion/physiology, Bacterial Physiological Phenomena, Bacteriological Techniques/methods, Escherichia coli/physiology, Hydrophobic and Hydrophilic Interactions, Pseudomonas aeruginosa/physiology, Solvents/chemistry, Staphylococcus aureus/physiology, Surface Properties
Pathogenicity	18505206	Comparison of agar dilution and E-test for antimicrobial susceptibility testing of Campylobacter coil isolates recovered from 80 Ontario swine farms.	Varela NP, Friendship R, Dewey C, Valdivieso A	Can J Vet Res		2008	Agar, Animals, Anti-Bacterial Agents/pharmacology, Campylobacter coli/drug effects/growth & development, Colony Count, Microbial/instrumentation/methods/standards/veterinary, Drug Resistance, Bacterial, Microbial Sensitivity Tests/instrumentation/methods/standards/*veterinary, Ontario, Reproducibility of Results, Sensitivity and Specificity, Swine, Swine Diseases/drug therapy/microbiology
Pathogenicity	18694532	Antibacterial and antifungal properties of human cerumen.	Lum CL, Jeyanthi S, Prepageran N, Vadivelu J, Raman R	J Laryngol Otol	10.1017/S0022215108003307	2008	Adolescent, Adult, Aged, Aged, 80 and over, Candida albicans/growth & development, Cerumen/microbiology/physiology, Child, Colony Count, Microbial, Ear, External/microbiology, Escherichia coli/growth & development, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Otitis Externa/prevention & control, Pseudomonas aeruginosa/growth & development, Staphylococcus aureus/growth & development, Young Adult
Pathogenicity	18725438	Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.	Tam VH, Ledesma KR, Vo G, Kabbara S, Lim TP, Nikolaou M	Antimicrob Agents Chemother	10.1128/AAC.01468-07	2008	Acinetobacter baumannii/drug effects/growth & development, Amikacin/administration & dosage, Aminoglycosides/administration & dosage, Anti-Bacterial Agents/administration & dosage, Computer Simulation, Dose-Response Relationship, Drug, Drug Resistance, Bacterial, Gentamicins/administration & dosage, Humans, Microbial Sensitivity Tests, Models, Biological, Pseudomonas aeruginosa/*drug effects/growth & development
Pathogenicity	18799470	Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.	Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Mocchegiani F, Chiodi L, Castelletti S, Gabrielli E, Saba V, Scalise G, Giacometti A	J Antimicrob Chemother	10.1093/jac/dkn393	2008	Animals, Anti-Bacterial Agents/administration & dosage/pharmacology/therapeutic use, Antimicrobial Cationic Peptides/administration & dosage/pharmacology/therapeutic use, Blood/microbiology, Drug Synergism, Drug Therapy, Combination, Endotoxins/blood, Injections, Intravenous, Magainins, Microbial Sensitivity Tests, Penicillanic Acid/analogs & derivatives/therapeutic use, Peritoneum/microbiology, Piperacillin/therapeutic use, Piperacillin, Tazobactam Drug Combination, Plasma/chemistry, Pseudomonas Infections/drug therapy, Pseudomonas aeruginosa/drug effects, Rats, Rats, Wistar, Rifampin/administration & dosage/pharmacology/therapeutic use, Survival Analysis, Treatment Outcome, Tumor Necrosis Factor-alpha/blood, Xenopus Proteins/administration & dosage/pharmacology/therapeutic use
Pathogenicity	18800908	Antimicrobial activities of the essential oils of Origanum onites L., Origanum vulgare L. subspecies hirtum (Link) Ietswaart, Satureja thymbra L., and Thymus cilicicus Boiss. & Bal. growing wild in Turkey.	Sarac N, Ugur A	J Med Food	10.1089/jmf.2007.0520	2008	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Lamiaceae, Oils, Volatile/isolation & purification/pharmacology, Origanum, Plant Extracts/pharmacology, Satureja, *Thymus Plant, Turkey	Enzymology
Pathogenicity	18835348	Ursolic, oleanolic and betulinic acids: antibacterial spectra and selectivity indexes.	Fontanay S, Grare M, Mayer J, Finance C, Duval RE	J Ethnopharmacol	10.1016/j.jep.2008.09.001	2008	Anti-Bacterial Agents/pharmacology/toxicity, Cell Line, Cell Survival/drug effects, Drug Resistance, Bacterial, Eukaryotic Cells/drug effects/metabolism, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Microbial Sensitivity Tests, Oleanolic Acid/pharmacology/toxicity, Pentacyclic Triterpenes, Toxicity Tests, Triterpenes/*pharmacology/toxicity	Metabolism
Pathogenicity	18852268	Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.	Bulitta JB, Ly NS, Yang JC, Forrest A, Jusko WJ, Tsuji BT	Antimicrob Agents Chemother	10.1128/AAC.00489-08	2008	Ceftazidime/pharmacology, Dose-Response Relationship, Drug, Models, Theoretical, Pseudomonas aeruginosa/*drug effects
Pathogenicity	18853314	Different application volumes of ethyl-cyanoacrylate tissue adhesive can change its antibacterial effects against ocular pathogens in vitro.	Romero IL, Paiato TP, Silva CB, Nigro JB, Malta S, Jenne Mimica LM, Soong HK, Hida RY	Curr Eye Res	10.1080/02713680802437692	2008	Anti-Bacterial Agents/administration & dosage, Bacteria/drug effects, Cyanoacrylates/administration & dosage, Escherichia coli/drug effects, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Streptococcus pneumoniae/drug effects, Tissue Adhesives/administration & dosage
Pathogenicity	18951808	Structure-activity relationship of antibacterial chalcones.	Avila HP, Smania Ede F, Monache FD, Smania A Jr	Bioorg Med Chem	10.1016/j.bmc.2008.09.064	2008	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Bacillus cereus/drug effects, Chalcones/chemical synthesis/chemistry/pharmacology, Escherichia coli/drug effects, Humans, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship
Pathogenicity	19142056	[Antimicrobial activity of soft and purified propolis extracts].	Pavilonis A, Baranauskas A, Puidokaite L, Mazeliene Z, Savickas A, Radziunas R	Medicina (Kaunas)	0812-09l	2008	Anti-Infective Agents/pharmacology, Candida albicans/drug effects, Drug Resistance, Microbial, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Phenols, Plant Extracts, Propolis/*pharmacology
Phylogeny	19152480	Additive activity of royal jelly and honey against Pseudomonas aeruginosa.	Boukraa L	Altern Med Rev		2008	Anti-Bacterial Agents/pharmacology, Fatty Acids/pharmacology, Honey/classification, Microbial Sensitivity Tests, *Pseudomonas aeruginosa/drug effects	Pathogenicity
Pathogenicity	19177851	Antimicrobial activity of endodontic sealers based on calcium hydroxide and MTA.	Tanomaru JM, Tanomaru-Filho M, Hotta J, Watanabe E, Ito IY	Acta Odontol Latinoam		2008	Aluminum Compounds/pharmacology, Anti-Infective Agents/pharmacology, Bismuth/pharmacology, Calcium Compounds/pharmacology, Calcium Hydroxide/pharmacology, Candida albicans/drug effects, Colony Count, Microbial, Drug Combinations, Enterococcus faecalis/drug effects, Humans, Materials Testing, Micrococcus luteus/drug effects, Oxides/pharmacology, Pseudomonas aeruginosa/drug effects, Root Canal Filling Materials/pharmacology, Salicylates/pharmacology, Silicates/*pharmacology, Staphylococcus aureus/drug effects, Temperature, Time Factors, Zinc Oxide-Eugenol Cement/pharmacology
Pathogenicity	19226402	Investigation of functional and morphological changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Origanum compactum essential oil.	Bouhdid S, Abrini J, Zhiri A, Espuny MJ, Manresa A	J Appl Microbiol	10.1111/j.1365-2672.2008.04124.x	2009	Anti-Bacterial Agents/pharmacology, Cell Membrane Permeability/drug effects, Chlorhexidine/pharmacology, Membrane Potentials/drug effects, Microbial Sensitivity Tests, Microscopy, Electron, Transmission, Oils, Volatile/chemistry/pharmacology, Origanum/chemistry, Plant Oils/chemistry/pharmacology, Polymyxin B/pharmacology, Potassium/metabolism, Pseudomonas aeruginosa/cytology/drug effects/ultrastructure, Staphylococcus aureus/cytology/*drug effects/ultrastructure	Metabolism
Pathogenicity	19265332	Effects of multipurpose contact-lens care solutions on adhesion of Pseudomonas aeruginosa to corneal epithelial cells.	Imayasu M, Shimizu H, Shimada S, Suzuki T, Cavanagh HD	Eye Contact Lens	10.1097/ICL.0b013e31819a67fd	2009	Bacterial Adhesion/drug effects, Cell Line, Transformed, Computer Systems, Contact Lens Solutions/adverse effects, Drug Combinations, Epithelium, Corneal/microbiology, Fluorescent Dyes, Humans, Microscopy, Confocal, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Organic Chemicals, Polymerase Chain Reaction, Pseudomonas aeruginosa/physiology
Pathogenicity	19413128	Composition and antimicrobial activity of Marrubium incanum Desr. (Lamiaceae) essential oil.	Petrovic S, Pavlovic M, Maksimovic Z, Milenkovic M, Couladis M, Tzakouc O, Niketic M	Nat Prod Commun		2009	Bacteria/drug effects, Gas Chromatography-Mass Spectrometry, Marrubium/chemistry, Microbial Sensitivity Tests, Montenegro, Oils, Volatile/analysis/isolation & purification/*toxicity	Enzymology
	19429353	Antimicrobial activity of Acacia mellifera extracts and lupane triterpenes.	Mutai C, Bii C, Vagias C, Abatis D, Roussis V	J Ethnopharmacol	10.1016/j.jep.2009.02.007	2009	Acacia/chemistry, Anti-Infective Agents/pharmacology, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Triterpenes/pharmacology
Enzymology	19455522	Enzymatic characterization of 30 kDa lipase from Pseudomonas aeruginosa ATCC 27853.	Izrael-Zivkovic LT, Gojgic-Cvijovic GD, Gopcevic KR, Vrvic MM, Karadzic IM	J Basic Microbiol	10.1002/jobm.200800229	2009	Chromatography, Gel, Chromatography, Ion Exchange, Enzyme Stability, Hydrogen-Ion Concentration, Kinetics, Lipase/chemistry/isolation & purification/metabolism, Methanol/chemistry, Octoxynol/chemistry, Pseudomonas aeruginosa/*enzymology, Structural Homology, Protein, Temperature	Phylogeny
Pathogenicity	19499805	[Antimicrobial activities of the culture supernatant of 293 cells transfected with recombinant HBD-2 gene eukyriotic expressive plasmid].	Wang H, Dong B, Zhou Y	Sheng Wu Yi Xue Gong Cheng Xue Za Zhi		2009	Anti-Infective Agents/pharmacology, Cell Line, Genetic Vectors, Humans, Kidney/cytology/embryology, Plasmids, Recombinant Proteins/genetics/metabolism/pharmacology, Transfection, beta-Defensins/genetics/*metabolism/pharmacology	Metabolism
Pathogenicity	19523971	Purification and characterization of a new L-amino acid oxidase from Daboia russellii siamensis venom.	Zhong SR, Jin Y, Wu JB, Jia YH, Xu GL, Wang GC, Xiong YL, Lu QM	Toxicon	10.1016/j.toxicon.2009.06.004	2009	Amino Acid Sequence, Chromatography, Gel, Electrophoresis, Polyacrylamide Gel, Escherichia coli/drug effects, Humans, L-Amino Acid Oxidase/chemistry/isolation & purification/pharmacology, Microbial Sensitivity Tests, Molecular Sequence Data, Platelet Aggregation/drug effects, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Substrate Specificity, Viper Venoms/enzymology	Enzymology
Pathogenicity	19548257	Screening of some Kenyan medicinal plants for antibacterial activity.	Wagate CG, Mbaria JM, Gakuya DW, Nanyingi MO, Kareru PG, Njuguna A, Gitahi N, Macharia JK, Njonge FK	Phytother Res	10.1002/ptr.2866	2010	Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Medicine, African Traditional, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Plants, Medicinal/chemistry
Pathogenicity	19597862	The occurrence of multidrug-resistant Pseudomonas aeruginosa on hydrocarbon-contaminated sites.	Kaszab E, Kriszt B, Atzel B, Szabo G, Szabo I, Harkai P, Szoboszlay S	Microb Ecol	10.1007/s00248-009-9551-7	2009	Drug Resistance, Multiple, Bacterial, Environmental Monitoring, Hungary, Hydrocarbons/analysis, Pseudomonas aeruginosa/drug effects/genetics/isolation & purification, Soil Pollutants/analysis	Enzymology
Pathogenicity	19688375	Tocopherol, carotene, phenolic contents and antibacterial properties of rose essential oil, hydrosol and absolute.	Ulusoy S, Bosgelmez-Tinaz G, Secilmis-Canbay H	Curr Microbiol	10.1007/s00284-009-9475-y	2009	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects, Carotenoids/chemistry/pharmacology, Oils, Volatile/chemistry/pharmacology, Phenols/chemistry/pharmacology, Plant Extracts/chemistry/pharmacology, Rosa/chemistry, Tocopherols/chemistry/pharmacology
Metabolism	19695163	[Proteomic study of peripheral blood lymphocytes of rabbits with severe burn and Pseudomonas aeruginosa sepsis].	Zeng JZ, Zhang PH, Li LL, Ren LC, Liang PF, Huang XY	Zhongguo Wei Zhong Bing Ji Jiu Yi Xue		2009	Animals, Burns/blood/complications, Disease Models, Animal, Lymphocytes/metabolism, Male, Proteome/metabolism, Proteomics, Pseudomonas Infections/blood/complications, Pseudomonas aeruginosa, Rabbits, Random Allocation, Sepsis/*blood/complications	Proteome
Metabolism	19715197	[Daily dynamics of particular pathogenicity factors and persistence of Staphylococcus aureus under the influence of exametabolites of associative microflora].	Timokhina TKh	Zh Mikrobiol Epidemiol Immunobiol		2009	Circadian Rhythm, Culture Media, Escherichia coli/metabolism, Pseudomonas aeruginosa/metabolism, Staphylococcus aureus/enzymology/pathogenicity, Virulence Factors/analysis/metabolism	Cultivation
Pathogenicity	19735193	The in vitro antimicrobial activities of the essential oils of some Lamiaceae species from Turkey.	Sarac N, Ugur A	J Med Food	10.1089/jmf.2008.0089	2009	Anti-Bacterial Agents/pharmacology, Antifungal Agents/pharmacology, Bacteria/drug effects, Candida/drug effects, Lamiaceae/chemistry, Microbial Sensitivity Tests, Oils, Volatile/isolation & purification/pharmacology, Plant Extracts/chemistry/*pharmacology, Turkey	Enzymology
Enzymology	19768999	Composition, antioxidant and antimicrobial activities of the essential oil of Marrubium deserti.	Laouer H, Yabrir B, Djeridane A, Yousfi M, Beldovini N, Lamamra M	Nat Prod Commun		2009	Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Anti-Infective Agents/chemistry/isolation & purification/pharmacology, Antifungal Agents/chemistry/isolation & purification/pharmacology, Antioxidants/chemistry/isolation & purification/pharmacology, Aspergillus flavus/drug effects, Candida albicans/drug effects, Escherichia coli/drug effects, Free Radical Scavengers/isolation & purification/pharmacology, Marrubium/chemistry, Oils, Volatile/chemistry/isolation & purification/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects	Phylogeny
Metabolism	19857930	Proteomic change of peripheral lymphocytes from scald injury and Pseudomonas aeruginosa sepsis in rabbits.	Zhang PH, Yang LR, Li LL, Zeng JZ, Ren LC, Liang PF, Huang XY	Burns	10.1016/j.burns.2009.03.006	2009	Animals, Blood Proteins/metabolism, Blotting, Western/methods, Burns/immunology/microbiology, Immune Tolerance, Lymphocytes/metabolism, Male, Proteomics/methods, Pseudomonas Infections/immunology, *Pseudomonas aeruginosa, Rabbits, Sepsis/immunology, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods
Enzymology	19858568	The in-vitro antimicrobial activity of some medicinal plants against beta-lactam-resistant bacteria.	Gangoue-Pieboji J, Eze N, Ngongang Djintchui A, Ngameni B, Tsabang N, Pegnyemb DE, Biyiti L, Ngassam P, Koulla-Shiro S, Galleni M	J Infect Dev Ctries	10.3855/jidc.77	2009	Anti-Bacterial Agents/isolation & purification/pharmacology, Bacteria/drug effects, Microbial Sensitivity Tests/methods, Plant Bark/chemistry, Plant Extracts/isolation & purification/pharmacology, Plant Leaves/chemistry, Plant Stems/chemistry, Plants, Medicinal/chemistry, *beta-Lactam Resistance	Phylogeny
Pathogenicity	19955747	Benzoxazine series of histidine kinase inhibitors as potential antimicrobial agents with activity against enterococci.	Mueller-Premru M, Zidar N, Spik VC, Krope A, Kikelj D	Chemotherapy	10.1159/000263228	2009	Anti-Bacterial Agents/pharmacology, Benzoxazines/pharmacology, Enterococcus/drug effects, Escherichia coli/drug effects, Histidine Kinase, Microbial Sensitivity Tests, Protein Kinase Inhibitors/pharmacology, Protein Kinases/drug effects/metabolism, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Vancomycin Resistance	Metabolism
Pathogenicity	19967999	Chemical composition and antibacterial activity of the essential oil of Monticalia andicola (Asteraceae) collected in Venezuela.	Baldovino S, Rojas J, Rojas LB, Lucena M, Buitrago A, Morales A	Nat Prod Commun		2009	Anti-Bacterial Agents/chemistry/pharmacology, Asteraceae/chemistry, Bacteria/drug effects, Chromatography, Gas, Gas Chromatography-Mass Spectrometry, Microbial Sensitivity Tests, Oils, Volatile/chemistry/*pharmacology, Venezuela
Pathogenicity	20060624	Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones.	Tomasic T, Zidar N, Mueller-Premru M, Kikelj D, Masic LP	Eur J Med Chem	10.1016/j.ejmech.2009.12.030	2009	Anti-Bacterial Agents/chemical synthesis/pharmacology, Bacteria/drug effects/growth & development, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Pyrimidines/chemical synthesis/pharmacology, Spectrometry, Mass, Electrospray Ionization, Spectrophotometry, Infrared, Thiazolidines/chemical synthesis/pharmacology
Pathogenicity	20084919	[Investigation of antibacterial activity of sertralin].	Coban AY, Tanriverdi Cayci Y, Keles Uludag S, Durupinar B	Mikrobiyol Bul		2009	Anti-Bacterial Agents/pharmacology, Antidepressive Agents/pharmacology, Bacteria/drug effects, Humans, Microbial Sensitivity Tests, Serotonin Uptake Inhibitors/pharmacology, Sertraline/*pharmacology
	20177496	Antibacterial and antioxidant activity of methanol extract of Evolvulus nummularius.	Pavithra PS, Sreevidya N, Verma RS	Indian J Pharmacol	10.4103/0253-7613.58514	2009
Pathogenicity	20428059	Synthesis and antimicrobial activity of novel Ag-N-hetero-cyclic carbene complexes.	Ozdemir I, Ozcan EO, Gunal S, Gurbuz N	Molecules	10.3390/molecules15042499	2010	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Candida albicans/drug effects, Candida tropicalis/drug effects, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Heterocyclic Compounds/chemical synthesis/chemistry/pharmacology, Imidazolidines/chemistry, Magnetic Resonance Spectroscopy, Methane/analogs & derivatives/chemistry, Nitrogen/chemistry, Pseudomonas aeruginosa/drug effects, Silver/chemistry, Staphylococcus aureus/drug effects
Pathogenicity	20456525	Functional and ultrastructural changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Cinnamomum verum essential oil.	Bouhdid S, Abrini J, Amensour M, Zhiri A, Espuny MJ, Manresa A	J Appl Microbiol	10.1111/j.1365-2672.2010.04740.x	2010	Anti-Bacterial Agents/pharmacology, Cell Membrane Permeability/drug effects, Cinnamomum/chemistry, Membrane Potentials/drug effects, Oils, Volatile/pharmacology, Potassium/metabolism, Pseudomonas aeruginosa/drug effects/metabolism/ultrastructure, Staphylococcus aureus/drug effects/metabolism/ultrastructure, Thiobarbiturates/analysis	Metabolism
Phylogeny	20521558	Chemical composition and antimicrobial activity of essential oils of Genista ulicina and G. vepres.	Lograda T, Chaker AN, Chalchat JC, Ramdani M, Silini H, Figueredo G, Chalarde P	Nat Prod Commun		2010	Algeria, Bacteria/drug effects, Disk Diffusion Antimicrobial Tests, Gas Chromatography-Mass Spectrometry, Genista/chemistry, Oils, Volatile/analysis/isolation & purification/pharmacology, Plant Extracts/analysis/isolation & purification/*pharmacology, Species Specificity	Enzymology
Pathogenicity	20549529	Absence of bacterial resistance to medical-grade manuka honey.	Cooper RA, Jenkins L, Henriques AF, Duggan RS, Burton NF	Eur J Clin Microbiol Infect Dis	10.1007/s10096-010-0992-1	2010	Anti-Infective Agents, Local/pharmacology, Drug Resistance, Bacterial, Drug Tolerance, Escherichia coli/drug effects/isolation & purification, *Honey, Humans, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/isolation & purification, Serial Passage, Staphylococcus aureus/drug effects/isolation & purification, Staphylococcus epidermidis/drug effects/isolation & purification	Enzymology
Pathogenicity	20578550	Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.	Naenna P, Noisumdaeng P, Pongpech P, Tribuddharat C	Southeast Asian J Trop Med Public Health		2010	Antibodies, Bacterial, Carbapenems/pharmacology, Drug Resistance, Bacterial/genetics/physiology, Humans, Imipenem/pharmacology, Meropenem, Microbial Sensitivity Tests, Porins/biosynthesis/genetics/isolation & purification, Pseudomonas aeruginosa/classification/*drug effects, Thienamycins/pharmacology	Phylogeny
Enzymology	20585118	Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model.	Bergen PJ, Bulitta JB, Forrest A, Tsuji BT, Li J, Nation RL	Antimicrob Agents Chemother	10.1128/AAC.00903-09	2010	Colistin/pharmacokinetics/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/*drug effects/metabolism	Pathogenicity
Pathogenicity	20589160	In-vitro antibacterial activity of selected medicinal plants from Longisa region of Bomet district, Kenya.	Cheruiyot KR, Olila D, Kateregga J	Afr Health Sci		2009	Animals, Anti-Bacterial Agents/isolation & purification/pharmacology, Escherichia coli/drug effects, Kenya, Microbial Sensitivity Tests, Plant Bark/chemistry, Plant Extracts/pharmacology, Plant Leaves/chemistry, Plants, Medicinal/chemistry, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/*drug effects	Enzymology
Cultivation	20730523	Influence of Legionella pneumophila and other water bacteria on the survival and growth of Acanthamoeba polyphaga.	Anacarso I, Guerrieri E, Bondi M, de Niederhausern S, Iseppi R, Sabia C, Contri M, Borella P, Messi P	Arch Microbiol	10.1007/s00203-010-0618-0	2010	Acanthamoeba/growth & development/microbiology, Coculture Techniques, Culture Media, Endocytosis, Legionella pneumophila/growth & development, Phagosomes/microbiology, Pseudomonas aeruginosa/growth & development, Trophozoites/growth & development, *Water Microbiology
Pathogenicity	20738067	Antibacterial effect of lanthanum calcium manganate (La0.67Ca0.33MnO3) nanoparticles against Pseudomonas aeruginosa ATCC 27853.	De D, Mandal SM, Gauri SS, Bhattacharya R, Ram S, Roy SK	J Biomed Nanotechnol	10.1166/jbn.2010.1113	2010	Calcium/chemistry/pharmacology, Cell Membrane/drug effects, Cell Proliferation/drug effects, Cells, Immobilized/metabolism, Lanthanum/chemistry/pharmacology, Manganese Compounds/chemistry/pharmacology, Metal Nanoparticles/chemistry, Microbial Sensitivity Tests, Particle Size, Pseudomonas aeruginosa/drug effects, X-Ray Diffraction	Metabolism
Pathogenicity	20936493	The effect of manuka honey on the structure of Pseudomonas aeruginosa.	Henriques AF, Jenkins RE, Burton NF, Cooper RA	Eur J Clin Microbiol Infect Dis	10.1007/s10096-010-1065-1	2010	Anti-Bacterial Agents/pharmacology, Honey, Humans, Microbial Sensitivity Tests, Microbial Viability/drug effects, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Pseudomonas aeruginosa/drug effects/ultrastructure
	21170546	Candida albicans and Pseudomonas aeruginosa adhesion on soft contact lenses.	Onurdag FK, Ozkan S, Ozgen S, Olmus H, Abbasoglu U	Graefes Arch Clin Exp Ophthalmol	10.1007/s00417-010-1595-3	2010	Bacterial Adhesion/physiology, Biofilms, Candida albicans/physiology, Colony Count, Microbial, Contact Lenses, Hydrophilic/microbiology, Pseudomonas aeruginosa/physiology
Pathogenicity	21190916	Antioxidant and antibacterial activities of selected varieties of thai mango seed extract.	Khammuang S, Sarnthima R	Pak J Pharm Sci		2011	Anti-Bacterial Agents/pharmacology, Antioxidants/pharmacology, Ascorbic Acid/chemistry, Bacteria/drug effects, Benzothiazoles/chemistry, Biphenyl Compounds/chemistry, Chromans/chemistry, Diffusion, Free Radical Scavengers/chemistry, Indicators and Reagents, Mangifera/*chemistry, Microbial Sensitivity Tests, Phenols/analysis, Picrates/chemistry, Plant Extracts/pharmacology, Seeds/chemistry, Sulfonic Acids/chemistry, Thailand
	21218074	Synthesis and antibacterial activity of triphenyltinbenzoate.	Choudhury MK, Zewdie B	Indian J Pharm Sci	10.4103/0250-474X.73923	2010
Pathogenicity	21294399	Antibacterial and antifungal activities from Siamese crocodile blood.	Leelawongtawon R, Siruntawineti J, Chaeychomsri W, Sattaponpan C	J Med Assoc Thai		2010	Alligators and Crocodiles, Animals, Anti-Bacterial Agents/pharmacology, Antifungal Agents/pharmacology, Bacteria/drug effects, Blood, Female, Freeze Drying, Fungi/drug effects, Microbial Sensitivity Tests
	21422203	Saturability of granulocyte kill of Pseudomonas aeruginosa in a murine model of pneumonia.	Drusano GL, Vanscoy B, Liu W, Fikes S, Brown D, Louie A	Antimicrob Agents Chemother	10.1128/AAC.01687-10	2011	Animals, Blood Bactericidal Activity, Disease Models, Animal, Female, Granulocytes/immunology, Mice, Pneumonia, Bacterial/immunology, Pneumonia, Ventilator-Associated/drug therapy, Pseudomonas aeruginosa/immunology
Pathogenicity	21514795	In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.	Kresken M, Korber-Irrgang B, Lauffer J, Decker-Burgard S, Davies T	Int J Antimicrob Agents	10.1016/j.ijantimicag.2011.01.028	2011	Amikacin/pharmacology, Anti-Bacterial Agents/pharmacology, Cephalosporins/pharmacology, Drug Synergism, Drug Therapy, Combination, Humans, Levofloxacin, Microbial Sensitivity Tests, Ofloxacin/pharmacology, Pseudomonas aeruginosa/drug effects/growth & development, Stem Cells, Time Factors
Pathogenicity	21528775	In vitro study of antibacterial activity of the alga Sargassum oligocystum from the Persian Gulf.	Tajbakhsh S, Pouyan M, Zandi K, Bahramian P, Sartavi K, Fouladvand M, Asayesh G, Barazesh A	Eur Rev Med Pharmacol Sci		2011	Anti-Bacterial Agents/isolation & purification/pharmacology, Escherichia coli/drug effects/growth & development, Indian Ocean, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Sargassum/chemistry, Seawater, Staphylococcus aureus/drug effects/growth & development, Staphylococcus epidermidis/drug effects/growth & development	Enzymology
Enzymology	21615035	Essential oil composition and antibacteral activity of Vismia baccifera fruits collected from Merida, Venezuela.	Rojas J, Buitrago A, Rojas L, Morales A, Lucena M, Baldovino S	Nat Prod Commun		2011	Anti-Bacterial Agents/chemistry, Clusiaceae/chemistry, Fruit/chemistry, Microbial Sensitivity Tests, Oils, Volatile/*chemistry/isolation & purification, Venezuela	Phylogeny
Biotechnology	21651846	[Reproduction of a rat model of burn with infection].	Zhang DW, Gong ZY, Peng YZ	Zhonghua Shao Shang Za Zhi		2011	Animals, Burns/microbiology, Disease Models, Animal, Male, Rats, Rats, Sprague-Dawley, Wound Infection/*microbiology
Pathogenicity	21653768	Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone.	Ross JE, Liverman LC, Jones RN	J Clin Microbiol	10.1128/JCM.00636-11	2011	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Fluoroquinolones/*pharmacology, Humans, Microbial Sensitivity Tests/standards, Quality Control
Pathogenicity	21756818	[Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa].	Liu MT, Sheng MY, Zhang Y, Li Y	Zhonghua Yi Xue Za Zhi		2011	Animals, Ciprofloxacin/administration & dosage/pharmacology/therapeutic use, Disease Models, Animal, Drug Resistance, Bacterial/drug effects/genetics, Drug Therapy, Combination, Microbial Sensitivity Tests, Mutation, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects/genetics, Rabbits, Tobramycin/administration & dosage/*pharmacology/therapeutic use
Pathogenicity	21771453	In vitro antibacterial effect of aqueous and ethanolic Moringa leaf extracts.	Peixoto JR, Silva GC, Costa RA, de Sousa Fontenelle JR, Vieira GH, Filho AA, dos Fernandes Vieira RH	Asian Pac J Trop Med	10.1016/S1995-7645(11)60069-2	2011	Anti-Bacterial Agents/isolation & purification/pharmacology, Bacteria/drug effects/growth & development, Humans, Microbial Sensitivity Tests/methods, Moringa oleifera/chemistry, Plant Extracts/isolation & purification/pharmacology, Plant Leaves/chemistry	Enzymology
Pathogenicity	21790913	Effects of ozone on membrane permeability and ultrastructure in Pseudomonas aeruginosa.	Zhang YQ, Wu QP, Zhang JM, Yang XH	J Appl Microbiol	10.1111/j.1365-2672.2011.05113.x	2011	Adenosine Triphosphate/analysis, Cell Membrane/drug effects/ultrastructure, Cell Membrane Permeability/drug effects, Cytoplasm/chemistry, Magnesium/analysis, Microbial Viability, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Ozone/pharmacology, Potassium/analysis, Pseudomonas aeruginosa/drug effects/physiology/ultrastructure, Vacuoles/ultrastructure
Pathogenicity	21822040	Investigation of the antimicrobial activity of Rhaponticum (Rhaponticum carthamoides D.C. Iljin) and shrubby cinquefoil (Potentilla fruticosa L.).	Jurkstiene V, Pavilonis A, Garsviene D, Juozulynas A, Samsoniene L, Dauksiene D, Jankauskiene K, Simoniene-Kazlauskiene G, Stankevicius E	Medicina (Kaunas)	1103-06e	2011	Anti-Infective Agents/chemistry/pharmacology, Bacteria/drug effects, Candida albicans/drug effects, Drug Resistance, Microbial, Leuzea/chemistry, Microbial Sensitivity Tests, Phytotherapy, Plant Extracts/chemistry/pharmacology, Potentilla/chemistry
Pathogenicity	21876058	Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.	Bergen PJ, Forrest A, Bulitta JB, Tsuji BT, Sidjabat HE, Paterson DL, Li J, Nation RL	Antimicrob Agents Chemother	10.1128/AAC.05028-11	2011	Anti-Bacterial Agents/pharmacology, Colistin/blood/pharmacology, Drug Resistance, Multiple, Bacterial/drug effects, Drug Synergism, Humans, Imipenem/blood/pharmacology, Microbial Sensitivity Tests, Pseudomonas Infections/blood/drug therapy, Pseudomonas aeruginosa/drug effects
Pathogenicity	21911563	Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.	Bergen PJ, Tsuji BT, Bulitta JB, Forrest A, Jacob J, Sidjabat HE, Paterson DL, Nation RL, Li J	Antimicrob Agents Chemother	10.1128/AAC.05298-11	2011	Anti-Bacterial Agents/pharmacokinetics/pharmacology/therapeutic use, Carbapenems/pharmacokinetics/pharmacology/therapeutic use, Colistin/pharmacokinetics/pharmacology/therapeutic use, Colony Count, Microbial, Cystic Fibrosis/drug therapy/microbiology, Doripenem, Drug Resistance, Multiple, Bacterial, Drug Synergism, Drug Therapy, Combination, Half-Life, Humans, Models, Biological, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects/growth & development/isolation & purification	Enzymology
Pathogenicity	21913399	[Antibacterial activity of nanostructured silver gel].	Chervinets VM, Bondarenko VM, Chervinets IuV, Ovchinnikov MM, Samoukina AM, Mikhailova ES, Petrova MB, Kharitonova EA, Briantseva VM	Zh Mikrobiol Epidemiol Immunobiol		2011	Animals, Anti-Bacterial Agents/pharmacology, Candida albicans/drug effects, Cysteine/pharmacology, Escherichia coli/drug effects, Gels, Male, Microbial Sensitivity Tests, Nanostructures, Pseudomonas aeruginosa/drug effects, Rats, Shigella sonnei/drug effects, Silver/pharmacology, Staphylococcus aureus/drug effects, Wound Healing/drug effects, Wound Infection/*microbiology
	21922927	Composition and antimicrobial activity of Seseli globiferum essential oil.	Janackovic P, Sokovic M, Vujisic L, Vajs V, Vuckovic I, Krivosej Z, Marin PD	Nat Prod Commun		2011	Apiaceae/chemistry, Gas Chromatography-Mass Spectrometry, Oils, Volatile/chemistry, Plant Components, Aerial/chemistry, Plant Oils/*chemistry
Pathogenicity	21933787	Suitability of a new antimicrobial aminosterol formulation for aerosol delivery in cystic fibrosis.	Alhanout K, Brunel JM, Dubus JC, Rolain JM, Andrieu V	J Antimicrob Chemother	10.1093/jac/dkr380	2011	Aerosols/chemistry/pharmacology, Anti-Bacterial Agents/chemistry/pharmacology, Bacterial Infections/drug therapy, Cholestanols/chemistry/pharmacology, Cystic Fibrosis/*complications, Drug Stability, Humans, Microbial Sensitivity Tests, Particulate Matter, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	21935774	[Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].	Acuner IC, Bayramoglu G, Birinci A, Cekic Cihan C, Bek Y, Durupinar B	Mikrobiyol Bul		2011	Anti-Bacterial Agents/pharmacology, Drug Resistance, Multiple, Bacterial, Humans, Meropenem, Microbial Sensitivity Tests/methods/standards, Pseudomonas aeruginosa/drug effects, Quality Control, Reproducibility of Results, Research Design/standards, Thienamycins/pharmacology
Enzymology	22011691	Antimicrobial effect of statins: organic solvents might falsify microbiological testing results.	Matzneller P, Manafi M, Zeitlinger M	Int J Clin Pharmacol Ther	10.5414/cp201581	2011	Anti-Infective Agents/pharmacology, Hydrogen-Ion Concentration, Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology, Methanol/pharmacology, Microbial Sensitivity Tests, Simvastatin/pharmacology, Solvents/pharmacology
Pathogenicity	22116462	Bactericidal effects of antimicrobial agents on epithelial cell-associated Pseudomonas aeruginosa.	Hirakata Y, Yano H, Arai K, Kitagawa M, Hatta M, Kunishima H, Kaku M	J Infect Chemother	10.1007/s10156-011-0342-y	2011	Animals, Anti-Bacterial Agents/pharmacology, Cell Line, Transformed, Cell Line, Tumor, Ciprofloxacin/pharmacology, Dogs, Epithelial Cells/microbiology, Gentamicins/pharmacology, Humans, Imipenem/pharmacology, Madin Darby Canine Kidney Cells, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects
	22186120	An in vitro and in vivo study on the intensity of adhesion and colonization by Staphylococcus epidermidis and Pseudomonas aeruginosa on originally synthesized biomaterials with different chemical composition and modified surfaces and their effect on expression of TNF-alpha, beta-defensin 2 and IL-10 in tissues.	Reinis A, Pilmane M, Stunda A, Vetra J, Kroica J, Rostoka D, Salms G, Vostroilovs A, Dons A, Berzina-Cimdina L	Medicina (Kaunas)	1110-06e	2011	Animals, Bacterial Adhesion, Biocompatible Materials/chemical synthesis/chemistry, Ceramics/chemistry, Glass/chemistry, Interleukin-10/biosynthesis, Prostheses and Implants/microbiology, Prosthesis Implantation, Pseudomonas aeruginosa/physiology, Rabbits, Staphylococcus epidermidis/physiology, Surface Properties, Tumor Necrosis Factor-alpha/biosynthesis, beta-Defensins/biosynthesis
Pathogenicity	22230976	Antibacterial and antioxidant activities of three endemic plants from Algerian Sahara.	Bouchouka E, Djilani A, Bekkouche A	Acta Sci Pol Technol Aliment	973178	2012	Acetates, Africa, Northern, Algeria, Anti-Bacterial Agents/analysis/pharmacology, Antioxidants/analysis/pharmacology, Brassicaceae/chemistry, Ferula/chemistry, Flavonoids/analysis, Fruit/chemistry, Genista/*chemistry, Plant Components, Aerial/chemistry, Plant Extracts/chemistry, Plants, Medicinal/chemistry, Staphylococcus aureus/drug effects
Pathogenicity	22302771	In vitro microbiology studies on a new peritoneal dialysis connector.	Di Bonaventura G, Cerasoli P, Pompilio A, Arrizza F, Di Liberato L, Stingone A, Sirolli V, Arduini A, Bonomini M	Perit Dial Int	10.3747/pdi.2011.00089	2012	Bacterial Infections/microbiology/prevention & control, Dialysis Solutions, Equipment Contamination/prevention & control, Humans, Peritoneal Dialysis/adverse effects/instrumentation, Peritonitis/microbiology/prevention & control, Pseudomonas aeruginosa/isolation & purification, Staphylococcus epidermidis/isolation & purification	Enzymology
Pathogenicity	22309915	New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation.	Barbuceanu SF, Saramet G, Almajan GL, Draghici C, Barbuceanu F, Bancescu G	Eur J Med Chem	10.1016/j.ejmech.2012.01.031	2012	Anti-Infective Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Bacterial Infections/drug therapy, Fungi/drug effects, Humans, Microbial Sensitivity Tests, Mycoses/drug therapy, Thiadiazoles/chemical synthesis/chemistry/pharmacology, Triazoles/chemical synthesis/chemistry/pharmacology
	22312374	The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats.	Gao X, Huang Y, Han Y, Bai CX, Wang G	Arch Med Sci	10.5114/aoms.2011.23403	2011
Enzymology	22338560	Antimicrobial activity of a 48-kDa protease (AMP48) from Artocarpus heterophyllus latex.	Siritapetawee J, Thammasirirak S, Samosornsuk W	Eur Rev Med Pharmacol Sci		2012	Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Antifungal Agents/pharmacology, Artocarpus/chemistry, Bacteria/drug effects, Electrophoresis, Gel, Two-Dimensional, Electrophoresis, Polyacrylamide Gel, Fungi/drug effects, Microbial Sensitivity Tests, Microscopy, Atomic Force, Peptide Hydrolases/chemistry/*pharmacology, Plant Proteins/chemistry/isolation & purification	Pathogenicity
Pathogenicity	22349957	Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C.	Masadeh MM, Mhaidat NM, Alzoubi KH, Al-Azzam SI, Shaweesh AI	Curr Microbiol	10.1007/s00284-012-0094-7	2012	Anti-Bacterial Agents/antagonists & inhibitors/pharmacology, Ascorbic Acid/antagonists & inhibitors/pharmacology, Bacteria/drug effects/isolation & purification, Bacterial Infections/microbiology, Ciprofloxacin/antagonists & inhibitors/pharmacology, Drug Antagonism, Humans, Microbial Sensitivity Tests, Vitamin E/antagonists & inhibitors/pharmacology	Enzymology
Pathogenicity	22461001	In vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement.	Samuel S, Mathew BS, Veeraraghavan B, Fleming DH, Chittaranjan SB, Prakash JA	J Orthop Traumatol	10.1007/s10195-012-0191-1	2012	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects/growth & development, Humans, Meropenem, Microbial Sensitivity Tests, Orthopedic Equipment/microbiology, Polymethyl Methacrylate/pharmacology, Prosthesis-Related Infections/microbiology/prevention & control, Thienamycins/*pharmacology	Enzymology
Pathogenicity	22474970	Essential oil composition and antibacterial activity of Monticalia greenmaniana (Asteraceae).	Cardenas J, Rojas J, Rojas-Fermin L, Lucena M, Buitrago A	Nat Prod Commun		2012	Anti-Bacterial Agents/chemistry/pharmacology, Asteraceae/chemistry, Bacteria/drug effects, Microbial Sensitivity Tests, Oils, Volatile/chemistry/pharmacology, Plant Components, Aerial/chemistry, Plant Oils/chemistry/pharmacology
	22577384	Evaluations of the Effects of Extremely Low-Frequency Electromagnetic Fields on Growth and Antibiotic Susceptibility of Escherichia coli and Pseudomonas aeruginosa.	Segatore B, Setacci D, Bennato F, Cardigno R, Amicosante G, Iorio R	Int J Microbiol	10.1155/2012/587293	2012
Pathogenicity	22594260	Synergistic antibacterial activity of Salvia officinalis and Cichorium intybus extracts and antibiotics.	Stefanovic OD, Stanojevic DD, Comic LR	Acta Pol Pharm		2012	Amoxicillin/pharmacology, Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Chicory/chemistry, Chloramphenicol/pharmacology, Drug Synergism, Plant Extracts/pharmacology, Salvia officinalis/chemistry
Genetics	22740676	Draft genome sequence of Pseudomonas aeruginosa strain ATCC 27853.	Fang X, Fang Z, Zhao J, Zou Y, Li T, Wang J, Guo Y, Chang D, Su L, Ni P, Liu C	J Bacteriol	10.1128/JB.00690-12	2012	Gene Expression Regulation, Bacterial/physiology, Genome, Bacterial, Molecular Sequence Data, Pseudomonas aeruginosa/classification/genetics	Phylogeny
Pathogenicity	22751540	In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.	Vidaillac C, Benichou L, Duval RE	Antimicrob Agents Chemother	10.1128/AAC.05996-11	2012	Acinetobacter baumannii/drug effects/growth & development/isolation & purification, Anti-Bacterial Agents/pharmacology, Colistin/pharmacology, Drug Resistance, Multiple, Bacterial/drug effects, Drug Synergism, Gram-Negative Bacterial Infections/microbiology, Humans, Klebsiella pneumoniae/drug effects/growth & development/isolation & purification, Microbial Sensitivity Tests, Microbial Viability/drug effects, Pseudomonas aeruginosa/drug effects/growth & development/isolation & purification, Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology, Vancomycin/*pharmacology	Enzymology
	22819168	Contribution of UVB radiation to bacterial inactivation by natural sunlight.	Oppezzo OJ	J Photochem Photobiol B	10.1016/j.jphotobiol.2012.06.011	2012	Absorption, Microbial Viability/radiation effects, Polyethylene Terephthalates/chemistry, Pseudomonas aeruginosa/physiology/radiation effects, Sunlight/adverse effects, Ultraviolet Rays/*adverse effects
Pathogenicity	22845330	Synthesis, characterization, and antimicrobial evaluation of some new hydrazinecarbothioamide, 1,2,4-triazole and 1,3,4-thiadiazole derivatives.	Guzeldemirci NU, Satana D, Kucukbasmaci O	J Enzyme Inhib Med Chem	10.3109/14756366.2012.700926	2012	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Dose-Response Relationship, Drug, Fungi/drug effects, Hydrazines/chemical synthesis/chemistry/pharmacology, Microbial Sensitivity Tests, Molecular Structure, Structure-Activity Relationship, Thiadiazoles/chemical synthesis/chemistry/pharmacology, Thiourea/analogs & derivatives/chemical synthesis/chemistry/pharmacology, Triazoles/chemical synthesis/chemistry/pharmacology
Metabolism	22850514	Effect of systemic infection induced by Pseudomonas aeruginosa on the brain uptake of colistin in mice.	Jin L, Li J, Nation RL, Nicolazzo JA	Antimicrob Agents Chemother	10.1128/AAC.00713-12	2012	Animals, Bacteremia/blood/metabolism, Blood-Brain Barrier/metabolism, Brain/metabolism, Colistin/metabolism, Cytokines/blood, Lipopolysaccharides/pharmacology, Male, Mice, Pseudomonas Infections/blood/metabolism, Pseudomonas aeruginosa/pathogenicity
Pathogenicity	22872187	Evaluation in vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP).	Marumo K, Komukai D, Hirose M, Nakamura H, Tanaka H, Ugajin K, Nagashima G, Yoshimura A	J Infect Chemother	10.1007/s10156-012-0456-x	2012	Anti-Bacterial Agents/pharmacology, Biofilms/drug effects, Colistin/pharmacology, Drug Resistance, Multiple, Bacterial, Humans, Microbial Sensitivity Tests, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/drug effects/*physiology
Enzymology	22925726	Inhibition of quorum sensing in Pseudomonas aeruginosa by sesquiterpene lactones.	Amaya S, Pereira JA, Borkosky SA, Valdez JC, Bardon A, Arena ME	Phytomedicine	10.1016/j.phymed.2012.07.003	2012	Anti-Bacterial Agents/isolation & purification/pharmacology, Asteraceae/chemistry, Biofilms/drug effects, Lactones/isolation & purification/pharmacology, Microbial Sensitivity Tests, Pancreatic Elastase/analysis, Pseudomonas aeruginosa/drug effects, Quorum Sensing/drug effects, Sesquiterpenes/isolation & purification/pharmacology	Phylogeny
	22992217	In vitro evaluation of anti-pathogenic surface coating nanofluid, obtained by combining Fe3O4/C12 nanostructures and 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl)-benzamides.	Anghel I, Limban C, Grumezescu AM, Anghel AG, Bleotu C, Chifiriuc MC	Nanoscale Res Lett	10.1186/1556-276X-7-513	2012
Metabolism	23072432	Antibiotic producing microorganisms from River Wiwi, Lake Bosomtwe and the Gulf of Guinea at Doakor Sea Beach, Ghana.	Tawiah AA, Gbedema SY, Adu F, Boamah VE, Annan K	BMC Microbiol	10.1186/1471-2180-12-234	2012	Anti-Bacterial Agents/metabolism, Bacteria/classification/isolation & purification/metabolism, Fresh Water/microbiology, Ghana, Humans, Microbial Sensitivity Tests, Seawater/microbiology	Phylogeny
Pathogenicity	23085653	Synergistic antibacterial activity of the essential oil of aguaribay (Schinus molle L.).	de Mendonca Rocha PM, Rodilla JM, Diez D, Elder H, Guala MS, Silva LA, Pombo EB	Molecules	10.3390/molecules171012023	2012	Anacardiaceae/chemistry, Anti-Bacterial Agents/chemistry/pharmacology, Drug Synergism, Escherichia coli/drug effects, Fruit/chemistry, Microbial Sensitivity Tests, Plant Extracts/chemistry/pharmacology, Plant Leaves/chemistry, Plant Oils/chemistry/*pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	23087515	Antibacterial activity of the venom of Heterometrus xanthopus.	Ahmed U, Mujaddad-Ur-Rehman M, Khalid N, Fawad SA, Fatima A	Indian J Pharmacol	10.4103/0253-7613.99332	2012	Animals, Anti-Bacterial Agents/isolation & purification/pharmacology, Dose-Response Relationship, Drug, Enterococcus faecalis/drug effects/physiology, Escherichia coli/drug effects/physiology, Gram-Negative Bacteria/drug effects/physiology, Gram-Positive Bacteria/drug effects/physiology, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects/physiology, Scorpion Venoms/isolation & purification/pharmacology, Scorpions, Staphylococcus aureus/drug effects/physiology	Enzymology
Pathogenicity	23158814	[Changes of drug-resistance of Pseudomonas aeruginosa in pediatric intensive care unit].	Wang LJ, Sun Y, Song WL, Zhang ZJ, Liu CF	Zhonghua Er Ke Za Zhi		2012	Adolescent, Ampicillin/pharmacology, Anti-Bacterial Agents/pharmacology, Cefazolin/pharmacology, Child, Child, Preschool, Cross Infection/microbiology/prevention & control, Drug Resistance, Multiple, Bacterial, Female, Humans, Imipenem/pharmacology, Infant, Intensive Care Units, Pediatric, Male, Microbial Sensitivity Tests, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/*drug effects/isolation & purification	Enzymology
Pathogenicity	23178215	Fabrication, characterization and in vitro profile based interaction with eukaryotic and prokaryotic cells of alginate-chitosan-silica biocomposite.	Balaure PC, Andronescu E, Grumezescu AM, Ficai A, Huang KS, Yang CH, Chifiriuc CM, Lin YS	Int J Pharm	10.1016/j.ijpharm.2012.10.045	2012	Alginates/chemistry, Anti-Bacterial Agents/administration & dosage/pharmacology, Cell Cycle/drug effects, Cell Survival/drug effects, Chitosan/chemistry, Drug Carriers/chemistry, *Drug Delivery Systems, Escherichia coli/drug effects, Eukaryotic Cells/drug effects/metabolism, Glucuronic Acid/chemistry, Hexuronic Acids/chemistry, Microscopy, Electron, Scanning, Prokaryotic Cells/drug effects/metabolism, Pseudomonas aeruginosa/drug effects, Silicon Dioxide/chemistry, Spectroscopy, Fourier Transform Infrared, Thermogravimetry	Metabolism
Pathogenicity	23202915	Optimized anti-pathogenic agents based on core/shell nanostructures and 2-((4-ethylphenoxy)ethyl)-N-(substituted-phenylcarbamothioyl)-benzamides.	Limban C, Grumezescu AM, Saviuc C, Voicu G, Predan G, Sakizlian R, Chifiriuc MC	Int J Mol Sci	10.3390/ijms131012584	2012	Anti-Infective Agents/chemistry/pharmacology, Benzamides/chemistry/pharmacology, Biofilms/drug effects, Nanostructures/chemistry, Pseudomonas aeruginosa/drug effects/physiology, Staphylococcus aureus/drug effects/physiology, Thiourea/analogs & derivatives/pharmacology
Genetics	23208601	Effect of long-term starvation in salty microcosm on biofilm formation and motility in Pseudomonas aeruginosa.	Elabed H, Maatallah M, Hamza R, Chakroun I, Bakhrouf A, Gaddour K	World J Microbiol Biotechnol	10.1007/s11274-012-1221-0	2012	Adenosylmethionine Decarboxylase/biosynthesis, Bacterial Adhesion, Biofilms/growth & development, DNA, Bacterial/chemistry/genetics, Electron Transport Complex IV/biosynthesis, Gene Expression Profiling, Locomotion, Molecular Sequence Data, Pseudomonas aeruginosa/growth & development/metabolism/*physiology, Sequence Analysis, DNA, Sodium Chloride/metabolism	Metabolism
Metabolism	23210926	Attenuation of Pseudomonas aeruginosa virulence by marine invertebrate-derived Streptomyces sp.	Naik DN, Wahidullah S, Meena RM	Lett Appl Microbiol	10.1111/lam.12034	2013	Animals, Chromobacterium/metabolism, Cinnamates/analysis/pharmacology, Dipeptides/analysis/pharmacology, India, Indoles/metabolism, Invertebrates/microbiology, Microbial Interactions, Pseudomonas aeruginosa/growth & development/pathogenicity/physiology, Pyocyanine/biosynthesis, Quorum Sensing/drug effects, Streptomyces/chemistry/classification/isolation & purification/*physiology, Virulence, Virulence Factors/metabolism	Phylogeny
Pathogenicity	23232977	Comparison of Rosco Neo-Sensitabs with Oxoid paper disks in EUCAST disk diffusion antimicrobial susceptibility testing on Mueller-Hinton agar.	Justesen US, Acar Z, Olsson K, Jensen TG, Kerrn MB, Skov RL, Gahrn-Hansen B	Eur J Clin Microbiol Infect Dis	10.1007/s10096-012-1785-5	2012	Agar, Anti-Infective Agents/pharmacology, Bacteria/drug effects, Bacterial Infections/microbiology, Culture Media, Disk Diffusion Antimicrobial Tests/instrumentation/methods/standards, Humans	Cultivation
Metabolism	23243235	Tissue distribution, expression, and antimicrobial activity of Anas platyrhynchos avian beta-defensin 6.	Peng KS, Ruan LS, Tu J, Qi KZ, Jiang LH	Poult Sci	10.3382/ps.2012-02562	2013	Animals, Antimicrobial Cationic Peptides/genetics/metabolism, Bacteria/drug effects, Candida albicans/drug effects, Defensins/genetics/metabolism, Ducks/metabolism, Female, Gene Expression Regulation/physiology, Male, Phylogeny, Tissue Distribution	Pathogenicity
Pathogenicity	23274224	Zn(II), Ni(II), Cu(II) and Pb(II) complexes of tridentate asymmetrical Schiff base ligands: synthesis, characterization, properties and biological activity.	Sahin M, Kocak N, Erdenay D, Arslan U	Spectrochim Acta A Mol Biomol Spectrosc	10.1016/j.saa.2012.11.006	2012	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Bacterial Infections/drug therapy, Coordination Complexes/chemical synthesis/chemistry/pharmacology, Copper/chemistry/pharmacology, Electron Spin Resonance Spectroscopy, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Humans, Lead/chemistry/pharmacology, Ligands, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Nickel/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Schiff Bases/chemical synthesis/chemistry/*pharmacology, Spectrophotometry, Ultraviolet, Spectroscopy, Fourier Transform Infrared, Staphylococcus aureus/drug effects, Streptococcus/drug effects, Zinc/chemistry/pharmacology
Pathogenicity	23297626	[Effect of Pseudomonas aeruginosa exometabolites on planktonic and biofilm cultures of Escherichia coli].	Kuznetsova MV, Karpunina TI, Maslennikova IL, Nesterova LIu, Demakov VA	Zh Mikrobiol Epidemiol Immunobiol		2012	Antibiosis, Biofilms/drug effects/growth & development, Culture Media, Conditioned/pharmacology, Escherichia coli K12/drug effects/growth & development, Luminescence, Luminescent Measurements, Oligopeptides/chemistry, Plankton/drug effects/growth & development, Pseudomonas aeruginosa/chemistry/metabolism, Pyocyanine/chemistry	Cultivation
Pathogenicity	23399122	Antimicrobial activity of carboxymethyl chitosan/polyethylene oxide nanofibers embedded silver nanoparticles.	Fouda MM, El-Aassar MR, Al-Deyab SS	Carbohydr Polym	10.1016/j.carbpol.2012.10.047	2012	Anti-Infective Agents/chemistry/pharmacology, Bacteria/drug effects/growth & development, Chitosan/analogs & derivatives/chemistry, Drug Stability, Metal Nanoparticles/chemistry, Nanofibers/chemistry, Nanotechnology, Polyethylene Glycols/chemistry, Silver/*chemistry
Pathogenicity	23424788	[Antimicrobial susceptibility in Pseudomonas aeruginosa strains taken from patients with cystic fibrosis].	Perez Monras MF, Batlle Almodovar Mdel C, Verdera Hernandez J, Hernandez AL	Rev Cubana Med Trop		2006	Anti-Bacterial Agents/pharmacology, Carrier State/epidemiology/microbiology, Child, Cuba/epidemiology, Cystic Fibrosis/complications, Disk Diffusion Antimicrobial Tests, Drug Resistance, Multiple, Bacterial, Humans, Pseudomonas Infections/epidemiology/etiology/microbiology, Pseudomonas aeruginosa/*drug effects/isolation & purification	Enzymology
Pathogenicity	23461830	Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial.	Ross JE, Scangarella-Oman N, Jones RN	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2013.01.007	2013	Anti-Bacterial Agents/pharmacology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Microbial Sensitivity Tests/methods/standards, *Quality Control
	23493936	In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide.	Masadeh MM, Mhaidat NM, Alzoubi KH, Hussein EI, Al-Trad EI	Infect Drug Resist	10.2147/IDR.S41501	2013
Pathogenicity	23498214	An investigation of the biochemical properties of tetrazines as potential coating additives.	Jaiswal S, Varma PC, O'Neill L, Duffy B, McHale P	Mater Sci Eng C Mater Biol Appl	10.1016/j.msec.2012.12.094	2013	Anti-Bacterial Agents/pharmacology, Antioxidants/metabolism, Bacterial Adhesion/drug effects, Coated Materials, Biocompatible/pharmacology, Electrochemical Techniques, Fluorescence Recovery After Photobleaching, Gram-Negative Bacteria/cytology/drug effects/growth & development, Gram-Positive Bacteria/cytology/drug effects/growth & development, Heterocyclic Compounds, 1-Ring/pharmacology, Kinetics, Magnetic Resonance Spectroscopy, Malondialdehyde/metabolism, *Materials Testing, Microbial Sensitivity Tests, Microscopy, Atomic Force, Microscopy, Electron, Scanning, Spectroscopy, Fourier Transform Infrared	Metabolism
Cultivation	23513190	Three Pseudomonas aeruginosa strains with different protease profiles.	Andrejko M, Zdybicka-Barabas A, Janczarek M, Cytrynska M	Acta Biochim Pol	2012_366	2013	Animals, Biological Assay, Culture Media, Gene Expression Regulation, Bacterial, Genome, Bacterial/genetics, Moths/microbiology, Peptide Hydrolases/genetics/metabolism, Pseudomonas aeruginosa/enzymology/genetics/physiology, Species Specificity, Virulence Factors/genetics	Genetics
Pathogenicity	23571533	Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells.	Naghmouchi K, Baah J, Hober D, Jouy E, Rubrecht C, Sane F, Drider D	Antimicrob Agents Chemother	10.1128/AAC.02328-12	2013	Animals, Bacteriocins/pharmacology, Chlorocebus aethiops, Colistin/pharmacology/toxicity, Drug Resistance, Multiple, Bacterial, Drug Synergism, Epithelial Cells/drug effects, Escherichia coli O157/drug effects, Gram-Negative Bacteria/classification/drug effects, Hemolysis, Humans, Kidney/cytology/drug effects, Leukocytes/drug effects, *Nisin/pharmacology, Pediocins, Vero Cells	Phylogeny
Phylogeny	23602123	Development of a novel reverse transcriptase polymerase chain reaction to determine the Gram reaction and viability of bacteria in clinical specimens.	Aarthi P, Bagyalakshmi R, Therese KL, Madhavan HN	Microbiol Res	10.1016/j.micres.2013.03.005	2013	Bacteria/classification/genetics/isolation & purification, Base Sequence, Escherichia coli/genetics, Humans, Molecular Sequence Data, RNA, Ribosomal, 16S/genetics, *Reverse Transcriptase Polymerase Chain Reaction/methods, Staphylococcus aureus/genetics	Pathogenicity
Enzymology	23681060	Anti-infective potential of marine invertebrates and seaweeds from the Brazilian coast.	Bianco EM, de Oliveira SQ, Rigotto C, Tonini ML, da Rosa Guimaraes T, Bittencourt F, Gouvea LP, Aresi C, de Almeida MT, Moritz MI, Martins CD, Scherner F, Carraro JL, Horta PA, Reginatto FH, Steindel M, Simoes CM, Schenkel EP	Molecules	10.3390/molecules18055761	2013	Animals, Anthozoa/chemistry, Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Antiprotozoal Agents/chemistry/isolation & purification/pharmacology, Bacteria/growth & development, Brazil, Chlorocebus aethiops, Cytotoxins/chemistry/isolation & purification/pharmacology, Leishmania braziliensis/growth & development, Porifera/chemistry, Seaweed/chemistry, Trypanosoma cruzi/growth & development, Urochordata/*chemistry, Vero Cells	Phylogeny
	23757948	Comparative study on the antibacterial activity of some flavonoids and their sulfonic derivatives.	Woznicka E, Kuzniar A, Nowak D, Nykiel E, Kopacz M, Gruszecka J, Golec K	Acta Pol Pharm		2013	Anti-Bacterial Agents/chemistry/pharmacology, Flavonoids/chemistry/pharmacology, Quercetin/analogs & derivatives/pharmacology, Structure-Activity Relationship, Sulfonic Acids/pharmacology
Pathogenicity	23769281	Photodynamic effect of hypericin on the microorganisms and primary human fibroblasts.	Kashef N, Borghei YS, Djavid GE	Photodiagnosis Photodyn Ther	10.1016/j.pdpdt.2012.11.007	2012	Anthracenes, Bacterial Physiological Phenomena/drug effects/radiation effects, Cells, Cultured, Dose-Response Relationship, Drug, Dose-Response Relationship, Radiation, Fibroblasts/cytology/drug effects/radiation effects, Humans, Lighting/methods, Microbial Viability/drug effects/radiation effects, Perylene/administration & dosage/analogs & derivatives, Photochemotherapy/methods, Photosensitizing Agents/administration & dosage
Pathogenicity	23774975	[In vitro activity of Eucalyptus smithii and Juniperus communis essential oils against bacterial biofilms and efficacy perspectives of complementary inhalation therapy in chronic and recurrent upper respiratory tract infections].	Camporese A	Infez Med		2013	Administration, Inhalation, Bacteriological Techniques, Biofilms/drug effects, Chronic Disease, Complementary Therapies, Eucalyptus, Humans, Juniperus, Oils, Volatile/pharmacology/therapeutic use, Phytotherapy, Pseudomonas Infections/drug therapy, Pseudomonas aeruginosa/drug effects/physiology, Recurrence, Respiratory Tract Infections/drug therapy, Staphylococcal Infections/drug therapy, Staphylococcus aureus/drug effects/physiology
Metabolism	23817103	Enzymatic degradation and bioactivity evaluation of C-6 oxidized chitosan.	Pierre G, Salah R, Gardarin C, Traikia M, Petit E, Delort AM, Mameri N, Moulti-Mati F, Michaud P	Int J Biol Macromol	10.1016/j.ijbiomac.2013.06.025	2013	Anti-Bacterial Agents/chemistry/pharmacology, Antiprotozoal Agents/chemistry/pharmacology, Chitosan/*chemistry/pharmacology, Cyclic N-Oxides/chemistry, Hydrolysis, Oxidation-Reduction
	23837231	Comparative study of antibacterial and antifungal effects of rigid gas permeable contact lens disinfecting solutions.	Kuzman T, Kutija MB, Kordic R, Popovic-Sui S, Jandrokovic S, Skegro I, Pokupec R	Coll Antropol		2013	Anti-Bacterial Agents/pharmacology, Antifungal Agents/pharmacology, Contact Lens Solutions/*pharmacology, Contact Lenses
Pathogenicity	23905026	Antimicrobial activity of green tea extract against isolates of methicillin-resistant Staphylococcus aureus and multi-drug resistant Pseudomonas aeruginosa.	Radji M, Agustama RA, Elya B, Tjampakasari CR	Asian Pac J Trop Biomed	10.1016/S2221-1691(13)60133-1	2013	Anti-Bacterial Agents/pharmacology, Drug Resistance, Multiple, Indonesia, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Plant Leaves/chemistry, Pseudomonas aeruginosa/drug effects, Species Specificity, Tea/chemistry	Phylogeny
	23935315	Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach.	Kountouras J, Sofianou D, Gavalas E, Sianou E, Zavos C, Meletis G, Tsiaousi E	Hippokratia		2012
Pathogenicity	23951794	Comparison of chlorine dioxide and dichloroisocyanurate disinfectants for use in the dental setting.	Patel M, Ebonwu J, Cutler E	SADJ		2012	Anti-Infective Agents/pharmacology, Bacillus subtilis/drug effects, Candida albicans/drug effects, Chlorine/pharmacology, Chlorine Compounds/pharmacology, Dental Disinfectants/pharmacology, Hepatitis B virus/drug effects, Humans, Materials Testing, Mycobacterium avium/drug effects, Mycobacterium tuberculosis/drug effects, Oxides/pharmacology, Pseudomonas aeruginosa/drug effects, Spores, Bacterial/drug effects, Staphylococcus aureus/drug effects, Streptococcus mutans/drug effects, Time Factors, Triazines/pharmacology
Phylogeny	23977310	Antimicrobial potential of endophytic fungi derived from three seagrass species: Cymodocea serrulata, Halophila ovalis and Thalassia hemprichii.	Supaphon P, Phongpaichit S, Rukachaisirikul V, Sakayaroj J	PLoS One	10.1371/journal.pone.0072520	2013	Anti-Infective Agents/pharmacology, Bacteria/drug effects, Base Sequence, Complex Mixtures/pharmacology, DNA, Ribosomal Spacer/genetics, Endophytes/drug effects/isolation & purification, Fungi/drug effects/isolation & purification/ultrastructure, Hydrocharitaceae/microbiology, Microbial Sensitivity Tests, Phylogeny, Species Specificity	Pathogenicity
Pathogenicity	23980504	Antimicrobial activity of caO nanoparticles.	Roy A, Gauri SS, Bhattacharya M, Bhattacharya J	J Biomed Nanotechnol	10.1166/jbn.2013.1681	2013	Anti-Bacterial Agents/administration & dosage/chemical synthesis, Bacterial Physiological Phenomena/drug effects, Calcium Compounds/administration & dosage/chemistry, Cell Survival/drug effects, Materials Testing, Nanocapsules/administration & dosage/chemistry/ultrastructure, Oxides/administration & dosage/chemistry, Particle Size
Pathogenicity	23983362	Antimicrobial activity of Carpolobia lutea extracts and fractions.	Nwidu LL, Nwafor PA, Vilegas W	Afr J Tradit Complement Altern Med		2012	Anti-Bacterial Agents/pharmacology, Antifungal Agents/pharmacology, Bacteria/drug effects, Candida albicans/drug effects, Nigeria, Plant Extracts/pharmacology, Polygalaceae
Pathogenicity	23988559	The effects of preservation procedures on antibacterial property of amniotic membrane.	Tehrani FA, Ahmadiani A, Niknejad H	Cryobiology	10.1016/j.cryobiol.2013.08.010	2013	Amnion/chemistry, Anti-Bacterial Agents/chemistry/*pharmacology, Bacterial Infections/prevention & control, Cryopreservation/methods, Escherichia coli/drug effects, Female, Freeze Drying/methods, Humans, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	24019229	Synthetic analogs of anoplin show improved antimicrobial activities.	Munk JK, Uggerhoj LE, Poulsen TJ, Frimodt-Moller N, Wimmer R, Nyberg NT, Hansen PR	J Pept Sci	10.1002/psc.2548	2013	Anti-Bacterial Agents/chemical synthesis/pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Antimicrobial Cationic Peptides/chemical synthesis/pharmacology, Candida albicans/drug effects, Drug Resistance, Bacterial, Enterococcus faecium/drug effects, Erythrocytes/drug effects, Escherichia coli/drug effects, Hemolytic Agents/chemical synthesis/pharmacology, Humans, Hydrophobic and Hydrophilic Interactions, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Wasp Venoms/chemical synthesis/*pharmacology
Pathogenicity	24020224	The antimicrobial screening of a Barbadian medicinal plant with indications for use in the treatment of diabetic wound infections.	Carrington S, Cohall DH, Gossell-Williams M, Lindo JF	West Indian Med J	10.7727/wimj.2011.223	2012	Anti-Bacterial Agents/therapeutic use, Bacterial Infections/drug therapy, Barbados, Ciprofloxacin/pharmacology, Colony-Forming Units Assay, Diabetic Foot/drug therapy, Dose-Response Relationship, Drug, Enterococcus faecalis/drug effects, Humans, Medicine, Traditional, Microbial Sensitivity Tests, Phytotherapy, Plant Extracts/therapeutic use, Plants, Medicinal, Pseudomonas aeruginosa/drug effects, Sanguinaria, Staphylococcus aureus/drug effects, Wound Healing/drug effects, Wound Infection/drug therapy
	24031917	Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains.	Torres IM, Bento EB, Almeida Lda C, de Sa LZ, Lima EM	Braz J Microbiol	10.1590/S1517-838220120003000020	2012
Pathogenicity	24055630	Probiotic properties of lactobacilli species isolated from children's feces.	Tulumoglu S, Yuksekdag ZN, Beyatli Y, Simsek O, Cinar B, Yasar E	Anaerobe	10.1016/j.anaerobe.2013.09.006	2013	Adolescent, Anti-Bacterial Agents/pharmacology, Antibiosis, Bacterial Adhesion, Bile Acids and Salts/toxicity, Child, Child, Preschool, Cholesterol/metabolism, Escherichia coli/growth & development, Feces/microbiology, Female, Humans, Hydrogen-Ion Concentration, Lactobacillus/drug effects/isolation & purification/physiology, Male, Microbial Sensitivity Tests, Microbial Viability/drug effects, Polysaccharides, Bacterial/metabolism, Probiotics/isolation & purification, Pseudomonas aeruginosa/growth & development, Staphylococcus aureus/growth & development	Metabolism
Biotechnology	24075344	Production of microbial medium from defatted brebra (Milletia ferruginea) seed flour to substitute commercial peptone agar.	Andualem B, Gessesse A	Asian Pac J Trop Biomed	10.1016/S2221-1691(13)60157-4	2013	Agar/chemistry, Bacteria/growth & development, Colony Count, Microbial, Culture Media/chemistry, Peptones/chemistry, Seeds/chemistry	Cultivation
Pathogenicity	24097361	Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study.	Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE	Toxicol Ind Health	10.1177/0748233713498458	2013	Anti-Bacterial Agents/pharmacology, Bacillus subtilis/drug effects, Curcumin/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Klebsiella pneumoniae/drug effects, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects
Pathogenicity	24188494	Synthesis and in vitro analysis of novel dihydroxyacetophenone derivatives with antimicrobial and antitumor activities.	Zbancioc AM, Miron A, Tuchilus C, Rotinberg P, Mihai CT, Mangalagiu II, Zbancioc G	Med Chem	10.2174/15734064113096660070	2014	Acetophenones/chemical synthesis/chemistry/pharmacology, Anti-Infective Agents/chemical synthesis/chemistry/pharmacology, Antineoplastic Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Candida albicans/drug effects, Chemistry Techniques, Synthetic, HeLa Cells, Humans, Inhibitory Concentration 50
Pathogenicity	24236547	Antibacterial activity of gemini quaternary ammonium salts.	Oblak E, Piecuch A, Guz-Regner K, Dworniczek E	FEMS Microbiol Lett	10.1111/1574-6968.12331	2013	Animals, Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects, Bacterial Adhesion/drug effects, Biofilms/drug effects, Hemolysis/drug effects, Microbial Sensitivity Tests, Mutagenicity Tests, Quaternary Ammonium Compounds/chemistry/*pharmacology, Saccharomyces cerevisiae/drug effects, Sheep
Genetics	24407638	Genome Sequence of Pseudomonas aeruginosa Strain LCT-PA41, with Changed Metabolism after Space Flight.	Liu C, Hu J, Fang X, Zhang D, Chang D, Wang J, Li T, Guo Y, Dai W, Liu C	Genome Announc	10.1128/genomeA.01124-13	2014		Metabolism
	24426114	Essential oils and herbal extracts as antimicrobial agents in cosmetic emulsion.	Herman A, Herman AP, Domagalska BW, Mlynarczyk A	Indian J Microbiol	10.1007/s12088-012-0329-0	2012
Pathogenicity	24460988	Antimicrobial activity of fluorescent Ag nanoparticles.	Bera RK, Mandal SM, Raj CR	Lett Appl Microbiol	10.1111/lam.12222	2014	Anti-Bacterial Agents/chemistry/pharmacology, Antifungal Agents/chemistry/pharmacology, Aspergillus niger/drug effects, Candida albicans/drug effects, Escherichia coli/drug effects, Fluorescence, Metal Nanoparticles, Microbial Sensitivity Tests, Particle Size, Pseudomonas aeruginosa/drug effects, Silver/chemistry/pharmacology, Staphylococcus epidermidis/drug effects
Pathogenicity	24506719	[Investigation of antimicrobial and antibiofilm effects of some preservatives used in drugs, cosmetics and food products].	Guven N, Kaynak Onurdag F	Mikrobiyol Bul		2014	Anti-Infective Agents/pharmacology, Bacteria/drug effects, Biofilms/drug effects, Candida albicans/drug effects/physiology, Cosmetics/chemistry, Food Preservatives/pharmacology, Glass, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Preservatives, Pharmaceutical/*pharmacology
Metabolism	24513029	Diverse effects of Galleria mellonella infection with entomopathogenic and clinical strains of Pseudomonas aeruginosa.	Andrejko M, Zdybicka-Barabas A, Cytrynska M	J Invertebr Pathol	10.1016/j.jip.2013.10.006	2014	Animals, Host-Parasite Interactions/physiology, Immunoblotting, Moths/immunology/metabolism/microbiology, Peptide Hydrolases/immunology/metabolism, Pseudomonas aeruginosa/immunology/pathogenicity, Virulence Factors/immunology/metabolism	Pathogenicity
Pathogenicity	24533504	Antibacterial activity of thioetherhydroxyethylsulfonamide derivatives.	Vellasco WT Jr, Guedes GP, Facchinetti V, Vasconcelos TR, Vaz MG, Cunico W, de Souza MV, de Paula GR, Fleming ME, Gomes CR	Med Chem	10.2174/1573406410666140218103022	2014	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Crystallography, X-Ray, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Microbial Sensitivity Tests, Models, Molecular, Molecular Structure, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Sulfonamides/chemical synthesis/chemistry/*pharmacology
Phylogeny	24596500	Antibacterial substances from marine algae isolated from Jeddah coast of Red sea, Saudi Arabia.	Al-Saif SS, Abdel-Raouf N, El-Wazanani HA, Aref IA	Saudi J Biol Sci	10.1016/j.sjbs.2013.06.001	2013
Genetics	24625870	Genome Sequence of Pseudomonas aeruginosa Strain LCT-PA220, Which Was Selected after Space Flight by Using Biolog's Powerful Carbon Source Utilization Technology.	Xu G, Hu J, Fang X, Zhang X, Wang J, Guo Y, Li T, Chen Z, Dai W, Liu C	Genome Announc	10.1128/genomeA.00169-14	2014
	24640147	[Comparison of antibacterial activities of Tobramycin inhalation solutions].	Pisarev VV	Antibiot Khimioter		2013	Administration, Inhalation, Anti-Bacterial Agents/pharmacology, Dose-Response Relationship, Drug, Escherichia coli/growth & development, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/growth & development, Staphylococcus aureus/growth & development, Tobramycin/*pharmacology
Enzymology	24704551	Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stingless bees (Tetragonula carbonaria) and fruit resins of Corymbia torelliana (Myrtaceae).	Massaro CF, Katouli M, Grkovic T, Vu H, Quinn RJ, Heard TA, Carvalho C, Manley-Harris M, Wallace HM, Brooks P	Fitoterapia	10.1016/j.fitote.2014.03.024	2014	Animals, Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Bees/chemistry, Biological Products, Flavonoids/chemistry/isolation & purification/pharmacology, Fruit/chemistry, Microbial Sensitivity Tests, Myrtaceae/chemistry, Propolis/chemistry, Pseudomonas aeruginosa/drug effects, Resins, Plant/chemistry/isolation & purification/pharmacology, Staphylococcus aureus/drug effects	Phylogeny
Enzymology	24760199	Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model.	Drusano GL, Liu W, Fikes S, Cirz R, Robbins N, Kurhanewicz S, Rodriquez J, Brown D, Baluya D, Louie A	J Infect Dis	10.1093/infdis/jiu237	2014	Animals, Anti-Bacterial Agents/administration & dosage/pharmacokinetics/therapeutic use, Dose-Response Relationship, Drug, Drug Resistance, Bacterial, Female, Granulocytes/physiology, Mice, Microbial Sensitivity Tests, Pneumonia, Bacterial/drug therapy/immunology/microbiology, Pseudomonas Infections/drug therapy/immunology/microbiology, Pseudomonas aeruginosa/physiology, Sisomicin/administration & dosage/*analogs & derivatives/pharmacokinetics/therapeutic use	Pathogenicity
Pathogenicity	24794452	In vitro evaluation of antimicrobial features of sugammadex.	Hanci V, Vural A, Hanci SY, Ali Kiraz H, Omur D, Unver A	Braz J Anesthesiol	10.1016/j.bjane.2013.09.003	2013	Anti-Infective Agents/pharmacology, Bacteria/drug effects, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Sugammadex, gamma-Cyclodextrins/pharmacology
Pathogenicity	24799418	Oligolysine-conjugated zinc(II) phthalocyanines as efficient photosensitizers for antimicrobial photodynamic therapy.	Ke MR, Eastel JM, Ngai KL, Cheung YY, Chan PK, Hui M, Ng DK, Lo PC	Chem Asian J	10.1002/asia.201402025	2014	Animals, Anti-Infective Agents/chemistry/pharmacology, Antiviral Agents/chemistry/pharmacology, Cell Line/virology, Chemistry Techniques, Synthetic, Dogs, Humans, Indoles/chemistry, Influenza A Virus, H1N1 Subtype/drug effects, Isoindoles, Madin Darby Canine Kidney Cells, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Organometallic Compounds/chemistry, Photochemotherapy/methods, Photosensitizing Agents/chemical synthesis/chemistry/pharmacology, Polylysine/chemistry, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Zinc Compounds
Pathogenicity	25036788	Photodynamic inactivation of bacteria and viruses using two monosubstituted zinc(II) phthalocyanines.	Ke MR, Eastel JM, Ngai KL, Cheung YY, Chan PK, Hui M, Ng DK, Lo PC	Eur J Med Chem	10.1016/j.ejmech.2014.07.022	2014	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Indoles/chemical synthesis/chemistry/pharmacology, Isoindoles, Methicillin Resistance, Microbial Sensitivity Tests, Molecular Structure, Organometallic Compounds/chemical synthesis/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Zinc Compounds
Pathogenicity	25077464	Antibacterial and anti-inflammatory activities of extract and fractions from Pyrrosia petiolosa (Christ et Bar.) Ching.	Cheng D, Zhang Y, Gao D, Zhang H	J Ethnopharmacol	10.1016/j.jep.2014.07.029	2014	Animals, Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology/toxicity, Anti-Inflammatory Agents/chemistry/isolation & purification/pharmacology/toxicity, Bacteria/drug effects/growth & development, Cell Line, Tumor, Disease Models, Animal, Disk Diffusion Antimicrobial Tests, Drug Stability, Edema/chemically induced/prevention & control, Ethanol/chemistry, Humans, Inflammation/chemically induced/prevention & control, Phytotherapy, Plant Components, Aerial, Plant Extracts/chemistry/isolation & purification/pharmacology/toxicity, Plants, Medicinal, *Polypodiaceae/chemistry, Solvents/chemistry, Xylenes	Enzymology
Pathogenicity	25230727	Phloroglucinols from anti-microbial deposit-resins of Australian stingless bees (Tetragonula carbonaria).	Massaro CF, Smyth TJ, Smyth WF, Heard T, Leonhardt SD, Katouli M, Wallace HM, Brooks P	Phytother Res	10.1002/ptr.5225	2014	Animals, Anti-Bacterial Agents/chemistry/pharmacology, Australia, Bees, Biological Products/chemistry/pharmacology, Flavonoids/chemistry/pharmacology, Gas Chromatography-Mass Spectrometry, Molecular Structure, Phloroglucinol/chemistry/pharmacology, Propolis/chemistry, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Terpenes/chemistry/pharmacology
	25278526	Draft Genome Assembly of Pseudomonas aeruginosa Quality Control Reference Strain Boston 41501.	Minogue TD, Daligault HE, Davenport KW, Broomall SM, Bruce DC, Chain PS, Coyne SR, Gibbons HS, Jaissle J, Chertkov O, Freitas T, Rosenzweig CN, Xu Y, Johnson SL	Genome Announc	10.1128/genomeA.00960-14	2014
Pathogenicity	25285879	Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.	Dosler S, Karaaslan E	Peptides	10.1016/j.peptides.2014.09.021	2014	Anti-Bacterial Agents/administration & dosage, Antimicrobial Cationic Peptides/administration & dosage, Biofilms/drug effects/growth & development, Cross Infection/drug therapy/microbiology, Humans, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects/pathogenicity
	25312182	Antibacterial and antibiofilm activities of polysaccharides, essential oil, and fatty oil extracted from Laurus nobilis growing in Lebanon.	Chmit M, Kanaan H, Habib J, Abbass M, Mcheik A, Chokr A	Asian Pac J Trop Med	10.1016/S1995-7645(14)60288-1	2014
Pathogenicity	25381167	Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa.	Rees VE, Bulitta JB, Nation RL, Tsuji BT, Sorgel F, Landersdorfer CB	J Antimicrob Chemother	10.1093/jac/dku437	2014	Anti-Bacterial Agents/pharmacology, Drug Resistance, Bacterial, Fluoroquinolones/pharmacology, Microbial Sensitivity Tests, Microbial Viability/drug effects, Pseudomonas aeruginosa/drug effects, Selection, Genetic, Time Factors
	25443443	[In vitro comparison of epidural bacteria filters permeability and screening scanning electron microscopy].	Sener A, Erkin Y, Sener A, Tasdogen A, Dokumaci E, Elar Z	Rev Bras Anestesiol	10.1016/j.bjan.2013.08.004	2014
Pathogenicity	25460314	Antibacterial and EGFR-tyrosine kinase inhibitory activities of polyhydroxylated xanthones from Garcinia succifolia.	Duangsrisai S, Choowongkomon K, Bessa LJ, Costa PM, Amat N, Kijjoa A	Molecules	10.3390/molecules191219923	2014	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects, Drug Synergism, ErbB Receptors/antagonists & inhibitors/metabolism, Fungi/drug effects, Garcinia/chemistry, Hydroxylation, Inhibitory Concentration 50, Microbial Sensitivity Tests, Protein Kinase Inhibitors/pharmacology, Xanthones/chemistry/*pharmacology	Metabolism
Pathogenicity	25466409	Anti-adherence potential of Enterococcus durans cells and its cell-free supernatant on plastic and stainless steel against foodborne pathogens.	Amel AM, Farida B, Djamila S	Folia Microbiol (Praha)	10.1007/s12223-014-0367-6	2014	Bacterial Adhesion/drug effects, Bacterial Proteins/metabolism, Biofilms/drug effects, Biological Products/metabolism, Enterococcus/metabolism/physiology, Environmental Microbiology, Food Microbiology, Gram-Negative Bacteria/drug effects/physiology, Gram-Positive Bacteria/*drug effects/physiology, Plastics, Stainless Steel, Temperature	Metabolism
Pathogenicity	25466477	Development of a novel resin with antimicrobial properties for dental application.	Castro DT, Holtz RD, Alves OL, Watanabe E, Valente ML, Silva CH, Reis AC	J Appl Oral Sci	10.1590/1678-775720130539	2014	Acrylic Resins/chemistry/pharmacology, Analysis of Variance, Anti-Infective Agents/chemistry/pharmacology, Candida albicans/drug effects/growth & development, Compressive Strength, Dental Prosthesis/microbiology, Hardness Tests, Materials Testing, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Reproducibility of Results, Silver/chemistry/pharmacology, Staphylococcus aureus/drug effects/growth & development, Statistics, Nonparametric, Streptococcus mutans/drug effects/growth & development, Surface Properties, Time Factors, Vanadates/chemistry/pharmacology
Pathogenicity	25517041	Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.	Birkun AA, Kubyshkin AV, Novikov NY, Krivorutchenko YL, Fedosov MI, Postnikova ON, Snitser AA	J Aerosol Med Pulm Drug Deliv	10.1089/jamp.2014.1161	2014	Administration, Inhalation, Amikacin/administration & dosage/chemistry, Animals, Anti-Bacterial Agents/administration & dosage/chemistry, Chemistry, Pharmaceutical, Disease Models, Animal, Drug Carriers, Drug Combinations, Lung/drug effects/microbiology/pathology, Male, Pneumonia, Bacterial/drug therapy/microbiology/pathology, Pseudomonas Infections/drug therapy/microbiology/pathology, Pseudomonas aeruginosa/drug effects/pathogenicity, Pulmonary Surfactants/*administration & dosage/chemistry, Rats, Wistar
Pathogenicity	25613850	Anti-virulence potential of eugenyl acetate against pathogenic bacteria of medical importance.	Musthafa KS, Voravuthikunchai SP	Antonie Van Leeuwenhoek	10.1007/s10482-014-0364-4	2015	Acetates/pharmacology, Anti-Bacterial Agents/pharmacology, Eugenol/analogs & derivatives/pharmacology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Pigments, Biological, Syzygium/chemistry, Virulence Factors/*antagonists & inhibitors
Pathogenicity	25656002	Compounds from Geijera parviflora with prostaglandin E2 inhibitory activity may explain its traditional use for pain relief.	Banbury LK, Shou Q, Renshaw DE, Lambley EH, Griesser HJ, Mon H, Wohlmuth H	J Ethnopharmacol	10.1016/j.jep.2015.01.033	2015	3T3 Cells, Analgesics/pharmacology, Animals, Anti-Inflammatory Agents/pharmacology, Australia, Cell Line, Cell Survival/drug effects, Dinoprostone/antagonists & inhibitors/metabolism, Escherichia coli/drug effects, Lipopolysaccharides, Medicine, Traditional, Mice, Nitric Oxide/metabolism, Pain/drug therapy, Plant Extracts/pharmacology, Plant Leaves, Pseudomonas aeruginosa/drug effects, *Rutaceae, Staphylococcus/drug effects, Tumor Necrosis Factor-alpha/metabolism	Metabolism
Pathogenicity	25697605	Antimicrobial activity of natural products from the flora of Northern Ontario, Canada.	Vandal J, Abou-Zaid MM, Ferroni G, Leduc LG	Pharm Biol	10.3109/13880209.2014.942867	2015	Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Antifungal Agents/pharmacology, Bacteria/drug effects, Biological Products/pharmacology, Chromatography, High Pressure Liquid, Fungi/drug effects, Indicators and Reagents, Microbial Sensitivity Tests, Ontario, Oxazines, Plant Extracts/pharmacology, Plants/*chemistry, Xanthenes
Pathogenicity	25716124	Design, synthesis and in vitro bactericidal/fungicidal screening of some vanadyl(IV)complexes with mono- and di-substituted ONS donor triazoles.	Sumrra SH, Hanif M, Chohan ZH	J Enzyme Inhib Med Chem	10.3109/14756366.2014.976565	2015	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Dose-Response Relationship, Drug, Drug Design, Fungi/drug effects, Microbial Sensitivity Tests, Molecular Structure, Organometallic Compounds/chemical synthesis/chemistry/pharmacology, Structure-Activity Relationship, Triazoles/chemistry/pharmacology, Vanadates/chemistry/pharmacology
Metabolism	25773717	Synthesis and antibacterial activity of novel 4-bromo-1H-indazole derivatives as FtsZ inhibitors.	Wang Y, Yan M, Ma R, Ma S	Arch Pharm (Weinheim)	10.1002/ardp.201400412	2015	Anti-Bacterial Agents/chemical synthesis/pharmacology, Bacterial Proteins/antagonists & inhibitors/metabolism, Cytoskeletal Proteins/antagonists & inhibitors/metabolism, Drug Design, Gram-Negative Bacteria/drug effects/growth & development, Gram-Positive Bacteria/drug effects/growth & development, Indazoles/chemical synthesis/pharmacology, Microbial Sensitivity Tests, Molecular Structure, Molecular Targeted Therapy, Structure-Activity Relationship	Pathogenicity
Pathogenicity	25777982	Multifunctional lanthanide and silver ion co-doped nano-chlorapatites with combined spectroscopic and antimicrobial properties.	Wiglusz RJ, Drulis-Kawa Z, Pazik R, Zawisza K, Dorotkiewicz-Jach A, Roszkowiak J, Nedelec JM	Dalton Trans	10.1039/c5dt00046g	2015	Anti-Bacterial Agents/chemistry/pharmacology, Apatites/chemistry/pharmacology, Erbium/chemistry/pharmacology, Escherichia coli/drug effects/growth & development, Europium/chemistry/pharmacology, Klebsiella pneumoniae/drug effects/growth & development, Microscopy, Electron, Transmission, Nanoparticles/chemistry/ultrastructure, Pseudomonas aeruginosa/drug effects/growth & development, Silver/chemistry/pharmacology, Spectrophotometry, Atomic, X-Ray Diffraction, Ytterbium/chemistry/pharmacology
Pathogenicity	25845400	Polarized currents inhibit in vitro growth of bacteria colonizing cutaneous ulcers.	Gomes RC, Brandino HE, de Sousa NT, Santos MF, Martinez R, Guirro RR	Wound Repair Regen	10.1111/wrr.12296	2015	Bacterial Infections/therapy, Colony Count, Microbial, Electric Stimulation, Escherichia coli/growth & development, Humans, In Vitro Techniques, Microbial Sensitivity Tests, Pseudomonas aeruginosa/growth & development, Skin Ulcer/microbiology/pathology, Staphylococcus aureus/growth & development, *Wound Healing
Pathogenicity	25925153	Photodynamic Inactivation Mediated by Erythrosine and its Derivatives on Foodborne Pathogens and Spoilage Bacteria.	Yassunaka NN, Freitas CF, Rabello BR, Santos PR, Caetano W, Hioka N, Nakamura TU, Abreu Filho BA, Graton Mikcha JM	Curr Microbiol	10.1007/s00284-015-0827-5	2015	Bacteria/drug effects/growth & development/radiation effects, Erythrosine/chemistry/pharmacology, Food Contamination/analysis, Food Microbiology, Light, Microbial Viability/drug effects/radiation effects, Photosensitizing Agents/chemistry/pharmacology	Biotechnology
	25954830	Blue Laser Inhibits Bacterial Growth of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.	de Sousa NT, Santos MF, Gomes RC, Brandino HE, Martinez R, de Jesus Guirro RR	Photomed Laser Surg	10.1089/pho.2014.3854	2015	Escherichia coli/radiation effects, Lasers, Semiconductor, Low-Level Light Therapy, Pseudomonas aeruginosa/radiation effects, Staphylococcus aureus/radiation effects
Pathogenicity	25973507	Antimicrobial activity and chemical composition of the essential oils of Portuguese Foeniculum vulgare fruits.	Mota AS, Martins MR, Arantes S, Lopes VR, Bettencourt E, Pombal S, Gomes AC, Silva LA	Nat Prod Commun		2015	Anti-Bacterial Agents/chemistry/pharmacology, Antifungal Agents/chemistry/pharmacology, Bacteria/drug effects, Foeniculum/chemistry, Fruit/chemistry, Fungi/drug effects, Oils, Volatile/chemistry/pharmacology, Plant Oils/chemistry/*pharmacology, Portugal
	26007246	In vitro assessment of antibacterial effect of garlic (allium sativum) extracts on pseudomonas aeruginosa.	Saha SK, Saha S, Hossain MA, Paul SK	Mymensingh Med J		2015	Anti-Bacterial Agents, *Garlic, Microbial Sensitivity Tests, Plant Extracts, Pseudomonas aeruginosa
Metabolism	26029669	Extracellular matrix-associated proteins form an integral and dynamic system during Pseudomonas aeruginosa biofilm development.	Zhang W, Sun J, Ding W, Lin J, Tian R, Lu L, Liu X, Shen X, Qian PY	Front Cell Infect Microbiol	10.3389/fcimb.2015.00040	2015	Bacterial Proteins/metabolism, Biofilms/growth & development, Extracellular Matrix/chemistry, Humans, Proteome/analysis, Pseudomonas aeruginosa/growth & development/metabolism/*physiology	Pathogenicity
Pathogenicity	26151838	Glucocorticoids can affect Pseudomonas aeruginosa (ATCC 27853) internalization and intracellular calcium concentration in cystic fibrosis bronchial epithelial cells.	Hussain R, Shahror R, Karpati F, Roomans GM	Exp Lung Res	10.3109/01902148.2015.1046199	2015	Anti-Inflammatory Agents/pharmacology, Apoptosis/drug effects, Bronchi/drug effects/metabolism/microbiology, Budesonide/pharmacology, Calcium/metabolism, Cell Line, Cells, Cultured, Cystic Fibrosis/metabolism/microbiology, Dexamethasone/pharmacology, Epithelial Cells/drug effects/metabolism/microbiology, Epithelium/drug effects/metabolism/microbiology, Glucocorticoids/pharmacology, Humans, Interleukin-6/pharmacology, Interleukin-8/pharmacology, Pseudomonas Infections, Pseudomonas aeruginosa/*drug effects	Metabolism
	26360679	Aminoglycoside Resistance in Clinical Isolates of Gram Negative Bacilli at the University Hospital of the West Indies, Jamaica: Comparison of Two Time Periods.	Reynolds-Campbell G, Nicholson A, Christian N, Hardie R, Cook J	West Indian Med J	10.7727/wimj.2014.040	2015
	26377009	Matrix-assisted laser desorption/ionization time-of-flight vs. fast-atom bombardment and electrospray ionization mass spectrometry in the structural characterization of bacterial poly(3-hydroxyalkanoates).	Impallomeni G, Ballistreri A, Carnemolla GM, Franco D, Guglielmino SP	Rapid Commun Mass Spectrom	10.1002/rcm.7168	2015	Polyhydroxyalkanoates/analysis/chemistry, Pseudomonas aeruginosa/chemistry, Spectrometry, Mass, Electrospray Ionization/methods, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods
Genetics	26450729	Draft Genome Sequences of Nine Pseudomonas aeruginosa Strains, Including Eight Clinical Isolates.	Jeraldo P, Cunningham SA, Quest D, Sikkink RA, O'Brien D, Eckloff BW, Patel R, Chia N	Genome Announc	10.1128/genomeA.01154-15	2015
Biotechnology	26485013	Antimicrobial activity of silver doped fabrics for the production of hospital uniforms.	Condo C, Messi P, Anacarso I, Sabia C, Iseppi R, Bondi M, de Niederhausern S	New Microbiol	496M817	2015	Bacteria/drug effects/growth & development, Clothing, Cross Infection/microbiology/prevention & control, Hospitals, Microbial Sensitivity Tests, Silver/pharmacology	Pathogenicity
	26604928	In Vitro Evaluation of Antimicrobial Efficacy of Extracts Obtained from Raw and Fermented Wild Macrofungus, Lenzites quercina.	Ogidi OC, Oyetayo VO, Akinyele BJ	Int J Microbiol	10.1155/2015/106308	2015
Enzymology	26614147	In vitro comparison of epidural bacteria filters permeability and screening scanning electron microscopy.	Sener A, Erkin Y, Sener A, Tasdogen A, Dokumaci E, Elar Z	Braz J Anesthesiol	10.1016/j.bjane.2013.08.004	2013	Analgesia, Epidural/instrumentation, Bacteria/isolation & purification, Bacterial Adhesion, Filtration/*instrumentation, Microscopy, Electron, Scanning, Permeability, Sterilization	Phylogeny
Pathogenicity	26647630	SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF NEW SULFONAMIDE ISOXAZOLO[5,4-b]PYRIDINE DERIVATIVES.	Poreba K, Pawlik K, Rembacz KP, Kurowska E, Matuszyk J, Dlugosz A	Acta Pol Pharm		2015	Anti-Bacterial Agents/chemical synthesis/pharmacology, Antineoplastic Agents/chemical synthesis/pharmacology, Humans, Isoxazoles/chemical synthesis/chemistry/pharmacology, MCF-7 Cells, Microbial Sensitivity Tests, Pyridines/chemical synthesis/chemistry/pharmacology, Sulfonamides/*chemical synthesis/pharmacology
Pathogenicity	26681052	Lactic acid bacteria protect human intestinal epithelial cells from Staphylococcus aureus and Pseudomonas aeruginosa infections.	Affhan S, Dachang W, Xin Y, Shang D	Genet Mol Res	10.4238/2015.December.16.5	2015	Antibiosis, Bacterial Adhesion, Cell Line, Cells, Cultured, Culture Media, Conditioned/pharmacology, Drug Resistance, Bacterial, Epithelial Cells/metabolism/microbiology, Gene Expression, Humans, Intestinal Mucosa/metabolism/microbiology, Lactobacillus/physiology, Microbial Sensitivity Tests, Microbial Viability/drug effects, Pseudomonas aeruginosa/drug effects/physiology, Staphylococcus aureus/drug effects/*physiology, Tumor Necrosis Factor-alpha/genetics/metabolism	Metabolism
Pathogenicity	26698267	Antimicrobial activity of some Alnus species.	Altinyay C, Eryilmaz M, Yazgan AN, Sever Yilmaz B, Altun ML	Eur Rev Med Pharmacol Sci		2015	Alnus/chemistry, Anti-Infective Agents/isolation & purification/pharmacology, Candida albicans/drug effects/growth & development, Escherichia coli/drug effects/growth & development, Medicine, Traditional/methods, Microbial Sensitivity Tests, Plant Extracts/isolation & purification/pharmacology, Plant Leaves/chemistry, Plants, Medicinal/chemistry, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus aureus/drug effects/growth & development	Enzymology
Pathogenicity	26747522	Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.	Adahoun MA, Al-Akhras MH, Jaafar MS, Bououdina M	Artif Cells Nanomed Biotechnol	10.3109/21691401.2015.1129628	2016	Anti-Infective Agents/chemistry/pharmacology, Antineoplastic Agents/chemistry/pharmacology, Bacteria/growth & development, Cell Line, Curcumin/chemistry/pharmacology, HEK293 Cells, Humans, Male, Nanoparticles/chemistry, Prostatic Neoplasms/drug therapy
Pathogenicity	26749812	Medicinal Plants Used by a Mbya-Guarani Tribe Against Infections: Activity on KPC-Producing Isolates and Biofilm-Forming Bacteria.	Brandelli CL, Ribeiro VB, Zimmer KR, Barth AL, Tasca T, Macedo AJ	Nat Prod Commun		2015	Bacterial Proteins/metabolism, Biofilms/drug effects, Brazil, Humans, Klebsiella pneumoniae/drug effects/enzymology/physiology, Medicine, Traditional, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Plants, Medicinal/chemistry, Pseudomonas aeruginosa/drug effects/physiology, Staphylococcus epidermidis/*drug effects/physiology, beta-Lactamases/metabolism	Metabolism
Pathogenicity	26751436	Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.	Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H	Molecules	10.3390/molecules21010062	2016	Animals, Anti-Bacterial Agents/pharmacology, Carbapenems/pharmacology, Escherichia coli/drug effects/growth & development, Escherichia coli Infections/drug therapy/mortality/pathology, Female, Klebsiella Infections/drug therapy/mortality/pathology, Klebsiella pneumoniae/drug effects/growth & development, Male, Mice, Mice, Inbred ICR, Microbial Sensitivity Tests, Pseudomonas Infections/drug therapy/mortality/pathology, Pseudomonas aeruginosa/drug effects/growth & development, Sepsis/drug therapy/microbiology/mortality/pathology, Staphylococcal Infections/*drug therapy/mortality/pathology, Staphylococcus aureus/drug effects/growth & development, Survival Analysis, Tablets
	26824520	gamma-Cyclodextrin capped silver nanoparticles for molecular recognition and enhancement of antibacterial activity of chloramphenicol.	Gannimani R, Ramesh M, Mtambo S, Pillay K, Soliman ME, Govender P	J Inorg Biochem	10.1016/j.jinorgbio.2016.01.008	2016	Anti-Bacterial Agents/pharmacology, Chloramphenicol/pharmacology, Metal Nanoparticles, Microscopy, Electron, Scanning, Molecular Dynamics Simulation, Silver/chemistry, Spectrum Analysis, gamma-Cyclodextrins/*chemistry
Enzymology	26850719	Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model.	Mohamed AF, Kristoffersson AN, Karvanen M, Nielsen EI, Cars O, Friberg LE	J Antimicrob Chemother	10.1093/jac/dkv488	2016	Anti-Bacterial Agents/pharmacokinetics/pharmacology, Bacterial Load, Colistin/pharmacokinetics/pharmacology, Drug Interactions, Drug Resistance, Bacterial, Meropenem, Microbial Sensitivity Tests, Microbial Viability/drug effects, Models, Biological, Pseudomonas aeruginosa/drug effects, Thienamycins/pharmacokinetics/pharmacology, Time Factors	Pathogenicity
	26855668	Synthesis and biological evaluation of new 1,3-thiazolidine-4-one derivatives of nitro-l-arginine methyl ester.	Panzariu AT, Apotrosoaei M, Vasincu IM, Dragan M, Constantin S, Buron F, Routier S, Profire L, Tuchilus C	Chem Cent J	10.1186/s13065-016-0151-6	2016
	26855743	Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa.	Moghoofei M, Fazeli H, Poursina F, Nasr Esfahani B, Moghim S, Vaez H, Hadifar S, Ghasemian Safaei H	Jundishapur J Microbiol	10.5812/jjm.25250	2015
Pathogenicity	26864941	Antibacterial and Antibiofilm Effects of Boron on Different Bacteria.	Sayin Z, Ucan US, Sakmanoglu A	Biol Trace Elem Res	10.1007/s12011-016-0637-z	2016	Anti-Bacterial Agents/pharmacology, Bacteria/growth & development, Bacterial Physiological Phenomena/drug effects, Biofilms/growth & development, Boron/*pharmacology
	26998253	Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity.	Grace JL, Huang JX, Cheah SE, Truong NP, Cooper MA, Li J, Davis TP, Quinn JF, Velkov T, Whittaker MR	RSC Adv	10.1039/C5RA24361K	2016
Pathogenicity	27137748	Enhanced nanocurcumin toxicity against (PC3) tumor and microbial by using magnetic field in vitro.	Aldahoun MA, Jaafar MS, Al-Akhras MH, Bououdina M	Artif Cells Nanomed Biotechnol	10.1080/21691401.2016.1178137	2016	Anti-Bacterial Agents/chemistry/metabolism/pharmacokinetics/pharmacology, Antineoplastic Agents/chemistry/metabolism/pharmacokinetics/pharmacology, Bacteria/drug effects, Biological Availability, Biological Transport, Cell Line, Tumor, Cell Membrane Permeability, Curcumin/chemistry/metabolism/pharmacokinetics/pharmacology, Erythrocytes/drug effects, Humans, Magnetic Fields, Male, Nanoparticles/chemistry, Prostatic Neoplasms/pathology	Enzymology
Pathogenicity	27141642	[Influence of Chlorhexidine and Prontosan on Dual Species and Monospecies Biofilms Formed by Staphylococcus aureus and Pseudomonas aeruginosa].	Kuznetsova MV, Encheva YA, Samartsev VA	Antibiot Khimioter		2015	Anti-Infective Agents, Local/administration & dosage/pharmacology, Betaine, Biguanides/pharmacology, Biofilms/drug effects/growth & development, Chlorhexidine/administration & dosage/analogs & derivatives/pharmacology, Microscopy, Atomic Force, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus aureus/drug effects/growth & development
Metabolism	27353373	Biomimetic synthesis of selenium nanoparticles by Pseudomonas aeruginosa ATCC 27853: An approach for conversion of selenite.	Kora AJ, Rastogi L	J Environ Manage	10.1016/j.jenvman.2016.06.029	2016	Aerobiosis, Biomimetics, Biotechnology/methods, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Nanoparticles/chemistry/metabolism, Oxidation-Reduction, Particle Size, Pseudomonas aeruginosa/metabolism, Selenious Acid/chemistry/metabolism, Selenium/chemistry/metabolism, Spectrophotometry, Ultraviolet, Spectroscopy, Fourier Transform Infrared, Spectrum Analysis, Raman, X-Ray Diffraction	Biotechnology
	27432414	Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus.	Yim J, Smith JR, Barber KE, Hallesy JA, Rybak MJ	Infect Dis Ther	10.1007/s40121-016-0121-2	2016
Pathogenicity	27521357	Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa.	Rees VE, Bulitta JB, Oliver A, Tsuji BT, Rayner CR, Nation RL, Landersdorfer CB	J Antimicrob Chemother	10.1093/jac/dkw297	2016	Anti-Bacterial Agents/pharmacology, Drug Resistance, Bacterial, Humans, Microbial Sensitivity Tests, Microbial Viability/drug effects, Pseudomonas aeruginosa/drug effects, Time Factors, Tobramycin/*pharmacology
Pathogenicity	27558673	New Adamantyl Chalcones: Synthesis, Antimicrobial and Anticancer Activities.	Tabbi A, Tebbani D, Caporale A, Saturnino C, Nabavi SF, Giuseppe P, Arra C, Canturk Z, Turan-Zitouni G, Merazig H, Sobarzo-Sanchez E, Rastrelli L	Curr Top Med Chem	10.2174/1568026616666160824121935	2017	Anti-Infective Agents/chemical synthesis/pharmacology, Antineoplastic Agents/chemical synthesis/pharmacology, Cell Line, Tumor, Chalcones/chemical synthesis/pharmacology, Drug Screening Assays, Antitumor, Humans, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests
	27570520	Planctomycetes as Novel Source of Bioactive Molecules.	Graca AP, Calisto R, Lage OM	Front Microbiol	10.3389/fmicb.2016.01241	2016
	27579573	Interfacial Stacks of Polymeric Nanofilms on Soft Biological Surfaces that Release Multiple Agents.	Herron M, Schurr MJ, Murphy CJ, McAnulty JF, Czuprynski CJ, Abbott NL	ACS Appl Mater Interfaces	10.1021/acsami.6b08608	2016
	27642330	Antibacterial Activity of Polyaniline Coated Silver Nanoparticles Synthesized from Piper Betle Leaves Extract.	Mamun Or Rashida M, Shafiul Islam M, Azizul Haque M, Arifur Rahman M, Tanvir Hossain M, Abdul Hamid M	Iran J Pharm Res		2016
Pathogenicity	27657031	Silver Nanocomposite Biosynthesis: Antibacterial Activity against Multidrug-Resistant Strains of Pseudomonas aeruginosa and Acinetobacter baumannii.	Silva Santos K, Barbosa AM, Pereira da Costa L, Pinheiro MS, Oliveira MB, Ferreira Padilha F	Molecules	10.3390/molecules21091255	2016
Metabolism	27664720	Phosphatidylcholine affects the secretion of the alkaline phosphatase PhoA in Pseudomonas strains.	Liu X, Long D, You H, Yang D, Zhou S, Zhang S, Li M, He M, Xiong M, Wang X	Microbiol Res	10.1016/j.micres.2016.02.001	2016	Alkaline Phosphatase/metabolism, Bacterial Proteins/chemistry/genetics/metabolism, Gene Expression Regulation, Bacterial, Mutation, Phosphatidylcholines/metabolism, Protein Transport, Pseudomonas/*physiology, Transcription, Genetic, Type II Secretion Systems
	27668025	A Novel Topical Combination Ointment with Antimicrobial Activity against Methicillin-Resistant Streptococcus aureus, Gram-Negative Superbugs, Yeasts, and Dermatophytic Fungi.	Thomson KS, Thomson GK, Biehle J, Deeb A, Crawford J, Herrera R	Curr Ther Res Clin Exp	10.1016/j.curtheres.2016.07.001	2016
Pathogenicity	27738866	The comparison of antimicrobial effectiveness of contact lens solutions.	Kal A, Toker MI, Kaya S	Int Ophthalmol	10.1007/s10792-016-0375-4	2016	Anti-Infective Agents/pharmacology, Bacteria/drug effects, Colony Count, Microbial, Contact Lens Solutions/pharmacology, Contact Lenses/microbiology, Disinfection/methods, Eye Infections, Bacterial/microbiology/prevention & control, Humans, Keratitis/microbiology/*prevention & control
Pathogenicity	27756910	Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.	Pan AJ, Mei Q, Ye Y, Li HR, Liu B, Li JB	J Antibiot (Tokyo)	10.1038/ja.2016.124	2016	Animals, Anti-Bacterial Agents/pharmacology, Diffusion Chambers, Culture, Drug Resistance, Bacterial/genetics, Escherichia coli/genetics, Escherichia coli Infections/drug therapy/microbiology, Female, Fosfomycin/pharmacology, Humans, Microbial Sensitivity Tests, Mutation, Oxygen, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/genetics, Selection, Genetic, Young Adult
	27761077	Assessment of In vitro Antibacterial Activity and Cytotoxicity Effect of Nigella sativa Oil.	Ugur AR, Dagi HT, Ozturk B, Tekin G, Findik D	Pharmacogn Mag	10.4103/0973-1296.191459	2016
	27871033	Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of novel quinoline bearing dihydropyridines.	Nkosi SM, Anand K, Anandakumar S, Singh S, Chuturgoon AA, Gengan RM	J Photochem Photobiol B	10.1016/j.jphotobiol.2016.10.009	2016	Anti-Infective Agents/chemistry/pharmacology, Antineoplastic Agents/chemistry/pharmacology, Dihydropyridines/chemistry, Drug Design, Molecular Docking Simulation, Quinolines/chemistry
Pathogenicity	27930849	Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.	Moreira CS, Silva AC, Novais JS, Sa Figueiredo AM, Ferreira VF, da Rocha DR, Castro HC	J Appl Microbiol	10.1111/jam.13369	2017	Anti-Bacterial Agents/pharmacology, Biofilms/drug effects, Enterobacter cloacae, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Gram-Positive Bacteria/drug effects, Humans, Klebsiella pneumoniae/drug effects, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Naphthoquinones/chemistry/pharmacology, Proteus mirabilis/drug effects, Pseudomonas aeruginosa/drug effects, Staphylococcus/drug effects, Vancomycin
Enzymology	28010769	The Effect of Pelargonium endlicherianum Fenzl. root extracts on formation of nanoparticles and their antimicrobial activities.	Seker Karatoprak G, Aydin G, Altinsoy B, Altinkaynak C, Kosar M, Ocsoy I	Enzyme Microb Technol	10.1016/j.enzmictec.2016.10.019	2016	Acetophenones/isolation & purification/pharmacology, Anti-Infective Agents/isolation & purification/pharmacology, Escherichia coli/drug effects, Gallic Acid/isolation & purification/pharmacology, Metal Nanoparticles/chemistry/ultrastructure, Microbial Sensitivity Tests, Nanotechnology, Pelargonium/*chemistry, Plant Extracts/chemistry/pharmacology, Plant Roots/chemistry, Plants, Medicinal/chemistry, Pseudomonas aeruginosa/drug effects, Quercetin/isolation & purification/pharmacology, Silver, Staphylococcus epidermidis/drug effects	Phylogeny
Pathogenicity	28031207	Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.	Lin YW, Zhou QT, Cheah SE, Zhao J, Chen K, Wang J, Chan HK, Li J	Antimicrob Agents Chemother	10.1128/AAC.02025-16	2017	Administration, Inhalation, Animals, Anti-Bacterial Agents/blood/pharmacokinetics/pharmacology, Area Under Curve, Biological Availability, Body Mass Index, Bronchoalveolar Lavage Fluid/chemistry/microbiology, Colistin/blood/pharmacokinetics/pharmacology, Cyclophosphamide, Disease Models, Animal, Drug Administration Schedule, Drug Dosage Calculations, Humans, Intubation, Intratracheal, Lung/drug effects/microbiology/pathology, Mice, Microbial Sensitivity Tests, Models, Statistical, Neutropenia/chemically induced/drug therapy/microbiology/pathology, Pseudomonas Infections/blood/drug therapy/microbiology/pathology, Pseudomonas aeruginosa/*drug effects/growth & development, Respiratory Mucosa/drug effects/microbiology/pathology	Enzymology
Pathogenicity	28074117	The Essential Oils of Rhaponticum carthamoides Hairy Roots and Roots of Soil-Grown Plants: Chemical Composition and Antimicrobial, Anti-Inflammatory, and Antioxidant Activities.	Skala E, Rijo P, Garcia C, Sitarek P, Kalemba D, Toma M, Szemraj J, Pytel D, Wysokinska H, Sliwinski T	Oxid Med Cell Longev	10.1155/2016/8505384	2016	Anti-Infective Agents/chemistry/pharmacology, Anti-Inflammatory Agents/chemistry/pharmacology, Astrocytes/cytology/drug effects/metabolism, Candida albicans/drug effects, Cell Line, Enterococcus faecalis/drug effects, Enzyme-Linked Immunosorbent Assay, Gas Chromatography-Mass Spectrometry, Humans, Interleukin-1beta/analysis, Interleukin-6/analysis, Leuzea/growth & development/metabolism, Lipopolysaccharides/toxicity, Microbial Sensitivity Tests, Oils, Volatile/analysis/chemistry/pharmacology, Plant Roots/metabolism, Pseudomonas aeruginosa/drug effects, Reactive Oxygen Species/metabolism, Saccharomyces cerevisiae/drug effects, Tumor Necrosis Factor-alpha/analysis	Metabolism
	28117314	Benzotriazole-Mediated Synthesis and Antibacterial Activity of Novel N-Acylcephalexins.	Agha KA, Abo-Dya NE, Ibrahim TS, Abdel-Aal EH, Hegazy WA	Sci Pharm	10.3390/scipharm84030484	2016
	28138386	Anti-bacterial efficacy of alcoholic hand rubs in the Kenyan market, 2015.	Ochwoto M, Muita L, Talaam K, Wanjala C, Ogeto F, Wachira F, Osman S, Kimotho J, Ndegwa L	Antimicrob Resist Infect Control	10.1186/s13756-017-0174-3	2017
	28155216	Evaluation of the role of substrate and albumin on Pseudomonas aeruginosa biofilm morphology through FESEM and FTIR studies on polymeric biomaterials.	Dutta Sinha S, Chatterjee S, Maiti PK, Tarafdar S, Moulik SP	Prog Biomater	10.1007/s40204-017-0061-2	2017
	28163960	Screening for antibacterial and antibiofilm activities in Astragalus angulosus.	Kanaan H, El-Mestrah M, Sweidan A, As-Sadi F, Bazzal AA, Chokr A	J Intercult Ethnopharmacol	10.5455/jice.20161018101720	2016
Pathogenicity	28174100	A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteria.	Zhu C, Schneider EK, Wang J, Kempe K, Wilson P, Velkov T, Li J, Davis TP, Whittaker MR, Haddleton DM	J Control Release	10.1016/j.jconrel.2017.02.005	2017	Acetic Acid/administration & dosage/chemistry/therapeutic use, Acinetobacter baumannii/drug effects/growth & development, Animals, Anti-Bacterial Agents/administration & dosage/chemistry/therapeutic use, Colistin/administration & dosage/chemistry/therapeutic use, Drug Resistance, Multiple, Bacterial/drug effects, Esters/administration & dosage/chemistry/therapeutic use, Kidney/drug effects/pathology, Mice, Microbial Sensitivity Tests, Polyethylene Glycols/administration & dosage/chemistry/therapeutic use, Prodrugs/administration & dosage/chemistry/therapeutic use, Pseudomonas Infections/drug therapy/microbiology/pathology, Pseudomonas aeruginosa/drug effects/growth & development
Pathogenicity	28189227	Antimicrobial activity of chemically modified dextran derivatives.	Tuchilus CG, Nichifor M, Mocanu G, Stanciu MC	Carbohydr Polym	10.1016/j.carbpol.2017.01.006	2017	Anti-Infective Agents/chemistry/pharmacology, Bacteria/drug effects, Dextrans/chemistry/pharmacology, Fungi/*drug effects, Microbial Sensitivity Tests
Pathogenicity	28257182	Poly(carboxylic acid)-Cyclodextrin/Anionic Porphyrin Finished Fabrics as Photosensitizer Releasers for Antimicrobial Photodynamic Therapy.	Castriciano MA, Zagami R, Casaletto MP, Martel B, Trapani M, Romeo A, Villari V, Sciortino MT, Grasso L, Guglielmino S, Scolaro LM, Mazzaglia A	Biomacromolecules	10.1021/acs.biomac.6b01752	2017	Anti-Infective Agents/pharmacology, Carboxylic Acids/chemistry, Cyclodextrins/chemistry, Microscopy, Electron, Scanning, Photochemotherapy, Photoelectron Spectroscopy, Photosensitizing Agents/pharmacology, Polypropylenes/chemistry, Porphyrins/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Spectrometry, Fluorescence, Spectroscopy, Fourier Transform Infrared, Staphylococcus aureus/drug effects, Textiles
Pathogenicity	28262118	In vitro cytotoxicity and antimicrobial activity of Talaromyces flavus SP5 inhabited in the marine sediment of Southern Coast of India.	Anand BG, Thomas CK, Prakash S	Chin J Nat Med	10.1016/S1875-5364(17)30016-X	2016	Anti-Bacterial Agents/chemistry/metabolism/pharmacology, Antineoplastic Agents/chemistry/metabolism/pharmacology, Bacteria/drug effects, Cell Line, Tumor, Fungi/drug effects, Gas Chromatography-Mass Spectrometry, Geologic Sediments/microbiology, Humans, India, Microbial Sensitivity Tests, Talaromyces/chemistry/genetics/isolation & purification/metabolism	Metabolism
Pathogenicity	28294414	Evaluation of phytochemicals from medicinal plants of Myrtaceae family on virulence factor production by Pseudomonas aeruginosa.	Musthafa KS, Sianglum W, Saising J, Lethongkam S, Voravuthikunchai SP	APMIS	10.1111/apm.12672	2017	Anti-Bacterial Agents/isolation & purification/pharmacology, Chromobacterium/drug effects, Gas Chromatography-Mass Spectrometry, Glycolipids/metabolism, Humans, Metabolic Networks and Pathways/drug effects, Molecular Docking Simulation, Phytochemicals/isolation & purification/pharmacology, Plant Extracts/isolation & purification/pharmacology, Plants, Medicinal/chemistry, Pseudomonas aeruginosa/drug effects, Syzygium/chemistry, Virulence Factors/*metabolism	Enzymology
Pathogenicity	28303823	Bacterial and fungal biofilm formation on contact lenses and their susceptibility to lens care solutions.	Kackar S, Suman E, Kotian MS	Indian J Med Microbiol	10.4103/ijmm.IJMM_16_273	2017	Anti-Infective Agents/pharmacology, Bacteria/drug effects/virology, Bacteriolysis, Biofilms/growth & development, Candida albicans/drug effects/physiology, Coliphages/growth & development, Colony Count, Microbial, Contact Lens Solutions/pharmacology, Contact Lenses/microbiology, Microscopy, Electron, Scanning, Spectrophotometry
Pathogenicity	28333961	Phytochemical investigation of Aloe pulcherrima roots and evaluation for its antibacterial and antiplasmodial activities.	Abdissa D, Geleta G, Bacha K, Abdissa N	PLoS One	10.1371/journal.pone.0173882	2017	Aloe/chemistry, Anti-Bacterial Agents/analysis/pharmacology, Antimalarials/analysis/pharmacology, Bacillus subtilis/drug effects, Escherichia coli/drug effects, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Plant Extracts/isolation & purification/pharmacology, Plant Roots/*chemistry, Plasmodium falciparum/drug effects, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects	Enzymology
Pathogenicity	28335779	Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates.	Cabassi CS, Sala A, Santospirito D, Alborali GL, Carretto E, Ghibaudo G, Taddei S	Ann Clin Microbiol Antimicrob	10.1186/s12941-017-0193-1	2017	Animals, Anti-Bacterial Agents/pharmacology, Cell Membrane/drug effects/ultrastructure, Cell Wall/drug effects/ultrastructure, Dogs, Drug Resistance, Multiple, Bacterial, Humans, Microbial Viability/drug effects, Microscopy, Electron, Scanning, Peptides/pharmacology, Pseudomonas Infections/microbiology/veterinary, Pseudomonas aeruginosa/drug effects/isolation & purification	Enzymology
Metabolism	28349539	Fermentation of sarshir (kaymak) by lactic acid bacteria: antibacterial activity, antioxidant properties, lipid and protein oxidation and fatty acid profile.	Hashemi SMB, Mousavi Khaneghah A, Kontominas MG, Es I, Sant'Ana AS, Martinez RR, Drider D	J Sci Food Agric	10.1002/jsfa.8329	2017	Animals, Anti-Bacterial Agents/chemistry/metabolism/pharmacology, Antioxidants/chemistry, Cattle, Dairy Products/analysis/microbiology, Escherichia coli O157/drug effects, Fatty Acids/chemistry/metabolism, Fermentation, Lactobacillus plantarum/metabolism, Lipids/chemistry, Milk/chemistry/microbiology, Milk Proteins/chemistry/metabolism/pharmacology, Oxidation-Reduction, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects	Pathogenicity
Metabolism	28389154	Stigmatellin Y - An anti-biofilm compound from Bacillus subtilis BR4 possibly interferes in PQS-PqsR mediated quorum sensing system in Pseudomonas aeruginosa.	Boopathi S, Vashisth R, Manoharan P, Kandasamy R, Sivakumar N	Bioorg Med Chem Lett	10.1016/j.bmcl.2017.03.074	2017	Anti-Bacterial Agents/chemistry/isolation & purification/metabolism/pharmacology, Bacillus subtilis/chemistry/metabolism, Bacterial Proteins/metabolism, Binding Sites, Chromatography, High Pressure Liquid, Ligands, Molecular Docking Simulation, Polyenes/chemistry/isolation & purification/metabolism/pharmacology, Protein Structure, Tertiary, Pseudomonas aeruginosa/physiology, Quorum Sensing/*drug effects, Tandem Mass Spectrometry	Enzymology
Metabolism	28401403	Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri.	Greifova G, Majekova H, Greif G, Body P, Greifova M, Dubnickova M	Folia Microbiol (Praha)	10.1007/s12223-017-0524-9	2017	Acetic Acid/analysis/metabolism/pharmacology, Anti-Bacterial Agents/analysis/metabolism/pharmacology, Escherichia coli/drug effects, Fermentation, Immunologic Factors/analysis/metabolism/pharmacology, Lactic Acid/analysis/metabolism/pharmacology, Lactobacillus reuteri/*chemistry/metabolism	Pathogenicity
Pathogenicity	28410852	Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design.	Huband MD, Ito A, Tsuji M, Sader HS, Fedler KA, Flamm RK	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2017.03.011	2017	Anti-Bacterial Agents/pharmacology, Cephalosporins/pharmacology, Drug Resistance, Multiple, Bacterial, Escherichia coli/drug effects, Humans, Iron/metabolism, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects, Quality Control	Metabolism
Pathogenicity	28465062	Self assembled snowball-like hybrid nanostructures comprising Viburnum opulus L. extract and metal ions for antimicrobial and catalytic applications.	Ildiz N, Baldemir A, Altinkaynak C, Ozdemir N, Yilmaz V, Ocsoy I	Enzyme Microb Technol	10.1016/j.enzmictec.2017.04.003	2017	Anti-Infective Agents/chemistry, Bacteria/drug effects, Candida/drug effects, Catalysis, Copper/chemistry, Drug Design, Metal Nanoparticles/chemistry, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Nanostructures/chemistry/ultrastructure, Plant Extracts/chemistry, Spectroscopy, Fourier Transform Infrared, Viburnum/*chemistry
Pathogenicity	28475974	Ultraviolet/ultrasound-activated persulfate for degradation of drug by zinc selenide quantum dots: Catalysis and microbiology study.	Fakhri A, Naji M, Tahami S	J Photochem Photobiol B	10.1016/j.jphotobiol.2017.04.024	2017	Anti-Bacterial Agents/chemistry/metabolism/pharmacology, Catalysis, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Kinetics, Methylphenidate/chemistry/metabolism/pharmacology, Microscopy, Electron, Transmission, Quantum Dots/chemistry, Selenium Compounds/chemistry, Sonication, Sulfides/chemistry, Temperature, Ultraviolet Rays, Zinc Compounds/*chemistry	Metabolism
Pathogenicity	28530185	Effect of GNP functionalisation and multiple N-methylation of beta-amyloid residue (32-37) on Gram-positive bacterium.	Hemmaragala NM, Abrahamse H, George BP	IET Nanobiotechnol	10.1049/iet-nbt.2016.0083	2017	Amyloid beta-Peptides/administration & dosage/chemistry, Cell Survival/drug effects/physiology, Drug Combinations, Drug Compounding/methods, Gold/administration & dosage/chemistry, Gram-Negative Bacteria/cytology/drug effects/physiology, Materials Testing, Metal Nanoparticles/administration & dosage/chemistry/ultrastructure, Methylation, Nanoconjugates/administration & dosage/chemistry/ultrastructure, Particle Size, Treatment Outcome
Pathogenicity	28543603	Silver nanoparticles: Antimicrobial activity, cytotoxicity, and synergism with N-acetyl cysteine.	Hamed S, Emara M, Shawky RM, El-Domany RA, Youssef T	J Basic Microbiol	10.1002/jobm.201700087	2017	Acetylcysteine/pharmacology, Anti-Infective Agents/pharmacology, Candida albicans/drug effects/ultrastructure, Cell Line, Drug Resistance, Bacterial, Drug Resistance, Fungal, Drug Synergism, Escherichia coli/drug effects/ultrastructure, Humans, Metal Nanoparticles/chemistry/toxicity, Microbial Sensitivity Tests, Muramic Acids/metabolism, Oxidoreductases/metabolism, Pseudomonas aeruginosa/drug effects/ultrastructure, Silver/metabolism/pharmacology/toxicity, Staphylococcus aureus/drug effects/ultrastructure	Metabolism
Pathogenicity	28559256	Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.	Lin YW, Zhou Q, Onufrak NJ, Wirth V, Chen K, Wang J, Forrest A, Chan HK, Li J	Antimicrob Agents Chemother	10.1128/AAC.00211-17	2017	Administration, Inhalation, Animals, Anti-Bacterial Agents/administration & dosage/pharmacokinetics, Disease Models, Animal, Female, Humans, Lung/microbiology, Mice, Microbial Sensitivity Tests, Polymyxin B/administration & dosage/pharmacokinetics, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects, Respiratory Tract Infections/*drug therapy/microbiology	Enzymology
Pathogenicity	28583022	Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures.	Miller N, Brassinne L, Allemeersch D	Acta Clin Belg	10.1080/17843286.2017.1331618	2017	Blood Culture/*instrumentation, Humans, Specimen Handling, Time Factors
Pathogenicity	28595075	Adsorption and photocatalysis efficiency of magnetite quantum dots anchored tin dioxide nanofibers for removal of mutagenic compound: Toxicity evaluation and antibacterial activity.	Fakhri A, Naji M, Nejad PA	J Photochem Photobiol B	10.1016/j.jphotobiol.2017.05.041	2017	A549 Cells, Adsorption, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Catalysis, Cell Line, Tumor, Cell Survival/drug effects, Ferrosoferric Oxide/chemistry, Humans, Hydrogen-Ion Concentration, Magnetics, Microscopy, Electron, Transmission, Nanofibers/chemistry/toxicity, Particle Size, Photolysis/radiation effects, Pseudomonas aeruginosa/drug effects/radiation effects, Quantum Dots/chemistry, Spectrophotometry, Ultraviolet, Staphylococcus aureus/drug effects/radiation effects, Tin Compounds/chemistry, X-Ray Diffraction
Pathogenicity	28604646	Effect of Supercritical Carbon Dioxide Extraction Parameters on the Biological Activities and Metabolites Present in Extracts from Arthrospira platensis.	Esquivel-Hernandez DA, Rodriguez-Rodriguez J, Cuellar-Bermudez SP, Garcia-Perez JS, Mancera-Andrade EI, Nunez-Echevarria JE, Ontiveros-Valencia A, Rostro-Alanis M, Garcia-Garcia RM, Torres JA, Chen WN, Parra-Saldivar R	Mar Drugs	10.3390/md15060174	2017	Anti-Infective Agents/chemistry/pharmacology, Antioxidants/chemistry/pharmacology, Bacteria/drug effects, Biological Factors/chemistry/pharmacology, Candida albicans/drug effects, Carbon Dioxide/chemistry, Fatty Acids/chemistry/pharmacology, Linoleic Acid/chemistry/pharmacology, Lutein/chemistry/pharmacology, Plant Extracts/chemistry/pharmacology, Pressure, Riboflavin/chemistry/pharmacology, Solvents/chemistry, Spirulina/*chemistry, Temperature, alpha-Tocopherol/chemistry/pharmacology, beta Carotene/chemistry/pharmacology
Phylogeny	28606056	Comparative genome and transcriptome analysis reveals distinctive surface characteristics and unique physiological potentials of Pseudomonas aeruginosa ATCC 27853.	Cao H, Lai Y, Bougouffa S, Xu Z, Yan A	BMC Genomics	10.1186/s12864-017-3842-z	2017	Adaptation, Physiological/genetics, Gene Expression Profiling, Genomic Islands/genetics, Genomics, Phylogeny, Polymorphism, Single Nucleotide, Prophages/physiology, Pseudomonas aeruginosa/genetics/physiology/virology, Species Specificity	Genetics
Metabolism	28648038	[Effects of Na(+) /H(+) exchanger 1 inhibitor on intestinal injury of rats with burn sepsis and the mechanism].	Li WP, Zhao GY, Yang XK	Zhonghua Shao Shang Za Zhi	10.3760/cma.j.issn.1009-2587.2017.06.013	2017	Animals, Anti-Arrhythmia Agents/pharmacology, Blotting, Western, Burns/complications/drug therapy/metabolism, Dextrans/blood, Enzyme-Linked Immunosorbent Assay, Fluorescein-5-isothiocyanate/analogs & derivatives, Guanidines/pharmacology, Interleukin-6/blood, Intestines/drug effects/injuries, Mice, NF-kappa B/blood/metabolism, Rats, Rats, Sprague-Dawley, Sepsis, Signal Transduction, Sodium-Hydrogen Exchanger 1, Sodium-Hydrogen Exchangers/antagonists & inhibitors/physiology, Soft Tissue Injuries, Sulfones/pharmacology, Transcription Factor RelA, Tumor Necrosis Factor-alpha/blood	Pathogenicity
Pathogenicity	28721659	Antimicrobial Activity of Selected Polyphenols and Capsaicinoids Identified in Pepper (Capsicum annuum L.) and Their Possible Mode of Interaction.	Mokhtar M, Ginestra G, Youcefi F, Filocamo A, Bisignano C, Riazi A	Curr Microbiol	10.1007/s00284-017-1310-2	2017	Anti-Infective Agents/chemistry/pharmacology, Bacteria/drug effects, Capsaicin/chemistry/pharmacology, Capsicum/chemistry, Disk Diffusion Antimicrobial Tests, Dose-Response Relationship, Drug, Drug Synergism, Microbial Sensitivity Tests, Plant Extracts/chemistry/pharmacology, Polyphenols/chemistry/*pharmacology
	28725151	Chemical constituents of Helichrysum italicum (Roth) G. Don essential oil and their antimicrobial activity against Gram-positive and Gram-negative bacteria, filamentous fungi and Candida albicans.	Djihane B, Wafa N, Elkhamssa S, Pedro HJ, Maria AE, Mohamed Mihoub Z	Saudi Pharm J	10.1016/j.jsps.2016.11.001	2016
Metabolism	28738346	Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.	Li Y, Huang J, Li L, Liu L	Cell Physiol Biochem	10.1159/000479411	2017	Alginates, Animals, Anti-Bacterial Agents/pharmacology, Azithromycin/pharmacology, Bacterial Proteins/antagonists & inhibitors/genetics/metabolism, Berberine/pharmacology, Biofilms/drug effects/growth & development, Chitinases/antagonists & inhibitors/genetics/metabolism, Cyclophosphamide, Cystic Fibrosis/microbiology, DNA, Bacterial/antagonists & inhibitors/biosynthesis, Drug Combinations, Drug Synergism, Glucuronic Acid/antagonists & inhibitors/biosynthesis, Hexuronic Acids/antagonists & inhibitors, Humans, Lung/drug effects/metabolism/microbiology, Metalloendopeptidases/antagonists & inhibitors/genetics/metabolism, Metalloproteases/antagonists & inhibitors/genetics/metabolism, Mice, Mice, Inbred BALB C, Microbial Sensitivity Tests, Neutropenia/chemically induced/drug therapy/genetics/pathology, Oligopeptides/antagonists & inhibitors/biosynthesis, Pseudomonas Infections/chemically induced/drug therapy/genetics/pathology, Pseudomonas aeruginosa/drug effects/growth & development/pathogenicity, Pyocyanine/antagonists & inhibitors/biosynthesis, Virulence Factors/antagonists & inhibitors/genetics/metabolism	Pathogenicity
Pathogenicity	28747232	Development of an accumulation assay and evaluation of the effects of efflux pump inhibitors on the retention of chlorhexidine digluconate in Pseudomonas aeruginosa and Staphylococcus aureus.	Mombeshora M, Mukanganyama S	BMC Res Notes	10.1186/s13104-017-2637-2	2017	ATP-Binding Cassette Transporters/antagonists & inhibitors, Anti-Infective Agents, Local/pharmacology, Chlorhexidine/analogs & derivatives/pharmacology, Cross Infection/prevention & control, Microbial Sensitivity Tests, Protein Synthesis Inhibitors/pharmacology, Pseudomonas aeruginosa/drug effects, Reserpine/pharmacology, Staphylococcus aureus/drug effects
Pathogenicity	28767978	Biosynthesized silver nanoparticles: are they effective antimicrobials?	Peiris MK, Gunasekara CP, Jayaweera PM, Arachchi ND, Fernando N	Mem Inst Oswaldo Cruz	10.1590/0074-02760170023	2017	Anti-Bacterial Agents/biosynthesis/chemistry/pharmacology, Colony Count, Microbial/methods, Gram-Negative Bacteria/drug effects/ultrastructure, Gram-Positive Bacteria/drug effects/ultrastructure, Humans, Metal Nanoparticles/chemistry/ultrastructure, Microscopy, Electron, Scanning, Pseudomonas aeruginosa/metabolism, Silver/metabolism/*pharmacology, Spectrophotometry, Ultraviolet, Spectroscopy, Fourier Transform Infrared	Metabolism
Pathogenicity	28840394	Lipophilic gold(I) complexes with 1,3,4-oxadiazol-2-thione or 1,3-thiazolidine-2-thione moieties: synthesis and their cytotoxic and antimicrobial activities.	de Almeida AM, de Oliveira BA, de Castro PP, de Mendonca CC, Furtado RA, Nicolella HD, da Silva VL, Diniz CG, Tavares DC, Silva H, de Almeida MV	Biometals	10.1007/s10534-017-0046-6	2017	Animals, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antineoplastic Agents/chemical synthesis/chemistry/pharmacology, Cell Line, Tumor, Chemistry Techniques, Synthetic, Cricetinae, Drug Evaluation, Preclinical, Escherichia coli/drug effects, Humans, Magnetic Resonance Spectroscopy, Mice, Microbial Sensitivity Tests, Organogold Compounds/chemical synthesis/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Thiones/chemistry
Pathogenicity	28854710	Pseudomonas aeruginosa Trent and zinc homeostasis.	Davies CB, Harrison MD, Huygens F	FEMS Microbiol Lett	10.1093/femsle/fnx151	2017	Biofilms, Cystic Fibrosis/microbiology, Homeostasis, Humans, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/drug effects/growth & development/metabolism, Zinc/*metabolism, Zinc Sulfate/pharmacology	Metabolism
Metabolism	28871684	[Identification and bactericidal activity of a novel Cathelicidin family member from skin of Bufu bufo gargarizans].	Zhan B, Gao YY, Lin WP, Jia GT, Sun TY, Lee WH	Zhongguo Zhong Yao Za Zhi	10.4268/cjcmm20160414	2016	Animals, Anti-Bacterial Agents/chemistry/metabolism/pharmacology, Antimicrobial Cationic Peptides/chemistry/genetics/metabolism/pharmacology, Bufonidae/genetics/metabolism, Escherichia coli/drug effects/growth & development, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Skin/chemistry/*metabolism, Staphylococcus aureus/drug effects/growth & development	Pathogenicity
Pathogenicity	28938203	Green synthesis, biological and spectroscopic study on the interaction of multi-component Mannich bases of imidazo[2,1-b]benzothiazoles with human serum albumin.	Maddili SK, Yandrati LP, Siddam S, Kannekanti VK, Gandham H	J Photochem Photobiol B	10.1016/j.jphotobiol.2017.08.026	2017	Animals, Anti-Infective Agents/chemical synthesis/chemistry/pharmacology, Benzothiazoles/chemistry/pharmacology, Cattle, DNA/chemistry/drug effects/metabolism, Fungi/drug effects, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Green Chemistry Technology, Humans, Imidazoles/chemistry/pharmacology, Mannich Bases/chemistry, Microbial Sensitivity Tests, Protein Denaturation, Serum Albumin/*chemistry, Spectrophotometry, Ultraviolet	Metabolism
Pathogenicity	29084746	Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.	Diez-Aguilar M, Morosini MI, Koksal E, Oliver A, Ekkelenkamp M, Canton R	Antimicrob Agents Chemother	10.1128/AAC.01650-17	2017	Anti-Bacterial Agents/pharmacology, Biofilms/drug effects, Cystic Fibrosis/microbiology, Drug Combinations, Drug Synergism, Fosfomycin/pharmacology, Humans, Microbial Sensitivity Tests/instrumentation/methods, Microfluidics, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects, Tobramycin/*pharmacology
Pathogenicity	29095556	Antibacterial and antifungal activities of pyroligneous acid from wood of Eucalyptus urograndis and Mimosa tenuiflora.	de Souza Araujo E, Pimenta AS, Feijo FMC, Castro RVO, Fasciotti M, Monteiro TVC, de Lima KMG	J Appl Microbiol	10.1111/jam.13626	2017	Anti-Bacterial Agents/isolation & purification/pharmacology, Antifungal Agents/isolation & purification/pharmacology, Brazil, Escherichia coli/drug effects, Eucalyptus/chemistry, Microbial Sensitivity Tests, Mimosa/chemistry, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Terpenes/isolation & purification/*pharmacology, Wood/chemistry, Yeasts/drug effects	Enzymology
Pathogenicity	29098912	In vitro antimicrobial effects of a novel Pentaherbs concoction for atopic dermatitis.	Hon KL, Ip M, Wong CK, Chan BCL, Leung PC, Leung TF	J Dermatolog Treat	10.1080/09546634.2017.1395804	2017	Anti-Infective Agents/pharmacology/therapeutic use, Dermatitis, Atopic/drug therapy/pathology, Drugs, Chinese Herbal/pharmacology/therapeutic use, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/*drug effects, Humans, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Staphylococcus aureus/drug effects
Pathogenicity	29177612	Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin.	Turlej-Rogacka A, Xavier BB, Janssens L, Lammens C, Zarkotou O, Pournaras S, Goossens H, Malhotra-Kumar S	Eur J Clin Microbiol Infect Dis	10.1007/s10096-017-3140-3	2017	Agar/chemistry, Anti-Bacterial Agents/metabolism/pharmacology, Colistin/metabolism/pharmacology, Disk Diffusion Antimicrobial Tests/methods, Drug Resistance, Multiple, Bacterial, Escherichia coli/drug effects, Humans, Klebsiella pneumoniae/drug effects, Pseudomonas aeruginosa/*drug effects	Metabolism
Pathogenicity	29203912	Bacterial resistance to silver nanoparticles and how to overcome it.	Panacek A, Kvitek L, Smekalova M, Vecerova R, Kolar M, Roderova M, Dycka F, Sebela M, Prucek R, Tomanec O, Zboril R	Nat Nanotechnol	10.1038/s41565-017-0013-y	2017	Anti-Bacterial Agents/chemistry/pharmacology, Drug Resistance, Bacterial, Drug Stability, Escherichia coli/drug effects, Metal Nanoparticles/chemistry, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Silver/chemistry/pharmacology
Pathogenicity	29215338	Evaluation of Antimicrobial Durability and Anti-Biofilm Effects in Urinary Catheters Against Enterococcus faecalis Clinical Isolates and Reference Strains.	Kart D, Kustimur AS, Sagiroglu M, Kalkanci A	Balkan Med J	10.4274/balkanmedj.2016.1853	2017	Anti-Infective Agents/pharmacology, Biofilms/drug effects, Catheter-Related Infections/microbiology/prevention & control, Catheters, Indwelling/microbiology, Coated Materials, Biocompatible, Enterococcus faecalis/drug effects/isolation & purification, Humans, In Vitro Techniques, Microbial Sensitivity Tests, Nitrofurazone/pharmacology, Silicones, Silver, Urinary Catheterization/adverse effects, Urinary Tract Infections/*microbiology/prevention & control	Enzymology
Pathogenicity	29216563	Synthesis and antimicrobial activity of amino acid and peptide derivatives of mycophenolic acid.	Siebert A, Wysocka M, Krawczyk B, Cholewinski G, Rachon J	Eur J Med Chem	10.1016/j.ejmech.2017.11.094	2017	Amino Acids/chemistry/pharmacology, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Molecular Structure, Mycophenolic Acid/chemical synthesis/chemistry/pharmacology, Peptides/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship
Metabolism	29223758	Biosynthesis and structural characterization of polyhydroxyalkanoates produced by Pseudomonas aeruginosa ATCC 27853 from long odd-chain fatty acids.	Impallomeni G, Ballistreri A, Carnemolla GM, Rizzo MG, Nicolo MS, Guglielmino SPP	Int J Biol Macromol	10.1016/j.ijbiomac.2017.12.037	2017	Fatty Acids/chemistry, Gas Chromatography-Mass Spectrometry, Magnetic Resonance Spectroscopy, Molecular Structure, Polyhydroxyalkanoates/biosynthesis/chemistry, Pseudomonas aeruginosa/metabolism, Spectrometry, Mass, Electrospray Ionization, Thermodynamics
Pathogenicity	29309652	Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa.	Holfeld L, Knappe D, Hoffmann R	J Antimicrob Chemother	10.1093/jac/dkx482	2018	Anti-Infective Agents/pharmacology, Antimicrobial Cationic Peptides/pharmacology, Escherichia coli/drug effects, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/*drug effects
	29404050	Chemical and microbiological characterization of tinctures and microcapsules loaded with Brazilian red propolis extract.	da Cruz Almeida ET, da Silva MCD, Oliveira JMDS, Kamiya RU, Arruda REDS, Vieira DA, Silva VDC, Escodro PB, Basilio-Junior ID, do Nascimento TG	J Pharm Anal	10.1016/j.jpha.2017.03.004	2017
Pathogenicity	29462537	[In vitro antibacterial activity of Curcuma longa (Zingiberaceae) against nosocomial bacteria in Monteria, Colombia].	Mendez Alvarez N, Angulo Ortiz A, Contreras Martinez O	Rev Biol Trop		2016	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects/growth & development, Colombia, Cross Infection/microbiology/prevention & control, Curcuma/chemistry, Enzyme-Linked Immunosorbent Assay, Ethanol/chemistry, Formazans, Microbial Sensitivity Tests, Oils, Volatile/pharmacology, Plant Extracts/*pharmacology, Reproducibility of Results, Tetrazolium Salts
Genetics	29463378	Single-Nucleotide Polymorphism Genotyping of exoS in Pseudomonas aeruginosa Using Dual-Color Fluorescence Hybridization and Magnetic Separation.	Tang Y, Ali Z, Dai J, Liu X, Wu Y, Chen Z, He N, Li S, Wang L	J Biomed Nanotechnol	10.1166/jbn.2018.2525	2018	Bacterial Proteins, Fluorescence, Genotype, Nucleic Acid Hybridization, Nucleotides, Polymorphism, Single Nucleotide, Pseudomonas aeruginosa	Phylogeny
Pathogenicity	29506207	Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model.	Bilal H, Peleg AY, McIntosh MP, Styles IK, Hirsch EB, Landersdorfer CB, Bergen PJ	J Antimicrob Chemother	10.1093/jac/dky045	2018	Anti-Bacterial Agents/pharmacokinetics, Cell Culture Techniques, Fosfomycin/pharmacokinetics, Humans, Microbial Sensitivity Tests, Models, Theoretical, Pseudomonas aeruginosa/drug effects	Enzymology
Phylogeny	29515231	Streptosporangium minutum sp. nov., isolated from garden soil exposed to microwave radiation.	Le Roes-Hill M, Durrell K, Prins A, Meyers PR	J Antibiot (Tokyo)	10.1038/s41429-018-0036-0	2018	Actinomycetales/classification/genetics/isolation & purification, Anti-Bacterial Agents/isolation & purification/pharmacology, DNA, Fungal/analysis, Databases, Genetic, Genotype, Microbial Sensitivity Tests, Microwaves, Sequence Analysis, DNA, Soil, Soil Microbiology	Enzymology
Phylogeny	29524547	Safety characterisation and inhibition of fungi and bacteria by a novel multiple enterocin-producing Enterococcus lactis 4CP3 strain.	Ben Braiek O, Cremonesi P, Morandi S, Smaoui S, Hani K, Ghrairi T	Microb Pathog	10.1016/j.micpath.2018.03.005	2018	Animals, Anti-Bacterial Agents/chemistry/metabolism/pharmacology, Bacteria/drug effects, Bacteriocins/metabolism/pharmacology, Bridged-Ring Compounds/chemistry/classification/metabolism/pharmacology, Enterococcus/classification/genetics/isolation & purification/metabolism, Foodborne Diseases, Fungi/*drug effects, Hot Temperature, Hydrogen-Ion Concentration, Palaemonidae/microbiology, Phylogeny, Probiotics, Species Specificity, Virulence Factors/genetics	Metabolism
Pathogenicity	29530530	Membrane-acting bacteriocin purified from a soil isolate Pediococcus pentosaceus LB44 shows broad host-range.	Kaur R, Tiwari SK	Biochem Biophys Res Commun	10.1016/j.bbrc.2018.03.062	2018	Amino Acid Sequence, Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Bacteria/drug effects, Bacterial Infections/drug therapy, Bacteriocins/chemistry/isolation & purification/pharmacology, Food Microbiology, Halobacteriaceae/drug effects, Humans, Pediococcus pentosaceus/chemistry, Soil Microbiology	Enzymology
	29551999	Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents Against Clinically Relevant Gram-Positive and Gram-Negative Pathogens.	Vega SC, Martinez DA, Chala MDS, Vargas HA, Rosas JE	Front Microbiol	10.3389/fmicb.2018.00329	2018
Pathogenicity	29575393	Photodynamic inactivation of foodborne bacteria by eosin Y.	Bonin E, Dos Santos AR, Fiori da Silva A, Ribeiro LH, Favero ME, Campanerut-Sa PAZ, de Freitas CF, Caetano W, Hioka N, Mikcha JMG	J Appl Microbiol	10.1111/jam.13727	2018	Bacteria/drug effects/radiation effects, Colony Count, Microbial, Eosine Yellowish-(YS)/pharmacology, Food Microbiology, Microbial Viability/drug effects/radiation effects, Photochemical Processes	Biotechnology
Pathogenicity	29587897	Antimicrobial Potential of Sicilian Honeys Against Staphylococcus aureus and Pseudomonas aeruginosa.	Coniglio MA, Lagana P, Faro G, Marranzano M	J AOAC Int	10.5740/jaoacint.17-0450	2018	Anti-Bacterial Agents/pharmacology, Honey, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Sicily, Staphylococcus aureus/drug effects
Pathogenicity	29603034	Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 mug.	Koeth LM, Matuschek E, Kahlmeter G, Stone G	Eur J Clin Microbiol Infect Dis	10.1007/s10096-018-3215-9	2018	Anti-Bacterial Agents/pharmacology, Azabicyclo Compounds/pharmacology, Ceftazidime/pharmacology, Disk Diffusion Antimicrobial Tests/instrumentation/methods, Drug Combinations, Enterobacteriaceae/*drug effects, Escherichia coli/drug effects, Humans, Klebsiella pneumoniae/drug effects, Pseudomonas aeruginosa/drug effects, Quality Control, beta-Lactamases/drug effects
Phylogeny	29644828	ANTIBACTERIAL PROPERTY TESTING OF TWO SPECIES OF TROPICAL PLANT LASIANTHUS (RUBIACEAE).	Napiroon T, Balslev H, Duangjai S, Sookchaloem D, Chayamarit K, Santimaleeworagun W, Vajrodaya S	Southeast Asian J Trop Med Public Health		2017	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects, Plant Extracts/chemistry/pharmacology, Rubiaceae/*chemistry/classification, Species Specificity	Pathogenicity
Pathogenicity	29738292	Comparison of antimicrobial activity of selected, commercially available wound dressing materials.	Szweda P, Gorczyca G, Tylingo R	J Wound Care	10.12968/jowc.2018.27.5.320	2018	Anti-Infective Agents, Local/therapeutic use, Bandages/standards, Chlorhexidine/supply & distribution/therapeutic use, Honey, Humans, Povidone-Iodine/therapeutic use, Silver/therapeutic use, Wound Healing/drug effects, Wound Infection/drug therapy
	29770172	Prevention of Cross-contamination Risk by Disinfection of Irreversible Hydrocolloid Impression Materials with Ozonated Water.	Savabi O, Nejatidanesh F, Bagheri KP, Karimi L, Savabi G	Int J Prev Med	10.4103/ijpvm.IJPVM_143_16	2018
Pathogenicity	29996552	Synthesis, Spectroscopic Characterization, and In Vitro Antibacterial Evaluation of Novel Functionalized Sulfamidocarbonyloxyphosphonates.	Bouzina A, Bechlem K, Berredjem H, Belhani B, Becheker I, Lebreton J, Le Borgne M, Bouaziz Z, Marminon C, Berredjem M	Molecules	10.3390/molecules23071682	2018	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Humans, Microbial Sensitivity Tests, Organophosphonates/chemical synthesis/chemistry/pharmacology, Oxazoles/chemical synthesis/chemistry/pharmacology, Pharmaceutical Preparations/chemistry
	30013274	Comparison of Antimicrobial Properties of Silver Nanoparticles Synthesized from Selected Bacteria.	Peiris MMK, Fernando SSN, Jayaweera PM, Arachchi NDH, Guansekara TDCP	Indian J Microbiol	10.1007/s12088-018-0723-3	2018
	30034318	Oxidative responses and defense mechanism of hyperpigmented P. aeruginosa as characterized by proteomics and metabolomics.	Thippakorn C, Isarankura-Na-Ayudhya C, Pannengpetch S, Isarankura-Na-Ayudhya P, Schaduangrat N, Nantasenamat C, Prachayasittikul V	EXCLI J	10.17179/excli2018-1238	2018
Pathogenicity	30044173	Titanium oxide nanoparticles fabrication, hemoglobin interaction, white blood cells cytotoxicity, and antibacterial studies.	Abdolmajid E, Kharazi H, Chalaki M, Khojasteh M, Haghighat S, Attar F, Nemati F, Falahati M	J Biomol Struct Dyn	10.1080/07391102.2018.1499555	2018	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects, Cell Proliferation/drug effects, Hemoglobins/metabolism, Humans, Leukocytes/drug effects/pathology, Metal Nanoparticles/administration & dosage/chemistry, Molecular Docking Simulation, Photosensitizing Agents/chemistry/pharmacology, Silver/chemistry, Spectrometry, Fluorescence, Titanium/chemistry/*pharmacology	Metabolism
Pathogenicity	30046488	Synthesis and characterization of ZnO phytonanocomposite using Strychnos nux-vomica L. (Loganiaceae) and antimicrobial activity against multidrug-resistant bacterial strains from diabetic foot ulcer.	Steffy K, Shanthi G, Maroky AS, Selvakumar S	J Adv Res	10.1016/j.jare.2017.11.001	2017
Pathogenicity	30095025	Antiplanktonic, antibiofilm, antiswarming motility and antiquorum sensing activities of green synthesized Ag-TiO2, TiO2-Ag, Ag-Cu and Cu-Ag nanocomposites against multi-drug-resistant bacteria.	Alavi M, Karimi N	Artif Cells Nanomed Biotechnol	10.1080/21691401.2018.1496923	2018	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/growth & development, Bacterial Physiological Phenomena/drug effects, Biofilms/drug effects/growth & development, Copper/chemistry/pharmacology, Nanocomposites/chemistry, Quorum Sensing/drug effects, Silver/chemistry/pharmacology, Titanium/chemistry/pharmacology
Biotechnology	30095422	Simplistic approach in extracellular synthesis of silver nanoparticles via bioreducing potential of Planococcus plakortidis strain BGCC-51 isolated from dye industry effluent soil.	Chokriwal A, Stephen BJ, Jain D, Singh A	IET Nanobiotechnol	10.1049/iet-nbt.2017.0251	2018	Biotechnology, Coloring Agents, Extracellular Space/metabolism, Metal Nanoparticles/chemistry, Oxidation-Reduction, Planococcaceae/chemistry/isolation & purification/metabolism, Silver/*chemistry, Soil Microbiology, Textile Industry	Metabolism
Pathogenicity	30187508	Antibacterial activity of traditional spices against lower respiratory tract pathogens: combinatorial effects of Trachyspermum ammi essential oil with conventional antibiotics.	Gradinaru AC, Trifan A, Spac A, Brebu M, Miron A, Aprotosoaie AC	Lett Appl Microbiol	10.1111/lam.13069	2018	Ammi/chemistry, Anti-Bacterial Agents/pharmacology, Carum/chemistry, Ciprofloxacin/pharmacology, Cyclohexane Monoterpenes, Cymenes, Drug Resistance, Multiple, Bacterial/drug effects, Drug Therapy, Combination, Humans, Microbial Sensitivity Tests, Monoterpenes/pharmacology, Oils, Volatile/pharmacology, Plant Oils/pharmacology, Pseudomonas aeruginosa/drug effects/isolation & purification, Respiratory System/microbiology, Respiratory Tract Infections/drug therapy/microbiology, Spices/analysis, Staphylococcus aureus/drug effects/isolation & purification, Streptococcus pneumoniae/drug effects/isolation & purification, Thymol/pharmacology	Enzymology
Enzymology	30188999	Stability and low induction propensity of cefiderocol against chromosomal AmpC beta-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.	Ito A, Nishikawa T, Ota M, Ito-Horiyama T, Ishibashi N, Sato T, Tsuji M, Yamano Y	J Antimicrob Chemother	10.1093/jac/dky317	2018	Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics, Carbapenems/pharmacology, Cephalosporins/pharmacology, Chromosomes, Bacterial, Drug Resistance, Multiple, Bacterial, Enterobacter cloacae/drug effects/enzymology/genetics, Imipenem/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/enzymology/genetics, beta-Lactamases/*genetics	Pathogenicity
Cultivation	30218696	Soup with or without meatballs: Impact of nutritional factors on the MIC, kill-rates and growth-rates.	Mouton JW	Eur J Pharm Sci	10.1016/j.ejps.2018.09.008	2018	Anti-Bacterial Agents/pharmacology, Bacteriological Techniques, Culture Media, Meropenem/pharmacology, *Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development	Pathogenicity
	30228029	Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.	Maria de Souza Morais S, Ferreira Rodigues N, Ingrid Oliveira da Silva N, Aparecido Salvador E, Rodrigues Franco I, Augusto Pires de Souza G, Henrique Cruvinel da Silva P, Gustavo Nogueira de Almeida L, Prado Rocha R, Carolina Toledo da Cunha Pereira A, Portela Ferreira G, Veras Quelemes P, Pereira de Araujo M, Fornias Sperandio F, Junia de Souza Santos L, Assis Martins Filho O, Cosme Cotta Malaquias L, Felipe Leomil Coelho L	Vaccine	10.1016/j.vaccine.2018.08.070	2018	Animals, Antibodies, Bacterial/blood, Antigens, Bacterial/immunology, Bacterial Load, Cytokines/immunology, Disease Models, Animal, Female, Lung/microbiology, Mice, Nanoparticles/chemistry, Pseudomonas Infections/immunology/prevention & control, Pseudomonas Vaccines/immunology, Pseudomonas aeruginosa, Serum Albumin, Bovine/chemistry, Vaccination
Pathogenicity	30244012	Formulation Optimization of Chitosan-Stabilized Silver Nanoparticles Using In Vitro Antimicrobial Assay.	Pansara C, Chan WY, Parikh A, Trott DJ, Mehta T, Mishra R, Garg S	J Pharm Sci	10.1016/j.xphs.2018.09.011	2018	Anti-Bacterial Agents/chemistry/pharmacology, Bacterial Infections/drug therapy, Biofilms/drug effects, Chitosan/chemistry/pharmacology, Escherichia coli/drug effects/physiology, Humans, Metal Nanoparticles/chemistry, Methicillin-Resistant Staphylococcus aureus/drug effects/physiology, Pseudomonas aeruginosa/drug effects/physiology, Silver/chemistry/pharmacology, Staphylococcus aureus/drug effects/physiology
Pathogenicity	30262284	Potential bactericidal activity of S. nux-vomica-ZnO nanocomposite against multidrug-resistant bacterial pathogens and wound-healing properties.	Steffy K, Shanthi G, Maroky AS, Selvakumar S	J Trace Elem Med Biol	10.1016/j.jtemb.2018.07.009	2018	Animals, Anti-Bacterial Agents/adverse effects/chemistry/pharmacology, Cell Line, Escherichia coli/drug effects, Flow Cytometry, HEK293 Cells, Humans, Methicillin-Resistant Staphylococcus aureus/drug effects, Mice, Microbial Sensitivity Tests, Nanocomposites/adverse effects/chemistry, Staphylococcus aureus/drug effects, Wound Healing/drug effects
Biotechnology	30271149	Botryococcus braunii as a bioreactor for the production of nanoparticles with antimicrobial potentialities.	Arevalo-Gallegos A, Garcia-Perez JS, Carrillo-Nieves D, Ramirez-Mendoza RA, Iqbal HM, Parra-Saldivar R	Int J Nanomedicine	10.2147/IJN.S174205	2018	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects/growth & development, Bioreactors/microbiology, Chlorophyta/chemistry, Metal Nanoparticles/administration & dosage/chemistry, Microbial Sensitivity Tests, Plant Extracts/chemistry/pharmacology, Silver/*chemistry	Pathogenicity
Pathogenicity	30295039	In vitro bactericidal activity of 0.6% povidone-iodine eye drops formulation.	Musumeci R, Bandello F, Martinelli M, Calaresu E, Cocuzza CE	Eur J Ophthalmol	10.1177/1120672118802541	2018	Administration, Ophthalmic, Anti-Infective Agents, Local/administration & dosage, Bacteria/drug effects, Escherichia coli/drug effects, Humans, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Ophthalmic Solutions, Pharmaceutical Preparations, Povidone-Iodine/*administration & dosage, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects
Pathogenicity	30317865	Antimicrobial activity of spices essential oils and its effectiveness on mature biofilms of human pathogens.	Condo C, Anacarso I, Sabia C, Iseppi R, Anfelli I, Forti L, de Niederhausern S, Bondi M, Messi P	Nat Prod Res	10.1080/14786419.2018.1490904	2018	Anti-Bacterial Agents/isolation & purification/pharmacology, Biofilms/drug effects, Candida albicans/drug effects, Cinnamomum zeylanicum/chemistry, Cuminum/chemistry, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Microbial Sensitivity Tests, Oils, Volatile/pharmacology/therapeutic use, Pseudomonas aeruginosa/drug effects, Spices, Syzygium/chemistry	Enzymology
Cultivation	30352435	Influence of Laboratory Culture Media on in vitro Growth, Adhesion, and Biofilm Formation of Pseudomonas aeruginosa and Staphylococcus aureus.	Wijesinghe G, Dilhari A, Gayani B, Kottegoda N, Samaranayake L, Weerasekera M	Med Princ Pract	10.1159/000494757	2018	Biofilms/growth & development, Culture Media, Humans, Microbiological Techniques/methods, Pseudomonas aeruginosa/growth & development, Staphylococcus aureus/growth & development	Pathogenicity
	30380603	Antibiotic Activity of Actinobacteria from the Digestive Tract of Millipede Nedyopus dawydoffiae (Diplopoda).	Glukhova AA, Karabanova AA, Yakushev AV, Semenyuk II, Boykova YV, Malkina ND, Efimenko TA, Ivankova TD, Terekhova LP, Efremenkova OV	Antibiotics (Basel)	10.3390/antibiotics7040094	2018
Pathogenicity	30409704	Iodine-supported titanium implants have good antimicrobial attachment effects.	Inoue D, Kabata T, Kajino Y, Shirai T, Tsuchiya H	J Orthop Sci	10.1016/j.jos.2018.10.010	2018	Anti-Infective Agents, Local/pharmacology, Bacterial Adhesion/drug effects, Candida albicans/drug effects/growth & development, Coated Materials, Biocompatible, Iodine/pharmacology, Methicillin-Resistant Staphylococcus aureus/drug effects/growth & development, Prostheses and Implants, Prosthesis Design, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus epidermidis/drug effects/growth & development, Surface Properties, Titanium
	30416716	Antimicrobial activity of Terminalia catappa brown leaf extracts against Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 27853.	Allyn OQ, Kusumawati E, Nugroho RA	F1000Res	10.12688/f1000research.15998.1	2018	Anti-Bacterial Agents, Microbial Sensitivity Tests, Plant Extracts, Pseudomonas aeruginosa, Staphylococcus aureus, *Terminalia
Enzymology	30473514	Phytochemical analysis and antimicrobial activity of aqueous and methanolic extracts of the flowers of Nelumbium speciosum.	Bashir S, Sial RN, Ashraf MU, Mushtaq MN, Adnan MA, Erum A	Pak J Pharm Sci		2018	Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Disk Diffusion Antimicrobial Tests, Dose-Response Relationship, Drug, Flowers/chemistry, Gram-Negative Bacteria/drug effects/growth & development, Gram-Positive Bacteria/drug effects/growth & development, Methanol/chemistry, Nelumbonaceae/chemistry, Phytochemicals/chemistry/isolation & purification/pharmacology, Plant Extracts/chemistry/isolation & purification/pharmacology, Solvents/chemistry, Water/chemistry	Phylogeny
Pathogenicity	30523603	Potential Properties of Lactobacillus plantarum F-10 as a Bio-control Strategy for Wound Infections.	Onbas T, Osmanagaoglu O, Kiran F	Probiotics Antimicrob Proteins	10.1007/s12602-018-9486-8	2019	Anti-Bacterial Agents/chemistry/pharmacology, Bacterial Proteins/genetics/metabolism, Biofilms/drug effects, Humans, Lactobacillus plantarum/chemistry, Methicillin-Resistant Staphylococcus aureus/drug effects/genetics/growth & development, Probiotics/chemistry/pharmacology, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/drug effects/genetics/growth & development/metabolism, Quorum Sensing/drug effects, Staphylococcal Infections/microbiology, Virulence Factors/genetics/metabolism, Wound Infection/*microbiology	Metabolism
Phylogeny	30532629	Identification and characterization of a novel antimicrobial peptide compound produced by Bacillus megaterium strain isolated from oral microflora.	Al-Thubiani ASA, Maher YA, Fathi A, Abourehab MAS, Alarjah M, Khan MSA, Al-Ghamdi SB	Saudi Pharm J	10.1016/j.jsps.2018.05.019	2018
	30538974	High-Temperature Short-Time Treatment of Human Milk for Bacterial Count Reduction.	Klotz D, Schreiner M, Falcone V, Jonas D, Kunze M, Weber A, Fuchs H, Hentschel R	Front Pediatr	10.3389/fped.2018.00359	2018
Pathogenicity	30561174	Isothiazolopyridine Mannich bases and their antibacterial effect.	Swiatek P, Strzelecka M	Adv Clin Exp Med	10.17219/acem/99310	2019	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Humans, Mannich Bases/*pharmacology, Microbial Sensitivity Tests, Spectroscopy, Fourier Transform Infrared
	30564023	Sterilization protocol for porous dental implants made by Selective Laser Melting.	Manea A, Bran S, Baciut M, Armencea G, Pop D, Berce P, Vodnar DC, Hedesiu M, Dinu C, Petrutiu A, Tomina D, Baciut G	Clujul Med	10.15386/cjmed-987	2018
Pathogenicity	30607721	Sub-lethal antimicrobial photodynamic inactivation: an in vitro study on quorum sensing-controlled gene expression of Pseudomonas aeruginosa biofilm formation.	Hendiani S, Pornour M, Kashef N	Lasers Med Sci	10.1007/s10103-018-02707-y	2019	Anti-Infective Agents/pharmacology, Biofilms/drug effects/growth & development, Gene Expression Regulation, Bacterial/drug effects, Genes, Bacterial, Methylene Blue/pharmacology, Microbial Viability/drug effects, Photochemotherapy, Pseudomonas aeruginosa/drug effects/genetics/physiology/ultrastructure, Quorum Sensing/*drug effects
Metabolism	30621590	Novel linear lipopeptide paenipeptin C' binds to lipopolysaccharides and lipoteichoic acid and exerts bactericidal activity by the disruption of cytoplasmic membrane.	Moon SH, Huang E	BMC Microbiol	10.1186/s12866-018-1381-7	2019	Anti-Bacterial Agents/metabolism/pharmacology, Cell Membrane/drug effects, Lipopeptides/isolation & purification/metabolism/pharmacology, Lipopolysaccharides/metabolism, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Teichoic Acids/metabolism	Pathogenicity
Pathogenicity	30630320	Antimicrobial effect of novel hydrogel matrix based on natural polysaccharide Sterculia urens.	Lipovy B, Holoubek J, Vacek L, Ruzicka F, Nedomova E, Postulkova H, Vojtova L	Epidemiol Mikrobiol Imunol	107027		Anti-Infective Agents/pharmacology, Bacteria/drug effects, Hydrogels/chemistry, Microbial Sensitivity Tests, Polysaccharides/pharmacology, *Sterculia/chemistry
Metabolism	30636598	Molecular Identification and Antimicrobial Activity of Vaginal Lactobacillus sp.	Eryilmaz M, Gurpinar SS, Palabiyik IM, Guriz H, Gerceker D	Curr Pharm Biotechnol	10.2174/1389201020666190110164123	2018	Acetic Acid/metabolism/pharmacology, Escherichia coli/drug effects, Female, Humans, Hydrogen Peroxide/metabolism/pharmacology, Lactic Acid/metabolism/pharmacology, Lactobacillus/isolation & purification/metabolism, Probiotics/isolation & purification/metabolism, Pseudomonas aeruginosa/drug effects, RNA, Ribosomal, 16S/genetics, Staphylococcus aureus/drug effects, Vagina/microbiology	Pathogenicity
Pathogenicity	30643404	Albumin binding, anticancer and antibacterial properties of synthesized zero valent iron nanoparticles.	Anbouhi TS, Esfidvajani EM, Nemati F, Haghighat S, Sari S, Attar F, Pakaghideh A, Sohrabi MJ, Mousavi SE, Falahati M	Int J Nanomedicine	10.2147/IJN.S188497	2018	Anti-Bacterial Agents/administration & dosage/chemistry, Antineoplastic Agents/administration & dosage/chemistry, Bacteria/drug effects/metabolism, Cell Proliferation/drug effects, Escherichia coli/drug effects/metabolism, Humans, Iron/administration & dosage/chemistry, Metal Nanoparticles/administration & dosage/chemistry, Molecular Docking Simulation, Neuroblastoma/drug therapy/pathology, Protein Conformation, Pseudomonas aeruginosa/drug effects/metabolism, Serum Albumin, Human/chemistry/*metabolism, Staphylococcus aureus/drug effects/metabolism, Tumor Cells, Cultured	Metabolism
Phylogeny	30646760	Potential of lactic acid bacteria from Pico cheese for starter culture development.	Camara SP, Dapkevicius A, Riquelme C, Elias RB, Silva C, Malcata FX, Dapkevicius M	Food Sci Technol Int	10.1177/1082013218823129	2019	Animals, Anti-Infective Agents, Cheese/analysis/microbiology, Fermentation, Food Microbiology, Lactobacillales/classification/isolation & purification/physiology, Milk/microbiology, RNA, Ribosomal, 16S/genetics	Biotechnology
	30682768	In Vitro Comparison of Antibacterial and Antibiofilm Activities of Selected Fluoroquinolones against Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus.	Masadeh MM, Alzoubi KH, Ahmed WS, Magaji AS	Pathogens	10.3390/pathogens8010012	2019
Pathogenicity	30687870	Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics.	Nussbaumer-Proll AK, Knotzer S, Eberl S, Reiter B, Stimpfl T, Jager W, Poschner S, Zeitlinger M	Eur J Clin Microbiol Infect Dis	10.1007/s10096-018-03452-4	2019	Anti-Bacterial Agents/metabolism/pharmacology, Bacteria/drug effects/growth & development, Ciprofloxacin/metabolism/pharmacology, Erythrocytes/metabolism/*physiology, Escherichia coli/drug effects/growth & development, Humans, Meropenem/metabolism/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus aureus/drug effects/growth & development, Tigecycline/metabolism/pharmacology	Metabolism
Pathogenicity	30698294	Synthesis and antimicrobial activity of novel 1,2,3-triazole-conjugates of quinazolin-4-ones.	Glowacka IE, Grzonkowski P, Lisiecki P, Kalinowski L, Piotrowska DG	Arch Pharm (Weinheim)	10.1002/ardp.201800302	2019	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Candida albicans/drug effects, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Molecular Structure, Quinazolinones/chemical synthesis/chemistry/pharmacology, Structure-Activity Relationship, Triazoles/chemical synthesis/chemistry/pharmacology
Phylogeny	30710587	Bioactive exopolysaccharide from Neopestalotiopsis sp. strain SKE15: Production, characterization and optimization.	Fooladi T, Soudi MR, Alimadadi N, Savedoroudi P, Heravi MM	Int J Biol Macromol	10.1016/j.ijbiomac.2019.01.203	2019	Anti-Infective Agents/chemistry/pharmacology, Antioxidants/chemistry/pharmacology, Ascomycota/chemistry/classification/genetics/metabolism, Chemical Phenomena, Fungal Polysaccharides/biosynthesis/chemistry/*pharmacology, Molecular Weight, Phylogeny, Spectrum Analysis	Biotechnology
Metabolism	30753921	Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are affected by sub-lethal photodynamic inactivation.	Hendiani S, Pornour M, Kashef N	Photodiagnosis Photodyn Ther	10.1016/j.pdpdt.2019.02.010	2019	Bacterial Proteins/drug effects/genetics/metabolism, Glycolipids/metabolism, Methylene Blue/pharmacology, Oxidative Stress, Photochemotherapy/methods, Photosensitizing Agents/pharmacology, Pseudomonas aeruginosa/drug effects/genetics/metabolism, Pyocyanine/metabolism, Quorum Sensing, Virulence Factors/metabolism	Pathogenicity
Pathogenicity	30792519	Novel 5-substituted derivatives of 2'-deoxy-6-azauridine with antibacterial activity.	Negrya SD, Efremenkova OV, Solyev PN, Chekhov VO, Ivanov MA, Sumarukova IG, Karpenko IL, Kochetkov SN, Alexandrova LA	J Antibiot (Tokyo)	10.1038/s41429-019-0158-z	2019	Animals, Anti-Bacterial Agents/chemical synthesis/pharmacology, Azauridine/analogs & derivatives/*chemical synthesis/pharmacology, Catalytic Domain, Cell Line, Cell Survival/drug effects, Humans, Microbial Sensitivity Tests, Molecular Docking Simulation, Molecular Structure, Mycobacterium smegmatis/drug effects, Mycobacterium tuberculosis/drug effects/enzymology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Thymidylate Synthase/drug effects	Enzymology
Metabolism	30831574	Pseudomonas aeruginosa alkaline protease exhibits a high renaturation capability.	Andrejko M, Sieminska-Kuczer A, Janczarek M, Janik E, Bednarczyk M, Gagos M, Cytrynska M	Acta Biochim Pol	10.18388/abp.2018_2741	2019	Bacterial Proteins/metabolism, Endopeptidases/metabolism, Pseudomonas aeruginosa/*enzymology, Spectroscopy, Fourier Transform Infrared	Enzymology
	30870986	Chemical Profile, Antibacterial Activity and Antibiotic-Modulating Effect of the Hexanic Zea Mays L. Silk Extract (Poaceae).	Carvalho ABL, Cruz CA, Freitas CLA, Aguiar JJDS, Nunes PLWS, Lima VMDS, Matias EFF, Muniz DF, Coutinho HDM	Antibiotics (Basel)	10.3390/antibiotics8010022	2019
	30905995	A Comparison of Bacterial Adhesion and Biofilm Formation on Commonly Used Orthopaedic Metal Implant Materials: An In vitro Study.	Malhotra R, Dhawan B, Garg B, Shankar V, Nag TC	Indian J Orthop	10.4103/ortho.IJOrtho_66_18	2019
	30906415	Determination of Antimicrobial Activity of Extracts of Indigenous Wild Mushrooms against Pathogenic Organisms.	Gebreyohannes G, Nyerere A, Bii C, Berhe Sbhatu D	Evid Based Complement Alternat Med	10.1155/2019/6212673	2019
	31052359	Specificity in the Susceptibilities of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus Clinical Isolates to Six Metal Antimicrobials.	Gugala N, Vu D, Parkins MD, Turner RJ	Antibiotics (Basel)	10.3390/antibiotics8020051	2019
Pathogenicity	31148374	Antimicrobial effects of local anaesthetics.	Kesici U, Demirci M, Kesici S	Int Wound J	10.1111/iwj.13153	2019	Anesthetics, Local/pharmacology/therapeutic use, Anti-Bacterial Agents/pharmacology/therapeutic use, Escherichia coli/drug effects, Humans, Lidocaine/pharmacology/therapeutic use, Mupirocin/pharmacology/therapeutic use, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/*drug effects
Phylogeny	31159162	Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions.	Diaz-Roa A, Espinoza-Culupu A, Torres-Garcia O, Borges MM, Avino IN, Alves FL, Miranda A, Patarroyo MA, da Silva PI Jr, Bello FJ	Molecules	10.3390/molecules24112077	2019	Amino Acid Sequence, Animals, Anti-Bacterial Agents/biosynthesis/chemistry/isolation & purification/pharmacology, Antimicrobial Cationic Peptides/biosynthesis/chemistry/isolation & purification/pharmacology, Bacteria/drug effects, Chemical Phenomena, Chromatography, High Pressure Liquid, Diptera/*metabolism, Dose-Response Relationship, Drug, Mass Spectrometry, Microbial Sensitivity Tests, Models, Molecular, Protein Conformation, Structure-Activity Relationship	Enzymology
Pathogenicity	31167844	Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel beta-Lactamase Inhibitor Enmetazobactam.	Belley A, Huband MD, Fedler KA, Watters AA, Flamm RK, Shapiro S, Knechtle P	J Clin Microbiol	10.1128/JCM.00607-19	2019	Anti-Bacterial Agents/pharmacology, Azabicyclo Compounds/pharmacology, Cefepime/pharmacology, Disk Diffusion Antimicrobial Tests/methods/standards, Enterobacteriaceae/drug effects, Microbial Sensitivity Tests/standards, Quality Control, Triazoles/pharmacology, beta-Lactamase Inhibitors/pharmacology
	31198423	Determination of In Vitro Antimicrobial Activity of Five Sri Lankan Medicinal Plants against Selected Human Pathogenic Bacteria.	De Zoysa MHN, Rathnayake H, Hewawasam RP, Wijayaratne WMDGB	Int J Microbiol	10.1155/2019/7431439	2019
Metabolism	31201902	Analysis of a long term starved Pseudomonas aeruginosa ATCC27853 in seawater microcosms.	Machreki Y, Kouidhi B, Machreki S, Chaieb K, Saenz Y	Microb Pathog	10.1016/j.micpath.2019.103595	2019	Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics/metabolism, Biofilms/growth & development, Colony Count, Microbial, Copper Sulfate/pharmacology, Drug Resistance, Bacterial/genetics/physiology, Electrophoresis, Gel, Pulsed-Field, Gene Expression Regulation, Bacterial, Genes, Bacterial, Genetic Variation/drug effects/physiology, Genotype, Imipenem/pharmacology, Microbial Sensitivity Tests, Microbial Viability, Multilocus Sequence Typing, Organic Chemicals/metabolism, Osmotic Pressure, Pancreatic Elastase/metabolism, Phenazines/metabolism, Phenotype, Pigments, Biological/metabolism, Pseudomonas aeruginosa/drug effects/genetics/growth & development/physiology, Pyocyanine/metabolism, Salt Tolerance/genetics/physiology, Seawater/microbiology, Sequence Alignment, Sodium Chloride/pharmacology, Starvation, Stress, Physiological/genetics/*physiology, Time Factors, Virulence Factors	Enzymology
Pathogenicity	31278704	Antimicrobial screening of some selected Turkish medicinal plants.	Moghaddam NS, Eryilmaz M, Altanlar N, Yildirim O	Pak J Pharm Sci		2019	Anti-Bacterial Agents/pharmacology, Antifungal Agents/pharmacology, Candida albicans/drug effects, Drug Evaluation, Preclinical, Escherichia coli/drug effects, Flowers/chemistry, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Plant Leaves/chemistry, Plants, Medicinal/chemistry, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Turkey
Pathogenicity	31365649	Evaluating antimicrobial and antioxidant capacity of endemic Phlomis russeliana from Turkey and its antiproliferative effect on Human Caco-2 Cell Lines.	Alpay M, Dulger G, Sahin IE, Dulger B	An Acad Bras Cienc	10.1590/0001-3765201920180404	2019	Anti-Bacterial Agents/isolation & purification/pharmacology, Antioxidants/isolation & purification/pharmacology, Caco-2 Cells, Candida albicans/drug effects, Disk Diffusion Antimicrobial Tests, Gram-Negative Bacteria/classification/drug effects, Gram-Positive Bacteria/classification/drug effects, Humans, Phlomis/chemistry, Plant Extracts/*pharmacology, Turkey	Phylogeny
Pathogenicity	31387343	Synthesis, Characterization and Antimicrobial Activity of Garcinol Capped Silver Nanoparticles.	Fernando HN, Kumarasinghe KGUR, Gunasekara TDCP, Wijekoon HPSK, Ekanayaka EMAK, Rajapaksha SP, Fernando SSN, Jayaweera PM	J Microbiol Biotechnol	10.4014/jmb.1904.04032	2019	Anti-Infective Agents/chemistry/pharmacology, Bacteria/drug effects, Candida albicans/drug effects, Drug Resistance, Microbial/drug effects, Drug Stability, Green Chemistry Technology, Metal Nanoparticles/chemistry, Microbial Sensitivity Tests, Molecular Structure, Silver/chemistry/pharmacology, Solubility, Terpenes/*chemistry/isolation & purification/pharmacology	Enzymology
Pathogenicity	31407479	Antibacterial effects of lidocaine and adrenaline.	Kesici S, Demirci M, Kesici U	Int Wound J	10.1111/iwj.13182	2019	Epinephrine/pharmacology, Escherichia coli/drug effects, Humans, In Vitro Techniques, Lidocaine/pharmacology, Microbial Sensitivity Tests/methods, Pseudomonas aeruginosa/drug effects, Sensitivity and Specificity, Staphylococcus aureus/*drug effects
Pathogenicity	31407480	Bacterial inhibition efficiency of prilocaine and bupivacaine.	Kesici S, Demirci M, Kesici U	Int Wound J	10.1111/iwj.13180	2019	Bupivacaine/pharmacology, Escherichia coli/drug effects, Humans, In Vitro Techniques, Microbial Sensitivity Tests, Prilocaine/pharmacology, Pseudomonas aeruginosa/drug effects, Sensitivity and Specificity, Staphylococcus aureus/*drug effects, Statistics, Nonparametric
Pathogenicity	31425793	Evaluation of rapid colistin susceptibility directly from positive blood cultures using a flow cytometry assay.	Fonseca E Silva D, Silva-Dias A, Gomes R, Martins-Oliveira I, Ramos MH, Rodrigues AG, Canton R, Pina-Vaz C	Int J Antimicrob Agents	10.1016/j.ijantimicag.2019.08.016	2019	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Blood Culture, Colistin/pharmacology, Drug Resistance, Bacterial, Gram-Negative Bacteria/*drug effects, Humans, Microbial Sensitivity Tests
Pathogenicity	31486592	In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM((R)) ).	Pinna A, Donadu MG, Usai D, Dore S, D'Amico-Ricci G, Boscia F, Zanetti S	Acta Ophthalmol	10.1111/aos.14243	2019	Anti-Infective Agents, Local/pharmacology, Candida/drug effects/isolation & purification, Colony Count, Microbial, Corneal Ulcer/microbiology, Culture Media, Humans, Microbial Sensitivity Tests, Ophthalmic Solutions/pharmacology, Pharmaceutical Preparations, Povidone-Iodine/pharmacology, Pseudomonas aeruginosa/drug effects/isolation & purification, Staphylococcus aureus/drug effects/isolation & purification, Staphylococcus epidermidis/drug effects/isolation & purification, Time Factors	Enzymology
	31496757	Evaluating the potential use of electronic tongue in early identification and diagnosis of bacterial infections.	Al Ramahi R, Zaid AN, Abu-Khalaf N	Infect Drug Resist	10.2147/IDR.S213938	2019
	31514280	Synthesis, Characterization, and Antimicrobial Activity of Magnesium-Doped Hydroxyapatite Suspensions.	Predoi D, Iconaru SL, Predoi MV, Stan GE, Buton N	Nanomaterials (Basel)	10.3390/nano9091295	2019
	31569362	Antibacterial Properties of a Novel Zirconium Phosphate-Glycinediphosphonate Loaded with Either Zinc or Silver.	Campoccia D, Ravaioli S, Vivani R, Donnadio A, Vischini E, Russo A, Visai L, Arciola CR, Montanaro L, Nocchetti M	Materials (Basel)	10.3390/ma12193184	2019
Metabolism	31585857	Overproduction of lipoxygenase from Pseudomonas aeruginosa in Escherichia coli by auto-induction expression and its application in triphenylmethane dyes degradation.	Lu J, Zhang C, Leong HY, Show PL, Lu F, Lu Z	J Biosci Bioeng	10.1016/j.jbiosc.2019.09.006	2019	Coloring Agents/metabolism, Escherichia coli/genetics/metabolism, Gene Expression Regulation, Bacterial, Lipoxygenase/genetics/metabolism, Pseudomonas aeruginosa/enzymology/genetics	Biotechnology
	31626597	A complex hierarchical quorum-sensing circuitry modulates phenazine gene expression in Pseudomonas aeruginosa.	Abd El-Aziz NK, Abd El-Hamid MI, El-Naenaeey EY	J Infect Dev Ctries	10.3855/jidc.8775	2018
	31632153	Investigating The Antimicrobial Activity Of Different Root Canal Filling Pastes In Deciduous Teeth.	Basir L, Khanehmasjedi M, Khosravi A, Ansarifar S	Clin Cosmet Investig Dent	10.2147/CCIDE.S214568	2019
	31652873	Study of Iron Piperazine-Based Chelators as Potential Siderophore Mimetics.	Loupias P, Dechamps-Olivier I, Dupont L, Vanlemmens P, Mullie C, Taudon N, Bouchut A, Dassonville-Klimpt A, Sonnet P	Pharmaceuticals (Basel)	10.3390/ph12040160	2019
Phylogeny	31664484	GC-IMS headspace analyses allow early recognition of bacterial growth and rapid pathogen differentiation in standard blood cultures.	Drees C, Vautz W, Liedtke S, Rosin C, Althoff K, Lippmann M, Zimmermann S, Legler TJ, Yildiz D, Perl T, Kunze-Szikszay N	Appl Microbiol Biotechnol	10.1007/s00253-019-10181-x	2019	Bacteremia/diagnosis/microbiology/mortality, Bacterial Typing Techniques/methods, Blood Culture, Escherichia coli/classification/growth & development/isolation & purification, Gas Chromatography-Mass Spectrometry, Humans, Principal Component Analysis, Pseudomonas aeruginosa/classification/growth & development/isolation & purification, Staphylococcus aureus/classification/growth & development/isolation & purification, Volatile Organic Compounds/analysis	Enzymology
Pathogenicity	31710159	In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa.	Chan WY, Hickey EE, Khazandi M, Page SW, Trott DJ, Hill PB	Vet Dermatol	10.1111/vde.12803	2019	Adjuvants, Pharmaceutic/pharmacology, Animals, Anti-Bacterial Agents/pharmacology, Bacteria/drug effects/pathogenicity, Biofilms/drug effects, Dog Diseases/drug therapy/microbiology, Dogs, Drug Synergism, Ionophores/pharmacology, Microbial Sensitivity Tests, Monensin/pharmacology, Otitis Externa/drug therapy/microbiology/veterinary, Proteus mirabilis/drug effects, Pseudomonas aeruginosa/drug effects, Pyrans/pharmacology, Staphylococcus aureus/drug effects
	31728266	Colistin-resistant Pseudomonas aeruginosa clinical strains with defective biofilm formation.	Azimi L, Lari AR	GMS Hyg Infect Control	10.3205/dgkh000328	2019
Enzymology	31733730	Antimicrobial and antioxidative potential of free and immobilised cellobiose dehydrogenase isolated from wood degrading fungi.	Sulej J, Osinska-Jaroszuk M, Jaszek M, Graz M, Kutkowska J, Pawlik A, Chudzik A, Bancerz R	Fungal Biol	10.1016/j.funbio.2019.09.007	2019	Anti-Infective Agents/isolation & purification/pharmacology, Antioxidants/isolation & purification/pharmacology, Basidiomycota/enzymology/isolation & purification, Biphenyl Compounds/metabolism, Carbohydrate Dehydrogenases/isolation & purification/metabolism/*pharmacology, Cellobiose/metabolism, Enzymes, Immobilized/pharmacology, Escherichia coli/drug effects/growth & development, Lactose/metabolism, Microbial Sensitivity Tests, Picrates/metabolism, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus aureus/drug effects/growth & development, Wood/microbiology	Metabolism
Pathogenicity	31744500	Antibacterial activities, proposed mode of action and cytotoxicity of leaf extracts from Triumfetta welwitschii against Pseudomonas aeruginosa.	Mombeshora M, Mukanganyama S	BMC Complement Altern Med	10.1186/s12906-019-2713-3	2019	Animals, Anti-Bacterial Agents/isolation & purification/pharmacology/toxicity, Erythrocytes/drug effects, Humans, Male, Mice, Mice, Inbred BALB C, Microbial Sensitivity Tests, Plant Extracts/isolation & purification/pharmacology/toxicity, Plant Leaves/chemistry, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/drug effects, Sheep, Triumfetta/*chemistry	Enzymology
Pathogenicity	31746726	First detected OXA-50 carbapenem-resistant clinical isolates Pseudomonas aeruginosa from Bulgaria and interplay between the expression of main efflux pumps, OprD and intrinsic AmpC.	Petrova A, Feodorova Y, Miteva-Katrandzhieva T, Petrov M, Murdjeva M	J Med Microbiol	10.1099/jmm.0.001106	2019	Bacterial Proteins/analysis/physiology, Carbapenems/pharmacology, Drug Resistance, Bacterial, Humans, Porins/physiology, Pseudomonas aeruginosa/drug effects/enzymology/isolation & purification, beta-Lactamases/analysis/*physiology	Enzymology
Pathogenicity	31804978	From bugs to drugs: Combating antimicrobial resistance by discovering novel antibiotics.	Abou Fayad A, Itani D, Miari M, Tanelian A, Iweir S, Matar GM	J Infect Dev Ctries	10.3855/jidc.10108	2018
Pathogenicity	31820692	Efficient Synthesis and Antibacterial Profile of Bis(2-hydroxynaphthalene- 1,4-dione).	Novais JS, Rosandiski AC, de Carvalho CM, de Saules Silva LS, Dos S Velasco de Souza LC, Santana MV, Martins NRC, Castro HC, Ferreira VF, Gonzaga DTG, de Resende GO, de C da Silva F	Curr Top Med Chem	10.2174/1568026619666191210160342	2020	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Dose-Response Relationship, Drug, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Microbial Sensitivity Tests, Molecular Structure, Naphthols/chemical synthesis/chemistry/pharmacology, Structure-Activity Relationship
Metabolism	31902923	Quorum Sensing Inhibitors against Chromobacterium violaceum CV026 Derived from an Actinomycete Metabolite Library.	Ohta T, Fukumoto A, Iizaka Y, Kato F, Koyama Y, Anzai Y	Biol Pharm Bull	10.1248/bpb.b19-00564	2020	Actinobacteria/metabolism, Chromobacterium/metabolism, Indoles/metabolism, Pigments, Biological/metabolism, Pseudomonas aeruginosa/growth & development/metabolism, Quorum Sensing
Pathogenicity	31905207	Antimicrobial activity of Asteraceae species against bacterial pathogens isolated from postmenopausal women.	Chiavari-Frederico MO, Barbosa LN, Carvalho Dos Santos I, Ratti da Silva G, Fernandes de Castro A, de Campos Bortolucci W, Barboza LN, Campos CFAA, Goncalves JE, Menetrier JV, Jacomassi E, Gazim ZC, Wietzikoski S, Dos Reis Livero FA, Wietzikoski Lovato EC	PLoS One	10.1371/journal.pone.0227023	2020	Anti-Bacterial Agents/isolation & purification/pharmacology, Asteraceae/chemistry, Bacteria/drug effects/isolation & purification, Female, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Microbial Sensitivity Tests, Plant Extracts/chemistry/pharmacology/therapeutic use, Postmenopause, Urinary Tract Infections/microbiology/therapy	Enzymology
Pathogenicity	32087073	Phytochemical analyses and antibacterial activities of Erodium, Euphorbia, Logoecia and Tamarix species.	Al-Hadid KJ, Al-Karablieh N, Sharab A, Mutlak I	J Infect Dev Ctries	10.3855/jidc.11776	2019	Anti-Bacterial Agents/chemistry/pharmacology, Euphorbia/chemistry, Geraniaceae/chemistry, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests/methods, Phytochemicals/analysis/pharmacology, Plant Extracts/chemistry/pharmacology, Plants, Medicinal/chemistry, Tamaricaceae/*chemistry
	32093383	Zinc(II) Complexes with Amino Acids for Potential Use in Dermatology: Synthesis, Crystal Structures, and Antibacterial Activity.	Abendrot M, Checinska L, Kusz J, Lisowska K, Zawadzka K, Felczak A, Kalinowska-Lis U	Molecules	10.3390/molecules25040951	2020	Amino Acids/chemistry, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Bacteria/growth & development, Coordination Complexes/chemical synthesis/chemistry/pharmacology, Microbial Sensitivity Tests, Molecular Structure, Zinc/*chemistry
Pathogenicity	32115355	The efficacy of povidone-iodine, hydrogen peroxide and a chemical multipurpose contact lens care system against Pseudomonas aeruginosa on various lens case surfaces.	Yamasaki K, Mizuno Y, Kitamura Y, McCanna DJ, Ngo W, Jones LW	Cont Lens Anterior Eye	10.1016/j.clae.2020.02.012	2020	Colony Count, Microbial, Contact Lens Solutions, Contact Lenses, Disinfection, Humans, Hydrogen Peroxide, Povidone-Iodine, Pseudomonas aeruginosa
Enzymology	32131897	Levofloxacin-ceftazidime administration regimens combat Pseudomonas aeruginosa in the hollow-fiber infection model simulating abnormal renal function in critically ill patients.	Zhao L, Li X, He X, Jian L	BMC Pharmacol Toxicol	10.1186/s40360-020-0396-5	2020	Anti-Bacterial Agents/pharmacokinetics/pharmacology, Ceftazidime/pharmacokinetics/pharmacology, Critical Illness, Drug Combinations, Drug Resistance, Bacterial/genetics, Humans, Kidney Diseases/drug therapy, Levofloxacin/pharmacokinetics/pharmacology, Microbial Sensitivity Tests, Models, Biological, Pseudomonas Infections/drug therapy, Pseudomonas aeruginosa/*drug effects/genetics	Pathogenicity
	32166777	Influence of a cell salvage washing system and leukocyte reduction filtration on bacterial contamination of canine whole blood ex vivo.	Hinson WD, Rogovskyy AS, Lawhon SD, Thieman Mankin KM	Vet Surg	10.1111/vsu.13410	2020	Animals, Blood/microbiology, Blood Transfusion, Autologous, Cohort Studies, Dogs/blood, Escherichia coli, Filtration/veterinary, Leukocyte Reduction Procedures/*veterinary, Leukocytes
Pathogenicity	32183502	Design, Synthesis, and Antimicrobial Evaluation of New Annelated Pyrimido[2,1-c][1,2,4]triazolo[3,4-f][1,2,4]triazines.	El Azab IH, Elkanzi NAA	Molecules	10.3390/molecules25061339	2020	Anti-Infective Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Fungi/drug effects, Microbial Sensitivity Tests/methods, Triazines/chemical synthesis/pharmacology, Triazoles/chemical synthesis/pharmacology
Pathogenicity	32213238	Antibacterial activity of chitosan/collagen membranes containing red propolis extract.	Loureiro KC, Barbosa TC, Nery M, Chaud MV, da Silva CF, Andrade LN, Correa CB, Jaguer A, Padilha FF, Cardoso JC, Souto E, Severino P	Pharmazie	10.1691/ph.2020.9050	2020	Anti-Bacterial Agents/pharmacology, Chitosan/pharmacology, Collagen/pharmacology, Microbial Sensitivity Tests, Propolis/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/*drug effects
Pathogenicity	32238100	Nanoporous iron oxide nanoparticle: hydrothermal fabrication, human serum albumin interaction and potential antibacterial effects.	Mehrabi M, Ghasemi MF, Rasti B, Falahati M, Mirzaie A, Hasan A	J Biomol Struct Dyn	10.1080/07391102.2020.1751296	2020	Anti-Bacterial Agents/pharmacology, Humans, Magnetic Iron Oxide Nanoparticles, Molecular Docking Simulation, Nanopores, Serum Albumin, Human, Spectrometry, Fluorescence, Thermodynamics
Pathogenicity	32248119	Antibacterial and Antibiofilm Activity of Biosynthesized Silver Nanoparticles Coated With Exopolysaccharides Obtained From Rhodotorula mucilaginosa.	Vazquez-Rodriguez A, Vasto-Anzaldo XG, Leon-Buitimea A, Zarate X, Morones-Ramirez JR	IEEE Trans Nanobioscience	10.1109/TNB.2020.2985101	2020	Anti-Bacterial Agents/biosynthesis/chemistry/pharmacology, Biofilms/drug effects, Fungal Polysaccharides/metabolism/pharmacology, Green Chemistry Technology, Metal Nanoparticles/chemistry, Nanocomposites/chemistry, Rhodotorula/chemistry, *Silver/chemistry/pharmacology	Metabolism
	32262972	Enhanced osteogenic and selective antibacterial activities on micro-/nano-structured carbon fiber reinforced polyetheretherketone.	Lu T, Li J, Qian S, Cao H, Ning C, Liu X	J Mater Chem B	10.1039/c6tb00268d	2016
Biotechnology	32296943	Use of hydrocarbons sludge as a substrate for the production of biosurfactants by Pseudomonas aeruginosa ATCC 27853.	Kezrane I, Harouna BM, Hamadache M, Benkortbi O, Amrane A	Environ Monit Assess	10.1007/s10661-020-08269-3	2020	Ecosystem, Hydrocarbons, Pseudomonas aeruginosa, Sewage, *Surface-Active Agents
Phylogeny	32300363	Isolation, Characterization, and Screening of Antimicrobial-Producing Actinomycetes from Soil Samples.	Sapkota A, Thapa A, Budhathoki A, Sainju M, Shrestha P, Aryal S	Int J Microbiol	10.1155/2020/2716584	2020
Pathogenicity	32387459	Photodynamic inactivation mediated by 5-aminolevulinic acid of bacteria in planktonic and biofilm forms.	Bohm GC, Gandara L, Di Venosa G, Mamone L, Buzzola F, Casas A	Biochem Pharmacol	10.1016/j.bcp.2020.114016	2020	Aminolevulinic Acid/metabolism/pharmacology, Biofilms/drug effects, Escherichia coli/drug effects, Gram-Negative Bacteria/drug effects/physiology, Gram-Positive Bacteria/drug effects/physiology, Light, Photochemotherapy/methods, Photosensitizing Agents/metabolism/pharmacology, Plankton/microbiology, Porphyrins/analysis/metabolism, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus, Staphylococcus epidermidis/drug effects/physiology, Time Factors	Metabolism
Stress	32387845	Heavy metals-resistant bacteria (HM-RB): Potential bioremediators of heavy metals-stressed Spinacia oleracea plant.	Desoky EM, Merwad AM, Semida WM, Ibrahim SA, El-Saadony MT, Rady MM	Ecotoxicol Environ Saf	10.1016/j.ecoenv.2020.110685	2020	Agriculture, Antioxidants, Ascorbic Acid, Bacillus/physiology, Biodegradation, Environmental, Cadmium, Chlorophyll, Glutathione, Metals, Heavy/analysis, Paenibacillus/physiology, Photosynthesis, Plant Leaves/chemistry, Soil, Soil Pollutants/analysis/toxicity, Spinacia oleracea/microbiology/physiology
Pathogenicity	32452982	In Vitro Antimicrobial Activity of a New Ophthalmic Solution Containing Hexamidine Diisethionate 0.05% (Keratosept).	Pinna A, Donadu MG, Usai D, Dore S, Boscia F, Zanetti S	Cornea	10.1097/ICO.0000000000002375	2020	Anti-Infective Agents/pharmacology, Benzamidines/pharmacology, Colony Count, Microbial, Eye Infections, Bacterial/drug therapy/microbiology, Humans, Microbial Sensitivity Tests, Ophthalmic Solutions, Staphylococcal Infections/drug therapy/microbiology, Staphylococcus aureus/*isolation & purification	Enzymology
	32454607	Antibacterial, Antitubercular and Antiviral Activity Evaluations of Some Arylidenehydrazide Derivatives Bearing Imidazo[2,1-b]thiazole Moiety.	Ulusoy Guzeldemirci N, Karaman B, Kucukbasmaci O	Turk J Pharm Sci	10.4274/tjps.25743	2017
	32454665	Structure Elucidation and Antimicrobial Activities of Secondary Metabolites from the Flowery Parts of Verbascum mucronatum Lam.	Kahraman C, Tatli II, Kart D, Ekizoglu M, Akdemir ZS	Turk J Pharm Sci	10.4274/tjps.50479	2018
Pathogenicity	32454720	Antimicrobial and Anti-Inflammatory Activity of Some Lathyrus L. (Fabaceae) Species Growing in Turkey.	Heydari H, Saltan Iscan G, Eryilmaz M, Bahadir Acikara O, Yilmaz Sarialtin S, Tekin M, Coban T	Turk J Pharm Sci	10.4274/tjps.galenos.2018.86719	2019
	32565831	Synthesis and In Vitro Antimicrobial and Anthelminthic Evaluation of Naphtholic and Phenolic Azo Dyes.	Adu JK, Amengor CDK, Mohammed Ibrahim N, Amaning-Danquah C, Owusu Ansah C, Gbadago DD, Sarpong-Agyapong J	J Trop Med	10.1155/2020/4850492	2020
Pathogenicity	32598252	Application of Phenotype Microarray for Profiling Carbon Sources Utilization between Biofilm and Non-Biofilm of Pseudomonas aeruginosa from Clinical Isolates.	Ismail NS, Subbiah SK, Taib NM	Curr Pharm Biotechnol	10.2174/1389201021666200629145217	2020	Anti-Bacterial Agents/pharmacology, Bacteriological Techniques, Biofilms/drug effects/growth & development, Carbon/metabolism, Environmental Microbiology, Humans, Metabolome/drug effects, Microarray Analysis, Microbial Sensitivity Tests, Phenotype, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/drug effects/*growth & development/isolation & purification/metabolism	Phenotype
	32637802	Diverse Pathway to Obtain Antibacterial and Antifungal Agents Based on Silica Particles Functionalized by Amino and Phenyl Groups with Cu(II) Ion Complexes.	Tomina VV, Furtat IM, Lebed AP, Kotsyuda SS, Kolev H, Kanuchova M, Behunova DM, Vaclavikova M, Melnyk IV	ACS Omega	10.1021/acsomega.0c01335	2020
	32733400	The Regulator PltZ Regulates a Putative ABC Transporter System PltIJKNOP of Pseudomonas aeruginosa ATCC 27853 in Response to the Antimicrobial 2,4-Diacetylphloroglucinol.	Guo DD, Luo LM, Ma HL, Zhang SP, Xu H, Zhang H, Wang Y, Yuan Y, Wang Z, He YX	Front Microbiol	10.3389/fmicb.2020.01423	2020
Phylogeny	32758289	Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa.	Zhao L, Wang S, Li X, He X, Jian L	Antimicrob Resist Infect Control	10.1186/s13756-020-00793-8	2020	Anti-Bacterial Agents/pharmacology, Ciprofloxacin/pharmacology, Drug Resistance, Bacterial/genetics, Fluoroquinolones/classification/pharmacology, Levofloxacin/pharmacology, Membrane Transport Proteins/genetics, Microbial Sensitivity Tests, Mutation, Pseudomonas aeruginosa/drug effects/*genetics	Pathogenicity
Pathogenicity	32766662	Antimicrobial activity and mechanism of peptide CM4 against Pseudomonas aeruginosa.	Li JF, Zhang JX, Li G, Xu YY, Lu K, Wang ZG, Liu JP	Food Funct	10.1039/d0fo01031f	2020	Anti-Infective Agents/pharmacology, Antimicrobial Cationic Peptides/pharmacology, Cell Membrane/drug effects/metabolism, DNA, Bacterial/genetics/isolation & purification, Escherichia coli/drug effects/genetics, Food Contamination/prevention & control, Food Microbiology, Meat/microbiology, Microbial Sensitivity Tests, Protein Conformation, Pseudomonas aeruginosa/*drug effects/genetics/metabolism	Metabolism
Biotechnology	32788409	Computational Basis for On-Demand Production of Diversified Therapeutic Phage Cocktails.	Mageeney CM, Sinha A, Mosesso RA, Medlin DL, Lau BY, Rokes AB, Lane TW, Branda SS, Williams KP	mSystems	10.1128/mSystems.00659-20	2020
Pathogenicity	32790958	Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis.	Millar BC, McCaughan J, Rendall JC, Moore JE	Clin Respir J	10.1111/crj.13262	2020	Adult, Anti-Bacterial Agents/pharmacology/therapeutic use, Ciprofloxacin/pharmacology/therapeutic use, Cystic Fibrosis/complications/drug therapy, Fluoroquinolones, Humans, Microbial Sensitivity Tests, Pseudomonas Infections/drug therapy, Pseudomonas aeruginosa
Phenotype	32800691	Cigarette smoke extract induces the Pseudomonas aeruginosa nfxC drug-resistant phenotype.	Xu M, Zhang H, Yu N, Dong Y, Wang W, Chen Y, Kang J	J Infect Chemother	10.1016/j.jiac.2020.07.013	2020	Anti-Bacterial Agents/pharmacology, Gene Expression Regulation, Bacterial, Humans, Microbial Sensitivity Tests, Pharmaceutical Preparations, Phenotype, Pseudomonas Infections/drug therapy, Pseudomonas aeruginosa/genetics, Smoking	Pathogenicity
Pathogenicity	32811579	Laboratory-based study of novel antimicrobial cold spray coatings to combat surface microbial contamination.	Lucas MDI, Botef I, Reid RG, van Vuuren SF	Infect Control Hosp Epidemiol	10.1017/ice.2020.335	2020	Anti-Bacterial Agents, Anti-Infective Agents/pharmacology, Humans, Laboratories, Longitudinal Studies, Methicillin-Resistant Staphylococcus aureus, Microbial Sensitivity Tests
	32819727	[Antimicrobial effects of fentanyl and bupivacaine].	Kesici S, Demirci M, Kesici U	Braz J Anesthesiol	10.1016/j.bjan.2020.04.010	2020	Anesthetics, Local/administration & dosage/pharmacology, Anti-Infective Agents/administration & dosage/pharmacology, Bupivacaine/administration & dosage/pharmacology, Drug Synergism, Fentanyl/administration & dosage/pharmacology, Hydrochloric Acid/pharmacology, Microbial Sensitivity Tests, Prospective Studies, Sodium Hydroxide/pharmacology
Pathogenicity	32823484	Unravelling the Antibacterial Activity of Terminalia sericea Root Bark through a Metabolomic Approach.	Anokwuru CP, Tankeu S, van Vuuren S, Viljoen A, Ramaite IDI, Taglialatela-Scafati O, Combrinck S	Molecules	10.3390/molecules25163683	2020	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects/metabolism, Metabolomics, Microbial Sensitivity Tests, Plant Bark/chemistry, Plant Extracts/chemistry/pharmacology, Terminalia/*chemistry	Metabolism
Pathogenicity	32888099	Intracellular biosynthesis of PbS quantum dots using Pseudomonas aeruginosa ATCC 27853: evaluation of antibacterial effects and DNA cleavage activities.	Ocal N, Ceylan A, Duman F	World J Microbiol Biotechnol	10.1007/s11274-020-02917-z	2020	Anti-Bacterial Agents/biosynthesis/chemistry/pharmacology, Antifungal Agents/chemistry/pharmacology, Bacteria/drug effects, DNA Cleavage/drug effects, Escherichia coli/drug effects, Fungi/drug effects, Lead/chemistry, Microbial Sensitivity Tests, Microscopy, Electron, Transmission, Nanoparticles, Nanostructures/chemistry, Particle Size, Pseudomonas aeruginosa/metabolism, Quantum Dots/chemistry/metabolism, Spectrophotometry, Ultraviolet, Sulfides/*chemistry, X-Ray Diffraction	Metabolism
Enzymology	32890760	Effects of dietary fern (Adiantum capillus-veneris) leaves powder on serum and mucus antioxidant defence, immunological responses, antimicrobial activity and growth performance of common carp (Cyprinus carpio) juveniles.	Hoseinifar SH, Jahazi MA, Mohseni R, Raeisi M, Bayani M, Mazandarani M, Yousefi M, Van Doan H, Torfi Mozanzadeh M	Fish Shellfish Immunol	10.1016/j.fsi.2020.09.001	2020	Adiantum, Animals, Bacteria/growth & development, Carps/blood/growth & development/immunology, Catalase/immunology, Diet/veterinary, Immunoglobulins/blood, Mucus/enzymology/immunology, Muramidase/blood/immunology, Plant Leaves, Plant Preparations/pharmacology, Powders, Serum, Skin/immunology, Superoxide Dismutase/immunology
Pathogenicity	32918678	Synergistically-acting Enterocin LD3 and Plantaricin LD4 Against Gram-Positive and Gram-Negative Pathogenic Bacteria.	Sheoran P, Tiwari SK	Probiotics Antimicrob Proteins	10.1007/s12602-020-09708-w	2020	Bacteriocins/pharmacology, Bridged-Ring Compounds, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/*drug effects
Pathogenicity	32972158	A pharmacodynamic study of a new gel containing an extract of Aloe vera and an extract of oak bark for potential treatment of periodontal diseases.	A TN, S ZD	Ceska Slov Farm	123709	2020	Aloe/chemistry, Anti-Infective Agents/pharmacology, Gels, Humans, Microbial Sensitivity Tests, Periodontal Diseases/drug therapy, Plant Bark/chemistry, Plant Extracts/pharmacology, Quercus/chemistry
	33027987	The Antibacterial and Anti-biofilm Activity of Metal Complexes Incorporating 3,6,9-Trioxaundecanedioate and 1,10-Phenanthroline Ligands in Clinical Isolates of Pseudomonas Aeruginosa from Irish Cystic Fibrosis Patients.	O'Shaughnessy M, McCarron P, Viganor L, McCann M, Devereux M, Howe O	Antibiotics (Basel)	10.3390/antibiotics9100674	2020
	33072469	Bacillus subtilis TR47II as a source of bioactive lipopeptides against Gram-negative pathogens causing nosocomial infections.	de Souza Freitas F, Coelho de Assis Lage T, Ayupe BAL, de Paula Siqueira T, de Barros M, Totola MR	3 Biotech	10.1007/s13205-020-02459-z	2020
Pathogenicity	33074530	Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies.	Cavalluzzi MM, Budriesi R, De Salvia MA, Quintieri L, Piarulli M, Milani G, Gualdani R, Micucci M, Corazza I, Rosato A, Viale M, Caputo L, Franchini C, Lentini G	Pharmacol Rep	10.1007/s43440-020-00167-2	2020	Animals, Anti-Bacterial Agents/pharmacology, Antidiarrheals/therapeutic use, Bacteria/drug effects, Colon/physiopathology, Diarrhea/drug therapy/microbiology/physiopathology, Dose-Response Relationship, Drug, Gram-Negative Bacterial Infections/drug therapy/microbiology, Gram-Positive Bacterial Infections/drug therapy/microbiology, Guinea Pigs, Ileum/physiopathology, Loperamide/therapeutic use, Male, Microbial Sensitivity Tests, Muscle Contraction/drug effects, Neuroprotective Agents/therapeutic use, Piperidines/therapeutic use, Quaternary Ammonium Compounds/therapeutic use, Rats, Rats, Sprague-Dawley, Thiazoles/therapeutic use
Pathogenicity	33075071	Examination of a first-in-class bis-dialkylnorspermidine-terphenyl antibiotic in topical formulation against mono and polymicrobial biofilms.	Miller M, Rogers JC, Badham MA, Cadenas L, Brightwell E, Adams J, Tyler C, Sebahar PR, Haussener TJ, Reddy HRK, Looper RE, Williams DL	PLoS One	10.1371/journal.pone.0234832	2020	Administration, Topical, Anti-Bacterial Agents/administration & dosage/chemistry/pharmacology, Bacteria/classification/drug effects/growth & development, Biofilms/drug effects/growth & development, Humans, Spermidine/analogs & derivatives/chemistry, Terphenyl Compounds/chemistry	Phylogeny
Pathogenicity	33086345	Methylene Blue Is an Effective Disclosing Agent for Identifying Bacterial Biofilms on Orthopaedic Implants.	Shaw JD, Brodke DS, Williams DL, Ashton NN	J Bone Joint Surg Am	10.2106/JBJS.20.00091	2020	Biofilms, Coloring Agents, Humans, In Vitro Techniques, Joint Prosthesis/microbiology, Methylene Blue, Microscopy, Electron, Scanning, Prosthesis-Related Infections/diagnosis/microbiology, Pseudomonas aeruginosa, Staphylococcus aureus
	33134573	Nutraceutical and antimicrobial potentials of Bambara groundnut (Vigna subterranean): A review.	Udeh EL, Nyila MA, Kanu SA	Heliyon	10.1016/j.heliyon.2020.e05205	2020
	33146331	Green Synthesis, Characterization and Antimicrobial Evaluation of Silver Nanoparticles for an Intracanal Dressing.	Bruniera JFB, Gabriel-Silva L, Goulart RS, Silva-Sousa YTC, Lara MG, Pitondo-Silva A, Miranda CES	Braz Dent J	10.1590/0103-6440202003897	2020	Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Bandages, Metal Nanoparticles, Microbial Sensitivity Tests, Silver/pharmacology
Pathogenicity	33147036	Effects of Polyethyelene Glycol-Desferrioxamine:Gallium Conjugates on Pseudomonas aeruginosa Outer Membrane Permeability and Vancomycin Potentiation.	Qiao J, Purro M, Liu Z, Xiong MP	Mol Pharm	10.1021/acs.molpharmaceut.0c00820	2020	Anti-Bacterial Agents/administration & dosage/pharmacokinetics, Cell Membrane Permeability/drug effects, Cephalosporins/administration & dosage/pharmacokinetics, Deferoxamine/chemistry/pharmacology, Drug Carriers/chemistry/pharmacology, Drug Compounding/methods, Drug Resistance, Multiple, Bacterial, Gallium/chemistry/pharmacology, HeLa Cells, Humans, Microbial Sensitivity Tests, Polyethylene Glycols/chemistry/pharmacology, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/drug effects, Toxicity Tests, Acute, Vancomycin/*administration & dosage/pharmacokinetics	Enzymology
Genetics	33151366	Comparative genomics of the sequential Pseudomonas aeruginosa isolates obtained from the continuous imipenem stress evolution.	Lu C, Zhou J, Zhang T, Li C, Chen J, Fan J, Qu L, Su X	Appl Microbiol Biotechnol	10.1007/s00253-020-10994-1	2020	Anti-Bacterial Agents/pharmacology, Drug Resistance, Bacterial/genetics, Genomics, Imipenem/pharmacology, Microbial Sensitivity Tests, Porins, Pseudomonas aeruginosa/drug effects/genetics	Stress
Cultivation	33154253	Use of fluorescence foldscope as an effective tool for detection of biofilm formation in Pseudomonas aeruginosa.	Deshamukhya C, Das BJ, Chetri S, Paul D, Chanda DD, Banerjee T, Bhattacharjee A	Indian J Med Microbiol	10.4103/ijmm.IJMM_20_118	2020	Agar, Biofilms/growth & development, Coloring Agents, Congo Red, Culture Media, Humans, Microscopy, Fluorescence/instrumentation, Pseudomonas aeruginosa/*physiology	Pathogenicity
	33179011	Efficacy of Levofloxacin Loaded Nonionic Surfactant Vesicles (Niosomes) in a Model of Pseudomonas aeruginosa Infected Sprague Dawley Rats.	Jankie S, Johnson J, Adebayo AS, Pillai GK, Pinto Pereira LM	Adv Pharmacol Pharm Sci	10.1155/2020/8815969	2020
Pathogenicity	33283901	Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety.	Bazine I, Bendjedid S, Boukhari A	Arch Pharm (Weinheim)	10.1002/ardp.202000291	2020	Alternaria/drug effects, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Fusarium/drug effects, Microbial Sensitivity Tests, Molecular Structure, Organophosphonates/chemical synthesis/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Sulfonamides/chemical synthesis/chemistry/pharmacology
Pathogenicity	33296391	Development and validation of a new microplate assay that utilises optical density to quantify the antibacterial activity of honeys including Jarrah, Marri and Manuka.	Green KJ, Dods K, Hammer KA	PLoS One	10.1371/journal.pone.0243246	2020	Anti-Bacterial Agents/analysis/pharmacology, Australia, Bacteria/drug effects, Bacterial Infections/drug therapy, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Honey/analysis, Humans, Microbial Sensitivity Tests/*methods, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	33341362	Inhibition of the clinical isolates of Acinetobacter baumannii by Pseudomonas aeruginosa: In vitro assessment of a case-based study.	Huang CW, Lin YS, Huang WC, Lai CC, Chien HJ, Hu NJ, Chen JH	J Microbiol Immunol Infect	10.1016/j.jmii.2020.11.006	2020	Acinetobacter Infections/microbiology, Acinetobacter baumannii, Anti-Bacterial Agents/pharmacology/therapeutic use, Drug Resistance, Multiple, Bacterial, Humans, Microbial Sensitivity Tests, Pseudomonas aeruginosa
	33362739	High-Throughput Identification of Antibacterials Against Pseudomonas aeruginosa.	Li S, She P, Zhou L, Zeng X, Xu L, Liu Y, Chen L, Wu Y	Front Microbiol	10.3389/fmicb.2020.591426	2020
	33376830	Jacaranda flower (Jacaranda mimosifolia) as an alternative for antioxidant and antimicrobial use.	Aguirre-Becerra H, Pineda-Nieto SA, Garcia-Trejo JF, Guevara-Gonzalez RG, Feregrino-Perez AA, Alvarez-Mayorga BL, Rivera Pastrana DM	Heliyon	10.1016/j.heliyon.2020.e05802	2020
Pathogenicity	33381566	Evaluation of Antibacterial Activity of Three Quaternary Ammonium Disinfectants on Different Germs Isolated from the Hospital Environment.	Ramzi A, Oumokhtar B, Ez Zoubi Y, Filali Mouatassem T, Benboubker M, El Ouali Lalami A	Biomed Res Int	10.1155/2020/6509740	2020	Acinetobacter baumannii/drug effects, Anti-Bacterial Agents/pharmacology, Biofilms/drug effects, Diffusion, Disinfectants/pharmacology, Enterobacter cloacae/drug effects, Escherichia coli/drug effects, Hospitals, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Morocco, Prospective Studies, Pseudomonas aeruginosa/drug effects, Quaternary Ammonium Compounds/*pharmacology, Risk, Risk Assessment, Staphylococcus aureus/drug effects	Phylogeny
Pathogenicity	33389853	The Antimicrobial Activities of Silver Nanoparticles Synthesized from Medicinal Mushrooms.	Klaus A, Petrovic P, Vunduk J, Pavlovic V, Van Griensven LJLD	Int J Med Mushrooms	10.1615/IntJMedMushrooms.2020035988	2020	Agaricus/chemistry, Anti-Infective Agents/chemistry/pharmacology, Basidiomycota/chemistry, Candida albicans/drug effects/growth & development, Escherichia coli/drug effects/growth & development, Fungal Polysaccharides/chemistry, Metal Nanoparticles/chemistry, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Silver/chemistry/pharmacology
Pathogenicity	33417780	Antibacterial, Antibiofilm, Antiquorum Sensing, Antimotility, and Antioxidant Activities of Green Fabricated Ag, Cu, TiO2, ZnO, and Fe3O4 NPs via Protoparmeliopsis muralis Lichen Aqueous Extract against Multi-Drug-Resistant Bacteria.	Alavi M, Karimi N, Valadbeigi T	ACS Biomater Sci Eng	10.1021/acsbiomaterials.9b00274	2019
Pathogenicity	33421270	The sponges Hymeniacidon perlevis and Halichondria panicea are reservoirs of antibiotic-producing bacteria against multi-drug resistant Staphylococcus aureus.	Rodriguez Jimenez A, Dechamps E, Giaux A, Goetghebuer L, Bauwens M, Willenz P, Flahaut S, Laport MS, George IF	J Appl Microbiol	10.1111/jam.14999	2021	Animals, Anti-Bacterial Agents/biosynthesis/pharmacology, Bacteria/metabolism, Methicillin Resistance/drug effects, Methicillin-Resistant Staphylococcus aureus/drug effects, Porifera/*microbiology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Vancomycin/pharmacology	Metabolism
Phylogeny	33424384	Synergistic effects of zinc oxide nanoparticles and various antibiotics combination against Pseudomonas aeruginosa clinically isolated bacterial strains.	Fadwa AO, Alkoblan DK, Mateen A, Albarag AM	Saudi J Biol Sci	10.1016/j.sjbs.2020.09.064	2020
Pathogenicity	33471227	Tribological, biocompatibility, and antibiofilm properties of tungsten-germanium coating using magnetron sputtering.	Kurt MS, Arslan ME, Yazici A, Mudu I, Arslan E	J Mater Sci Mater Med	10.1007/s10856-020-06477-4	2021	Biocompatible Materials/chemistry, Biofilms, Cell Survival, Coated Materials, Biocompatible/chemistry, Corrosion, Crystallography, X-Ray/methods, Fibroblasts/metabolism, Germanium/chemistry, Humans, Materials Testing, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Pseudomonas aeruginosa/drug effects, Stainless Steel/chemistry, Staphylococcus aureus/drug effects, Surface Properties, Titanium/chemistry, Tungsten/chemistry, X-Ray Diffraction	Metabolism
	33656844	Design, Synthesis, and Biological Evaluation of Light-Activated Antibiotics.	Shchelik IS, Tomio A, Gademann K	ACS Infect Dis	10.1021/acsinfecdis.1c00015	2021	Anti-Bacterial Agents/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa, Staphylococcus aureus, Vancomycin/pharmacology
Pathogenicity	33677023	Dual antimicrobial and anticancer activity of a novel synthetic alpha-helical antimicrobial peptide.	Thankappan B, Sivakumar J, Asokan S, Ramasamy M, Pillai MM, Selvakumar R, Angayarkanni J	Eur J Pharm Sci	10.1016/j.ejps.2021.105784	2021	Animals, Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Antimicrobial Cationic Peptides/pharmacology, Cell Membrane, Humans, Microbial Sensitivity Tests, Pseudomonas aeruginosa
Pathogenicity	33734645	In-laboratory quality control of nutrients for automatic bacteriology analyzer YUNON(R)Labstar 50.	Boronina LG, Samatova EV, Kukushkina MP, Panova SA, Ustyugova SS	Klin Lab Diagn	10.51620/0869-2084-2021-66-2-110-114	2021	Anti-Bacterial Agents, Bacterial Infections, Bacteriology, Child, Humans, Laboratories, Microbial Sensitivity Tests, Nutrients, Quality Control
	33747702	Annulohypoxylon sp. strain MUS1, an endophytic fungus isolated from Taxus wallichiana Zucc., produces taxol and other bioactive metabolites.	Gauchan DP, Velez H, Acharya A, Ostman JR, Lunden K, Elfstrand M, Garcia-Gil MR	3 Biotech	10.1007/s13205-021-02693-z	2021
	33768737	Design and evaluation of the antimicrobial properties of ackee seed extract silver nanoparticle film formulations.	Odeniyi MA, Olusomoka E, Odeniyi OA, Adebayo-Tayo BC	Polim Med	10.17219/pim/130388	2020	Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Blighia, *Metal Nanoparticles, Microbial Sensitivity Tests, Pichia, Plant Extracts/pharmacology, Seeds, Silver/pharmacology, Spectroscopy, Fourier Transform Infrared
	33804932	Mixed Pluronic-Cremophor Polymeric Micelles as Nanocarriers for Poorly Soluble Antibiotics-The Influence on the Antibacterial Activity.	Tanase MA, Raducan A, Oancea P, Ditu LM, Stan M, Petcu C, Scomoroscenco C, Ninciuleanu CM, Nistor CL, Cinteza LO	Pharmaceutics	10.3390/pharmaceutics13040435	2021
	33807402	Antimicrobial Activity of Selected Medicinal Plants from a Sub-Saharan African Country against Bacterial Pathogens from Post-Operative Wound Infections.	Owusu E, Ahorlu MM, Afutu E, Akumwena A, Asare GA	Med Sci (Basel)	10.3390/medsci9020023	2021	Africa South of the Sahara, Anti-Bacterial Agents/pharmacology, Bacteria, Escherichia coli, Methicillin-Resistant Staphylococcus aureus, Microbial Sensitivity Tests, Phytochemicals, Plants, Medicinal, Pseudomonas aeruginosa, Staphylococcus aureus, *Wound Infection
Pathogenicity	33855077	One-Pot Reducing Agent-Free Synthesis of Silver Nanoparticles/Nitrocellulose Composite Surface Coating with Antimicrobial and Antibiofilm Activities.	Kumarasinghe KGUR, Silva WCH, Fernando MDA, Palliyaguru L, Jayawardena PS, Shimomura M, Fernando SSN, Gunasekara TDCP, Jayaweera PM	Biomed Res Int	10.1155/2021/6666642	2021	Anti-Infective Agents/pharmacology, Bacteria/drug effects/growth & development, Bacterial Adhesion/drug effects, Biofilms/drug effects, Collodion/pharmacology, Kinetics, Metal Nanoparticles/chemistry/ultrastructure, Microbial Sensitivity Tests, Particle Size, Photoelectron Spectroscopy, Reducing Agents, Silver/*pharmacology, Spectrometry, X-Ray Emission, Spectrophotometry, Ultraviolet, Spectroscopy, Fourier Transform Infrared, Surface Plasmon Resonance, Surface Properties, Temperature, Thermogravimetry, Time Factors	Enzymology
	33855490	Synthesis and Biological Evaluation of Some Novel S-beta-D-Glucosides of 4-Amino-5-alkyl-1,2,4-triazole-3-thiones Derivatives.	Aghkand AR, Akbaridilmaghani K, Ghezelbash ZD, Asgharib B	Acta Chim Slov	Aghkand-2019-2	2019
Phylogeny	33892286	Antibacterial and synergistic activity of 6beta-hydroxy-3-oxolup-20(29)-en-28-oic acid (6beta-hydroxy betunolic acid) isolated from Schumacheria castaneifolia vahl.	Wickramasingha WGD, Jayasinghe S, Karunaratne DN, Ekanayake EWMA, Liyanapathirana V, Karunaratne V	Bioorg Med Chem	10.1016/j.bmc.2021.116142	2021	Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Bacteria/drug effects, Dilleniaceae/chemistry, Dose-Response Relationship, Drug, Microbial Sensitivity Tests, Molecular Conformation, Plant Extracts/chemistry/isolation & purification/pharmacology, Structure-Activity Relationship	Enzymology
Pathogenicity	33895758	Microbiological aspects of conservative treatment of periodontal disease using gel-based preparations.	Lyubchenko OV, Velihoria IE, Polyakova SV, Ivanov OE, Tzyhanova NB, Pushkar LY, Sirota OM, Tzyhanova IV	Pol Merkur Lekarski	PML290-125	2021	Anti-Bacterial Agents/pharmacology/therapeutic use, Conservative Treatment, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Microbial Sensitivity Tests, Periodontal Diseases/drug therapy
Pathogenicity	33953282	Antibacterial composite coatings of MgB2 powders embedded in PVP matrix.	Badica P, Batalu ND, Burdusel M, Grigoroscuta MA, Aldica G, Enculescu M, Gradisteanu Pircalabioru G, Popa M, Marutescu LG, Dumitriu BG, Olariu L, Bicu A, Purcareanu B, Operti L, Bonino V, Agostino A, Truccato M, Chifiriuc MC	Sci Rep	10.1038/s41598-021-88885-2	2021	Anti-Bacterial Agents/pharmacology, Cell Line, Coated Materials, Biocompatible/pharmacology, Dermis/drug effects, Enterococcus faecalis/drug effects/growth & development, Escherichia coli/drug effects/growth & development, Humans, Povidone/pharmacology, Pseudomonas aeruginosa/drug effects/growth & development, Staphylococcus aureus/drug effects/growth & development
	33953751	The Antibacterial Activity of Crude Extracts of Secondary Metabolites from Bacterial Endophytes Associated with Dicoma anomala.	Makuwa SC, Serepa-Dlamini MH	Int J Microbiol	10.1155/2021/8812043	2021
Pathogenicity	34000197	Ag-Doped and Antibiotic-Loaded Hexagonal Boron Nitride Nanoparticles as Promising Carriers to Fight Different Pathogens.	Gudz KY, Antipina LY, Permyakova ES, Kovalskii AM, Konopatsky AS, Filippovich SY, Dyatlov IA, Slukin PV, Ignatov SG, Shtansky DV	ACS Appl Mater Interfaces	10.1021/acsami.1c03775	2021	Anti-Bacterial Agents/chemistry/pharmacology, Antifungal Agents/chemistry/pharmacology, Bacteria/drug effects, Boron Compounds/chemistry, Candida/drug effects, Drug Carriers/chemistry, Gentamicins/chemistry/pharmacology, Nanoparticles/chemistry, Silver/*chemistry
	34025160	Assessing the diversity of bacterial communities from marine sponges and their bioactive compounds.	Bibi F, Naseer MI, Azhar EI	Saudi J Biol Sci	10.1016/j.sjbs.2021.03.042	2021
Pathogenicity	34066034	Lemon Oils Attenuate the Pathogenicity of Pseudomonas aeruginosa by Quorum Sensing Inhibition.	Luciardi MC, Blazquez MA, Alberto MR, Cartagena E, Arena ME	Molecules	10.3390/molecules26102863	2021	Anti-Bacterial Agents/chemistry/pharmacology, Bacterial Proteins/metabolism, Bicyclic Monoterpenes/chemistry/pharmacology, Biofilms/drug effects, Citrus/chemistry, Cyclohexane Monoterpenes/chemistry/pharmacology, Drug Resistance, Multiple, Bacterial/drug effects, Gas Chromatography-Mass Spectrometry, Limonene/chemistry/pharmacology, Oils, Volatile/chemistry/pharmacology, Pancreatic Elastase/metabolism, Plant Oils/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects/metabolism/pathogenicity, Pyocyanine/biosynthesis, Quorum Sensing/*drug effects, Signal Transduction/drug effects, Virulence, Virulence Factors, Volatile Organic Compounds/chemistry/pharmacology	Metabolism
Pathogenicity	34076085	The essential oils of Grewia Lasiocarpa E. Mey. Ex Harv.: chemical composition, in vitro biological activity and cytotoxic effect on Hela cells.	Akwu NA, Naidoo Y, Channangihalli ST, Singh M, Nundkumar N, Lin J	An Acad Bras Cienc	10.1590/0001-3765202120190343	2021	Anti-Bacterial Agents/pharmacology, Antioxidants, Grewia, HeLa Cells, Humans, Microbial Sensitivity Tests, Oils, Volatile/pharmacology, Plant Oils
Pathogenicity	34146200	Platelet activation and antimicrobial activity of L-PRF: a preliminary study.	Melo-Ferraz A, Coelho C, Miller P, Criado MB, Monteiro MC	Mol Biol Rep	10.1007/s11033-021-06487-7	2021	Anti-Infective Agents/blood/chemistry/pharmacology, Blood Platelets/metabolism, Candida albicans/drug effects, Enterococcus faecalis/drug effects, Humans, Leukocytes/chemistry, Platelet Activation/genetics, Platelet-Rich Fibrin/chemistry, Platelet-Rich Plasma/metabolism, Pseudomonas aeruginosa/drug effects, Wound Healing/*genetics	Metabolism
	34205938	Phytochemical Profile and Microbiological Activity of Some Plants Belonging to the Fabaceae Family.	Obistioiu D, Cocan I, Tirziu E, Herman V, Negrea M, Cucerzan A, Neacsu AG, Cozma AL, Nichita I, Hulea A, Radulov I, Alexa E	Antibiotics (Basel)	10.3390/antibiotics10060662	2021
Pathogenicity	34252992	Novel Phenyl-Based Bis-quaternary Ammonium Compounds as Broad-Spectrum Biocides.	Frolov NA, Fedoseeva KA, Hansford KA, Vereshchagin AN	ChemMedChem	10.1002/cmdc.202100284	2021	Acinetobacter baumannii/drug effects, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Candida albicans/drug effects, Cryptococcus neoformans/drug effects, Disinfectants/chemical synthesis/chemistry/pharmacology, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Klebsiella pneumoniae/drug effects, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Molecular Structure, Pseudomonas aeruginosa/drug effects, Quaternary Ammonium Compounds/chemical synthesis/chemistry/pharmacology, Structure-Activity Relationship
Pathogenicity	34328492	Chalcogenide nanoparticles and organic photosensitizers for synergetic antimicrobial photodynamic therapy.	Garin C, Alejo T, Perez-Laguna V, Prieto M, Mendoza G, Arruebo M, Sebastian V, Rezusta A	J Mater Chem B	10.1039/d1tb00972a	2021	Anti-Bacterial Agents/chemistry/pharmacology, Antifungal Agents/chemistry/pharmacology, Candida albicans/drug effects, Cell Survival/drug effects, Copper/chemistry/pharmacology, Fibroblasts/drug effects, Humans, Indocyanine Green/chemistry/pharmacology, Keratinocytes/drug effects, Microbial Sensitivity Tests, Nanoparticles/chemistry, Particle Size, Photochemotherapy, Photosensitizing Agents/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Sulfides/chemistry/pharmacology
	34356796	An Application of Imipenem Discs or P. aeruginosa ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria.	Bogiel T, Rzepka M, Gospodarek-Komkowska E	Antibiotics (Basel)	10.3390/antibiotics10070875	2021
	34358033	Reduced Level of Tear Antimicrobial and Immunomodulatory Proteins as a Possible Reason for Higher Ocular Infections in Diabetic Patients.	Kallo G, Varga AK, Szabo J, Emri M, Tozser J, Csutak A, Csosz E	Pathogens	10.3390/pathogens10070883	2021
Phylogeny	34381426	Selective Thermotolerant Lactic Acid Bacteria Isolated From Fermented Juice of Epiphytic Lactic Acid Bacteria and Their Effects on Fermentation Quality of Stylo Silages.	Pitiwittayakul N, Bureenok S, Schonewille JT	Front Microbiol	10.3389/fmicb.2021.673946	2021
	34392638	Chemical composition, antioxidant, and antimicrobial activities of two essential oils from Algerian propolis.	Boulechfar S, Zellagui A, Asan-Ozusaglam M, Bensouici C, Erenler R, Yildiz I, Tacer S, Boural H, Demirtas I	Z Naturforsch C J Biosci	10.1515/znc-2021-0028	2021	Anti-Infective Agents/chemistry/pharmacology, Antioxidants/chemistry/pharmacology, Microbial Sensitivity Tests, Oils, Volatile/chemistry/pharmacology, Plant Oils, *Propolis
	34394399	Endophytic Fungi from Alstonia boonei De Wild and Greenwayodendron suaveolens (Engl. and Diels) Verdc. subsp. Suaveolens Possess Inhibitory Activity against Pneumonia Causing Bacteria.	Demeni PCE, Betote PHD, Kom CW, Tchamgoue EN, Ndedi Moni EDF, Foumane Maniepi JS, Agbor GA, Nyegue MA	Evid Based Complement Alternat Med	10.1155/2021/9966323	2021
	34418450	Green synthesis, characterization and bioactivity of biogenic zinc oxide nanoparticles.	Gur T, Meydan I, Seckin H, Bekmezci M, Sen F	Environ Res	10.1016/j.envres.2021.111897	2021	Anti-Bacterial Agents, Metal Nanoparticles, Microbial Sensitivity Tests, Nanoparticles, Spectroscopy, Fourier Transform Infrared, X-Ray Diffraction, *Zinc Oxide
Pathogenicity	34437917	S-layer protein 2 of vaginal Lactobacillus crispatus 2029 enhances growth, differentiation, VEGF production and barrier functions in intestinal epithelial cell line Caco-2.	Abramov VM, Kosarev IV, Priputnevich TV, Machulin AV, Abashina TN, Chikileva IO, Donetskova AD, Takada K, Melnikov VG, Vasilenko RN, Khlebnikov VS, Samoilenko VA, Nikonov IN, Sukhikh GT, Uversky VN, Karlyshev AV	Int J Biol Macromol	10.1016/j.ijbiomac.2021.08.150	2021	Alkaline Phosphatase/genetics/metabolism, Bacterial Adhesion/drug effects, Caco-2 Cells, Cell Differentiation/drug effects, Cell Membrane Permeability/drug effects, Cell Proliferation/drug effects, Electric Impedance, Enterocytes/drug effects/metabolism, Female, Gene Expression Regulation, Enzymologic/drug effects, Humans, Lactase/genetics/metabolism, Lactobacillus crispatus/chemistry, Membrane Glycoproteins/pharmacology, RNA, Messenger/genetics/metabolism, Sucrase/genetics/metabolism, Vagina/microbiology, Vascular Endothelial Growth Factor A/biosynthesis	Metabolism
	34443553	Antimicrobial Activity of MgB2 Powders Produced via Reactive Liquid Infiltration Method.	Padhi SK, Baglieri N, Bonino V, Agostino A, Operti L, Batalu ND, Chifiriuc MC, Popa M, Burdusel M, Grigoroscuta MA, Aldica GV, Radu D, Badica P, Truccato M	Molecules	10.3390/molecules26164966	2021
	34496958	Alkaloid profiling and antimicrobial activities of Papaver glaucum and P. decaisnei.	Jafaar HJ, Isbilen O, Volkan E, Sariyar G	BMC Res Notes	10.1186/s13104-021-05762-x	2021	Alkaloids/pharmacology, Anti-Infective Agents/pharmacology, Chromatography, Thin Layer, *Papaver, Plant Extracts/pharmacology
	34579365	Antimicrobial Potential and Phytochemical Profile of Wild and Cultivated Populations of Thyme (Thymus sp.) Growing in Western Romania.	Beicu R, Alexa E, Obistioiu D, Cocan I, Imbrea F, Pop G, Circioban D, Moisa C, Lupitu A, Copolovici L, Copolovici DM, Imbrea IM	Plants (Basel)	10.3390/plants10091833	2021
	34595891	The Remarkable Antibiofilm Activity of the Sweet Tooth Mushroom, Hydnum repandum (Agaricomycetes), Displaying Synergetic Interactions with Antibiotics.	Dizeci N, Karaca B, Onar O, Cihan AC, Akata I, Yildirim O	Int J Med Mushrooms	10.1615/IntJMedMushrooms.2021040148	2021	Agaricales, Anti-Bacterial Agents/pharmacology, Basidiomycota, Biofilms, Methicillin-Resistant Staphylococcus aureus, Microbial Sensitivity Tests
Pathogenicity	34641314	Bruguiera gymnorhiza (L.) Lam. at the Forefront of Pharma to Confront Zika Virus and Microbial Infections-An In Vitro and In Silico Perspective.	Bibi Sadeer N, Haddad JG, Oday Ezzat M, Despres P, Abdallah HH, Zengin G, Uysal A, El Kalamouni C, Gallo M, Montesano D, Mahomoodally MF	Molecules	10.3390/molecules26195768	2021	Anti-Bacterial Agents/chemistry/pharmacology, Antifungal Agents/chemistry/pharmacology, Antiviral Agents/chemistry/pharmacology, Brazil, Candida albicans/drug effects/growth & development, Computer Simulation, Drug Synergism, Escherichia coli/drug effects/growth & development, Klebsiella pneumoniae/drug effects/growth & development, Mauritius, Microbial Sensitivity Tests, Microbial Viability/drug effects, Plant Extracts/chemistry/pharmacology, Proteus mirabilis/drug effects/growth & development, Pseudomonas aeruginosa/drug effects/growth & development, Rhizophoraceae/chemistry, Staphylococcus aureus/drug effects/growth & development, Zika Virus/drug effects/growth & development
Pathogenicity	34641589	Sintered and 3D-Printed Bulks of MgB2-Based Materials with Antimicrobial Properties.	Badica P, Batalu ND, Chifiriuc MC, Burdusel M, Grigoroscuta MA, Aldica GV, Pasuk I, Kuncser A, Popa M, Agostino A, Operti L, Padhi SK, Bonino V, Truccato M	Molecules	10.3390/molecules26196045	2021	Anti-Infective Agents/pharmacology, Bacteria/drug effects, Boron Compounds/pharmacology, Candida parapsilosis/drug effects, Enterococcus faecalis/drug effects, Enterococcus faecium/drug effects, Escherichia coli/drug effects, Fungi/drug effects, Magnesium Compounds/*pharmacology, Microbial Sensitivity Tests, Polyesters/pharmacology, Printing, Three-Dimensional, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	34645923	Novel magnetic organic-inorganic hybrids based on aromatic polyamides and ZnFe2O4 nanoparticles with biological activity.	Eivazzadeh-Keihan R, Ghafori Gorab M, Aghamirza Moghim Aliabadi H, Mahdavi M, Akbarzadeh AR, Maleki A, Ghafuri H	Sci Rep	10.1038/s41598-021-99842-4	2021	Anti-Bacterial Agents, Anti-Infective Agents/chemistry, Biotechnology, Diamines/chemistry, Escherichia coli/drug effects, Escherichia coli Infections, Ferric Compounds/chemistry, Magnetic Phenomena, Magnetics, Magnetite Nanoparticles/chemistry, Metal Nanoparticles, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Nanoparticles, Nanotechnology, Nylons/chemistry, Phthalic Acids/chemistry, Pseudomonas aeruginosa/drug effects, Spectroscopy, Fourier Transform Infrared, Staphylococcal Infections, Staphylococcus aureus/drug effects, Tetrazolium Salts/chemistry, Thiazoles/chemistry, X-Ray Diffraction, Zinc Oxide/*chemistry/pharmacology	Biotechnology
	34653022	Medical Evaluation of the Antimicrobial Activity of Rose Oil on Some Standard Bacteria Strains and Clinical Isolates.	Demirel S	Altern Ther Health Med	AT6887	2021
	34771983	Mesoporous Silica and Titania-Based Materials for Stability Enhancement of Polyphenols.	Prundeanu M, Brezoiu AM, Deaconu M, Gradisteanu Pircalabioru G, Lincu D, Matei C, Berger D	Materials (Basel)	10.3390/ma14216457	2021
Biotechnology	34825011	Growth Optimization of Lactobacillus acidophilus for Production of Antimicrobial Peptide Acidocin 4356: Scale up from Flask to Lab-Scale Fermenter.	Modiri S, Kasra Kermanshahi R, Reza Soudi M, Dad N, Ebadi M, Shahbani Zahiri H, Akbari Noghabi K	Iran J Biotechnol	10.30498/ijb.2021.218725.2686	2021
	34825647	Eco-friendly intracellular biosynthesis of CdS quantum dots using Pseudomonas aeruginosa: Evaluation of antimicrobial effects and DNA cleavage activities.	Ocal N, Ceylan A, Duman F	Recent Pat Nanotechnol	10.2174/1872210515666210719122353	2021
	34826535	Silver nanoparticles from residual biomass: Biosynthesis, characterization and antimicrobial activity.	Muraro PCL, Pinheiro LDSM, Chuy G, Vizzotto BS, Pavoski G, Espinosa DCR, Rech VC, da Silva WL	J Biotechnol	10.1016/j.jbiotec.2021.11.003	2021	Aloe/chemistry, Anti-Infective Agents/pharmacology, Biomass, Ecosystem, Green Chemistry Technology, Metal Nanoparticles, Plant Extracts, Silver/pharmacology, Staphylococcus aureus
	34827362	A Systematic Study of the Antibacterial Activity of Basidiomycota Crude Extracts.	Clericuzio M, Bivona M, Gamalero E, Bona E, Novello G, Massa N, Dovana F, Marengo E, Robotti E	Antibiotics (Basel)	10.3390/antibiotics10111424	2021
Pathogenicity	34836646	Ortho-hydroxy bioactive schiff base compounds: Design, comprehensive characterization, photophysical properties and elucidation of antimicrobial and mutagenic potentials.	Nibras Qader Qader I, Obali I, Ismet Ucan H, Uysal A, Yilmaz Obali A, Kul M	Bioorg Chem	10.1016/j.bioorg.2021.105507	2021	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Candida albicans/drug effects, Coordination Complexes/chemical synthesis/chemistry/pharmacology, Dose-Response Relationship, Drug, Drug Design, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Molecular Structure, Photochemical Processes, Schiff Bases/chemical synthesis/chemistry/pharmacology, Structure-Activity Relationship
Pathogenicity	34849334	Mucoadhesive silver nanoparticle-based local drug delivery system for peri-implantitis management in COVID-19 era. Part 1: antimicrobial and safety in-vitro analysis.	Dhingra K, Dinda AK, Kottarath SK, Chaudhari PK, Verma F	J Oral Biol Craniofac Res	10.1016/j.jobcr.2021.11.007	2021
Phylogeny	34854720	Isolation, Whole-Genome Sequencing, and Annotation of Three Unclassified Antibiotic-Producing Bacteria, Enterobacter sp. Strain RIT 637, Pseudomonas sp. Strain RIT 778, and Deinococcus sp. Strain RIT 780.	Schroeter MN, Gazali SJ, Parthasarathy A, Wadsworth CB, Miranda RR, Thomas BN, Hudson AO	Microbiol Resour Announc	10.1128/MRA.00863-21	2021
Enzymology	34897528	Combined Application of MMT K10 Supported Copper Oxide Nanoparticles for Complete Removal of Cr(VI) from Aqueous Solution and Their Antibacterial Potential.	Gupta MK, Tandon PK, Afroz M, Agrahari S	Acta Chim Slov	Gupta-2021-3	2021	Adsorption, Anti-Bacterial Agents/chemistry/pharmacology, Bentonite/chemistry, Chromium/chemistry/isolation & purification, Copper/chemistry/pharmacology, Metal Nanoparticles/chemistry, Microbial Sensitivity Tests, Nanocomposites/chemistry, Particle Size, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Water Pollutants, Chemical/chemistry/isolation & purification, Water Purification/methods	Phylogeny
	34917051	Development of an In-House Rapid Antimicrobial Susceptibility Testing Protocol for Positive Blood Culture and Its Implementation in Routine Microbiology Laboratories.	Cao M, Huang L, Hu Y, Fang Y, Zhang R, Chen G	Front Microbiol	10.3389/fmicb.2021.765757	2021
Pathogenicity	34956387	Comparative Study of Antimicrobial, Anti-Inflammatory, and Antioxidant Activities of Different Parts from Pterocarpus Santalinoides l'Her. Ex. DC (Fabaceae).	Ayena AC, Anani K, Dosseh K, Agbonon A, Gbeassor M	Evid Based Complement Alternat Med	10.1155/2021/8938534	2021
Enzymology	35005941	Preventing Pseudomonas aeruginosa Biofilms on Indwelling Catheters by Surface-Bound Enzymes.	Asker D, Awad TS, Raju D, Sanchez H, Lacdao I, Gilbert S, Sivarajah P, Andes DR, Sheppard DC, Howell PL, Hatton BD	ACS Appl Bio Mater	10.1021/acsabm.1c00794	2021	Animals, Biofilms, Catheters, Indwelling/microbiology, Central Venous Catheters, Glycoside Hydrolases/pharmacology, Pseudomonas aeruginosa, Rats
Pathogenicity	35011355	Phytochemical Profile, Antimicrobial, Cytotoxic, and Antioxidant Activities of Fresh and Air-Dried Satureja nabateorum Essential Oils.	Al-Maharik N, Jaradat N	Molecules	10.3390/molecules27010125	2021	Anti-Infective Agents/chemistry/pharmacology, Antioxidants/chemistry/pharmacology, Candida albicans/drug effects, Cyclohexane Monoterpenes/chemistry, Cymenes/chemistry, Enterococcus faecium/drug effects, Escherichia coli/drug effects, Free Radical Scavengers/metabolism, Gas Chromatography-Mass Spectrometry, Humans, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Oils, Volatile/chemistry/pharmacology, Phytochemicals/chemistry/pharmacology, Plant Extracts/chemistry/pharmacology, Proteus vulgaris/drug effects, Satureja/chemistry, Staphylococcal Infections/*drug therapy, Thymol/chemistry	Metabolism
	35030691	Lipase-Responsive Electrospun Theranostic Wound Dressing for Simultaneous Recognition and Treatment of Wound Infection.	Singh H, Li W, Kazemian MR, Yang R, Yang C, Logsetty S, Liu S	ACS Appl Bio Mater	10.1021/acsabm.9b00076	2019
	35052908	Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in Pseudomonas aeruginosa.	Yuan Y, Rosado-Lugo JD, Zhang Y, Datta P, Sun Y, Cao Y, Banerjee A, Parhi AK	Antibiotics (Basel)	10.3390/antibiotics11010030	2021
Pathogenicity	35054915	eDNA Inactivation and Biofilm Inhibition by the PolymericBiocide Polyhexamethylene Guanidine Hydrochloride (PHMG-Cl).	Moshynets OV, Baranovskyi TP, Iungin OS, Kysil NP, Metelytsia LO, Pokholenko I, Potochilova VV, Potters G, Rudnieva KL, Rymar SY, Semenyuta IV, Spiers AJ, Tarasyuk OP, Rogalsky SP	Int J Mol Sci	10.3390/ijms23020731	2022	Anti-Infective Agents/chemical synthesis/chemistry/pharmacology, Biofilms/drug effects, DNA, Bacterial/chemistry/drug effects, Disinfectants/chemistry/pharmacology, Guanidines/chemical synthesis/chemistry/*pharmacology, Nucleic Acid Conformation/drug effects, Pseudomonas aeruginosa/drug effects/genetics, Staphylococcus aureus/drug effects/genetics, Structure-Activity Relationship
	35097270	Ciprofloxacin-Tethered 1,2,3-Triazole Conjugates: New Quinolone Family Compounds to Upgrade Our Antiquated Approach against Bacterial Infections.	Agarwal A, Singh P, Maurya A, Patel UK, Singh A, Nath G	ACS Omega	10.1021/acsomega.1c05303	2022
Pathogenicity	35112784	Structural, biocompatibility, and antibacterial properties of Ge-DLC nanocomposite for biomedical applications.	Arslan ME, Kurt MS, Aslan N, Kadi A, Oner S, Cobanoglu S, Yazici A	J Biomed Mater Res B Appl Biomater	10.1002/jbm.b.35027	2022	Anti-Bacterial Agents/pharmacology, Carbon/chemistry, Coated Materials, Biocompatible/chemistry, Germanium, Humans, Nanocomposites, Pseudomonas aeruginosa, Staphylococcus aureus, Surface Properties
	35142937	Antimicrobial activities of fungus comb extracts isolated from Indomalayan termite (Macrotermes gilvus Hagen) mound.	Witasari LD, Wahyu KW, Anugrahani BJ, Kurniawan DC, Haryanto A, Nandika D, Karlinasari L, Arinana A, Batubara I, Santoso D, Rachmayanti Y, Firmansyah D, Sudiana IK, Hertanto DM	AMB Express	10.1186/s13568-022-01359-0	2022
Enzymology	35162856	Capillary Zone Electrophoresis in Tandem with Flow Cytometry in Viability Study of Various ATCC Bacterial Strains under Antibiotic Treatment.	Kupczyk W, Maslak E, Railean-Plugaru V, Pomastowski P, Jackowski M, Buszewski B	Int J Environ Res Public Health	10.3390/ijerph19031833	2022	Anti-Bacterial Agents/pharmacology, Bacteria, Electrophoresis, Capillary, Flow Cytometry, Microbial Sensitivity Tests
	35215329	Design, Characterization, and Antimicrobial Evaluation of Copper Nanoparticles Utilizing Tamarixinin a Ellagitannin from Galls of Tamarix aphylla.	Orabi MAA, Salem-Bekhit MM, Taha EI, Abdel-Sattar ES, Alqahtani OS, Al-Joufi FA, Abdel-Wahab BA, Alshabi AM, Alyami HS, Ahmad J, Hatano T	Pharmaceuticals (Basel)	10.3390/ph15020216	2022
	35252674	Gallium-Curcumin Nanoparticle Conjugates as an Antibacterial Agent against Pseudomonas aeruginosa: Synthesis and Characterization.	Ramesh G, Kaviyil JE, Paul W, Sasi R, Joseph R	ACS Omega	10.1021/acsomega.1c06398	2022
	35256712	Antimicrobial activity of supramolecular salts of gallium(III) and proflavine and the intriguing case of a trioxalate complex.	Guerrini M, d'Agostino S, Grepioni F, Braga D, Lekhan A, Turner RJ	Sci Rep	10.1038/s41598-022-07813-0	2022	Anti-Bacterial Agents/pharmacology, Escherichia coli, *Gallium/pharmacology, Microbial Sensitivity Tests, Oxalates/pharmacology, Proflavine/pharmacology, Pseudomonas aeruginosa, Salts/pharmacology
Pathogenicity	35265355	Computer Program for Detection and Analyzing the Porin-Mediated Antibiotic Resistance of Bacteria.	Savinova TA, Samchenko AA, Bocharova YA, Mayansky NA, Chebotar IV	Sovrem Tekhnologii Med	10.17691/stm2021.13.6.02	2021	Drug Resistance, Bacterial, Microbial Sensitivity Tests, Porins/genetics, Pseudomonas aeruginosa/*drug effects/genetics, Software
	35267830	Sustainable Antibacterial and Antiviral High-Performance Copper-Coated Filter Produced via Ion Beam Treatment.	Jung S, Yang JY, Jang D, Kim T, Baek KH, Yoon H, Park JY, Kim SK, Hong J, Ryoo S, Jang HW, Lee S	Polymers (Basel)	10.3390/polym14051007	2022
	35268830	Anthraquinones from the Aerial Parts of Rubia cordifolia with Their NO Inhibitory and Antibacterial Activities.	Luo H, Qin W, Zhang H, Ren FC, Fang WT, Kong QH, Yang L, Zhang JM, Fang CW, Hu JM, Liu SJ	Molecules	10.3390/molecules27051730	2022	*Rubia
Pathogenicity	35269342	Loaded n-Hydroxyapatite/SSG 3D Scaffolds as a Drug Delivery System of Nigella sativa Fractions for the Management of Local Antibacterial Infections.	Dalli M, El Guerraf A, Azizi SE, Benataya K, Azghar A, Mi-Kyung J, Maleb A, Bonglee K, Gseyra N	Nanomaterials (Basel)	10.3390/nano12050856	2022
	35289853	Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing.	Matuschek E, Longshaw C, Takemura M, Yamano Y, Kahlmeter G	J Antimicrob Chemother	10.1093/jac/dkac080	2022	Anti-Bacterial Agents/pharmacology, Cephalosporins/pharmacology, Escherichia coli, Gram-Negative Bacteria, Iron, Microbial Sensitivity Tests, Pseudomonas aeruginosa, Reproducibility of Results
Pathogenicity	35300362	Investigating antimicrobial features and drug interactions of sedoanalgesics in intensive care unit: an experimental study.	Unlu O, Bingul ES, Kesici S, Demirci M	ADMET DMPK	10.5599/admet.1042	2021
	35389643	Unique Carbazole-Oxadiazole Derivatives as New Potential Antibiotics for Combating Gram-Positive and -Negative Bacteria.	Xie YP, Sangaraiah N, Meng JP, Zhou CH	J Med Chem	10.1021/acs.jmedchem.2c00001	2022	Anti-Bacterial Agents/pharmacology/therapeutic use, Bacteria, Carbazoles/pharmacology, Gram-Negative Bacteria, Gram-Positive Bacteria, Microbial Sensitivity Tests, Oxadiazoles/pharmacology
	35425576	Coordination complexes constructed from pyrazole-acetamide and pyrazole-quinoxaline: effect of hydrogen bonding on the self-assembly process and antibacterial activity.	Chkirate K, Karrouchi K, Chakchak H, Mague JT, Radi S, Adarsh NN, Li W, Talbaoui A, Essassi EM, Garcia Y	RSC Adv	10.1039/d1ra09027e	2022
	35428425	Conglomeratin: a new antibacterial flavonol derivative from Macaranga conglomerata Brenan (Euphorbiaceae).	Hashim I, Onyari JM, Omosa LK, Maru SM, Nchiozem-Ngnitedem VA, Karpoormath R	Nat Prod Res	10.1080/14786419.2022.2061481	2022
	35456808	Biofilm Growth on Simulated Fracture Fixation Plates Using a Customized CDC Biofilm Reactor for a Sheep Model of Biofilm-Related Infection.	Kay W, Hunt C, Nehring L, Barnum B, Ashton N, Williams D	Microorganisms	10.3390/microorganisms10040759	2022
Pathogenicity	35506506	Novel axially symmetric and unsymmetric silicon(IV) phthalocyanines having anti-inflammatory groups: synthesis, characterization and their biological properties.	Gumusgoz Celik G, Gonca S, Sahin B, Ozdemir S, Atilla D, Gurek AG	Dalton Trans	10.1039/d2dt00652a	2022	Anti-Bacterial Agents/chemistry, Anti-Infective Agents/chemistry, Anti-Inflammatory Agents/pharmacology, Anti-Inflammatory Agents, Non-Steroidal/pharmacology, Antioxidants/chemistry, Chelating Agents/pharmacology, Diclofenac, Escherichia coli, Indoles/chemistry/pharmacology, Isoindoles, Microbial Sensitivity Tests, Silicones/pharmacology
	35515379	'Hairy' root extracts as source for 'green' synthesis of silver nanoparticles and medical applications.	Kobylinska N, Shakhovsky A, Khainakova O, Klymchuk D, Avdeeva L, Ratushnyak Y, Duplij V, Matvieieva N	RSC Adv	10.1039/d0ra07784d	2020
	35519960	Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains.	Vargas-Casanova Y, Rodriguez-Mayor AV, Cardenas KJ, Leal-Castro AL, Munoz-Molina LC, Fierro-Medina R, Rivera-Monroy ZJ, Garcia-Castaneda JE	RSC Adv	10.1039/c9ra00708c	2019
	35530396	Template synthesis, DNA binding, antimicrobial activity, Hirshfeld surface analysis, and 1D helical supramolecular structure of a novel binuclear copper(ii) Schiff base complex.	Goudarziafshar H, Yousefi S, Abbasi Tyula Y, Dusek M, Eigner V	RSC Adv	10.1039/d2ra00719c	2022
	35547113	Enhanced Biosynthesis of Fatty Acids Contributes to Ciprofloxacin Resistance in Pseudomonas aeruginosa.	Su YB, Tang XK, Zhu LP, Yang KX, Pan L, Li H, Chen ZG	Front Microbiol	10.3389/fmicb.2022.845173	2022
	35547306	Identification of 4-isopropyl-thiotropolone as a novel anti-microbial: regioselective synthesis, NMR characterization, and biological evaluation.	Elagawany M, Hegazy L, Cao F, Donlin MJ, Rath N, Tavis J, Elgendy B	RSC Adv	10.1039/c8ra06297h	2018
	35561980	Assessment of bacteriophage-encoded endolysin as a potent antimicrobial agent against antibiotic-resistant Salmonella Typhimurium.	Kim J, Kim JC, Ahn J	Microb Pathog	10.1016/j.micpath.2022.105576	2022
Pathogenicity	35566083	In Silico and Experimental Investigation of the Biological Potential of Some Recently Developed Carprofen Derivatives.	Dumitrascu F, Udrea AM, Caira MR, Nuta DC, Limban C, Chifiriuc MC, Popa M, Bleotu C, Hanganu A, Dumitrescu D, Avram S	Molecules	10.3390/molecules27092722	2022	Anti-Bacterial Agents/chemistry/pharmacology, Carbazoles, Escherichia coli, Gram-Negative Bacteria, Gram-Positive Bacteria, HeLa Cells, Humans, Microbial Sensitivity Tests
	35579741	Promising Endophytic Alternaria alternata from Leaves of Ziziphus spina-christi: Phytochemical Analyses, Antimicrobial and Antioxidant Activities.	Elghaffar RYA, Amin BH, Hashem AH, Sehim AE	Appl Biochem Biotechnol	10.1007/s12010-022-03959-9	2022
	35583079	The antimicrobial effect of calcium-doped titanium is activated by fibrinogen adsorption.	Cao H, Dauben TJ, Helbing C, Jia Z, Zhang Y, Huang M, Muller L, Gu S, Zhang X, Qin H, Martin K, Bossert J, Jandt KD	Mater Horiz	10.1039/d1mh02009a	2022
	35594246	Antibiofilm and cytotoxic potential of extracellular biosynthesized gold nanoparticles using actinobacteria Amycolatopsis sp. KMN.	Kabiri F, Aghaei SS, Pourbabaee AA, Soleimani M, Komeili Movahhed T	Prep Biochem Biotechnol	10.1080/10826068.2022.2076244	2022
	35625293	Antimicrobial Potential of Conjugated Lignin/Morin/Chitosan Combinations as a Function of System Complexity.	Yaneva Z, Beev G, Rusenova N, Ivanova D, Tzanova M, Stoeva D, Toneva M	Antibiotics (Basel)	10.3390/antibiotics11050650	2022
Metabolism	35742941	Mutations of gammaCOP Gene Disturb Drosophila melanogaster Innate Immune Response to Pseudomonas aeruginosa.	Chifiriuc MC, Bologa AM, Ratiu AC, Ionascu A, Ecovoiu AA	Int J Mol Sci	10.3390/ijms23126499	2022	Animals, Drosophila Proteins/physiology, Drosophila melanogaster/metabolism, Immunity, Innate/genetics, Male, Mutation, Pseudomonas aeruginosa/physiology
	35745014	The Ability of Nuclease-Resistant RNA Aptamer against Streptococcus suis Serotype 2, Strain P1/7 to Reduce Biofilm Formation In Vitro.	Matchawong A, Srisawat C, Sangboonruang S, Tharinjaroen CS	Molecules	10.3390/molecules27123894	2022	Animals, Aptamers, Nucleotide/pharmacology, Biofilms, Serogroup, Streptococcal Infections/microbiology, Streptococcus suis, Swine, Swine Diseases/microbiology
Pathogenicity	35803975	Biofabrication of ZnO/Malachite nanocomposite and its coating with chitosan to heal infectious wounds.	Rajabloo Z, Farahpour MR, Saffarian P, Jafarirad S	Sci Rep	10.1038/s41598-022-15768-5	2022	Anti-Bacterial Agents/chemistry/pharmacology, Chitosan/chemistry/pharmacology, Humans, Interleukin-10/pharmacology, Interleukin-6/pharmacology, Nanocomposites/chemistry, Organometallic Compounds, Transforming Growth Factor beta/pharmacology, Tumor Necrosis Factor-alpha/pharmacology, Wound Healing, Wound Infection/drug therapy, Zinc Oxide/chemistry/pharmacology
	35890128	Phenolic Secondary Metabolites and Antiradical and Antibacterial Activities of Different Extracts of Usnea barbata (L.) Weber ex F.H.Wigg from Calimani Mountains, Romania.	Popovici V, Bucur L, Gird CE, Popescu A, Matei E, Cozaru GC, Schroder V, Ozon EA, Fita AC, Lupuliasa D, Aschie M, Caraiane A, Botnarciuc M, Badea V	Pharmaceuticals (Basel)	10.3390/ph15070829	2022
Pathogenicity	35927722	Generation of a recombinant antibody for sensitive detection of Pseudomonas aeruginosa.	Lim GM, Kim JK, Kim EJ, Lee CS, Kim W, Kim BG, Jeong HJ	BMC Biotechnol	10.1186/s12896-022-00751-9	2022	Animals, Antibodies, Bacterial/metabolism, Antigens, Bacterial, Enzyme-Linked Immunosorbent Assay, Humans, Mammals, Pseudomonas Infections/diagnosis, Pseudomonas aeruginosa	Metabolism
Proteome	35973647	Biofilm matrix proteome of clinical strain of P. aeruginosa isolated from bronchoalveolar lavage of patient in intensive care unit.	Egorova DA, Solovyev AI, Polyakov NB, Danilova KV, Scherbakova AA, Kravtsov IN, Dmitrieva MA, Rykova VS, Tutykhina IL, Romanova YM, Gintsburg AL	Microb Pathog	10.1016/j.micpath.2022.105714	2022	Bacterial Proteins/metabolism, Biofilms, Bronchoalveolar Lavage, Extracellular Polymeric Substance Matrix, Humans, Intensive Care Units, Proteome/metabolism, Pseudomonas aeruginosa	Metabolism
	36009963	New Pyrazolo-Benzimidazole Mannich Bases with Antimicrobial and Antibiofilm Activities.	Zalaru C, Dumitrascu F, Draghici C, Tarcomnicu I, Marinescu M, Nitulescu GM, Tatia R, Moldovan L, Popa M, Chifiriuc MC	Antibiotics (Basel)	10.3390/antibiotics11081094	2022
Biotechnology	36134984	Green Production and Interaction of Carboxylated CNTs/Biogenic ZnO Composite for Antibacterial Activity.	Hussain S, Khakwani N, Faiz Y, Zulfiqar S, Shafiq Z, Faiz F, Elhakem A, Sami R, Aljuraide NI, Farid T, Aljabri MD, Rahman MM	Bioengineering (Basel)	10.3390/bioengineering9090437	2022
	36143368	Photocatalytic and Antimicrobial Activities of Biosynthesized Silver Nanoparticles Using Cytobacillus firmus.	Saied E, Hashem AH, Ali OM, Selim S, Almuhayawi MS, Elbahnasawy MA	Life (Basel)	10.3390/life12091331	2022
Enzymology	36144000	3D Printed Microfluidic Bioreactors Used for the Preferential Growth of Bacterial Biofilms through Dielectrophoresis.	Csapai A, Toc DA, Popa F, Tosa N, Pascalau V, Costache C, Botan A, Popa CO	Micromachines (Basel)	10.3390/mi13091377	2022
	36234263	Essential Oils as Antimicrobial Active Substances in Wound Dressings.	Gheorghita D, Grosu E, Robu A, Ditu LM, Deleanu IM, Gradisteanu Pircalabioru G, Raiciu AD, Bita AI, Antoniac A, Antoniac VI	Materials (Basel)	10.3390/ma15196923	2022
	36268299	Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis.	Sihotang TSU, Widodo ADW, Endraswari PD	Ann Med Surg (Lond)	10.1016/j.amsu.2022.104674	2022
Phylogeny	36289975	In Silico Study for Algerian Essential Oils as Antimicrobial Agents against Multidrug-Resistant Bacteria Isolated from Pus Samples.	Aouf A, Bouaouina S, Abdelgawad MA, Abourehab MAS, Farouk A	Antibiotics (Basel)	10.3390/antibiotics11101317	2022		Pathogenicity
	36296456	Antimicrobial Activity of Silver and Gold Nanoparticles Prepared by Photoreduction Process with Leaves and Fruit Extracts of Plinia cauliflora and Punica granatum.	Franzolin MR, Courrol DDS, Silva FRO, Courrol LC	Molecules	10.3390/molecules27206860	2022	Silver/pharmacology/chemistry, Gold/pharmacology, Metal Nanoparticles/chemistry, Pomegranate, Fruit, Methicillin-Resistant Staphylococcus aureus, Excipients, Microbial Sensitivity Tests, Anti-Infective Agents/pharmacology/chemistry, Lythraceae, Anti-Bacterial Agents/pharmacology, Escherichia coli, Gram-Positive Bacteria, Myrtaceae, Plant Extracts/pharmacology/chemistry, Plant Leaves
	36296523	Effect of Culture Conditions on Fatty Acid Profiles of Bacteria and Lipopolysaccharides of the Genus Pseudomonas-GC-MS Analysis on Ionic Liquid-Based Column.	Mezo E, Hartmann-Balogh F, Madaraszne Horvath I, Bufa A, Marosvolgyi T, Kocsis B, Makszin L	Molecules	10.3390/molecules27206930	2022	Gas Chromatography-Mass Spectrometry/methods, Fatty Acids/analysis, Ionic Liquids, Lipopolysaccharides, Agar, Pseudomonas aeruginosa, Pseudomonas putida
	36329943	Characteristics of Ag-incorporated bioactive glasses prepared by a modified sol-gel method with a shortened synthesis time and without the use of catalysts.	Hoa BT, Phuc LH, Hien NQ, Vinh LK, Tien NA, Hiep DT, Vi VT, Ly DN, Long NV, Hieu TT, Linh LV, Minh NT, Xuan Vuong B	RSC Adv	10.1039/d2ra05671b	2022
	36354995	New Alkylpyridinium Anthraquinone, Isocoumarin, C-Glucosyl Resorcinol Derivative and Prenylated Pyranoxanthones from the Culture of a Marine Sponge-Associated Fungus, Aspergillus stellatus KUFA 2017.	Machado FP, Rodrigues IC, Gales L, Pereira JA, Costa PM, Dethoup T, Mistry S, Silva AMS, Vasconcelos V, Kijjoa A	Mar Drugs	10.3390/md20110672	2022	Animals, Isocoumarins/pharmacology/chemistry, Porifera/chemistry, Fungi/chemistry, Anthraquinones/pharmacology/chemistry, Anti-Bacterial Agents/chemistry, Resorcinols, Microbial Sensitivity Tests
	36420624	Synthesis of new benzimidazole derivatives containing 1,3,4-thiadiazole: their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies.	Acar Cevik U, Isik A, Evren AE, Kapusiz O, Gul UD, Ozkay Y, Kaplancikli ZA	SAR QSAR Environ Res	10.1080/1062936X.2022.2149620	2022	Microbial Sensitivity Tests, Molecular Docking Simulation, Molecular Dynamics Simulation, Escherichia coli, Quantitative Structure-Activity Relationship, Anti-Infective Agents/pharmacology, Anti-Bacterial Agents, Thiadiazoles/pharmacology, Benzimidazoles/pharmacology, Candida albicans
	36432956	Catalytic Reduction of Dyes and Antibacterial Activity of AgNPs@Zn@Alginate Composite Aerogel Beads.	Benali F, Boukoussa B, Benkhedouda NE, Cheddad A, Issam I, Iqbal J, Hachemaoui M, Abboud M, Mokhtar A	Polymers (Basel)	10.3390/polym14224829	2022

Reference

@id	authors	catalogue	doi/url	title	journal	pubmed
565	Curators of the DSMZ	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 1117)	https://www.dsmz.de/collection/catalogue/details/culture/DSM-1117
20215	Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.		10.1099/ijsem.0.004332	List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218	Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.		10.1016/j.syapm.2013.11.002	StrainInfo introduces electronic passports for microorganisms.	Syst Appl Microbiol. 37: 42-50 2014	24321274
41849	Curators of the CIP		https://brclims.pasteur.fr/brcWeb/souche/detail/1/10888
46633	Curators of the CCUG	Culture Collection University of Gothenburg (CCUG) (CCUG 17619)	https://www.ccug.se/strain?id=17619
66792	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann		https://diaspora-project.de/progress.html#genomes	Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770	Curators of the JCM		https://jcm.brc.riken.jp/en/
67772	Curators of the UCCCB		https://ucccb.uc.pt/
68369				Automatically annotated from API 20NE
68382				Automatically annotated from API zym
69479	João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.		https://microbeatlas.org/	MicrobeAtlas 1.0 beta
69480	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann		https://diaspora-project.de/progress.html#genomes	Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
69481	Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch		10.21203/rs.3.rs-2527258/v1	Predictions based on the model GenomeNet Sporulation v. 1
81968	Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.		10.60712/SI-ID92376.1	StrainInfo: A central database for resolving microbial strain identifiers
116094	Curators of the CIP	Collection of Institut Pasteur (CIP 76.110)	https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2076.110

General

NCBI tax id

strain history

Name and taxonomic classification

LPSN

synonyms

Morphology

cell morphology

colony morphology

pigmentation

Culture and growth conditions

culture medium

culture temp

Physiology and metabolism

oxygen tolerance

antibiogram

spore formation

halophily

observation

metabolite utilization

metabolite production

metabolite tests

enzymes

fatty acid profile

fatty acids

API zym

API 20NE

API biotype100

Isolation, sampling and environmental information

isolation

isolation source categories

taxonmaps

Safety information

risk assessment

Sequence information

16S sequences

Genome sequences

GC content

Genome-based predictions

predictions

External links

straininfo link

literature

Reference